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ABSTRACT 
Axonal regeneration following nerve injury requires the complex orchestration of various 
molecular events. Neurite outgrowth can be initiated by a variety of cues from the extracellular 
environment, including neurotrophins (e.g. nerve growth factor; NGF) and the extracellular 
matrix (ECM). Biological responses to neurotrophins are mediated by two distinct receptors: 
Trks, which initiate distinct signalling for the promotion of growth and survival, and p75NTR. 
Signalling pathways initiated by p75NTR exhibit considerable complexity and can e licit a variety 
of paradoxical physiological responses depending upon cellular context. Biological responses to 
ECM components, including laminin (LN), are mediated by a group of receptors known as 
integrins, which facilitate signal transmission to regulate cellular behaviour. Signalling pathways 
initiated by NGF and LN, have been previously reported to synergize resulting in optimized 
axonal regeneration of sensory neurons. The present series of studies sought to explore the 
molecular mechanisms underlying the enhanced growth initiated by stimulation with 
neurotrophins and LN, with a particular focus on the roles of the NGF receptors; specifically, 
TrkA phosphorylation-induced signalling cascades, and events associated with p75NTR ligand-
dependent and independent signalling. 
My initial studies utilized a series ofPC12 cell derivatives expressing TrkA 
phosphorylation mutants, to investigate the potential role of TrkA in the regulation of p75NTR 
expression. I determined that TrkA played a role in the regulation of constitutive p75NTR 
expression, and further, controlled the upregulation ofp75NTR in response to neurotrophin 
stimulation. In a subsequent study, I demonstrated that this occurred via a Phospholipase C y-
Protein Kinase C Ci-dependent mechanism, and confirmed the existence of this regulatory pathway 
in cerebellar granule neurons (CGN). I further investigated the contribution of the ECM to 
regenerative growth, in both its capacity to signal synergistically with the TrkA receptor for the 
enhancement of early signalling intermediates, and its ability to elicit growth in a neurotrophin-
independent scenario. Strikingly, integrin activation in the absence of neurotrophins was 
responsible for the promotion of neurite outgrowth via a rapid and potent Egr-1-dependent 
increase in the expression of the phosphatase PTEN, which relocalized to the nucleus where it 
dephosphorylated transcription factor Sp I, thereby decreasing its ability to bind to the p75NTR 
promoter, resulting in the subsequent downregulation of p75NTR and depression of Rho activity. 
This novel ECM-induced signalling paradigm was also determined to occur in CGNs, and 
following the development of a unique motility assay, I demonstrated that interference with thi 
cascade impaired motility, suggesting that this signalling cascade may contribute to the 
developmental migration of CGNs. 
p75NTR is a unique and flexible pleiotropic receptor which may promote or inhibit cell 
growth depending upon the presence or absence of neurotrophins. Taken together, the results of 
these studies detail the mechanisms involved in the upregulation ofp75NTR expression in the 
presence of neurotroph ins, but additionally present a novel signalling paradigm initiated by the 
ECM for the downregulation of the p75NTR in the absence of neurotrophin stimulation. 
Interestingly, both cenarios result in the promotion of neurite outgrowth and cellular motility as a 
result ofthe flexible signalling interactions ofp75NTR, particularly those involving Rho, which 
can directly influence cytoskeletal dynamics. 
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Chapter 1: Introduction 
Axonal regeneration following nerve injury requires the complex orchestration of 
a series of molecular events that allow the neuron to survive, re-grow and re-innervate the 
original target for functional recovery. The potential for axonal regeneration vastly 
differs between the peripheral nervous system (PNS) and the central nervous system 
(CNS), and regenerative ability is largely considered to be a consequence of the local 
microenvironment. The process of neurite outgrowth is heavily influenced by both 
growth-promoting and inhibitory factors in the extracellular environment, which bind 
receptors to exert their actions on the newly formed growth cone to promote extension or 
collapse respectively. As such, the vast differences in PNS and CNS microenvironments 
contribute to differential activation of signalling events that regulate regenerative 
outgrowth (reviewed in Busch and Silver, 2007; Huber et al., 2003 ; Lemons and Condie, 
2008; Liu et al., 2006). Elucidating the signalling cascades initiated in the PNS which 
result in successful regenerative growth, both in terms of neurotrophin responsiveness and 
effects of permissive growth environments, is likely to provide insight into ways of 
enhancing CNS repair. The present series of studies sought to explore the molecular 
mechanisms underlying the enhanced neurite outgrowth initiated by stimulation with 
neurotrophins (including nerve growth factor) and extracellular matrix components 
(including laminin) in a sympathetic neuron model in order to optimize regenerative 
growth, and apply the consequent findings to the CNS. 
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1.1 Nervous System Injury 
The nervous system is a complex biological arrangement of interconnected neural 
networks which translate molecular cues from receptor ligations into electrical impulses 
to transmit signals reciprocally between the periphery and the brain for the regulation of 
complex human behaviours. While stability of this network is necessary to maintain 
higher order CNS function, this fixed wiring limits the ability of the adult mammalian 
CNS to recover from injury (Liu et al., 2006). The disruption of normal architecture by 
even small local injuries can result in devastating consequences and irreparable disability. 
Individual neurons, which comprise the basic signalling unit of the nervous 
system, have a relatively simple morphology. Although a multitude of classifications 
exist, all neurons share several common features ofbasic architecture including a 
relatively small cell body and a single polarized axon that can extend considerable 
distances from the cell body and is responsible for the conduction of impulses. It is this 
unique geometry that renders neurons susceptible to axon damage (axotomy). 
Nerve injury is heterogeneous in terms of both cause and outcome. Axotomy can 
be the result of physical injury (contusion, compression, penetration or transection), 
autoimmune disease, neurodegenerative disease, infection or diabetes, and it can result in 
a spectrum of pain, numbness, weakness or paralysis and/or a range of cognitive deficits 
with consequences dependent upon the severity, extent and location of the injury 
(reviewed in Okano et al. , 2007; Thuret et al. , 2006). 
Acute CNS injury (eg. spinal cord injury) is essentially irreversible as functional 
recovery is severely limited, leaving the affected individual with diminished quality of 
life and immense costs associated with a lifetime of care (reviewed in Thuret et al. , 2006). 
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The permanency of the damage is attributable to the restriction of axonal regeneration or 
plasticity imposed in part by the local CNS microenvironment. This is in contrast to the 
peripheral nervous system (PNS), where axonal regeneration following nerve injury 
occurs quite readily, yielding some functional recovery even in the adult, though it is 
often incomplete and rarely perfect (reviewed in He and Koprivica, 2004; Liu et al., 2006; 
Walmsley and Mir, 2007). Successful repair of the nervous system requires injured axons 
to survive, re-grow and reconnect with their original targets to mediate the recovery of 
function (reviewed in Bandtlow, 2003; Raivich and Mak:wana, 2007), all of which can 
occur to varying extents depending on the location and subset of neurons. Great strides 
have been made in our understanding of the barriers preventing CNS regeneration and a 
better, more complete understanding of components involved in promoting the successful 
PNS regenerative response may provide cues for strategies to initiate a regenerative 
response in the CNS. 
1.1.1 Neuronal Response to Axotomy 
Axonal injury initiates a series of molecular events, cellular responses and 
ultrastructural changes, some of which are clearly involved in the mounting of a 
regenerative response in the PNS. Injury-induced stress signals arise from the loss of 
both neuronal activity (Al-Majed et al., 2000; Brushart et al., 2005) and trophic support 
from the innervation target (Raivich et al., 1991 ; Shadiack et al., 2001), and can be 
induced by the rapid influx of a variety of extracellular ions, including Ca++ and Na+, 
through the transiently open membrane before it reseals (Berdan et al. , 1993; Y oo et al., 
3 
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2003). These signals mediate early chromatolytic changes in axotomized neurons of the 
PNS: the cell body swells, the nucleus shifts to an eccentric position in the cell soma and 
the rough endoplasmic reticulum takes on a fragmented appearance (Lieberman, 1971). 
This is accompanied by metabolic changes including a dramatic increase in mRNA and 
protein synthesis, and alterations in gene expression. Axotomy induces the upregulation 
of adhesion molecules, transcription factors, structural components required for growth, 
and growth associated proteins (reviewed in Chen et al., 2007; Raivich and Makwana, 
2007). Axotomy can also induce a rapidly elevated level of cyclic adenosine 
mono phosphate (cAMP) in some populations of peripheral neurons (Neumann et al. , 
2002; Qiu et al., 2002b), which consequently enhances the intrinsic growth capacity of 
the neuron, possibly by upregulating polyamine synthesis, as polyamines have been 
demonstrated to stimulate neurite outgrowth both in vitro and in vivo (Oble et al. , 2004; 
Schreiber et al., 2004; Sebille and Bondoux-Jahan, 1980). Furthermore, the injured axon, 
and surrounding glia, increase expression of growth factors, cytokines, neuropeptides and 
extracellular matrix molecules to create a favourable environment for regenerative growth 
in the PNS (reviewed in Raivich and Makwana, 2007). Axotomy induced molecular 
changes are largely reversible if regeneration is successful, as it often is in the PNS. 
However, if the regenerative response fails, as it often does in the CNS, it can lead to an 
extended period of apoptosis, demyelination, and synaptic stripping, wherein the 
innervation target atrophies and the synaptic input to the affected neuron withdraws, 
collectively resulting in cavitation and more distant effects (reviewed in Thuret et al., 
2006). 
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These molecular events are accompanied by alterations to the cellular 
organization. Axotomy divides the axon into two segments. The distal segment is 
isolated from the cell body and responds to damage by retracting from its postsynaptic 
target and undergoing Wallerian degeneration (Becerra et al., 1995), a process in which 
recruitment of phagocytic macro phages, working in concert with Schwarm cells, leads to 
the clearance of myelin fragments and axon-derived debris (Chen et al., 2007; Makwana 
and Raivich, 2005). While the distal portion of the axon itself degenerates, connective 
tissue often remains, creating a distal stump. The proximal segment remains attached to 
the cell body and if the cell survives the insult, the Ca ++ influx initiates cytoskeletal 
remodelling for the formation of a growth cone at the severed edge, which appears 
fundamentally equivalent to those of developing fibres (Spira et al., 2001), though 
evidence is emerging to suggest that development and regenerative growth are distinct 
processes (reviewed in Zhou and Snider, 2006). Axonal sprouts from the proximal 
segment can enter the distal stump and re-extend toward the original target, guided by 
environmental factors that promote growth cone movement in the developing nervous 
system. This process is quite successful in all three branches of the PNS (motor, sensory 
and autonomic). Even in the CNS, proximal stumps form growth cones and sprout, but 
long distance regeneration is rare, rendering CNS injury irreversible. 
1.1.2 Signalling at the Growth Cone 
Axons are required to extend long distances during both developmental and 
regenerative growth (Zhou and Snider, 2006). Axonal extension is a highly regulated 
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process in which outgrowth, guidance and branching are carefully orchestrated and a 
trajectory is determined by the deployment of spatially and temporally regulated 
extracellular factors which act on the growth cone at the leading tip of the growing axon 
(Dickson, 2002; Huber et al., 2003; Song and Poo, 2001; Tessier-Lavigne and Goodman, 
1996). The growth cone is a dynamic and motile structure. It serves as the major site of 
reception and interpretation of extracellular cues that direct cytoskeletal changes and 
rapidly responds to these cues to acutely alter axon behaviour. As such, the growth cone 
is responsible for the interpretation of a fine balance of attractive and repulsive cues to 
achieve an intricate pattern of innervations (Huber et al. , 2003). 
The growth cone is comprised of two elements: filopodia are finger-like 
projections of bundled F-actin, which constantly probe the extracellular terrain in search 
of growth and guidance cues, and lamellipodia are broad webs of cross-linked actin 
filaments, which also play a role in detecting the extracellular environment (Figure 1.1 
A). Growth cone advance initiates axonal elongation via actin polymerization at the 
leading edge, the retrograde flow ofF -actin, and the depolymerization of actin at the 
opposite end for a treadmilling effect. Growth promoting molecules enhance actin 
polymerization and prevent the retrograde flow of actin resulting in the forward advance 
of the growth cone. Subsequent microtubule polymerization and bundling within the core 
complete the formation of a newly formed axon segment. Repulsive cues are just as 
important to axon guidance and can result in collapse of the growth cone and axon 
retraction by promoting actin depolymerization and enhancing the retrograde actin flow 
(Huber et al., 2003; Mallavarapu and Mitchison, 1999; Mitchison and Kirschner, 1988; 
Suter and Forscher, 2000). 
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The initiation of axon growth requires specific stimulation of the growth cone by 
factors in the extracellular environment which are transduced to organize local axon 
assembly, a process which involves a coordinated regulation of gene expression in the 
nucleus, protein expression in the soma and along the length of the axon, the anterograde 
transport ofraw materials and the assembly of the cytoskeletal elements into new axons 
(Zhou and Snider, 2006). The response of the growth cone to extracellular growth and 
guidance cues is dependent upon the intracellular state of the growth cone, and the 
presence of an adhesive and permissive substrate. 
A variety of extracellular molecules, including short, intermediate and long range 
target-derived factors, are recognized to influence axon extension (Huber et al. , 2003). 
As well, growth-inducing and trophic molecules are released following injury to act on 
the proximal tip to induce regenerative growth (reviewed in Chen et al. , 2007; Raivich 
and Makwana, 2007). The final changes that occur in response to these extracellular 
signals, whether the signals trigger or inhibit growth, are changes to the cytoskeleton. 
These diverse signals translate into cytoskeletal changes leading to axon extension by 
convergence of intracellular signalling pathways on a common set of effectors that 
mediate cytoskeletal dynamics. Cytoskeletal assembly is a highly conserved process that 
is regulated by a common set of molecules across cell types and species: the family of 
proteins known as Rho GTPases (Dickson, 2001 ; Hall, 1998; Luo, 2000; Luo, 2002). 
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1.1.2.1 Rho GTPases 
Rho GTPases comprise a family of proteins that serve as molecular switches to 
regulate cytoskeletal structure and dynamics. Any signalling cascade that has an effect on 
growth cone dynamics must ultimately effect changes to the cytoskeleton (Filbin, 2003). 
Rho GTPases play an essential role in translating extracellular signals into changes in 
cytoskeletal proteins, and can transduce signalling pathways stimulated by receptor-
ligand interaction to cytoskeletal changes in the growth cone by serving as convergence 
points which exert control over the dynamics of actin polymerization and 
depolymerisation, thus regulating actin filament assembly or disassembly. These proteins 
thereby possess the ability to modulate varied cellular responses including morphological 
changes, neurite outgrowth, proliferation, adhesion, phagocytosis and migration 
(Dickson, 2001 ; Hall, 1998; Luo, 2000; Luo, 2002). 
Rho GTPases cycle between GTP-bound active and GDP-bound inactive forms. 
This cycling is regulated by the opposing activities of guanine nucleotide exchange 
factors (GEF) and GTPase activating proteins (GAP). GEFs facilitate the exchange of 
GDP for GTP thereby activating Rho GTPases and allowing them to recruit effector 
proteins. GAPs activate the endogenous GTPase activity resulting in hydrolysis of GTP 
to GDP, thus disrupting the interaction with effectors and resulting in inactivation (Figure 
1.1 B). A third regulatory element, guanine dissociation inhibitors (GDI) sequester 
inactive Rho and inhibit formation of active Rho-GTP. When GTP-bound, Rho GTPases 
can interact with intracellular effectors to reorganize the cytoskeleton both by regulating 
actin filament assembly/disassembly through polymerization control and by directing 
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actin/myosin contractility to control retrograde transport ofF-actin in the growth cone 
(reviewed in Dickson, 2001; Hall, 1998; Huber et al. , 2003 ; Luo, 2000; Luo, 2002). 
Receptors modulate the activity of GTPases by coupling directly or indirectly to GEFs 
and GAPs upon ligation. 
The best known family members, Cdc42, Rae and Rho all play roles in regulation 
of lamellipodial and filopodia! dynamics. Cdc42 and Rae mediate growth cone attraction 
and growth by promoting extension of the filopodia and lamellipodia respectively. 
Conversely, Rho activity causes growth cone repulsion and collapse by promoting actin 
depolymerisation in the growth cone. GTPase actions are exerted through interactions 
with downstream effectors. Cdc42 effectors include N-WASP, a key regulator of the 
Arp2/3 complex which controls actin filament nucleation and branching (Higgs and 
Pollard, 2001) and thereby promotes actin polymerization. Actin polymerization is also 
regulated by profilin, which controls the addition of actin monomers to the plus end of 
actin filaments (Suetsugu et al. , 1998), working with proteins of the VASP/Ena family 
that prevent actin capping. Cdc42 and Rae effector, p21-activated kinase (PAK) prevents 
retrograde flow of actin by dephosphorylating myosin (Kamm and Stull, 1985). These 
signalling interactions collectively contribute to promotion of growth. 
Conversely, Rho effector protein, Rho associated kinase (ROCK) activates LIMK 
which inhibits the activity of cofilin (actin depolymerizing factor) thereby inhibiting actin 
filament disassembly and preventing the necessary actin treadmilling necessary for 
growth (Arber et al. , 1998). ROCK also promotes actin-myosin contractility and 
retrograde flow ofF -actin through the phosphorylation of myosin, also resulting in the 
inhibition of neurite outgrowth (Amano et al., 1996) (Figure 1.1 B). Not surprisingly, 
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receptors for multiple classes of growth cone chemorepellents (Eph/ephrins, 
plexinlsemaphorins, Robo/slit) cause growth cone collapse by activating Rho (reviewed 
in Huber et al., 2003) and the inhibition of Rho or ROCK results in improved 
regenerative growth (Borisoff et al. , 2003; Ellezam et al., 2002; Fournier et al., 2003). 
Thus since Rho GTPases are central regulators of actin cytoskeletal modulation and 
retrograde F -actin flow, processes essential for extension of regenerating axons, they are 
central players in the success and failure of the growth process. 
1.2 Inhibition of Adult CNS Axonal Regeneration 
In the adult nervous system, there exists a striking dichotomy in regenerative 
ability between the CNS and the PNS. Neurons subjected to axotomy in the PNS can 
mount a vigorous regenerative reaction, while those axons injured in the CNS fail to 
mount a regenerative response regardless of where the cell body resides ( eg. the central 
branch of the dorsal root ganglion (DRG) axon fails to regenerate despite the fact that the 
cell body is located in the PNS). The failure of nerves to regenerate in the CNS is 
traditionally ascribed to two limiting factors: an inhospitable environment and the 
neuron's response to that environment, a phenomenon referred to as intrinsic growth 
capacity (reviewed in Domeniconi and Filbin, 2005; Liu et al., 2006). Not only is the 
CNS microenvironment relatively devoid of growth promoting neurotrophic factors, but it 
is also abundantly rich in inhibitory molecules associated with myelin debris which is 
cleared far more slowly in the CNS than in the PNS (David et al., 1990). Additionally, 
glial cells unique to the CNS undergo changes that are counterproductive to regenerative 
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growth in the CNS including the formation of an impenetrable physical barrier known as 
the glial scar and the secretion of growth inhibitory chondroitin sulphate proteoglycans 
(reviewed in David and Lacroix, 2003; Liu et al., 2006). Finally, the intrinsic state of the 
adult CNS neurons is less conducive to a regenerative growth response, relative to their 
neonatal or PNS counterparts (Neumann et al., 2005; Qiu et al. , 2002a; Qiu et al., 2002b). 
These intrinsic and extrinsic factors are not mutually exclusive entities, as intrinsic 
capacity can be modulated by extracellular cues (David and Aguayo, 1981; Goldberg et 
al., 2002; Richardson et al., 1980) and the response to extracellular cues is dependent 
upon the intrinsic state of the neuron (Bandtlow, 2003). Because the intrinsic capacity 
and extrinsic cues for growth are invariably linked, I will briefly discuss the roles of each. 
1.2.1 Intrinsic Factors Inhibiting CNS Regeneration 
Normal development of the CNS is reliant upon accurate intrinsic cellular 
programs in addition to extrinsic informative cues provided by the extracellular 
environment. Regenerative growth occurs under the same restraints and may be dictated 
by similar parameters. The regenerative capacity of the adult mammalian CNS is 
extremely limited (reviewed in Okano et al., 2007), and this is not solely a consequence 
of the local microenvironment, but also seems to be a property acquired with maturation. 
The CNS of young animals can undergo successful regeneration (Bregman et al., 1989; 
Fry et al. , 2003; Hasan et al. , 1993; Saunders et al. , 1998; Shimizu et al., 1990), which 
suggests developmental changes are central to the loss of this response. The regenerative 
ability of young neurons is lost during late postnatal development, a time period 
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corresponding to the onset of myelination (Bandtlow, 2003 ; Keirstead et al. , 1992); 
however environmental changes are not solely responsible for the loss (Chen et al. , 
1995a; Dusart et al., 1997; Goldberg et al. , 2002; Li et al. , 1995). When cultured under 
identical conditions, adult CNS neurons extend more slowly than their neonate or PNS 
counterparts (Blackmore and Letourneau, 2006). Furthermore, young neurons respond 
differently to inhibitors in myelin and are capable of extending through the adult CNS 
environment (Blackmore and Letourneau, 2006). The response to extracellular cues is 
clearly regulated by the intracellular state of the neuron and loss ofthe ability to 
regenerate may in fact be due to target-derived stop signals delivered after the neurons 
form synaptic connections; changes which fail to reverse after axotomy (Zhou and Snider, 
2006). Regardless of origin, the loss of intrinsic growth capacity is likely mediated by 
intracellular levels of cyclic adenosine monophosphate (cAMP) (Cai et al. , 2001 ). 
cAMP levels are endogenously high in young neurons and levels fall sharply with 
age coinciding with the loss of regenerative ability (Domeniconi and Filbin, 2005; Filbin, 
2006). cAMP levels are dramatically increased in peripheral neurons after injury, but not 
in central neurons (Neumann et al., 2002; Qiu et al. , 2002a; Qiu et al. , 2002b), and 
alterations in cAMP levels can dictate the response of a growing axon to guidance cues, 
neurotrophic factors and myelin associated inhibitory proteins; high cAMP levels favour 
attraction, and low cAMP levels favour repulsion (Song et al., 1998; Song et al., 1997). 
The intrinsic state of the neuron can thus be manipulated by injection of cAMP, cAMP 
analogues (db-cAMP) or by a conditioning lesion, a phenomenon wherein a lesion to the 
peripheral branch of the DRG results in elevated cAMP triggering a regenerative response 
to a later injury of the central branch which normally would not be capable of 
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regenerative growth (Cai et al., 2001; Kao et al., 2002; Lu et al., 2004; Neumann et al., 
2002; Qiu et al., 2002a; Qiu et al., 2002b ). Artificial elevation of intracellular cAMP 
levels can also induce adult CNS neurons to regenerate despite the presence of myelin 
associated inhibitory molecules (Neumann et al. , 2002; Qiu et al., 2002a; Qiu et al., 
2002b), and blocking cAMP can render young neurons susceptible to inhibition by 
myelin (Domeniconi and Filbin, 2005). 
cAMP signalling proceeds via protein kinase A (PKA) which may regulate 
cytoskeletal organization by inactivating Rho for immediate growth cone collapse (Qiu et 
al. , 2002a; Snider et al. , 2002). It also induces Arginase I transcription and subsequent 
polyamine synthesis, both reported to promote regenerative growth in the PNS (Cai et al. , 
2002). Intrinsic regenerative capacity can therefore be restored by blocking Rho activity, 
increasing cAMP levels or delivery of neurotrophic factors via infusion, hybridoma graft 
or viral transduction which are also associated with elevated cAMP levels (reviewed in 
(Fawcett, 2002). 
Maturational events clearly contribute to the diminished growth capacity of adult 
mammalian CNS neurons. Notwithstanding, these neurons do retain adequate potential to 
extend long axons if presented with a favourable environment, rich in neurotrophic 
factors and permissive extracellular matrix molecules (Benfey and Aguayo, 1982; David 
and Aguayo, 1981 ), suggesting that the CNS microenvironment plays a key role in the 
inhibition of regenerative growth. 
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1.2.2 Extrinsic Factors Inhibiting CNS Regenerative Growth 
Although multiple factors are likely to underlie the failure of adult CNS neurons 
to regenerate, there is little doubt that the developmentally regulated changes to the CNS 
microenvironment play a key role. The fact that isolated adult CNS neurons can be 
encouraged to extend long processes in vitro suggests that the failure to regenerate is not 
solely attributable to the lack of intrinsic growth ability, but is also a function of a poor 
extracellular microenvironment, devoid of growth promoting factors, but instead 
containing an adverse glial reaction and multiple inhibitory molecules (Benfey and 
Aguayo, 1982; Crutcher, 1989; David and Aguayo, 1981; David and Lacroix, 2003; 
Richardson et al., 1980; Schnell and Schwab, 1990). 
1.2.2.1 The Glial Scar 
Injury to the CNS results in the formation of a glial scar, a dynamic and dense 
impenetrable barrier of scar tissue which surrounds the site of the lesion, usually oriented 
perpendicular to the neuraxis, and serves to reseal the blood brain barrier and compact 
inflammatory cells (Berry et al., 1983). The glial scar is largely comprised of astrocytes 
that have undergone reactive gliosis, a reaction in which cells enlarge and extend 
hypertrophic interdigitating processes to enmesh the lesion site. Injury-induced 
disruption of the blood brain barrier results in the invasion of non-CNS factors including 
those involved in the inflammatory response (Fitch et al. , 1999; Preston et al., 200 I), but 
also fibroblasts which invade the lesion core and induce the astrocytic expression of 
repulsive guidance cues including semaphorins, eph/ephrins, and slit, which act to repel 
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axons (Bundesen et al., 2003; De Winter et al. , 2002; Goldshmit et al., 2004; Hagino et 
al. , 2003; Pasterkamp et al., 1999). Thus the glial scar is not simply a physical barrier, 
but also contains multiple secreted and transmembrane molecular inhibitors of axonal 
growth, which induce the formation of dystrophic growth cones. 
Notably, reactive astrocytes express several types of chondroitin sulphate 
proteoglycans (CSPG) including brevican, phosphacan, aggrecan, neurocan and NG2, and 
this production is exacerbated by the inflammatory reaction (Bandtlow and Zimmermann, 
2000; Dou and Levine, 1994; Fawcett and Asher, 1999; Jones et al. 2002). CSPGs have 
been demonstrated to mediate inhibition of axon growth via the glycosaminoglycan 
(GAG) chains (Chen et al., 2002; Dou and Levine, 1994). CSPGs are clearly inhibitory 
but largely unknown in terms of receptor and signalling, although it is clear that 
activation of the Rho-ROCK signalling cascade is a necessary step in mediating CSPG-
associated inhibition in vitro (Borisoff et al., 2003; Dergham et al., 2002; Monnier et al., 
2003), and it has been suggested that C PGs interfere with integrin signalling as integrin 
overexpression can promote axon growth despite the presence ofCSPGs (Condie, 2001). 
The formation of the glial scar is essential to seclusion of the damaged site and 
protection of surrounding area from secondary injury, as genetic ablation of reactive 
astrocytes prevents the blood brain barrier from resealing leading to increased lesion size, 
enhanced cell death, and exacerbated immune response (Faulkner et al., 2004). 
Fortunately, the glial scar is not an insurmountable obstacle. While the development of 
the scar begins within hours of injury, it can take as long as two weeks to fully mature 
(Berry et al. , 1983), presenting a window of opportunity for axonal regeneration. 
Furthermore, the inhibitory effects of the scar can be overcome by enzymatic removal of 
17 
CSPGs using chondroitinase ABC (chABC) (Bradbury et al. , 2002; Moon et al., 2001), 
and inhibition of Rho activity downstream of CSPG exposure resulted in a significant but 
limited number of axons growing across the scar (Dergham et al. , 2002; Winton et al., 
2002). 
1.2.2.2 CNS Myelin 
The non-permissive nature of the CNS microenvironment was first appreciated by 
Cajal in 1927, and the axon growth inhibition associated with myelin components is a 
significant contributor to this hostile environment. Indeed the onset of myelination 
correlates temporally with the end of the regeneration permissive period during 
development (Bregman et al., 1993; Hasan et al., 1993; Kalil and Reh, 1982; Saunders et 
al., 1998; Tolbert and Der, 1987; Treheme et al. , 1992). 
CNS myelin is produced by mature differentiated oligodendrocytes, and the 
process of axon myelination occurs late in development, generally after the growth cone 
has reached its target. Intact myelin insulates the axon and allows for saltatory 
conduction, but myelin can be disrupted by injury resulting in myelin debris strewn about 
the lesion site. This debris is cleared through the process ofWallerian degeneration. 
However, while Wallerian degeneration occurs rapidly in the PNS, it is a relatively slow 
process in the CNS, where it can take months to years to adequately remove myelin 
fragments and is questionably ever complete (reviewed in David and Lacroix, 2003; 
Filbin, 2006). 
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The concept of myelin inhibition was explored by Berry (1982) who demonstrated 
that axons of the CNS could regenerate successfully following chemical axotomy that 
doesn' t damage myelin, but not following a mechanical injury. Similarly, atraumatic 
transplantation of adult DRG into white matter can result in successful regenerative 
growth, providing that the myelin is not disrupted (Davies et al. , 1997; Davies et al., 
1999). Schwab and colleagues identified damaged CNS myelin as a substrate inhibitory 
to the regeneration of injured CNS axons (Caroni and Schwab, 1988a; Caroni and 
Schwab, 1988b; Savio and Schwab, 1989; Schwab and Thoenen, 1985). Indeed, CNS 
myelin homogenates are capable of inducing growth cone collapse in vitro (Bandtlow et 
al. , 1990; Savio and Schwab, 1989). Conversely, PNS myelin produced by Schwann cells 
does not possess potent neurite outgrowth inhibitory activity (Carbonetto et al. , 1987; 
Crutcher, 1989; Khan et al., 1990; Sagot et al. , 1991 ; Savio and Schwab, 1989). 
1.2.2.2.1 Myelin Associated Inhibitory Proteins 
The search for molecular components present in CNS myelin that impair 
regenerative growth led to the identification of three molecules that act as potent neurite 
growth inhibitors in vitro: Nogo, Myelin-associated glycoprotein (MAG) and 
oligodendrocyte myelin glycoprotein (OMgp) (Caroni and Schwab, 1988a; Caroni and 
Schwab, 1988b; Chen et al., 2000; GrandPre et al. , 2000; Prinjha et al. , 2000; Spillmann 
et al., 1998). 
NogoA is the largest of the 3 Nogo isoforms, and is highly expressed by 
oligodendrocytes of the CNS, but not by Schwann cells of the PNS, consistent with its 
19 
role as a myelin associated inhibitor (Liu et al., 2006). Structurally, NogoA has two 
transmembrane domains flanking a 66 amino acid extracellular loop (GrandPre et al. , 
2000; Huber and Schwab, 2000). Functionally it has two known inhibitory domains 
capable of inducing growth cone collapse: the 66 amino acid extracellular loop (Nogo66) 
and theN-terminal region (amino-Nogo) (Chen et al. , 2000; Fournier et al. , 2001 ; Prinjha 
et al. , 2000). NogoA potently inhibits axonal regeneration in the damaged CNS, and may 
function in the normal CNS to prevent abnormal sprouting. 
MAG is a member of the immunoglobulin superfamily. It is expressed by both 
CNS and PNS myelinating glial cells, but is ten-fold more abundant in the CNS (Trapp, 
1988; Trapp, 1990), and is upregulated by CNS injury (Mingorance et al. , 2005). It 
possesses both adhesive and inhibitory properties dependent upon the age of the neuron; 
MAG promotes axonal growth from young neurons but potently inhibits regenerative 
growth from older cells (Cai et al. , 2001 ; DeBe liard et al., 1996). Furthermore, it plays a 
key role in the maintenance of myelin architecture and limits plasticity (Schachner and 
Bartsch, 2000). 
OMgp is another myelin associated protein that is localized to the cell surface. It 
also possesses potent growth cone collapsing activity and thus prevents neurite outgrowth 
(Kottis et al. , 2002; Wang et al., 2002b). 
The contribution of each myelin component to the inhibition of axonal extension 
is dependent upon several factors, including the relative abundance of each component, 
and therefore the likelihood of growth cone contact, and the presence of all components 
of the receptor complex. 
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1.2.2.2.2 Myelin Associated Inhibitor Protein Receptors and Signal Transduction 
While the receptor for amino-Nogo has yet to be identified, the receptor for Nogo-
66 was identified by Strittmater and colleagues in 2001 to be a protein now known as the 
Nogo receptor (NgR) (Fournier et al. , 2001). It was further demonstrated that a direct 
interaction between Nogo-66 and NgR was necessary to induce growth cone collapse 
(Fournier et al., 2001). The other myelin proteins, MAG and OMgp, lack sequence 
similarity or domain homology to Nogo-66, but were nonetheless shown to bind NgR to 
exert their effects as well, though this activity was linked to separate binding sites ofNgR 
(Domeniconi and Filbin, 2005; Kottis et al. , 2002; Liu et al. , 2002; Wang et al., 2002b). 
NgR crystallization elucidated the ability of this receptor to bind diverse ligands by 
illustrating the presence of numerous different binding platforms (Barton et al., 2003), 
and this redundancy explains the poor efficacy of the therapeutic blockade of only a 
single component of myelin. The forced expression ofNgR in myelin unresponsive cells 
can render them responsive to myelin inhibition (Fournier et al. , 2001 ). In contrast, 
dominant negative forms ofNgR, or siRNA mediated suppression ofNgR can 
dramatically decrease the inhibitory effects of myelin (Ahmed et al., 2005; Domeniconi et 
al. , 2002; Wang et al. , 2002a; Wang et al., 2002b), and DRG lacking NgR do not show 
growth cone collapse in the presence of myelin associated inhibitors (Kim et al., 2003). 
NgR is a glycosyl phosphatidylinositol (GPI)-linked protein and therefore 
possesses no transmembrane or cytoplasmic intracellular signalling domains. As a result, 
NgR has distinct inability to transduce signals from myelin across the membrane, and 
thus a second molecule is required for the transduction of inhibitory signals. The 
transducing element of this receptor complex was identified to be p75NTR, the low 
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affinity neurotrophin receptor (Wang et al. , 2002a). As such, the partial genetic deletion 
of p 7 5NTR ex on III or the overexpression of a truncated version in neurons removes the 
ability of myelin to inhibit growth from these cells (Wang et al. , 2002a; Yamashita et al. , 
2002). However, axonal regeneration of all neurons is inhibited by myelin, but not all 
neurons express p75NTR. In many neurons, p75NTR expression can be induced by 
injury (Martinez-Murillo et al., 1998). Alternatively, TAJ/TROY, another tumour 
necrosis factor (TNF) superfamily member expressed in many adult neurons, can 
substitute for p75NTR and serve as an alternate co-receptor (Park et al., 2005; Shao et al. , 
2005). A third component ofthis receptor complex is LINGO-I , which is believed to 
promote the association of ligand-bound NgR and transducing partner p75NTR (Mi et al., 
2004). 
Myelin-induced growth cone collapse via NgR-p75NTR receptor complex induces 
cytoskeletal changes, and as such, likely involves the key regulators of actin dynamics, 
the Rho GTPases. In fact, Rho was implicated in mediating the effects of myelin 
associated inhibitory proteins before NgR was even discovered (Lehmann et al. , 1999). 
Exposure to myelin results in increased activity of Rho in neurons (Fournier et al. , 2003 ; 
Schweigreiter et al. , 2004; Winton et al. , 2002) and the inactivation of Rho or 
downstream effector ROCK using dominant negative forms or a cell permeable inhibitor 
blocks the effects of myelin and allow neurites to grow over inhibitory substrates 
(Ellezam et al. , 2002). Stimulation of Rho activity is therefore critical for myelin 
associated signal transduction downstream ofNgR, as is activation of Rho effector 
ROCK and consequent actinomyosin contractility which initiates growth cone collapse 
and neurite retraction. Myelin associated inhibitors also inactivate Rae, although it 
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remains unclear whether this is necessary or sufficient to prevent myelin associated 
inhibition (Niederost et al., 2002). Nonetheless, NgR-p75NTR complex signalling 
through Rho-ROCK has implications for axonal regeneration in the adult mammalian 
CNS. The inactivation of Rho or ROCK activity promotes axonal growth despite the 
presence of myelin associated inhibitory proteins and in some cases has led to functional 
recovery (Dergham et al., 2002; Fournier et al., 2003; Lehmann et al. , 1999). 
1.2.3 Therapeutic Intervention 
Tremendous increases in our understanding of the barriers preventing regeneration 
in the CNS and why this ability differs in adult PNS and embryonic/neonatal neurons of 
both systems, have in turn lead to the development of multiple strategies designed to 
overcome barriers, including a poor extracellular environment, and enhance axonal 
regeneration for therapeutic recovery of function. Multiple strategies have proven 
effective in protecting cells from secondary cell death and promoting varying amounts of 
regenerative growth (reviewed in David and Lacroix, 2003; Fawcett, 2002; Filbin, 2006; 
Thuret et al., 2006). The majority of the proposed strategies attempt to subvert the 
inhibition imposed by the CNS microenvironment by blocking inhibitors or their 
receptors, or by altering the neuronal response to the inhibitors via alteration of the 
neuron' s interpretation of inhibitory cues. In this regard, the intrinsic growth potential of 
CNS neurons can be manipulated by exogenous elevation of cAMP levels, or by 
inactivation of Rho, both of which can be accomplished by the infusion of neurotrophic 
factors (reviewed in David and Lacroix, 2003; Fawcett, 2002). Neurotrophic factors are 
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however, not solely effective as they often result in unacceptable side effects, and chronic 
injury is often associated with a gradual loss of growth factor receptors (Kwon et al. , 
2004). 
Strategies aimed specifically at overcoming the inhibition of the glial scar include 
enzymatic digestion of inhibitory CSPGs using chondroitinase, which has been shown to 
permit the extension of axons into the glial scar (Bradbury et al. , 2002; Moon et al., 
2001). Furthermore, the transplantation of olfactory ensheathing cells (OECs) derived 
from the regeneration permissive olfactory system, were able to migrate through the glial 
scar carrying axons with them to mediate regenerative growth (Li et al., 1998b; Ramon-
Cueto et al., 2000). 
A comprehensive effort to overcome the inhibition associated with a myelin rich 
environment of the CNS has led to the development of multiple blocking antibodies and 
peptides directed at the myelin associated inhibitory proteins themselves, and their 
receptor complex, and have resulted in varying degrees of success, thwarted in part by the 
redundancy of the ligands for the NgR-p75NTR receptor complex (reviewed in David and 
Lacroix, 2003; He and Koprivica, 2004). 
Successful regeneration has also been achieved by the provision of growth 
promoting extracellular factors, generally in the form of tissue grafts. David and Aguayo 
(1982) demonstrated that the transplantation of a segment of peripheral nerve was 
sufficient to encourage the successful regenerative growth of retinal neurons to yield 
functional connections. Peripheral nerve grafts have since been shown to support the 
ingrowth of various axonal types in the CNS (reviewed in He and Koprivica, 2004; 
Thuret et al., 2006). Grafts of Schwann cells, a prominent PNS glial type, are reported to 
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promote the extension and remyelination of spinal axons (Bamber et al., 2001; Takami et 
al., 2002; Xu et al., 1995a; Xu et al., 1995b) which subsequently become 
electrophysiologically active (Pinzon et al. , 2001). As previously mentioned, grafting of 
OECs can promote CNS regeneration, though not under all circumstances, and fetal 
spinal cord transplantation has yielded some modest success (Bregman et al. , 1993; 
Jakeman and Reier, 1991; Kunkel-Bagden and Bregman, 1990; Reier et al. , 1992). 
Whether these grafts are acting as relays or conduits or simply providing permissive cues 
that signal to promote outgrowth, the improved extracellular environment promotes 
regenerative growth and functional recovery, but can frequently suffer from a graft-host 
barrier in which the re-extended axons fail to exit the graft and re-enter the host 
environment, a key step to reformation of functional synapses for the recovery of 
function. However, this graft-host interface can be overcome by the provision of growth 
factors (Menei et al. , 1998; Xu et al. , 1995a), which are also an abundant component of 
the PNS and recognized to contribute to the permissive nature of the PNS environment. 
Relative to the PNS, where more than 90% of axons can be induced to regenerate 
under optimal conditions, experimental intervention in the CNS promotes the 
regenerative growth of only a small percentage of the original fibre tract (Bradbury and 
McMahon, 2006), and the distance the CNS axons are able to extend is severely limited. 
For example, in one study, Nogo neutralization was reported to induce only 5% of the 
corticospinal tract axons to regenerate after injury, and in general less than 10% of central 
neurons will regenerate at least two spinal segments ( 4-6 mm) enough to be of functional 
use (Bradbury eta!., 2002; Bregman et al., 1995; GrandPre eta!., 2002). Surprisingly, 
this minor amount of re-growth is sufficient to yield a disproportionate return of function, 
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likely owing in part to the same mechanisms that allow for more than 80% axon loss 
before deficits become apparent (Coumans et al. , 200 I; Fawcett, 2002). 
Each of the strategies discussed here have produced significant regeneration with 
variable degrees of success when applied to rodent CNS injury models. It is apparent that 
multiple factors can act synergistically to promote regenerative growth and that 
combination strategies will be necessary for optimal recovery of function. The majority 
of studies to date promote regenerative growth by altering the extracellular environment. 
While it remains unclear if the mechanisms regulating PNS regenerative growth are 
relevant to the CNS situation and can be harnessed to promote CNS growth after injury, it 
is necessary and important to determine how the permissive environment of PNS impacts 
intracellular signalling and consequent regenerative behaviour, which will be the focus of 
this project. 
1.3 The Promotion of PNS Axonal Regeneration 
In contrast to the CNS situation, PNS axotomy is often followed by a spontaneous 
and successful regenerative response. PNS injury results in the elevation of intracellular 
cAMP levels, thereby activating the intrinsic growth program (Qiu et al. , 2002b ). This is 
well demonstrated by the aforementioned conditioning lesion of the peripheral branch of 
the DRG, which can subsequently induce the regenerative growth ofthe central process 
into the CNS (Neumann and Woolf, 1999; Richardson and Issa, 1984). These effects can 
be mimicked by the infusion of cAMP analogues (db-cAMP) (Neumann et al. , 2002; Qiu 
et al. , 2002a; Qiu et al., 2002b). However, activation ofthe intrinsic growth program will 
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increase regenerative ability but functionally successful regeneration remains dependent 
on the availability of a positive and substantiating substrate, specific stimulatory signals 
and/or the existence of axon guidance cues to direct axonal growth towards an 
appropriate target. As such, successful regenerative growth of the PNS is largely 
attributable to the local extracellular environment and the presence of permissive 
molecules therein. The PNS microenvironment is rich in soluble neurotrophic factors and 
the extracellular matrix (ECM) is comprised largely of laminins (LN) (reviewed in Chen 
et al., 2007). Furthermore, the PNS is devoid of astrocytes and expresses vastly fewer 
proportion of inhibitory proteins than the CNS, including tenfold less MAG (Trapp, 
1990), and any injury induced debris is rapidly cleared from the PNS by Wallerian 
degeneration. 
The major glial component of the PNS is Schwann cells, which both ensheath and 
myelinate peripheral axons and form a continuous basal lamina. Schwann cells respond 
to injury by de-differentiating and undergoing a proliferative reaction, subsequently 
becoming migratory and forming into parallel alignment to create permissive tubes 
known as Bands ofBunger (Fawcett and Keynes, 1990). They also secrete a variety of 
neurotrophic factors, as well as LN, an ECM component that is permissive to neurite 
outgrowth (Chiu et al. , 1991 ). The deposition of permissive ECM components such as 
LN, and the availability of neurotrophic factors contribute to the creation of a favourable 
environment for the promotion of axonal regeneration. Determination of the cellular 
effects of these growth promoting molecules may reveal why these PNS neurons are able 
to regenerate spontaneously and successfully. 
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1.3.1 The Role of Neurotrophins in Promoting PNS Regenerative Growth 
Neurotrophins are a small group of dimeric growth factors implicated in the 
development and maintenance of different populations of neurons. NGF is the prototypic 
member of a highly conserved family derived from a common ancestral gene (reviewed 
in Huang and Reichardt, 2001), which also includes BDNF, NT-3 and NT-4/5. NGF was 
originally characterized for its ability to stimulate growth, differentiation, survival and 
maintenance of peripheral sensory and sympathetic neurons during development and after 
injury (reviewed in Levi-Montalcini, 1987), but has since been appreciated to regulate 
many aspects of neuronal development and function including myelination, apoptosis, 
proliferation and plasticity (Arevalo and Wu, 2006; Bibel and Barde, 2000; Hennigan et 
al. , 2007; Kaplan and Miller, 2000; Lewin and Barde, 1996; Lu et al., 2005; Sofroniew et 
al. , 2001). 
During development and beyond, neurotrophins are produced and constitutively 
secreted by targets of sensory and sympathetic innervations, including skin, muscle, and 
endocrine tissue. Neurotrophins can also be secreted by non-neuronal cells, and by 
sympathetic and sensory neurons themselves to exert paracrine or autocrine actions (Levi-
Montalcini et al. , 1995; Levi-Montalcini et al., 1996; Reichardt, 2006). Transiently 
required growth factors may also derive from sources other than the final target, including 
intermediate targets that axons encounter and extend beyond while en route to their final 
destination to provide trophic support to neurons that have not yet contacted their final 
targets (Farinas et al. , 1998; Farinas et al., 1996; Huang et al., 1999; Ringstedt et al. , 
1999). Neurotrophin expression can be modulated by neuronal electrical activity (Castren 
et al. , 1992; Dragunow et al. , 1993; Patterson et al. , 1992; Rocamora et al. , 1996), or in 
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response to nerve injury. Peripheral nerve injury can result in a significant increase in the 
synthesis and subsequent availability of a multitude of extracellularly acting neurotrophic 
factors, including, but certainly not limited to, NGF (reviewed in Raivich and Makwana, 
2007). This enhanced expression of neurotrophins is due in part to the infiltration of 
macrophages associated with the inflammatory reaction, which secrete cytokines to 
induce NGF synthesis by Schwann cells and fibroblasts in the lesioned area (Heumann et 
al., 1987a; Heumann et al., 1987b ). 
Neurotrophins are synthesized as a precursor form, which undergoes post-
translational processing to generate mature forms (Fahnestock et al., 2004; Lee et al. , 
2001). Neurotrophin activity is thus regulated by the proteases (including furin and other 
pro-hormone convertases) responsible for the conversion ofpro-neurotrophin to its 
mature form. Inefficient intracellular processing results in the secretion of substantial 
quantities of the biologically active uncleaved pro-neurotrophin form which preferentially 
activates p75NTR, the low affinity neurotrophin receptor, and this ligation is associated 
with the induction of signalling for apoptosis (Lee et al., 2001). Pro-neurotrophin 
secretion is significantly enhanced following axonal insult or degeneration (Fahnestock et 
al., 2001; Harrington et al., 2004; Pedraza et al. , 2005), and the survival or death of 
neurons co-expressing both neurotrophin receptors could depend on the relative 
processing of neurotrophin ligands: increased processing favors Trk-dependent survival, 
while decreased processing favors p75NTR-mediated death (Lee et al. , 2001). The 
processing, packaging, transport and secretion of neurotrophins are all important post-
transcriptional regulators of neurotrophin activity, but the biological responses elicited by 
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neurotrophins are often specified not only by the ligand itself, but also by the temporal 
pattern and spatial localization of stimulation (Segal, 2003 ). 
Neurotrophin signalling is broad based, dynamically regulated and context 
dependent. NGF alone is capable of promoting an exceptionally varied set of responses 
that requires a highly regulated and widely cascading signal transduction mechanism. 
The extensive repertoire of potential neurotrophin signalling elements permits minute 
distinctions depending on the relative expression of downstream effectors, and the 
complexity is partially explained by the dual high and low affinity receptor paradigm that 
regulates responses to the NGF family of neurotrophins (Friedman and Greene, 1999; 
Reichardt, 2006; Sofroniew et al., 2001). In the adult, neurotrophins and their receptors 
continue to be expressed and dynamically regulated by a variety of cell types (Huang and 
Reichardt, 2001; Reichardt, 2006; Sofroniew et al., 2001). NGF is further demonstrated 
to have dual modes of function: signalling locally has been shown to regulate growth 
cone motility and thus promote neurite extension and steering, while internalization and 
transport to the cell soma promotes survival and differentiation through actions on gene 
induction to ensure viability of developing sensory and sympathetic neurons (Huang and 
Reichardt, 2001; Kaplan and Miller, 2000; Reichardt, 2006; Sofroniew et al., 2001 ). 
Neurotrophins are also recognized to promote axonal extension of responsive neurons 
including CNS axons. Different categories of CNS neurons express neurotrophin 
receptors and respond in culture to NGF, BDNF and NT-3 stimulation. During postnatal 
development, many neurons lose absolute dependence on growth factors for acute 
survival, and thus neurotrophins change primary function from the promotion of survival 
to the support of process outgrowth and the determination of phenotype (Davies, 1998; 
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Lewin and Barde, 1996). Mature sensory neurons do not require NGF derived from the 
periphery for continued survival (Lindsay, 1988; Rich et al., 1984) and exogenous 
application ofNGF, or injury induced upregulation, can often result in inappropriate 
sprouting and consequent hyperalgesia. In contrast, many sympathetic neurons require 
NGF both during development and in the adult for continued survival. The molecular 
signals that control injury response and attempts at repair are just beginning to be 
untangled, but clearly involve the dynamic regulation of growth factors and their 
receptors. 
1.3.2 Neurotrophin Receptors 
Neurotrophin receptors are widely expressed in the PNS and CNS both during 
development and in the adult. They are present on both pre-synaptic axon terminals and 
post-synaptic dendrites, and as such neurotrophins can function as target-derived factors 
influencing developing afferents, but also display anterograde influence to regulate post-
synaptic targets (Lessmann et al. , 2003). Neurotrophin responsive cells display both low 
affinity and high affinity binding sites, consistent with the concept that the biological 
effects ofNGF family of neurotrophins are mediated by two structurally distinct receptors 
(Bothwell, 1995; Kaplan and Miller, 1997). Each neurotrophin binds to a specific 
member ofthe Trk family of receptor tyrosine kinases (RTK) with high affinity. NGF 
binds to TrkA, both BDNF and NT-4/5 interact with TrkB, and NT-3 preferentially binds 
TrkC. Additionally all of these neurotrophins are able to interact with p75NTR, the low 
affinity pan-neurotrophin receptor. Neurotrophin responsiveness is dictated by the 
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relative cell type specific expression ofTrk and/or p75NTR, which are frequently, but not 
always, coexpressed. When coexpressed, Trk and p75NTR exist in a paradoxical 
relationship and can either collaborate with or inhibit each other' s actions to coordinate 
and modulate neuronal responses to stimulation. As such, receptor activation can result 
in a wide variety of responses, both acute local effects and alterations in gene expression 
initiated by retrograde transport (reviewed in Arevalo and Wu, 2006; Hennigan et al. , 
2007; Huang and Reichardt, 2001 ; Lewin and Barde, 1996; Reichardt, 2006; Sofroniew et 
al., 2001). 
1.3.2.1 Trk Receptors 
Trk receptors are 140 kDa transmembrane glycosylated protein products encoded 
by a proto-oncogene, which belong to a family of RTKs. Each Trk contains an 
extracellular region comprised of immunoglobulin (Ig)-like binding domains. The 
membrane proximal Ig domain (Ig-2) is the major site of ligand binding, though other 
extracellular regions have been demonstrated to contribute to ligand binding, either 
directly or allosterically. A short transmembrane domain spans the membrane once and 
terminates with a cytoplasmic domain containing sites of tyrosine kinase activity (Huang 
and Reichardt, 2001 ; Reichardt, 2006; Sofroniew et al., 2001). 
Trk receptors are primarily activated by the mature, and not the pro- form of the 
neurotrophin gene product (Lee et al. , 2001). Ligand binding to the Ig-2 domain ofTrk 
results in receptor homodimerization and subsequent transphosphorylation of specific 
tyrosine residues on the cytoplasmic tail. Tyrosines at positions 670, 674 and 675 are 
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within the autoregulatory loop (activation domain) of the tyrosine kinase domain, which 
controls tyrosine kinase activity (Huang and Reichardt, 2003). Phosphorylation of the 
activation domain is sufficient to recruit Trk into lipid rafts following ligand engagement, 
where it is placed in proximity to a concentration of effector molecules (Du et al. , 2000; 
Duet al. , 2003). Two tyrosine residues outside of the activation domain form the major 
sites of endogenous autophosphorylation downstream of receptor activation. With regard 
to TrkA, the tyrosine at position 490 within the NPXY motif of the juxtamembrane 
domain, and the tyrosine at position 785 within the YLDIG motif of the carboxy terminus 
generate docking sites for phosphotyrosine binding (PTB) and Src-homology 2 (SH2) 
domain containing proteins (Loeb et al. , 1994; Obermeier et al., 1993a; Obermeier et al. , 
1993b; Stephens et al. , 1994) to initiate the activation of well-characterized signalling 
cascades (Figure 1.2) including those involving Ras-MAPK, PLC-y, and PI3K, which 
will be discussed in detail below. 
Different populations of neurons express different Trk receptor isoforms. While 
the Trk expression dictates neurotrophin responsiveness, Trk family members A, Band C 
have highly homologous intracellular domains: the phosphorylation sites and downstream 
signalling cascades are very similar in nature to those described for TrkA above (Atwal et 
al. , 2000; Middlemas et al. , 1994; Yuen and Mobley, 1999; Zirrgiebel et al. , 1995). 
Notwithstanding, signalling initiated by different Trk ligations has distinct subtleties 
important to biological responses. In the case ofTrkB which binds two distinct ligands, 
the signals initiated by each are not identical. NT -4/5 ligation initiates greater activation 
ofMAPK and c-fos than BDNF (Minichiello et al. , 1998). During development, TrkA 
can also be activated by two distinct ligands, as NT-3 exhibits binding promiscuity in the 
33 
-----------------------------------
Figure 1.2: Schematic illustration of TrkA, the high affinity NGF receptor and its 
associated signaling pathways. TrkA ligation results in the phosphorylation of 
Y674/675 of the activation loop, and phosphorylation ofY490 and Y785. Y490 
phosphorylation creates a docking site for She, and results in the subsequent activation of 
the Ras-MAPK cascade. Phosphorylated Y785 interacts with PLCy, which signals 
downstream to activate several PKC isoforms, as well as the MAPK cascade. TrkA 
ligation is also associated with the activation of the PI3K-Akt signaling cascade. Adapted 
from Tucker and Mearow, 2008, in press. 
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absence ofp75NTR. NGF and NT-3 both signal through TrkA in developing sympathetic 
neurons to stimulate proximal and distal extension respectively. Although both 
neurotrophins use the same signalling mechanisms to promote sympathetic axon growth 
at two different stages of development, only NGF:TrkA interactions can support the 
retrograde transport to mediate survival (Belliveau et al., 1997; Glebova and Ginty, 2004; 
Kuruvilla et al. , 2004) thus awarding the target-derived neurotrophin (NGF) exclusive 
control over the precise number of neurons that ultimately remain to innervate the target 
(Kuruvilla et al. , 2004). Finally, specific subtleties in receptor-ligand interaction direct the 
subsequent intracellular signalling activities and retrograde transport which allows Trk 
receptor activation to regulate gene expression and thus participate in a broad rar1ge of 
cellular behaviours including cell survival, proliferation, differentiation, synaptic 
plasticity, and importantly, remodelling of the cytoskeleton for axonal extension both 
during development and following nerve injury (Arevalo and Wu, 2006; Huang and 
Reichardt, 2003). 
The interaction ofNGF with TrkA at the nerve terminal and subsequent receptor 
activation has local effects on signalling at axon terminals that affect growth cone 
motility and guidance, but is also thought to induce the internalization and retrograde 
transport of the ligand-receptor complex (Beattie et al. , 1996; Grimes et al. , 1997; Grimes 
et al., 1996). This has been suggested to occur via formation of an endocytic vesicle, 
which contains not only catalytically active Trk, but may also contain a variety of 
signaJling intermediates with which Trk interacts including She, Rap, ERKl/2 and PLOy 
(Howe et al. , 2001 ; Wu et al., 2001). For this reason, this structure is referred to as a 
"signalling endosome". These vesicles are then transported to the nucleus in a dynamin-
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dependent manner (York et al., 2000; Zhang et al., 2000), where they induce nuclear 
responses to affect gene transcription (Reichardt, 2006). 
1.3.2.1.1 Trk-induced Ras-MAPK signalling 
The Ras-MAPK pathway is a consistent and conserved cascade for the 
transduction of extracellular stimuli, and amplification of associated cellular responses, 
and results in transcriptional regulation essential to survival and differentiation in many 
neuronal types (reviewed in Arevalo and Wu, 2006; Huang and Reichardt, 2003; Kaplan 
and Miller, 2000). It also plays a role in the promotion of neurite outgrowth, though this 
appears to be cell-type specific. The activity of the Ras-MAPK cascade is necessary and 
sufficient to induce neurite outgrowth in PC12 cells (Burry, 2001) and plays a key role in 
sympathetic axonal extension (Glebova and Ginty, 2005), but is not associated with 
neurite outgrowth of SH-SY5Y neuroblastoma cells and is of minimal importance to adult 
DRG growth (Kimpinski and Mearow, 2001). 
The activation of the TrkA receptor results in transphosphorylation of tyrosine 
490 of the cytoplasmic tail, which creates a docking site for PTB and SH2 domain 
containing proteins (Obermeier et al. , 1993b; Stephens et al., 1994). This is the site of 
interaction with adapter protein, She, which becomes activated upon binding and 
subsequently recruits the growth factor related binding protein (Grb2)-Son of Sevenless 
(SOS) complex. SOS is a GEF for Ras and thus results in the rapid yet transient 
activation of Ras (Stephens et al 1994 ). Activated Ras subsequently promotes the 
sequential activation of protein kinases Raf, MAPK kinase (MEK) and the MAPKs ERK1 
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and ERK2 (English et al. , 1999). The phosphorylation ofERK can also activate Rsk 
kinases resulting in the phosphorylation of CREB necessary for transcription of genes that 
regulate differentiation and survival (Pearson et al. , 2001 ). Furthermore, the 
phosphorylation of ERK on crucial tyrosine and threonine residues induces its nuclear 
translocation for the activation of transcription factors (Pearson et al., 2001). ERK1 and 2 
activate Elk-1 (Segal, 2003), whose phosphorylation stimulates its interactions that 
collectively induce c-fos, an early transcriptional event necessary for differentiation 
(Ginty et al. , 1994; Greenberg et al., 1986; Sheng and Greenberg, 1990). 
The activation ofMAPK via the above detailed mechanism is transient. The 
prolonged activation ofMAPK may require the interaction ofTrk with FRS-2, anN-
myristoylated protein which is also able to interact with tyrosine 490 of the TrkA 
cytoplasmic tail (Kao et al., 2001; Meakin et al. , 1999). Activated FRS-2 subsequently 
recruits adapter protein Grb2 and protein phosphatase SH-PTP2, but also Crk which binds 
and activates Rap 1 GEF C3G (Meakin et al. , 1999), thus resulting in activation of Rap 1 
and B-Raf, and the prolonged activation ofMAPK necessary for differentiation. 
Multiple signalling cascades can result in MAPK activation and each has 
overlapping but distinct targets in the cell, allowing both convergent and divergent 
signalling cascades to ensure robust and sustained activation of ERK, with the possibility 
of subtle modulation oftemporal dynamics and resultant control of gene transcription and 
consequent biological responses. 
1.3.2.1.2 Trk-induced PLC-y-PKC signalling 
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The PLC-y-initiated signalling pathway is a distinct neurotrophin-induced 
signalling cascade that has the ability to influence growth cone motility and subsequent 
axon extension in response to extracellular stimuli, exerting both local and transcriptional 
effects. Trk ligation and dimerization also results in transphosphorylation of tyrosine at 
position 785 in TrkA cytoplasmic tail creating a docking site for the direct SH2 domain-
mediated interaction ofPLC-y1 , which subsequently becomes tyrosine phosphorylated 
(Stephens et al. , 1994). Activated PLC-yl can them employ its enzymatic phospholipase 
activity to catalyze the hydrolysis of membrane phosphatidylinositides, resulting in the 
release of products inositol 1 ,4,5 triphosphate (IP3) and diacylglycerol (DAG). IP3 binds 
specific intracellular receptors to promote the release of Ca ++ from intracellular stores, 
thereby elevating intracellular Ca ++ concentration which can indirectly activate MAPK 
and PI3K signalling cascades (Rhee, 2001). DAG promotes the activation of multiple 
PKC isoforms, including PKC-o. PKC-o activity in particular is capable of promoting 
neurite outgrowth ofPC12 cells by multiple means, including activation ofMEK-ERK 
cascade (Corbit et al. , 1999), apparently acting between Raf and MEK, and signalling via 
PLC-y-PKC-o is reported to control the expression and activity of multiple proteins 
including transcription factors, growth associated proteins (GAP-43), and ion channels of 
the TRP family (Klein et al., 2005; Minichiello et al., 2002; Toledo-Aral et al., 1995). As 
such, PLC-y signalling is involved in the growth response at many levels and is 
appreciated to have a notable role in synaptic plasticity. Furthermore, PLC-y activity is 
implicated in chemotropism and regulation of growth cone behaviour, both through the 
activation of PKC isoforms downstream and through the formation of an intracellular 
Ca ++ gradient, which is essential for growth cone guidance (Arevalo and Wu, 2006). 
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1.3.2.1.3 Trk-induced PI3K signalling 
In several neuronal populations, neurotrophin-induced PI3K activity is critical for 
the ability of the Trk receptor to convey signals for the promotion of cell survival. In 
fact, PI3K activation and downstream phosphorylation of Akt are demonstrated to be 
responsible for up to 80% of neurotrophin-induced survival of PC 12 cells, as well as 
cerebellar, sympathetic, sensory, cortical and motor neurons (Bartlett et al. , 1997; 
Crowder and Freeman, 1998; Dudek et al. , 1997). 
Class I PI3Ks are heterodimers comprised of a regulatory subunit (p85) and a 
catalytic subunit (p 11 0) which are constitutively associated (Fruman et al. , 1998). Trk 
ligation and subsequent activation can in turn activate PI3K by a variety of different 
signalling interactions. The phosphorylation of tyrosine at position 490 of the Trk.A 
cytoplasmic tail creates a docking site for She (Obermeier et al. , 1993b). Activated She 
can subsequently recruit Grb2 and/or Gab1 /2. These intermediaries can bind the 
regulatory subunit ofPI3K leading to its activation (Holgado-Madruga et al. , 1997). 
Gab 1 is of particular importance as its disruption decreases survival in PC 12 cells 
(Holgado-Madruga et al. , 1997). Additionally, PI3K can be stimulated by direct 
interaction of the catalytic subunit with activated Ras (Downward, 1998), and the 
inhibition of Ras can impair survival by suppressing PI3K activity (Figure 1.3). 
Importantly, the activation ofPI3K occurs at the plasma membrane rather than in 
signalling endosomes. In fact, the inhibition ofTrk endocytosis results in increased PI3K 
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activity (Macinnis and Campenot, 2002; York et al., 2000; Zhang et al. 2000). This 
membrane localization is important to the downstream function of PI3K. Once activated, 
PI3K acts as a lipid kinase and generates 3' phosphoinositides: primarily PIP3, but also 
PIP and PIP2, all of which display signalling capacity. 3' phospholipids are capable of 
binding to the PH domain of a variety of downstream effectors, including PDK-1 and 
Akt, resulting in activation (reviewed in Kaplan and Miller, 2000; Reichardt, 2006). 
Lipid bound PDK-1 further activates Akt (Alessi et al. , 1997). Akt activity subsequently 
serves as a hub for the activation of a plethora of cascades with multiple effects including, 
but not limited to, the prevention of apoptosis and the concomitant promotion of survival. 
In this regard, Akt substrates include BAD, a proapoptotic protein which is sequestered 
upon phosphorylation and thereby rendered ineffective (Datta et al., 1997), and members 
ofthe Forkhead transcription factors (FKHRL1) which are also sequestered upon 
phosphorylation to prevent the transcription of proapoptotic genes (Brunet et al., 2001 ; 
Zheng et al. , 2002). Phosphorylated Akt can also activate NFKB via phosphorylation of 
its inhibitor IKB and targeting it for degradation (Foehr et al., 2000; Hamanoue et al., 
1999; Wooten et al. , 2001 ), thus releasing NFKB and consequently promoting the 
transcription of pro-survival genes. 
The activation of PI3K has also been implicated in the regulation of neurite 
outgrowth, guidance and differentiation in some populations of neurons. 3 ' 
phosphoinositides generated by PI3K activation are able to recruit GEFs for Cdc42 and 
Rae to the plasma membrane thereby exerting regulatory control over cytoskeletal 
organization and resulting in the promotion oflamellipodial and filopodia! formation 
(Yuan et al., 2003). Furthermore, downstream phosphorylation of Akt can subsequently 
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Figure 1.3 Schematic illustration of the Trk-induced activation of the PI3K-Akt 
signaling cascade. TrkA ligation results in the activation ofPI3K, which increases the 
concentration of 3' phosphatidylinositols, resulting in the activation of Akt. Akt 
subsequently activates a variety of downstream signaling pathways which impact survival 
and growth in many systems. PTEN negatively regulates the activity ofPI3K, acting to 
decrease the concentration of 3 '-phosphatidyinositols, and thereby impairing the 
activation of Akt. Adapted from Penninger and Woodgett, Science, 2001 Dec. 
294(5549): 2116-2118. 

phosphorylate and inactivate GSK3~, an event known to promote neurite outgrowth, at 
least partially through regulation of microtubule binding protein, APC (Chin et al. , 2005; 
Filipenko et al. , 2005; Zhou et al., 2004). 
The primary endogenous antagonist ofPI3K signalling is a phosphatase known as 
phosphatase and tensin homolog deleted on chromosome ten (PTEN) (Figure 1.3). PTEN 
possesses a large binding pocket and is thus able to accommodate the bulky 
3 'phosphoinositides, resulting in their dephosphorylation, which subsequently negatively 
regulates the activation of Akt and its associated survival pathways (Salmena et al., 
2008). In addition to its lipid phosphatase activities, PTEN also possesses protein 
phosphatase activities in vitro, although the purpose in vivo remains largely unknown 
(Yamada and Araki, 2001). The activation ofPI3K-Akt signalling is likely to mediate 
survival and growth on a number of levels depending on cell type and target availability, 
and thus its regulation is central to the development of a variety of neuronal populations. 
Nonetheless, PTEN is a versatile protein that exhibits biological properties in addition to 
PI3K antagonism. Genetic deletion studies have demonstrated a crucial role for PTEN in 
normal brain development. Specifically, PTEN function appears to be vital to the 
regulation of proper neuronal size, migration, polarity, differentiation, genomic stability 
and process morphology (reviewed in Chang et al., 2007; Salmena et al. , 2008; van 
Diepen and Eickholt, 2008). Its deletion or mutation is therefore associated with multiple 
defects in neural development including disorganized patterning, hypertrophy (Backman 
et al., 2001 ; Groszer et al. , 2001 ; Kwon et al. , 2001 ; Li et al. , 2003; Marino et al. , 2002; 
Nayeem et al., 2007) and the development of numerous tumour associated syndromes (Li 
and Sun, 1998; Liaw et al. , 1997). Alterations in PTEN function have also proven crucial 
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for responses that require dynamic regulation of the neuronal cytoskeleton (Arevalo and 
Rodriguez-Tebar, 2006; Chad born et al., 2006), through mechanisms that appear to be 
PI3K independent (Mahimainathan and Choudhury, 2004; Tamura et al. , 1998). PTEN 
shares significant sequence homology with cytoskeletal components tensin and auxillin 
(Li et al., 1997), suggesting that its targets may be cytoskeletal (Myers and Tonks, 1997), 
and PTEN is proposed to play a role in neurite outgrowth potentially via regulation of 
phosphorylation dependent interactions between tau and microtubules (Zhang et al. , 
2006a; Zhang et al. , 2006b ). Thus the functional relevance of PTEN extends beyond 
suppression of tumours and antagonism of PI3 K. This phosphatase is emerging as a key 
regulator of development and normal physiology, as well as pathological states in both 
the developing and adult nervous systems (Chang et al. , 2007; Li et al. , 2003; van Diepen 
and Eickholt, 2008). 
1.3.2.2 p75NTR Receptor 
p75NTR was the first identified receptor for NGF (Johnson et al. , 1986) and was 
subsequently shown to bind each neurotrophin with similar low affinity (Rodriguez-Tebar 
et al., 1990); neurotrophins bind p75NTR with approximately 1000 fold lower affinity 
than they bind to their cognate Trk receptors. Despite the ability ofp75NTR to bind all 
neurotrophins of the NGF family, the binding kinetics of each interaction differs in terms 
of rate constant and spatial arrangements of positively charged residues, thus providing 
p75NTR the ability to discriminate among ligands (Rodriguez-Tebar et al. , 1990; 
Rodriguez-Tebar et al. , 1992; Ryden et al., 1995). 
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p75NTR is a 399 amino acid, Type 1 transmembrane protein that is a member of 
the tumor necrosis factor receptor (TNFR) superfamily. While p75NTR shares several 
specifically conserved TNFR characteristics including the extracellular domain cysteine 
rich repeats (Y an and Chao, 1991) and the intracellular death domain (Liepinsh et al. , 
1997), it also displays significant deviation from the standard TNFR activity. p75NTR 
demonstrates a propensity to dimerize rather than trimerize like the majority ofTNFRs, 
and binds NGF with a 2:1 stoichiometry unlike other TNFRs (He and Garcia, 2004). 
The p75NTR promoter lacks consensus TATA or CAAT sequences, but instead 
displays multiple GC-rich sequences which represent Sp 1 binding motifs (Sehgal et al., 
1988). The resultant gene product displays a distinct lack of catalytic motifs. The ability 
of p75NTR to transduce signals is instead largely dependent upon two potential 
mechanisms: the availability of co-receptors and the subsequent recruitment of 
intracellular signalling partners (reviewed in Reichardt, 2006; Roux and Barker, 2002), 
and a cleavage cascade. In this regard, p75NTR undergoes a series of sequential 
cleavages: proteolytic shedding of the extracellular domain is followed by regulated 
intramembrane proteolysis (RIP). This process is dependent upon a- and y-secretases, 
and results in the release of an intracellular domain fragment, which is thought to possess 
signalling capabilities (DiStefano and Johnson, 1988; Jung et al. , 2003). In support of 
this, a cleavage-resistant mutant version ofp75NTR demonstrated altered ability to 
interact with other proteins and activate NFKB (Zampieri and Chao, 2006). 
p75NTR is highly expressed in the developing nervous system by a wide variety 
of neuronal populations in both the CNS and PNS, where it is thought to contribute to 
appropriate growth and development of the nervous system. Neural crest cells express 
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p75NTR as they migrate to sites of ganglia formation, and levels increase as they undergo 
differentiation (Heuer et al., 1990). Sympathetic and most sensory neurons, cerebellar 
neurons, cholinergic neurons ofthe basal forebrain, retinal neurons, hippocampal neurons 
and motor neurons of the spinal cord all express p75NTR during the period of 
developmental axon extension (Bucket al., 1987; Ernfors et al. , 1988; Large et al., 1989; 
von Bartheld et al., 1991; Yan and Johnson, 1988). Typically, p75NTR expression is 
dramatically reduced following target innervation; expression becomes more restricted in 
the adult nervous system where it is often downregulated to undetectable levels (1% of 
embryonic levels) (Heumann et al., 1987b) but it is notably retained in the adult 
sympathetic and sensory populations as well as in basal forebrain cholinergic neurons 
(Ruit et al., 1990; Verge et al., 1989). 
p75NTR expression can also be robustly induced by injury in a wide variety of 
cell types, and is associated with multiple pathological or chronic degenerative diseases, 
including seizure (Roux et al. , 1999), spinal cord injury (Dubreuil et al. , 2003), ischemia 
(Greferath et al. , 2002), multiple sclerosis, diabetic neuropathy, Alzheimer' s disease 
(Y aar et al. , 1997), and is a prognostic marker on multiple tumour types (Descamps et al. , 
2001). p75NTR expression is closely correlated with degenerative changes and apoptosis 
observed after neuronal trauma, and can be experimentally induced in the CNS by kainic 
acid (Hennigan et al. , 2007). It is unclear whether p75NTR induction plays a role in the 
progression of these diseases, or is part of an attempt at regeneration. 
While the engagement ofTrk almost certainly elicits growth, survival, and 
differentiation responses, the functional role of p75NTR is far less clearly understood. 
Genetic deletion studies have been hindered by the continued expression of alternatively 
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spliced and truncated versions thus confounding results (Paul et al., 2004; von Schack et 
al., 2001). Nevertheless, the functions attributed to p75NTR are diverse, complex and 
somewhat paradoxical: p75NTR activity has been linked to the promotion of both 
survival and apoptosis, the promotion and inhibition of neurite outgrowth, and the 
enhancement of both proliferation and differentiation (reviewed in Arevalo and Wu, 
2006; Roux and Barker, 2002) (Figure 1.4). The physiological outcome of p75NTR 
activation appears to depend upon ligand identity, co-receptor availability and 
intracellular interactions. Cell type and developmental stage may further influence 
biological responses mediated by p75NTR associated signalling, both p75NTR 
autonomous cascades and Trk-dependent signalling. 
1.3.2.2.1 p75NTR Autonomous Signaling 
1.3.2.2.1.1 p75NTR Signalling for Apoptosis 
While the exact purpose of this receptor has been a matter of considerable 
controversy for many years, it has been well-characterized for its role in the promotion of 
apoptosis in the absence ofTrk receptor co-expression. In the absence of concurrent Trk 
activation, neurotrophin ligation of p75NTR can facilitate apoptosis (Rabizadeh et al. , 
1993). The addition ofBDNF to cultures of sympathetic neurons, which lack TrkB 
expression, causes an apoptotic response (Bamji et al. , 1998) that can be abrogated by the 
introduction of Trk, (Davey and Davies, 1998; Yoon et al. , 1998). Furthermore, 
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Figure 1.4: Schematic illustration of selected p75NTR cytoplasmic interactions and 
outcomes. p75NTR signals via the recruitment of various intracellular signaling proteins 
and adapters which allows p75NTR signaling to result in a variety of different outcomes 
depending upon context. Adapted from Roux and Barker, Progress in Neurobiology, 
2002 June 67(3): 203-233. 
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neurotrophin-dependent apoptosis occurs in TrkA knockout mice, thereby suggesting this 
outcome to be the result ofp75NTR autonomous signalling (Majdan et al. , 2001). 
The presence of p75NTR is also essential for the induction of apoptosis that 
ensues following growth factor withdrawal or NGF deprivation (Barrett, 2000; Barrett 
and Georgiou, 1996). A decrease in p75NTR expression correlates with decreased or 
delayed apoptosis (Bamji et al., 1998), while an increase in p75NTR expression 
accelerates apoptosis, and is associated with a decreased number of cortical, sensory and 
sympathetic neurons (Majdan et al. , 1997). Injury-induced expression of p75NTR also 
correlates with enhanced apoptosis, and the use of p75NTR antisense oligonucleotides 
can rescue axotomized neurons from death (Cheema et al., 1996). 
There are multiple means established by which p75NTR is recognized to induce 
apoptosis, and the majority of them depend upon the orchestration of several downstream 
interacting proteins. The cytoplasmic tail of p75NTR is appreciated to interact with a 
variety of adapters and transcription repressors which have been demonstrated to disrupt 
the cell cycle and promote apoptosis (reviewed in Roux and Barker, 2002). These include 
NRIF, NRAGE, TRAF-6, NADE and SC-1. NRAGE is recruited to the plasma 
membrane upon NGF stimulation and interferes with the association of p75NTR with Trk 
(Salehi et al. , 2000), while NADE associates directly with the p75NTR intracellular death 
domain in an NGF -dependent fashion and promotes the activation of caspases for the 
induction of apoptosis. Dominant negative caspase-9 is demonstrated to attenuate 
p75NTR-induced apoptosis (Wang et al. , 2001). JNK signalling is also recognized to 
contribute to caspase-9 activation (Bruckner et al., 2001), and adapter TRAF-6 links 
p75NTR to the activation of the JNK signalling cascade (Wajant et al. , 2001 ; Yoon et al., 
51 
1998) which results in the activation of p53 (Aloyz et al., 1998). p53 has multiple targets, 
including proapoptotic Bax and the induction ofFasL expression (Le-Niculescu et al. , 
1999). JNK is strongly activated following p75NTR ligation, and following NGF 
withdrawal (Aloyz et al., 1998), and this can be prevented by genetic deletion ofTRAF-6 
or NRIF (Linggi et al., 2005; Yeiser et al. , 2004), or by the concurrent activation ofTrk 
which silences JNK-p53 death via Ras and PBK activity for the repression of apoptosis 
(reviewed by Kaplan and Miller, 2000). 
Ligand binding to p75NTR is also known to activate sphingomyelinase activity in 
a trk-independent fashion to inititate sphingomyelin hydrolysis and the generation of 
ceramide (Dobrowsky et al., 1995). Cerami de is a structural component of the cell 
membrane, but it also possesses second messenger capabilities that can induce apoptotic 
effects (reviewed by Bloch! and Blochl, 2007) in different types through modulation of 
many signalling cascades including ERK, JNK, NFKB (reviewed by Huang and 
Reichardt, 2001), and may directly inhibit PI3K activity (Zhou et al. , 1998). 
Finally, as previously mentioned, p75NTR serves as the preferred receptor for the 
pro-form of neurotrophins, which bind p75NTR with higher affinity and induce apoptosis 
at lower concentrations (Lee et al., 2001 ). The induction of apoptosis by pro-
neurotrophins requires the interaction ofp75NTR with co-receptor sortilin, a Vps10p 
domain containing protein (Nykjaer et al. , 2004). The ability of p75NTR to induce rapid 
and appropriate apoptosis during development allows for the elimination of neurons 
unsuccessful in obtaining appropriate trophic support and thus regulates innervation 
density and patterning (reviewed in Huang and Reichardt, 2001). The apoptotic function 
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of p75NTR could also be critical following neuronal injury or degeneration (Ferri et al., 
1998; Roux et al., 1999). 
1.3.2.2.1.2 p75NTR Signalling for Survival 
Paradoxically, signalling via p75NTR is also implicated in the promotion of 
survival, primarily via the ligand-dependent activation ofNFKB. An NGF-induced 
interaction between p75NTR and TRAF-6 results in the sequential phosphorylation of 
IKK and IKB resulting in the liberation ofNFKB, which translocates to the nucleus to 
trigger prosurvival expression changes (Hamanoue et al. , 1999; Middleton et al., 2000). 
Furthermore, NGF exposure is able to promote the survival of cortical neurons 
from excitotoxicity, which must be dependent upon p75NTR, since these neurons do not 
express TrkA (Kurne et al., 2000; Shimohama et al. , 1993), and a mutant form ofNGF 
that binds only p75NTR can inhibit apoptosis induced by serum deprivation (Hughes et 
al., 2001) potentially via the activation of Akt (Roux et al., 2001). A role for p75NTR in 
the promotion of survival is supported by studies ofthe p75NTR exon IV knockout 
mouse, which presents with a severe loss of peripheral sensory neurons (von Schack et 
al. , 2001). 
1.3.2.2.1.3 p75NTR Signalling for Growth 
Another major biological function of p75NTR is to dramatically influence growth: 
p75NTR can promote growth in collaboration with Trk (see section 1.3.2.3), but can also 
inhibit growth acting autonomously using signalling interactions distinct from those 
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activated by Trk (Hempstead, 2002). p75NTR knockout mice exhibit slower extension of 
axons (Bentley and Lee, 2000) and reduced outgrowth (Yamashita et al. , 1999) ofboth 
motor and sensory neurons, but the elimination ofp75NTR also led to robust sprouting of 
adult sympathetic nerve fibres on myelin and resulted in cholinergic hyperinnervation of 
the hippocampus (Yeo et al. , 1997). Additionally, selective activation of p75NTR, by 
stimulating NGF-dependent DRG neurons with BDNF for example, impairs neurite 
outgrowth (Kimpinski et al. , 1999). 
p75NTR constitutively activates Rho, a small GTPase known to potently inhibit 
axonal outgrowth, by functioning as a displacement factor to facilitate the release of Rho 
from Rho-GDI (Yamashita and Tohyama, 2003 ; Yamashita eta!., 1999). In fact, the 
overexpression of p75NTR is sufficient to activate endogenous Rho in a variety of 
neuronal and non-neuronal cell types, and this activation inhibits the cytoskeletal 
remodelling necessary for axonal extension. This growth inhibition is reversed upon 
neurotrophin binding to p75NTR, which abrogates the p75NTR-dependent activation of 
Rho (Yamashita et al. , 1999), thus permitting neurite outgrowth. 
p75NTR interaction with co-receptor NgR and subsequent transduction of signals 
from myelin associated inhibitory proteins also results in the activation of Rho and the 
associated inhibition of neurite outgrowth (Fournier et al., 2003; Schweigreiter et al., 
2004; Winton et al. , 2002). The modulation of Rho activity is critical to p75NTR 
influence over neurite outgrowth, and this modulation is dependent upon the proportion 
ofunliganded versus liganded p75NTR, as well as the presence of inhibitory ligands 
notably abundant after injury. 
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1.3.2.3 Trk-p75NTR Interaction 
While p75NTR clearly possesses autonomous signalling abilities, it can also 
signal collaboratively with Trk receptors to enhance neurite outgrowth through a variety 
of mechanisms. The assembly ofmultiprotein complexes including receptors and 
constituents facilitates the physical interaction between p75NTR and Trk receptors. 
These complexes can include caveolin, which provides a platform for interaction 
(Bilderback et al. , 1999), ARMS, and p62-TRAP -6-IRAK, which associate to form a 
scaffold for interactions (Wooten et al. , 2001) and recruit E2 ubiquitin ligase to facilitate 
receptor internalization (Geetha et al. , 2005). 
p75NTR is capable of modulating Trk function on a number oflevels. p75NTR 
collaborates with Trk to promote high affinity neurotrophin binding by assisting in the 
formation of high affinity binding sites (Hempstead et al. , 1991 ), or acting as a surface 
reservoir to concentrate the ligands locally and present them to Trk in a favourable 
binding conformation to increase the rate of association ofNGF with Trk. In support of 
this hypothesis, the disruption ofNGF binding to p75NTR impairs the ability ofNGF to 
activate Trk (Barker and Shooter, 1994; Clary and Reichardt, 1994; Lachance et al. , 1997; 
Verdi et al., 1994) and a mutant NGF that binds only Trk is far less efficient at inducing 
biological responses (Barker and Shooter, 1994; Ryden et al. , 1997). p75NTR may also 
influence Trk allosterically thereby conferring high affinity binding, as the 
transmembrane and intracellular domains of p75NTR are necessary to mediate this 
interaction (Esposito et a!., 2001 ). 
55 
p75NTR is able to modulate both the affinity and the selectivity ofTrkA ligation, 
potentiating activation in low ligand situations, and inlllbiting activation ofTrkA by NT-3 
(Hantzopoulos et al., 1994; Verdi et al. , 1994). It is also reported to enhance the 
phosphorylation ofTrk (MacPhee and Barker, 1997) and its downstream signalling 
intermediates, including She (Epa et al., 2004) thereby enhancing Trk activity and 
promoting neurite outgrowth. Furthermore p75NTR is reported to influence the 
ubiquitination ofTrk (Arevalo et al. , 2006; Geetha et al. , 2005; Makkerh et al. , 2005). 
Suppression of ubiquitination delays the internalization and degradation of Trk to prolong 
signalling. Alternatively, p75NTR has also been reported to promote Trk endocytosis and 
retrograde transport via recruitment of E2-E3 ubiquitin ligases, such that internalized Trk 
can promote intracellular signalling reactions. 
While p75NTR clearly enhances the function ofTrkA, this crosstalk is 
bidirectional, as the function and activity ofp75NTR is dependent upon the activation 
status ofTrk (Bamji et al., 1998; Davey and Davies, 1998). Trk-mediated signalling can 
actively suppress the proapoptotic signals elicited by p75NTR ligation. In the absence of 
Trk, neurotrophins are far more effective at inducing apoptosis (reviewed in Huang and 
Reichardt, 2003) as both the Ras-MAPK and PI3K signalling cascades can inhibit the 
activation of JNK-p53 resulting in the repression of apoptosis (Mazzoni et al. , 1999). 
This ensures that p75NTR ligation promotes the efficacy ofTrk signalling when both 
receptors are activated. Trk is also reported to suppress ceramide production (Dobrowsky 
et al., 1995), but does not exert global inhibition over all p75NTR autonomous signalling 
cascades. Trk does not inhibit NFKB activation (Y oon et al. , 1998) and this prosurvival 
cascade actually represents a key point of collaboration between Trk and p75NTR 
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(Hamanoue et al., 1999) that provides a synergistic contribution to survival. The two 
receptors may also synergistically promote survival through activation of Akt (Kaplan 
and Miller, 2000). 
1.3.3 The Role of the Extracellular Matrix in Promoting Regenerative Growth 
Like normal nervous system development, axonal regeneration after injury relies 
on appropriate adhesion to a positive and substantiating substrate and the presence of 
extrinsic informative cues; both functions that can be fulfilled by molecules that comprise 
the ECM (reviewed in Luckenbill-Edds, 1997). The composition ofthe ECM, or 
basement membrane, is dynamic since the individual protein components secreted and 
remodelled by resident cells are regulated temporally and spatially throughout 
development to create subtle distinctions in composition that govern axon pathfinding 
mechanisms by establishing boundaries between permissive and non-permissive areas, 
while attractive and repulsive cues orient the movement of the growth cone at the tip of 
the leading process for the correct positioning of neurons (Giancotti and Ruoslahti , 1999; 
Lemons and Condie, 2008; Porcionatto, 2006). In fact, the classical function of the ECM 
is simply to provide an adhesive substrate for axon growth, but is further appreciated for 
its ability to initiate signalling cascades in a receptor-dependent manner (Miranti and 
Brugge, 2002). 
As the identity of insoluble protein components that comprise the ECM network 
were individually established, it was discovered that a tripeptide motif (RGD) was 
common to the majority ofECM proteins and could mediate adhesive interactions with 
57 
the cell surface via receptors known as integrins (Pierschbacher and Ruoslahti, 1984; 
Ruoslahti and Pierschbacher, 1986). Successful regeneration of the PNS is at least 
partially attributable to the PNS ECM, which is rich in LN that persists to adulthood 
(Martin and Timpl, 1987). In contrast, the adult CNS lacks permissive ECM proteins, 
potentially contributing to the inability of adult CNS axons to regrow. The increased 
expression of adhesion molecules following axotomy is considered to be one of the 
driving forces permitting the extension of the elongating axon (Ekstrom eta!. , 2003; 
Kloss eta!., 1999; Vogelezang et al. , 2001 ; Wallquist et al. , 2004; Werner et al. , 1998; 
Werner eta!., 2000), and the interaction of the growth cone with the extracellular 
substrate is critical for regeneration as a large part of regenerative growth depends on 
molecules that regulate surface-cytoskeletal interaction to modify actin polymerization, 
organization and disassembly (Baas and Ahmad, 2001; Bouquet eta!., 2004; Ellezam et 
a!. , 2002; Schmidt eta!., 1995; Zhang et al. , 2003). 
1.3.3.1 Laminin 
Laminins (LN) represent a major component of the basal lamina of the PNS 
(Martin and Timpl, 1987), and comprise an important family of ECM glycoproteins that 
bind integrin receptors (reviewed in Luckenbill-Edds, 1997; Mecham, 1991 ). LN is 
composed of three polypeptide chains, A, Bl and B2 (also known as a , P andy subunits) 
connected with disulphide linkages to forn1 a cross-shaped molecule capable of self-
assembling to form polymeric sheets (Timpl and Brown, 1996). Multiple LN isoforms 
(denoted LN 1-15) are regionally distributed (Colognato et al. , 2005), and vary in 
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combination of a, p andy subunits. LN-1 is a critical isoform for nervous system 
development and is abundantly expressed in the PNS, synthesized and secreted into the 
extracellular environment by resident cells, including Schwann cells, where it interacts 
with receptors on the cell surface and thereby orchestrates changes in cell behaviour 
(Luckenbill-Edds, 1997). 
Since LN is critical for the formation of the basal lamina, and thus essential to 
development, genetic ablation of LN has been unable to provide information regarding its 
postnatal functions (Bonner and O'Connor, 200 I). Nonetheless, each specific domain of 
the LN molecule is recognized to participate in distinct cellular functions, including the 
promotion of cell adhesion, neurite outgrowth, migration and interaction with other 
glycoproteins (Powell and Kleinman, 1997; Tashiro et al., 1989), and the function of LN 
in general appears to change depending on the developmental stage, shifting from 
directing neural crest cell migration (Previtali et al., 2001; Tarone et al. , 2000) to 
promoting neurite outgrowth and guidance (Forrester and Garriga, 1997; Garcia-Alonso 
et al., 1996). 
In the PNS, LN-1 is a predominant mediator of neurite outgrowth influencing the 
behaviour of the growth cone by a variety of means (Luckenbill-Edds, 1997). Besides 
providing an adhesive substrate for growth, LN is further implicated as an attractive 
guidance cue (Kuhn et al. , 1995) itself, and is demonstrated to influence neuronal 
response to other guidance cues by suppressing intracellular cAMP levels (Hopker et al. , 
1999). 
LN expression is dramatically upregulated following nerve injury (Doyu et al., 
1993; Kuecherer-Ehret et al., 1990; Wallquist eta!., 2002), and is associated with the 
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permissive Bands of Blli1ger (Fawcett and Keynes, 1990). Furthermore, genetic ablation 
of the LNy1 subunit impairs regenerative growth (Chen and Strickland, 2003), as does the 
use of a LN-specific antibody (Wang et al., 1992). LN is also a strong promoter of 
neurite outgrowth in vitro (reviewed in Luckenbill-Edds, 1997). Collectively, these 
studies indicate a role for LN in axonal regeneration following nerve injury, which could 
entail supporting survival and migration of Schwann cells and serving as a substrate for 
axon extension. 
1.3.3.2 Integrins 
The cell surface receptors that bind the RGD motif of ECM proteins are a family 
of proteins known as integrins, named for their ability to integrate extracellular cues with 
intracellular cytoskeletal changes (Giancotti and Ruoslahti, 1999). Integrins are well 
recognized for structural roles facilitating adhesion and forming connections between the 
ECM on the exterior of the cell and the cytoskeleton on the interior of the cell to establish 
tissue architecture and regulate cell shape, but they are further appreciated for their role in 
bidirectional transduction of signals, and thus are central to a wide range of biological 
processes, including proliferation, apoptosis, motility, differentiation, synaptogenesis and 
axonal extension (Coppolino and Dedhar, 2000; Lemons and Condie, 2008; Schlaepfer 
and HW1ter, 1998). As such, integrin signalling is W1derstood to participate in both the 
development of the nervous system and axonal regeneration following nerve injury. 
Integrins are heterodimeric transmembrane receptors comprised of non-covalently 
associated a and ~ subW1its selected from at least 19a and 8~ chains to form more than 24 
60 
unique combinations (Alam et al., 2007). The a and p chains have large extracellular 
domains that together form the ligand binding domain and each subunit contributes to the 
ligand selectivity of the receptor. The subunits possess a single transmembrane domain 
and a short cytoplasmic C-terminus of variable length, but typically short and devoid of 
catalytic motifs (Giancotti and Ruoslahti, 1999; Lemons and Condie, 2008). Most 
integrin heterodimers can function as a receptor for multiple ECM components, there is 
generally more than one integrin pair capable of recognizing any given ligand (Table 1 ), 
and many integrins recognize the RGD sequence common to multiple ECM ligands 
(Hynes, 1992; Pierschbacher and Ruoslahti, 1984; Ruoslahti and Pierschbacher, 1986). 
Despite this considerable overlap, integrins are capable of distinguishing specific ligands 
and can generate both common and specific signals to yield specific biological outcomes 
(Kumar, 1998). 
Integrin receptors are widely expressed in all cell types, including neurons 
(Lemons and Condie, 2008), but expression is cell-type specific (Kumar, 1998). In 
neuronal cells the regulation of integrin surface expression is a function of both the 
amount of available ligand and the specific composition of the ECM (Condie and 
Letourneau, 1997; Strachan and Condie, 2004). Additionally, a variety of integrin 
subunits are upregulated following axotomy (Ekstrom et al. , 2003 ; Kloss et al., 1999; 
Vogelezang et al., 2001; Wallquist et al. , 2004; Werner et al. , 2000). Notably, injury can 
induce expression ofLN-binding integrins in both cell bodies and regenerating axons 
(Hammarberg et al. , 2000), and this increased integrin expression is correlated with 
successful regeneration of the PNS (Lemons and Condie, 2008). This suggests a role for 
integrins in successful regenerative growth that warrants further investigation. 
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Table 1: Integrins and their Ligands. Recognized integrin alP combinations and their ligand 
interactions are presented here. The specific alP interactions determine the functional specificity 
of the receptor complexes. Note that multiple combinations recognize the same ligand, and each 
alP combination can recognize multiple ligands. Table adapted from Alam et al (2007) J. Cell. 
Physiol. 213: 649-653, Takada et al (2007) Genome Bioi. 8(215):211-215. 
p Subunit a Subunit Ligand 
(31 al Laminin, collagen 
a2 Laminin, collagen thrombospondin, E-cadherin, tenascin 
a3 Laminin, collagen, fibronectin, entactin, thrombospondin, uPar 
a4 Fibronectin, VCAM-1 , osteopontin, ADAM, ICAM, MAdCAM-1 , 
thrombospondin, Lu/BCAM, CDI4, JAM-2, uPAR 
a5 Fibronectin, L I, osteopontin, fibrillin, thrombospondin, ADAM, NOV 
a6 Laminin, thrombospondin, Cyr61, ADAM, uPAR 
a7 Lam in in 
a8 Fibronectin, tenascin, nephronectin, vitronectin, osteopontin, TGF-~-LAP 
a9 Tenascin, VCAM-1 , osteopontin, uPAR, plasmin, angiostatin, ADAM, 
VEGF 
aiO Collagen, laminin 
all Collagen 
av Fibronectin, osteopontin, TGF-(3-LAP, L I 
~2 aL ICAM 
aM iC3b, fibrinogen, factor X, ICAM, heparin 
ax iC3b, fibrinogen, collagen, ICAM, heparin 
ao ICAM, VCAM-1 , fibrinogen, fibronectin, vitronectin, Cyr61, plasminogen 
~3 an Fibrinogen, fibronectin, von Willebrand factor, vitronectin, 
thrombospondin, disintegrin, osteopontin, Cyr61, ICAM, L I 
av Vitronectin, fibrinogen, fibronectin, von Willebrand factor, 
thrombospondin, fibrillin , tenascin, PECAM- 1, BSP, ADAM, ICAM, FAF-
2, uPA, angiostatin, TGF-f3-LAP, Del-l , Ll , MMP, osteopontin, 
cardiotoxin, uPAR, plasmin, Cyr61, tumstatin, NOV 
f34 a6 Laminin 
f35 av Vitronectin, osteopontin, fibronectin, TGF-f3-LAP, NOV, BSP, MGF-E8 
~6 av Fibronectin, tenascin, vitronectin, TGF-~-LAP, osteopontin, ADAM 
~7 a4, a iEL Fibronectin, VCAM, MAdCAM-1, osteopontin 
aE E-cadherin 
f38 av Vitronectin, laminin, TGF-_13-LAP 
1.3.3.2.1 Role of Integrins in Growth 
The process of axon extension is contingent upon the protrusion and motility of 
the growth cone at the leading edge (Huber eta!., 2003). Neuronal attachment to the 
ECM is typically sufficient to induce the formation of filopodia which probe the 
environment. Integrins concentrated at the tips of the filopodia initiate points of adhesion 
which allow for the organization of the actin rich lamellipodium as cells spread on the 
ECM (Giancotti and Ruoslahti, 1999) and regulates growth cone motili.ty. Because ofthe 
intimate connection between integrins and actin, integrins serve as a mechanical link 
between the ECM and cytoskeletal organization, but they also mediate the activation of a 
remarkable number of classical signalling pathways inside the cell (Schlaepfer and 
Hunter, 1998). 
Integrin activation results in the suppression of cAMP (Lemons and Condie, 
2006). As previously noted, enhancing cAMP signalling can promote regenerative 
growth (Cai et al. , 2001; Qiu et a!. , 2002a; Qiu et a!., 2002b ), but this is accurate only 
when integrin activation is low (Lemons and Condie, 2006). Integrin activation 
combined with elevated cAMP results in growth cone collapse, likely as a result of 
modulation of Rho GTPases, Rae and Rho. Both cAMP and integrins influence the 
activity of Rho GTPases (Lemons and Condie, 2006; Ridley, 2000; Schwartz and Shattil, 
2000) which in turn, regulate the actin cytoskeleton. Growth cone motility is thus 
regulated by a balance of integrin activation, cAMP and Rho GTPase activation. Rae 
activity in particular must be balanced, as both dominant negative and constitutively 
active forms of Rae suppress neurite extension (Kuhn eta!., 1998; Luo eta!., 1994). 
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An array of approaches has revealed the importance of integrins in promoting 
neurite outgrowth. Genetic deletion of the a7 subunit (which recognizes LN) is 
associated with significantly impaired regeneration after facial nerve axotomy (Werner et 
al. , 2000), although these mice upregulate ~1 after injury thereby promoting central 
axonal sprouting (Werner et al., 1998). Conversely the overexpression of integrin 
subunits is sufficient to restore the regenerative capacity of adult sensory neurons making 
it comparable to the embryonic situation (Condie, 2001). Additionally, forced integrin 
expression and the provision of a complimentary ligand can permit extending axons to 
overcome inhibitory environmental elements including CSPGs and myelin associated 
components (Condie et al., 1999). As further supporting evidence, the marked induction 
ofLN-binding integrins results after axotomy ofthe peripheral branch of the DRG axon, 
but not after injury to the central branch of the DRG axon, thus correlating with 
regenerative success (Wallquist et al., 2004). This discrepancy can be overcome by a 
preconditioning lesion, which elevates expression of a5 and a7, subsequently promoting 
growth cone motility and enhancing growth (Ekstrom et al. , 2003; Gardiner et al., 2007). 
The ability of a neuron to regulate surface expression of integrin receptors significantly 
contributes to the ability of the growth cone to maintain an intermediate level of 
attachment and constant motility over widely varying amounts of LN and suboptimal 
substrata (Condie, 2001; Condie and Letourneau, 1997; Condie et al., 1999; Lemons et 
al. , 2005). In fact, neonatal growth cones can regenerate in CSPG-rich environments by 
elevating integrin surface expression. Adult neurons do not adapt spontaneously but 
forced integrin overexpression can abrogate inhibition induced by the environment 
(reviewed in Lemons and Condie, 2008). Also contributing to this finite control is the 
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availability of extracellular ligand, and the regulation of the functional state of the 
integrin; that is, the ability of the intracellular state of the cell to modulate integrin 
function (Takagi et al. , 2002). 
1.3.3.2.2 Integrin Activation and Signaling 
As previously indicated, integrin receptors are able to signal bidirectionally, 
transmitting information across the plasma membrane in both directions (Coppolino and 
Dedhar, 2000; Giancotti and Ruoslahti, 1999). Integrin affinity for ligand is regulated by 
signals that initiate inside the cell and are conducted extracellularly (inside-out 
signalling), while integrin ligation transmits extracellular signals inside the cell (outside-
in signalling). The regulation of growth can therefore be influenced not only by the 
surface expression level or repertoire of integrins, but also by the activation state of these 
receptors, which dictates functionality and can be altered during developmental 
maturation and in response to ECM, providing a sophisticated mechanism for the 
regulation of integrin activity at the cell surface (Coppolino and Dedhar, 2000; Lemons 
and Condie, 2006). As a result, integrins can exist in an inactivated low-affinity 
conformation, where the extracellular domain of each subunit exists in a folded 
conformation and the transmembrane and cytoplasmic domains are laterally associated, or 
in an activated high-affinity conformation, where the extracellular domains swing open 
distally and the transmembrane and cytoplasmic domains separate (Xiao et al. , 2004). 
This allosteric switch can be induced via effector binding to the intracellular tails of the 
integrin (Tadokoro et al., 2003; Vinogradova et al. , 2002), or by extracellular ligation of 
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the receptor (Takagi et al., 2002). In the activated conformation, p 1 cytoplasmic tails 
become linked to the actin cytoskeleton via the actions of cytoplasmic adapter proteins 
(Critchley, 2004; Liddington and Ginsberg, 2002) and this can promote regenerative 
growth under poor environmental conditions where growth promoting molecules are 
sparse (Ivins et al. , 2000; Lemons and Condie, 2006; Neugebauer and Reichardt, 1991). 
1.3.3.2.2.1 Inside-Out Signaling 
Integrins can bind and interpret ECM molecules, transmitting this information into 
the cell, but information can also be transmitted in the reverse direction, from the 
cytoplasmic tail to the extracellular domain (Kolanus and Seed, 1997; Schwartz et al. , 
1995) to regulate the activation state of integrins on the cell surface. Inside-out signalling 
occurs primarily via two mechanisms: intracellular signals can induce changes in ligand 
binding affinity through propagation of a conformational change from the cytoplasmic 
tail to the extracellular domain, thus creating a conformation more favourable to ligand 
binding (Hughes et al., 1996; O'Toole et al., 1994; O'Toole et al. , 1991). Secondly, 
intracellular signals can alter the avidity of integrin-ligand interactions by redistributing 
receptors within the plasma membrane, creating clusters of integrins which can promote 
multivalent interactions necessary for full receptor activation (Brown, 1997; Shattil and 
Ginsberg, 1997). Changes in avidity are thought to be regulated at least in part by the 
cytoskeleton that permits lateral movement of the integrins (Harris et al. , 2000; van 
Kooyk and Figdor, 2000), as well as by adapters and enzymes, including PI3K, PKC, Ras 
and Rap, among others (Shimizu, 1996; van Kooyk et al., 1999). 
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1.3.3.2.2.2.0utside-In Signaling 
Interaction of an integrin heterodimer extracellular domain with ECM molecules 
can induce rapid activation of the integrin, which is critical for the inward transmission of 
signals for the modulation of cellular activities. Outside-in signalling can mediate cell 
adhesion, survival, growth and migration, by ligating ECM molecules and transducing 
signals through multi protein complex interactions and the initiation of biochemical 
cascades allowing the cell to interpret the extracellular environment and respond 
appropriately (Coppolino and Dedhar, 2000; Lemons and Condie, 2008; Miranti and 
Brugge, 2002). Since the integrin cytoplasmic tail lacks catalytic activity, the 
transduction of extracellular signals required integrin aggregation within the plane of the 
membrane (Giancotti and Ruoslahti , 1999) and the subsequent recruitment of adapter 
proteins, non-receptor protein tyrosine kinases and cytoskeletal elements to form focal 
adhesions wherein signalling is facilitated by the high local concentration of these 
proteins (Bray et al., 1998). The activated state of integrins is necessary, but not 
sufficient to induce clustering. This also requires the presence of PIP2 and tal in, and 
immobilization of the ligand (Cluzel et al. , 2005). Furthermore, both receptor clustering 
and ligand occupancy are central for full activation of integrin-mediated responses 
(Miyamoto et al. , 1995). 
1.3.3.2.3 Integrin Associated Signalling Cascades 
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Integrin-ECM interactions at the cell surface induce receptor clustering and 
recruitment of a variety of intracellular effectors, some of which link directly to the actin 
cytoskeleton to alter cell morphology, but others initiate tyrosine and serine 
phosphorylation events triggering multiple parallel downstream signalling cascades that 
interact and coordinate to change gene expression and alter cellular behaviour to drive a 
growth response (Coppolino and Dedhar, 2000; Giancotti and Ruoslahti, 1999; Kumar, 
1998; Tucker et al., 2005; Tucker et al., 2006; Tucker et al. , 2008). A large number of 
proteins have been demonstrated to associate transiently or stably to focal adhesions and 
interact via multiple binding domains on each molecule to create a web of proteins that is 
difficult to detangle in terms of the sequence of signal transduction events (reviewed in 
Miranti and Brugge, 2002) downstream of integrin ligation (Figure 1.5). Nonetheless, 
several critical interactions have been elucidated. 
The cytoplasmic tail of the ~ subunit interacts directly with cytoskeletal 
components including talin and a-actinin (Horwitz et al., 1986; Otey et al. , 1990), which 
subsequently interact with other cytoskeletal elements, zyxin, paxillin, and vinculin, 
which in turn, bind tensin. This resulting focal adhesion scaffolding is critical for 
maintenance of cell-substrate adhesion (Burridge et al., 1988). 
The ~1 cytoplasmic tail can also interact directly with theN-terminal domain of 
focal adhesion kinase (F AK), which plays a central role in integrin-stimulated signalling 
events (Chen et al. , 1995b; Lewis and Schwartz, 1995; Miyamoto et al. , 1995; Schaller et 
al. , 1995). Upon integrin activation, F AK localizes to sites of focal adhesion and 
becomes autophosphorylated at tyrosine 397, creating a docking site for SH2-domain 
containing proteins, including Src and Src Family kinases (SFK) (Schaller et al. , 1994; 
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Figure 1.5: Schematic illustration of integrin-mediated intracellular interactions. 
Integrin ligation results in aggregation and the subsequent recruitment of various adapters 
and kinases, including F AK, Src and ILK, providing direct links to the actin cytoskeleton 
and initiating multiple biochemical cascades. Adapted from Miranti and Brugge, Nature 
Cell Biology 2002 4: E83-E90. 
Aas Raf 
Figure 1.5 
Schlaepfer et al., 1994). Src can further phosphorylate F AK at other tyrosine residues, 
promoting full catalytic activity ofF AK, and creating additional SH2 binding sites for the 
transduction of signals to many downstream pathways. For example, binding of She or 
Grb2-SOS results in the activation of the Ras-MAPK cascade (Schlaepfer and Hunter, 
1997), which results in the induction of transcription factor activity for the promotion of 
growth and differentiation (reviewed in Kumar, 1998), but can also promote migration in 
a transcription-independent manner (Klemke et al., 1997). The F AK-Src complex also 
results in the phosphorylation ofF AK associated proteins, including paxillin, tensin, 
vinculin, and large adapter p 130CAS (Schlaepfer and Hunter, 1997; Vuori et al. , 1996), 
and promotes a direct interaction between the C-terminus ofF AK and tal in (Chen et al. , 
1995b ). Furthermore, phosphorylation ofF AK enables it to interact with PI3K, either 
directly or through Src, resulting in its activation (Chen et al. , 1996a), and the 
downstream activation of Akt. 
Another protein demonstrated to interact with the p 1 intracellular domain is 
Integrin-linked Kinase (ILK), which can function as both an adapter and a 
serine/threonine kinase to mediate cellular attachment and signal transduction 
downstream of integrin activation (Hannigan et al. , 1996). ILK influences the activity of 
GSK3 P and Akt and thereby likely has a role in neuronal growth and survival 
(Delcommenne et al. , 1998; Persad et al. , 2000; Persad et al., 2001 ). 
Integrins are complex bidirectional receptors that have direct links to the 
cytoskeleton and are capable of instigating diverse molecular interactions and initiating 
numerous downstream signalling pathways, and are therefore well-positioned to be 
central regulators of both developmental and regenerative growth responses. 
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1.4 Rat Pheochromocytoma Cells as a Model for Axonal Regeneration 
Rat pheochromocytoma (PC12) cells were clonally derived in 1976 from a 
transplantable rat pheochromocytoma (Greene and Tischler, 1976) and have since been 
used extensively in the study of fundamental problems relating to neuronal cell 
differentiation and function. PC12 cells display multiple features of sympathicoblasts, 
the precursors to post-mitotic sympathetic neurons, and can be differentiated by 
prolonged exposure to NGF to acquire the phenotypic properties of mature sympathetic 
neurons. In this regard, the robust response to NGF occurs via the two distinct receptors, 
p75NTR and TrkA, and results in cessation of proliferation, extension of neurite 
outgrowth, generation of electrical excitability and functional synapse formation (Greene, 
1982; Shafer and Atchison, 1991 ). Thus PC 12 cells serve as a valuable model for the 
study ofNGF responses, which is further complimented by the ease of genetic mutability. 
The introduction of new genes and modifications can be propagated as permanent lines. 
A prime example of this technique has been used in this series of studies. An NGF-
nonresponsive PC 12 cell line, which arose as a spontaneous mutation to lack TrkA 
expression, was transfected with a series of mutated Trk receptors. The resulting stable 
cell lines were previously used for the dissection of specific Trk-mediated signalling 
pathways (Obermeier et al. , 1993a; Obermeier et al. , 1993 b; Stephens et al., 1994 ). 
PC 12 cells are also a useful model for the study of neuronal interactions with the 
ECM (Tomaselli et al. , 1987). These cells possess the ability to extend neurites across 
collagen (Col), LN or fibronectin (FN) coated substrates, which closely approximates the 
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response of sympathetic neurons (Tomaselli et al. , 1987). Both cell types share common 
structurally homologous ECM receptors which selectively interact with distinct structural 
domains of LN (Tomaselli et al. , 1987). Investigations of neuronal interaction with ECM 
proteins are hindered by the requirement for pure neuronal cultures in sufficient quantities 
for biochemical analyses. The use of neuronal cell lines, like PC 12, can circumvent this 
difficulty. PC12 cells are well characterized, homogeneous, stable and respond to NGF 
and ECM with reasonable fidelity to normal sympathetic neurons (Greene, 1982; Hosang 
and Shooter, 1985; Tomaselli et al. , 1987). 
Despite these many advantages, the use ofPC12 cells also has limitations: they 
are derived from tumour cells and thus cannot be interpreted as an exact model of 
neuronal behaviour. They do not form dendrites and differ from neurons regarding 
formation of synaptic connections. For this reason, findings must be replicated and 
verified in primary neuron cultures. Furthermore, PC12 cells can be subject to 
spontaneous mutation and the inadvertent selection of a subpopulation with 
characteristics that differ from the norm. As changes over time are inevitable, all 
experiments in these studies have been performed with passage number lower than 10. 
Primary neuronal cultures possess obvious advantages with respect to the 
physiological relevance of experimental outcomes. However, these cells must often be 
cultured at a particular developmental stage to ensure viability, are more difficult to 
maintain long-term, and cultures are rarely free of non-neuronal contaminants. 
Furthermore, primary neurons are notoriously difficult to transfect, and thus cannot be 
easily manipulated on a genetic level. The present series of studies utilizes cultures of 
various CNS neurons, including cerebellar granule neurons (CGN) and hippocampal 
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neurons to determine the effects of neurotrophic and ECM stimulation on cellular 
responses, both biochemical and functional. Neurons isolated from the postnatal cerebral 
cortex were not used for these studies, as they lose the ability to adhere to LN shortly 
after birth. 
1.5 Purpose of the Study 
Like growth and guidance of the developing nervous system, axonal regeneration 
following nerve injury is largely dependent upon factors found in the extracellular 
environment. One of the key factors involved in regenerative neurite outgrowth, is the 
trophic support provided by the neurotrophins, including NGF, which stimulates the 
initiation and extension of neurites by binding to two structurally distinct receptors. Trk.A 
ligation and subsequent phosphorylation of the cytoplasmic tail initiates discrete 
signalling cascades for the promotion of growth and survival. p75NTR, the low affinity 
receptor is associated with a variety of signalling interactions, both ligand-dependent and 
independent, and ligation outcome depends upon Trk.A coexpression. 
Another key factor involved in the promotion of axonal regeneration following 
nerve injury is the existence of a permissive environment, the signals from which are 
mediated by the integrin receptors. Integrins themselves are capable of initiating a wide 
variety of signalling interactions upon ligand binding and subsequent aggregation. 
Because ECM proteins and neurotrophins promote axonal regeneration using similar 
intracellular signalling cascades, optimized neurite outgrowth may potentially be 
achieved through synergistic or cooperative crosstalk between cascades activated by 
75 
neurotrophins and those activated by ECM proteins, which integrate to stimulate 
reorganization of the cytoskeleton and induce requisite gene expression for a regenerative 
response. These signalling interactions may occur at several levels, from receptor 
transactivation, to cooperative activation of downstream components, to modulation of 
co-receptor expression or activity, thus enabling a tightly controlled cellular response. 
The goal of this project was to investigate signal transduction steps activated by 
neurotrophin and ECM ligands to determine how these pathways may cooperate in order 
to promote optimal axonal regeneration. Elucidating neuronal growth or regeneration 
programs in PNS neurons is likely to provide insights into ways of enhancing CNS repair. 
I hypothesize that TrkA plays a role in cooperative signalling with integrins that results in 
enhanced neurite outgrowth, and that particular phosphorylation sites on the TrkA 
cytoplasmic tail are important to this cooperativity, by promoting enhanced activation of 
downstream signalling intermediates and receptors necessary for promotion of growth, 
through pathway crosstalk or intersection or by removing inhibition. Additionally, any 
growth response is likely to depend on a contribution from p75NTR, which has the 
potential to impact growth both in the presence and absence of ligand. Integrin signalling 
may be enhancing NGF signalling by promoting further activation ofTrk-induced 
intermediates or suppressing p75NTR-induced inhibition. These signalling interactions 
may alter actin dynamics which is important for both axonal regeneration and cell 
migration. 
Objective 1: Determine the effects ofTrkA signalling on p75NTR expression using 
TrkA phosphorylation mutants. The cellular responses to NGF are mediated by two 
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structurally unrelated receptors, TrkA and p75NTR, which have been shown to interact 
resulting in reciprocal modulation of function. It is essential to investigate what effects 
p75NTR signalling is having with regard to both its well known role in moderating 
TrkA:NGF signalling and its own autonomous cascades, and I hypothesized that NGF 
may be acting via a Trk-induced signalling cascade to influence p75NTR expression. In 
this study, the modulation of p75NTR expression by specific TrkA autophosphorylation 
sites in the presence or absence ofNGF was examined. We have used cell lines derived 
from PC12 cells that express either no endogenous TrkA (PC12nnr5) or TrkA receptors 
mutated via site-directed mutagenesis to abrogate the individual tyrosine residues on the 
cytoplasmic tail (Y490F, Y785F, Y490/785F) (Chapter 2). Upon determination that NGF 
results in the upregulation ofp75NTR expression in those cell lines that express a 
functional Y785 phosphorylation site, pharmacological inhibition and siRNAs were 
utilized to investigate the mechanism by which NGF induces the upregulation of p75NTR 
expression (Chapter 3). 
Objective 2: Investigate the impact of permissive ECM component, LN, on the 
expression of p75NTR, and determine how this relates to neurite outgrowth. LN is a 
key factor in promoting axonal regeneration, working co-ordinately to regulate growth in 
conjunction with neurotrophin signals. While LN-mediated mechanisms are not well-
defined, they likely represent a complex interplay between enhancement of permissive 
cues and downregulation of those which are inhibitory. I hypothesized that LN may 
signal cooperatively with Trk-activated cascades to enhance regenerative growth, either 
by promoting the phosphorylation of signalling intermediates essential to growth, or by 
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decreasing the presence of inhibitory signals. This study used NGF-differentiated PC12 
cells to investigate potential interactions between LN and NGF-mediated signalling 
pathways, and correlated these events with their impact on regenerative growth. I also 
examined the impact ofLN on the expression ofp75NTR, which has the potential to 
inhibit neurite outgrowth in the absence of neurotrophins (Chapter 4 ). 
Objective 3: Determine the role of LN-mediated downregulation of p75NTR in CNS 
neurons. Having determined that LN-mediates a downregulation of p75NTR expression 
that is dependent upon PTEN induction and results in enhanced regeneration ofPC12 
cells, I subsequently investigated whether these signalling interactions occur in neonatal 
hippocampal neurons, and whether they correlate with enhanced growth (Chapter 4). 
Having determined that the LN-mediated alterations in PTEN and p75NTR were 
associated with influence over actin cytoskeletal remodelling via changes in active Rho, I 
hypothesized that this signalling cascade may also play a role in neuronal migration. I 
determined that LN-mediated changes in PTEN and p75NTR correlate temporally with 
the period of developmental migration of cerebellar granule neurons from the external 
granule layer to the internal granule layer. Investigation ofLN-mediated cell migration 
was undertaken using a novel motility assay (Chapter 5), and I used a variety of 
pharmacological inhibitors, siRNA and genetic overexpression to determine ifthe LN-
induced changes in PTEN and p75NTR were associated with the regulation of cerebellar 
granule neuron migration (Chapter 6). 
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Objective 4: Determine the mechanism by which PTEN downregulates p75NTR 
expression. My previous study indicated that the LN-mediated downregulation of 
p75NTR was at least partially transcriptional in nature. I therefore hypothesized that 
PTEN could be influencing the activity of transcription factors that regulate p75NTR 
expression. To study the molecular interactions between the induction ofPTEN 
expression and the subsequent downregulation ofp75NTR, I employed a series ofPTEN 
activation mutants, localization immunocytochemistry and a variety of techniques to 
analyze the DNA-binding ability oftranscription factor Spl. These results were 
subsequently applied to the study of cerebellar granule neurons (Chapter 7). 
Objective 5: Investigate the regulation of PTEN expression by both TrkA and 
integrin associated signalling cascades. Having determined that both TrkA and PTEN 
each independently regulate p75NTR expression, I hypothesized that TrkA could 
modulate PTEN expression upstream of changes to p75NTR. I therefore investigated 
whether TrkA phosphorylation sites had any influence over PTEN expression, and 
whether this influence could modulate cellular behaviours including growth and 
migration (Chapter 8). Furthermore, as integrin activation can induce PTEN expression, I 
hypothesized that this induction was due to downstream activation of integrin-associated 
signalling components. I examined the LN-mediated induction ofPTEN, and 
investigated the role of integrin-associated signalling components in this induction using 
pharmacological and genetic inhibition (Chapter 9). 
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Brief Summary of Results: The results of these studies detail signalling events required 
for the regulation of p75NTR expression for the promotion of neurite outgrowth and 
motility. The neurotrophin-induced upregulation of p75NTR occurs via the PLC-y-PKC-
8 signalling cacscade initiated by ligation of the Trk receptor. The ECM signals via 
integrin activation and associated focal adhesion formation to induce Egr-1 activity which 
results in a rapid and potent upregulation of phosphatase PTEN. PTEN relocalizes to the 
nucleus where it exerts protein phosphatase activity over transcription factor Sp 1 to 
decrease its DNA binding activity to the p75NTR promoter, resulting in decreased 
p75NTR transcription. This is followed by a decrease in p75NTR protein expression 
which is associated with a decrease in constitutively active Rho, and a subsequent growth 
or motility response. Collectively these studies demonstrate the importance of different 
modes of modulating p75NTR expression to control its signalling interactions, which can 
influence the cytoskeleton for both growth and motility responses in a variety of neuronal 
cell types. 
Schematic overview of thesis results and associated chapters is provided in Figure 1.6. 
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Figure 1.6: Schematic overview of thesis results and associated chapters. 
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THESIS CO-AUTHORSIDP STATEMENT 
This thesis is comprised of 11 chapters. Chapter 1 introduces the background and 
rationale for the thesis work. Chapters 2-9 contain the original data compiled from each 
of the projects completed for the thesis. Chapter 10 gives a discussion which highlights 
the cohesiveness of the projects completed during this study, while Chapter 11 
summarizes the major conclusions of this work. 
A great majority of the work described in this thesis was performed by the author, 
Sherri Rankin, whose primary role was a contribution to the design of the research 
proposal, development of research methodology, data collection and analysis, and 
preparation of the manuscripts. Chapter 2 was published as a first-author paper entitled: 
"Trk.A NGF receptor plays a role in the modulation of p75NTR expression" in 
Neuroscience Letters, 2005, volume 383, pp.305-31 0. The work comprising Chapter 3 
has been accepted for publication as a first-author paper entitled: "Neurotrophin-
induced upregulation of p75NTR via a Protein Kinase C-delta dependent 
mechanism" in Brain Research, 2008, volume 1217, pp. 10-24. A portion of the work 
comprising Chapter 4 has been accepted for publication as a first author paper entitled 
"Neurite Outgrowth is Enhanced by Laminin-Mediated Downregulation of the Low 
Affinity Neurotrophin Receptor, p75NTR" in Journal of Neurochemistry, 2008. The 
work comprising Chapter 5 was published as a first-author manuscript entitled "A 
method to assess multiple aspects of the motile behaviour of adherent PC12 cells on 
applied biological substrates" in Journal of Neuroscience Methods, 2006, volume 156, 
pp. 55-63. The work comprising Chapter 7 has been accepted for publication as a first 
author paper entitled "PTEN downregulates p75NTR expression by decreasing the 
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DNA binding activity of Spl" in Biochemical and Biophysical Research 
Communications, 2008. The author appreciates and recognizes those contributions made 
by others as follows: The real-time RT-PCR studies used throughout this thesis were all 
performed by Cliff Guy, who also provided assistance with DNA cloning for construct 
creation and lentiviral production, and assisted with the EMSA and ChiP analyses 
presented in Chapter 7. Masuma Rahimtula provided extensive assistance with animal 
dissection for Chapters 3 and 4, technical assistance with assay design in Chapter 5, and 
was responsible for the preparation of chemical compounds used throughout the thesis. 
Dr. Mearow played a pivotal role in the experimental design, and participated in the 
trouble-shooting, and correction and improvement of the manuscripts. 
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Chapter 2: TrkA NGF receptor plays a role in the modulation of p75NTR 
expression 
This study has been published in Neuroscience Letters in August 2005, volume 383, pp. 
305-310. 
2.0 Summary 
The cellular response to nerve growth factor (NGF) is mediated by two structurally 
unrelated receptors, TrkA and p75 neurotrophin receptor (p75NTR), which have been 
shown to interact resulting in reciprocal modulation of function. In this study, we have 
examined the modulation of p75NTR protein expression by specific TrkA 
autophosphorylation sites in the presence or absence ofNGF. We have used cell lines 
derived from PC12 cells that express either no endogenous TrkA (PC12nnr5) or TrkA 
receptors mutated via site-directed mutagenesis to abrogate individual tyrosine 
autophosphorylation sites on the cytoplasmic tail (Y490F, Y785F, Y490/785F). Results 
indicate that in the absence of TrkA in PC 12nnr5 cells there is reduced constitutive 
p75NTR expression, which can be restored to different degrees by transfection of the 
Y490F TrkA or the Y490/785F TrkA, but not by transfection ofthe Y785F TrkA. In 
addition, the expression ofp75NTR was upregulated in the presence ofNGF in the 
parental and Y490F cell lines only. Together these results indicate a role for the 
individual tyrosine autophosphorylation sites ofTrkA in regulating p75NTR expression. 
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2.1 Introduction 
Nerve Growth Factor (NGF) is a neurotrophic factor that is essential for the 
growth, survival and maintenance of the developing nervous system, influencing specific 
populations of sensory, sympathetic and central nervous system neurons (Barde, 1989; 
Cattaneo and McKay, 1990; Huang and Reichardt, 2001; Levi-Montalcini, 1987; Ruit et 
al. , 1990). In PC 12 cells, it is instrumental in the cessation of cellular proliferation and 
neurite outgrowth that is characteristic of neuronal differentiation (Greene and Tischler, 
1976; Greene, 1982). 
The biological effects ofNGF are mediated by two structurally unrelated 
receptors, TrkA and p75 neurotrophin receptor (p75NTR). p75NTR, classically known as 
the low-affinity NGF receptor, is a member of the tumor necrosis factor (TNF) receptor 
superfamily, traditionally associated with apoptosis. While p75NTR is able to bind all 
neurotrophins in the NGF family with equal affinity (Levi-Montalcini, 1987), ligand 
binding is not associated with intrinsic enzymatic activity (Roux and Barker, 2002). In 
contrast, NGF binding to the receptor tyrosine kinase TrkA results in receptor 
dimerization and transautophosphorylation of specific tyrosine residues on the 
cytoplasmic tails. These phosphorylated residues then serve as docking sites for proteins, 
which in tum become tyrosine phosphorylated to initiate signalling cascades (Kaplan and 
Miller, 2000). 
TrkA contains only 2 cytoplasmic tyrosine residues outside of the kinase domain: 
Y490 binds She, resulting in activation ofthe Ras/MAPK signalling cascade, while Y785 
serves as a site for PLCy interactions. These specific pathways have been dissected using 
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mutated PC12 derivatives, and the individual cascades were found to compensate for each 
other in regards to neurite outgrowth (Loeb et al., 1994; Obermeier et al. , 1993a; Stephens 
et al., 1994). 
PC12 cells express both TrkA and p75NTR NGF receptors, and are commonly 
used for mutational analysis ofthe role ofTrkA in NGF-mediated survival and 
differentiation responses due to their ease of mutability. When studying NGF responses, 
it is essential to be aware of the full complement ofNGF surface receptors mediating all 
NGF signals, as well as potential mutations that may influence the expression of one or 
the other NGF receptor. p75NTR is typically studied in regards to its role in 
collaborating functionally with TrkA, but no studies to date have addressed the potential 
role ofTrkA in modulating p75NTR expression. 
Since TrkA overexpression was noted to coincide with an increase in the number 
of low-affinity binding sites for NGF (Hempstead et al. , 1992), and the absence of TrkA 
in PC12nnr5 cells was accompanied by a decreased expression ofp75NTR mRNA (Loeb 
et al., 1991), we employed a well characterized PC12 derived mutant model to investigate 
the importance of the individual TrkA cytoplasmic tail autophosphorylation sites in the 
modulation ofp75NTR expression. 
2.2 Materials and Methods 
2.2.1 Cell culture 
The experimental model consisted of parental PC 12 cells, and 4 mutated PC 12 
derivative cell lines (gifts from Dr. David Kaplan), which were employed in earlier 
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studies examining the role of individual TrkA autophosphorylation sites in NGF 
signalling cascades (Green et al., 1986; Loeb and Greene, 1993; Loeb et al., 1994; 
Stephens et al., 1994). PC12nnr5 cells were derived by mutating parental PC12 cells 
using ethyl methanesulfonate (EMS), as described by Green et al. (Green et al., 1986). 
PC12 derivatives expressing mutated TrkA receptors (Y490F, Y785F, Y490/785F) were 
created by Stephens et al. (Stephens et al., 1994). Briefly, PC12nnr5 cells were 
transfected to express a TrkA receptor that had been altered via site-directed mutagenesis 
to abrogate either one or both ofthe autophosphorylation sites of the cytoplasmic tail. 
Cells were maintained on rat-tail collagen-coated tissue culture flasks in RPMI 
medium supplemented with 10% horse serum, 5% fetal calf serum and 1% 
penicillin/streptomycin/glutamine solution. In the case of mutated lines Y 490F, Y785F 
and Y 490/785F, media was additionally supplemented with Geneticin G418 ( 4j.iL/mL) to 
ensure continued selection of the mutant population. All cells were incubated at 37° C in 
5% C02. 
2.2.2 Western blot analyses 
For Western blot analysis, cells were trypsinized and subcultured on Poly-D-
Lysine coated 12-well plates in serum-starved conditions for 24 hours in the presence or 
absence ofNGF (50ng/mL). Cells were then harvested in the presence of sodium 
orthovanadate and subsequently subjected to lysis overnight at 4° C prior to centrifugation 
(10,000 rpm, 5min). A BCA protein assay (Pierce, Rockford IL) was used to determine 
protein concentration and equivalent amounts of protein (50j.ig) were loaded onto 8% 
SDS-polyacrylamide gels. Gels were subsequently transferred to nitrocellulose 
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membranes that were then exposed to Ponceau red to ensure equal protein loading. After 
washing in TBS, blots were blocked in 3% non-fat dry milk for 1 hour at room 
temperature, and then incubated with a primary antibody directed toward either p75NTR 
(MC192; Oncogene, San Diego CA) or TrkA (06-574; Upstate Biotechnology, 
Charlottesville, VA) overnight at 4° C. A second p75NTR antibody (REX; a kind gift 
from Dr. L Reichardt) was also used in some experiments to detect p75NTR expression. 
A final incubation with HRP-conjugated secondary antibody (AP307P, AP308P; 
Chemicon, Temecula, CA) for 1 hour at room temperature was followed by visualization 
using an ECL method. Each experiment was repeated three times, subjected to 
densitometry and normalized to mitogen-activated protein kinase (MAPK) to ensure 
equal protein for comparison. Statistical analysis was performed using GraphPad Prism 4 
with significance being determined using one-way ANOV A testing. 
2.2.3 Real-time RT -PCR 
For real time RT-PCR analysis, cells were subcultured on Poly-D-Lysine coated 
12-well plates in serum-starved conditions for 24 hours in the presence or absence of 
NGF (50ng/mL). RNA was isolated using Trizol reagent (Invitrogen) as per the 
manufacturer's instructions and was subsequently treated with DNase (Ambion) to 
remove traces of contaminating DNA. RNA was reverse transcribed to eDNA using 
MMLV reverse transcriptase (Invitrogen) prior to use as template for real-time PCR 
amplification using the following PCR primer pairs: p75plus 5' -
TGCATCTGAGCTGGTGTCTGTCTT, p75minus 5' -TGCGTACAATGCTCC 
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TGGTCTCTT, GAPDH plus 5'-CCATCACCATCTTCCAGGAG, GAPDH minus 5'-
CCTGCTTCACCACCTTCTTG. PCR amplification was performed using the Roche 
LightCycler and quantified using SYBR green I. P75NTR mRNA expression was 
subsequently normalized using the housekeeping gene, GAPDH. 
2.2.4 Immunocytochemistry 
For immunocytochemical studies, cells were trypsinized and subcultured serum-
free on Poly-D-Lysine coated 16-well chamber slides for 24 hours in the presence or 
absence ofNGF (50ng/mL), prior to fixation in 4% formaldehyde for 15 min. Cells were 
then permeabilized with 0.1% Triton-X-I 00 and blocked with 10% normal goat serum in 
PBS for 1 hour at room temperature. Cells were incubated with a monoclonal antibody 
directed against p75NTR (MC 192,0ncogene) and a polyclonal antibody directed against 
TrkA (Upstate Biotechnology) for 16 hours at 4° C, followed by incubation with Cy2- and 
Cy5-tagged secondary antibodies (Jackson ImmunoResearch Laboratories Inc.) for 1 hour 
at room temperature. Finally slides were coverslipped with glycerol, and the receptor 
expression patterns were visualized using confocal laser scanning microscopy. 
2.3 Results 
Western blot analyses illustrate that the constitutive level of p75NTR protein 
expression is reduced in PC12nnr5 cells to 38.8+/-5.22% relative to the parental cell line 
(Fig 2.1A). This result is consistent with other studies that have noted reduced p75NTR 
mRNA (Loeb et al., 1991) and a reduced number of low affinity binding sites (Green et 
al., 1986) associated with the PC12nnr5 cell line. In PC12nnr5 cells transfected with the 
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Fig. 2.1. Constitutive p75NTR expression. A. Constitutive p75NTR protein expression 
is significantly reduced in PC12nnr5 cells that lack NGF receptor TrkA. Expression of 
p75NTR can be restored to different degrees by expression of a TrkA receptor mutated to 
abrogate autophosphorylation at Y 490 or Y 490/785, but not by expression of a TrkA 
receptor mutated to abrogate autophosphorylation site at Y785. Values expressed 
represent the mean p75NTR protein expression, relative to MAPK, of9 experiments +/-
SEM. *p<0.05 as determined by one-way ANOV A. HEK293 cells which do not express 
p75NTR, served as a negative control. B. Constitutive p75NTR mRNA expression, as 
determined by real time RT-PCR quantification ofSYBR green I, displays a similar 
trend. Values expressed represent the mean p75NTR mRNA expression of9 experiments 
+/- SEM. *p<0.005 as determined by one - way ANOV A. 
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Y490F TrkA receptor, p75NTR protein expression is restored to levels greater than the 
parental line (122.0+/-9.2%). In contrast, in PC12nnr5 cells transfected with the Y785F 
TrkA receptor, p75NTR expression is not significantly different from the PC12nnr5 
constitutive expression, remaining 51.9+/-6.26% lower than wild-type. Transfection of 
the PC12nnr5 cell line with the Y490/785F TrkA receptor restored p75NTR protein 
expression to levels not significantly different from wild-type (119.9+/-10.5%) (Fig 
2.1A). These results are confirmed by the p75NTR expression patterns noted in both the 
mRNA expression profile (Fig. 2.1 B), and the immunocytochemical assessment (Fig 2.2). 
It is conceivable that the amount ofTrkA introduced into the cells could be 
influencing the expression ofp75NTR separately from the phosphorylation site 
alterations. The mutant cell lines employed in this study were selected as low-expressers 
in terms ofTrkA, (personal communication, Dr. D. Kaplan), and this was confirmed both 
by Western blot analysis ofTrkA levels expressed by each cell line (Fig. 2.3), and by 
immunocytochemistry (data not shown). All mutant lines express between 0% and 
20.5+/-2.8% of the TrkA levels associated with wild type PC12 cells, thus eliminating the 
possibility that a TrkA overexpression is the cause of the p75NTR overexpression noted 
in Y 490F cells. 
Since NGF is a known trigger for p75NTR upregulation in neurons in vitro 
(Lindsay et al., 1990), in vivo (Kitzman et al. , 1998; Wyatt and Davies, 1993), and in 
PC 12 cells (Doherty et al. , 1988), we investigated whether or not the addition ofNGF to 
the culture media would result in upregulation of p75NTR in the presence of a mutated 
TrkA receptor. By Western blot analysis, we determined that only the wild-type and 
Y490F cell lines responded to 24 hours ofNGF exposure with a significant increase of 
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Fig 2.2. p75NTR immunoreactivity. Photomicrographs illustrating the p75NTR 
expression patterns of parental PC12 cells (A,B), PC12nnr5 cells lacking TrkA (C,D) and 
cell lines expressing mutated TrkA receptors: Y 490F (E,F), Y785F (G,H) and Y 490/785F 
(I,J). A, C, E, G, and I represent control conditions, and B, D, F, H, and J are 
representative of cells plated in the presence ofNGF (50 ng/mL) for 24 hours. PC12nnr5 
and Y785F cell lines express low levels ofp75NTR, and receptor upregulation is not 
noted in response to NGF. In contrast, PC1 2, Y490F and Y490/785F cell lines 
constitutively express higher levels ofp75NTR, though only PC12 and Y490F exhibit 
NGF-dependent p75NTR upregulation. Scale bar, 20~-tm. 
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Fig 2.3. TrkA expression in the presence or absence of NGF. All PC 12 derivative cell 
lines expressing mutated TrkA receptors used in this study express low constitutive levels 
ofTrkA relative to the parental PC12 cells. In response to NGF (50ng/mL), PC12 cells 
exhibit a significant decrease in TrkA receptor expression after 24 hours. In contrast, 
cells expressing the Y 490F mutation exhibit a significant increase in TrkA expression 
under the same NGF stimulation conditions. None of the other cell lines tested 
demonstrated any significant changes in TrkA expression in response to NGF treatment. 
HEK293 cells which do not express TrkA were used as a negative control. Values 
expressed represent the mean TrkA protein expression, relative to MAPK, of 3 
experiments+/- SEM. *p<O.OOI as determined by one-way ANOY A. 
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p75NTR protein expression (Fig 2.4). Wild-type PC12 cells increased p75NTR 
expression 119.4+/-21.5% above unstimulated condition, while Y490F cells also 
displayed significantly elevated p75NTR expression above the unstimulated condition. 
The PC12nnr5 cells, and cells expressing the Y785F or Y490/785F Trk.A receptors 
showed no significant changes in p75NTR expression in response to NGF after 24 hours 
of exposure. 
Further Western blot analyses ofTrk.A expression in response to NGF revealed 
differential responses between the cell lines as well. Wild-type PC 12 cells decreased 
Trk.A expression to 26.1+/-1.0% of control following 24 hours of exposure to NGF. In 
contrast, Y 490F cells exhibited a significant increase in Trk.A expression relative to the 
unstimulated condition. Again, PC12nnr5, Y785F and Y490/785F cells showed no 
significant changes in Trk.A expression in response to NGF at 24 hours (Fig 2.3). 
Previous studies have established that NGF causes a lasting downregulation ofTrk.A 
(Grimes et al., 1996). As such, we cannot rule out a differential time course of 
internalization or receptor turnover as a possible explanation for the differential Trk.A 
expression of wild-type and Y 490F cells in response to NGF treatment. 
2.4 Discussion 
In this study, we have used PC12nnr5 cells transfected with mutated Trk.A 
receptors and cultured the stable derivatives in the presence or absence ofNGF to 
illustrate that the presence of particular autophosphorylation sites on the cytoplasmic tail 
of the Trk.A NGF receptor can modulate the protein expression ofp75NTR. PC12nnr5 
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Fig 2.4. p75NTR expression in the presence or absence of NGF. Following exposure 
to NGF (50ng/mL) for 24 hours, p75NTR protein expression was significantly 
upregulated in parental PC12 cells and derivatives expressing only the Y490F TrkA 
mutation. The NGF-nonresponsive cell line (PC12nnr5), and the derivatives expressing 
the Y785F TrkA mutation or both the Y 490/785F TrkA mutations showed no significant 
changes in p75NTR protein expression in response to NGF. HEK293 cells were used as a 
negative control. Values expressed represent the mean p75NTR protein expression, 
relative to MAPK, of3 experiments +/- SEM. *p<O.OOl as determined by one-way 
ANOVA. 
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cells were originally isolated and characterized to be phenotypically identical to the 
parental cell line in the absence ofNGF, but were found to possess only 12 to 49% of 
NGF surface binding sites (Green et al., 1986). In the presence ofNGF, these cells are 
deficient in c-fos activity, which is known to be associated with p75NTR activation by 
NGF (Barker and Shooter, 1994), and ultimately, lack NGF responses due to an absence 
of the TrkA receptor (Green et al. , 1986). Transfection ofPC12nnr5 cells with TrkA 
eDNA was found to completely restore all NGF responses back to wild-type levels (Loeb 
and Greene, 1993; Loeb et al., 1991). 
The mutated cell lines used in the study have been well characterized with respect 
to neurite outgrowth and TrkA activation of signalling cascades, but have never been used 
to address modulation of p75NTR expression. We have used this model to illustrate that 
the restoration of the TrkA receptor in a variety of mutated forms has a significant 
influence on p75NTR protein expression. The mutant cell lines, Y 490F, Y785F and 
Y490/785F all express low levels of their respective TrkA NGF receptors, removing the 
possibility that quantity of TrkA expressed regulates the expression of p75NTR 
independently of phosphorylation site associations. While PC12nnr5 cells display low 
constitutive levels of p75NTR relative to the parental cell line, the expression of a 
mutated TrkA receptor lacking both of the Y490 and Y785 phosphorylation sites resulted 
in a restoration of p75NTR protein back to wild-type levels. However, the expression of 
TrkA with an abrogated Y490 phosphorylation site resulted in an overexpression of 
p75NTR protein relative to wild-type levels. In contrast, the expression of TrkA lacking 
the Y785 phosphorylation site did not restore the expression ofp75NTR protein above 
those levels seen in PC12nnr5 cells. Expression ofp75NTR thus appears to be regulated 
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by PLCy since loss of the Y785 site, required for recruitment ofPLCy to the Trk receptor, 
results in low levels ofp75NTR expression. The results further suggest that Ras 
activation via phosphorylation of the Y 490 site, necessary for She binding to Trk and 
downstream activation ofRas, may be negatively regulating p75NTR expression, since 
p75NTR expression was found to be highest in the cells expressing TrkA with the 
mutated Y490 site. The data also point out that the effects ofNGF on both p75NTR and 
TrkA expression are mediated via TrkA, since NGF does not alter receptor expression in 
the PC12nnr5 cells; treatment of the cells with K252a also blocks the effects ofNGF 
(data not shown). 
TrkA and p75NTR are co-expressed throughout much of the developing nervous 
system, though typically neurons possess a 10-fold higher number ofp75NTR than TrkA 
(Chao and Hempstead, 1995). Single receptor systems exist, and p75NTR can signal 
autonomously to exert a variety of effects (reviewed in Teng and Hempstead, 2004), but 
co-expression allows p75NTR and TrkA to associate, creating high affinity binding sites 
for NGF, which are important to the rapid internalization and subsequent retrograde 
transport ofNGF signals for growth and survival (Ross et al., 1998; Teng and Hempstead, 
2004). 
p75NTR has been postulated to assume many roles, including sequestration of 
NGF, altering the affinity ofTrk receptors for the appropriate ligand (reviewed in 
Hasegawa et al., 2004 ), and rapid apoptotic elimination of neurons unsuccessful in 
obtaining appropriate neurotrophic support (Bamji et al., 1998). Interestingly, p75NTR 
has also recently been found to increase the phosphorylation of She, an adaptor protein 
that is known to associate with the Y490 phosphorylation site ofthe TrkA cytoplasmic 
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tail (Epa et al., 2004). Most of these roles identify areas where p75NTR functionally 
supports TrkA, or modulates TrkA function. Several studies agree that cross-talk 
between p75NTR and TrkA is likely bi-directional, but few studies examine the 
reciprocal interactions. It has been noted, however, that TrkA can exert an inhibitory 
influence on p75NTR signalling, delaying activation ofNF-kappa-B (reviewed in 
Mamidipudi and Wooten, 2002). 
p75NTR upregulation has been associated with cases of nerve injury (Goettl et al., 
2004), and exposure to NGF. NGF is known to result in the upregulation ofp75NTR in 
the developing nervous system in the period preceding target innervation, marking the 
transition to NGF dependence for survival (Wyatt and Davies, 1993). PC 12 cells have 
also been shown to increase p75NTR in response to NGF treatment (Doherty et al., 
1988), a finding that is consistent with the wild-type results of the present study. The fact 
that the presence ofNGF only causes elevated p75NTR expression in the two lines that 
express a functional Y785 phosphorylation site implicates PLCy or downstream 
intermediates of the PLCy signalling cascade as key components in the regulatory actions 
ofTrkA on p75NTR expression. The molecular dissection of the role ofTrkA in 
regulating p75NTR expression in PC12 cells is the subject of an ongoing investigation. 
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Chapter 3: Neurotrophin-Induced Upregulation of p75NTR via a Protein Kinase 
C-delta-Dependent Mechanism 
This study has been published in Brain Research in 2008, volume I 2I 7, pp. I 0-24 
3.0 Summary 
Neurotrophins exert their biological effects via p75NTR and Trk receptors. Functional 
interplay between these two receptors has been widely explored with respect to p75NTR 
enhancing the activation and signalling ofTrk, but few studies address the bidirectional 
aspects. We have previously demonstrated that the expression ofp75NTR can be 
differentially modulated by different Trk receptor mutations. Here we investigate the 
mechanism of Nerve Growth Factor (NO F)-induced upregulation of p75NTR expression. 
We utilize pharmacological inhibition to investigate the role of various TrkA-associated 
signalling intermediates in this regulatory cascade. Notably, the inhibition of 
phospholipase C-y (PLC- y) using U73122, prevented the NGF-induced upregulation of 
p75NTR protein and mRNA. The inhibition of protein kinase C-8 (PKC-8) activation by 
rottlerin, a selective PKC-8 inhibitor, and by small interfering RNA (siRNA) directed 
against PKC-8 also inhibited this NGF-induced upregulation. Finally, we also show that 
in cerebellar granule neurons, BDNF acting via TrkB increases p75NTR expression in a 
PKC-8 dependent manner. These results indicate the importance ofTrk-dependent PLC-
'Y and PKC-8 activation for downstream regulation ofp75NTR protein expression in 
response to neurotrophin stimulation, a process that has implications to the survival and 
growth of the developing nervous system. 
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3.1 Introduction 
Nerve Growth Factor (NGF) is the prototypic member of a highly conserved 
family of neurotrophins that also includes Brain Derived Neurotrophic Factor (BDNF), 
Neurotrophin-3 (NT-3), and Neurotrophin 4/5 (NT-4/5) among others (Ip et al. , 1993). 
Neurotrophins play crucial roles in the development and maintenance of the vertebrate 
nervous system and are essential for cellular differentiation and survival (Cowley et al., 
1994; Ernfors et al., 1994; Klein et al. , 1994; Klein et al. , 1993; Smeyne et al., 1994). 
Neurotrophin effects are mediated by two distinct receptors: p75NTR, a pan-neurotrophin 
receptor, and a specific member of the receptor tyrosine kinase Trks (reviewed in 
Hasegawa et al., 2004). TrkA binds NGF, TrkB binds BDNF and NT-4/5, and TrkC 
binds NT-3. While these receptors can often display binding promiscuity, these 
interactions are relatively specific in the presence ofp75NTR co-expression (Barker, 
1998; Benedetti eta!., 1993; Mischel eta!., 2001; Rodriguez-Tebar eta!., 1992). Trk 
activation by ligand binding consists of receptor dimerization and transphosphorylation of 
specific tyrosine residues of the cytoplasmic tail, which initiate signalling cascades by 
serving as docking or interaction sites for other signalling intermediates with Src 
homology 2 (SH2) binding domains (Loeb et a!., 1994; Obermeier et a!., 1993a; 
Obermeier et al. , 1993b; Stephens et al. , 1994). In the case ofNGF receptor TrkA, the 
only tyrosine residues outside of the kinase domain to become phosphorylated upon 
receptor activation are at positions 490 and 785 (Stephens et al. , 1994). Y490 
phosphorylation creates a docking site for the She adapter protein, which in turn activates 
the Ras-MAPK pathway. This site also binds adapters FRS2 and FRS3 (Dixon eta!., 
2006; Meakin et a!. , 1999). Y785 phosphorylation allows for the direct interaction of 
105 
.,--,-..,..----------------------------------------------
TrkA with Phospholipase C-y (PLC-y), whose downstream effectors include protein 
kinase C (PKC) isoforms and mitogen-activated protein kinase (MAPK) (Loeb et al., 
1994; Obermeier et al. , 1993a; Obermeier et al., 1993b; Stephens et al. , 1994). Also 
associated with TrkA autophosphorylation is the recruitment of the adaptor protein GAB 1 
which leads to activation of the Phosphoinositide-3-Kinase (PI3K)/Akt signalling cascade 
for neuronal survival. Together these signalling cascades modulate the NGF-induced 
growth, survival and maintenance of various populations of sensory, sympathetic and 
central nervous system neurons (reviewed in Roux and Barker, 2002). 
Trks are frequently co-expressed with p75NTR throughout the nervous system 
(reviewed in (Dechant and Barde, 2002). p75NTR, a 75kDa glycoprotein, is a member of 
the tumor necrosis factor (TNF) superfamily typically known for their roles in apoptosis 
(Dechant and Barde, 2002; Higuchi et al. , 2003b) and is often studied for its apparent 
paradoxical roles in survival and death. p75NTR binds all neurotrophins with equal 
affinity, and although it is not associated with intrinsic enzymatic activity, it recruits a 
multiplicity of intracellular signalling partners and co-receptors to exert a diverse array of 
effects depending on cellular context (reviewed in Hasegawa et al., 2004; Nykjaer et al., 
2005). Besides autonomous activation of apoptotic signalling cascades (Carter et al., 
1996; Casaccia-Bonnefil et al., 1996), p75NTR is known to constitutively activate RhoA 
leading to a suppression of neurite outgrowth that is reversible upon p75NTR binding 
NGF (Yamashita et al., 1999). Furthermore, p75NTR has been shown to play a role in 
the enhancement ofTrkA activation and signalling (Epa et al. , 2004; Nykjaer et al. , 
2005), particularly at low ligand concentrations, and complexes with TrkA to form the 
high affinity binding site (Teng and Hempstead, 2004). 
106 
-----·--------- ----------
The role ofp75NTR in enhancing TrkA function is well known, but the 
bidirectionality of this system is largely ignored. TrkA overexpression results in an 
increase in p75NTR protein expression (Hempstead et al., 1992), while PC12 mutants 
lacking TrkA display decreased p75NTR mRNA (Loeb et al., 1991). Our previous study 
showed that mutation of the phosphorylation sites of the TrkA receptor resulted in 
differential expression ofp75NTR (Rankin et al., 2005). Here we investigate the 
mechanism by which Trk influences p75NTR expression via downstream activation of 
signalling intermediates. Our results show that Irk-dependent activation of PLCy acts via 
PKC-<> to result in increased p75NTR expression. Both NGF (via TrkA) and BDNF (via 
TrkB) exert similar effects and show a general mechanism by which p75NTR expression 
can be regulated. This regulation may play a role in determining survival and axonal 
growth in response to target-derived neurotrophins in the developing nervous system. 
3.2 Materials and Methods 
3.2.1 Cell Culture 
The experimental model consisted of wild-type rat pheochromocytoma (PC12) cells, and 
4 mutated PC12 derivative cell lines (gifts from Dr. David Kaplan, Hospital for Sick 
Children, Toronto, ON). PC12nnr5 cells were derived by mutating parental PC12 cells 
using ethyl methanesulfonate (EMS), as described by Green et al. (Green et al., 1986). 
PC12 derivatives expressing mutated TrkA receptors (Y490F, Y785F, and Y490/785F) 
were created by Stephens et al. (Stephens et al., 1994). Briefly, PC12nnr5 cells, which 
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lack endogenous TrkA, were transfected to express a TrkA receptor that had been altered 
via site-directed mutagenesis to abrogate either one or both of the autophosphorylation 
sites of the cytoplasmic tail. 
Cell lines were maintained on rat-tail collagen-coated tissue-culture flasks in 
RPMI 1640 medium (Invitrogen, Burlington ON) supplemented with 10% horse serum 
(Invitrogen), 5% fetal calf serum (Invitrogen) and 1% penicillin/streptomycin/glutamine 
solution (Invitrogen). In the case of mutated lines Y490F, Y785F and Y490/785F, media 
was additionally supplemented with Geneticin G418 ( 4 ~1/ml) to ensure continued 
selection of the mutant population. Cells were incubated at 37°C in 5% C02, and cultured 
to 80% confluence prior to trypsinization for subculturing purposes. 
3.2.2 Primary neuronal culture 
Cultures enriched in granule neurons were obtained from cerebella of 8-day old Sprague 
Dawley rat pups as described previously (Jiang et al. , 2003). Cerebella were stripped of 
meninges, finely chopped and dissociated by enzymatic digestion using 0.25% Trypsin-
EDTA followed by mechanical tritration. The culture medium was Dulbecco's Modified 
Eagle Medium (DMEM) supplemented with 10% FCS, 25 mM KCl and 1% 
penicillin/streptomycin solution (Invitrogen). Cells were seeded onto PL-coated 12-well 
culture plates at a density of 1.8 x 106 cells/mi. Cells were incubated at 37°C in 5% C02, 
and cytosine arabinoside was added 24h later to inhibit the proliferation of non-neuronal 
constituents. On the seventh day in vitro (DIV), glucose (50~1 of a 100mM solution) was 
added to each culture well to maintain survival, as culture medium was not replaced, and 
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cultures were used on 8 DIV unless otherwise specified. This method yields cultures 
consisting of approximately 95% cerebellar granule neurons (Jiang et al. , 2003). 
3.2.3 Inhibition Studies 
For anti-NGF studies, cells were subcultured on Poly-lysine-coated, (PL; 40 J.lg/ml; BD 
Biosciences, Mississauga ON) 12-well plates under serum-starved conditions in the 
presence or absence of either anti-NGF (5 J.lM) or a control lgG (5 J.lM) concomitant to 
stimulation with exogenous NGF (50 ng/ml; Harlan, Indianapolis IN) for 24 h. 
For pharmacological inhibition studies, cells were similarly subcultured on PL-
coated 12-well plates under serum-starved conditions. The various pharmacological 
inhibitors, K252a (200 nM, Calbiochem, La Jolla CA), U0126 (10 J.!M; Calbiochem), 
L Y294002 (10 J.!M; Calbiochem), U73343 (5 J.!M; Calbiochem) U73122 (5 J.!M; 
Calbiochem), or rottlerin (5 J.!M; Sigma, St. Louis MO) were separately added to 
individual wells 30 min post-plating. Inhibitor concentrations were empirically 
determined to provide the required inhibition (Fig 3.3A, 3.3D, 3.4C) with no detriment to 
viability (Fig.3.8) (Dodge et al., 2002; Mearow et al., 2002). NGF stimulation was 
initiated by the addition ofNGF (50 ng/ml) to culture medium 2 h following introduction 
of the inhibitor. Cells were then allowed to incubate for 24 hat 37°C in 5% C02• 
3.2.4 Small Interfering RNA constructs and transfection 
SiRNA constructs were synthesized commercially (Dharmacon, Lafayette CO) based on 
previously reported target sequences specific for rat PKC-8: 5' -UGA CAA GAU UAU 
CGG CCG CTT-3 ' and 5'-GCG GCC GAU AAU CUU GUC ATT-3 ' (Irie et al. , 2002). 
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PC 12 cells were transfected with 250 nM of PKC-& siRNA using the Amaxa 
electroporation system according to manufacturer's protocols (Cell Line Nucleofector kit, 
program U-29). The siRNA transfection efficiency was assessed to be >70% based on 
transfection of Alexa fluor-labelled negative control siRNA (scrambled; target sequence 
AATTCTCCGAACGTGTCACGT; Qiagen, Mississauga ON). Following transfection, 
cells were washed in RPMI and cultured on PL-coated 12-well culture plates under 
reduced serum conditions for 48 hat 37°C, 5% C02, prior to the addition ofNGF 
(50ng/ml). Protein was harvested 72 h following electroporation, 24 h after the addition 
ofNGF, and prepared for Western blotting. 
PKC-& siRNA was introduced to the cerebellar granule neurons at 6DIV, using a 
calcium phosphate coprecipitation method as previously described (Bingham et al. , 
2006). Briefly, conditioned medium was removed and saved for replacement later. Cells 
were washed twice with transfection medium (DMEM supplemented with 25mM KCl). 
A calcium phosphate coprecipitate of siRNA oligos was prepared and applied to the cells 
dropwise. Following an incubation of2 h, cells were washed twice with transfection 
media and returned to incubate in the conditioned media previously removed. At 8DIV, 
cells were stimulated with BDNF and left 72 h post stimulation prior to collection for 
Western blotting. 
3.2.5 Western Blot Analysis 
For Western analyses, cells were harvested in the presence of sodium orthovanadate (100 
mM in TBS) and subsequently subjected to lysis (10% glycerol, 1% NP-40, sodium 
vanadate, sodium fluoride, sodium dodecyl sulphate (SDS) and 1 protease inhibitor 
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cocktail tablet (Roche Scientific, Laval, QC)) overnight at 4° C prior to centrifugation 
(10,000 g, 5 min). A BCA protein assay (Pierce, Rockford IL) was used to determine 
protein concentration and equivalent amounts of protein (50 1-1g) were electrophoresed on 
8% SDS-polyacrylamide gels. Protein was subsequently transferred to nitrocellulose 
membranes that were then exposed to Ponceau red to ensure equal protein loading. After 
washing in TBS, blots were blocked in 3% non-fat dry milk for 1 hat room temperature, 
and then incubated with a primary antibody directed toward either p75NTR (clone MC-
192; GR10; Oncogene, San Diego CA) or mitogen-activated protein kinase (MAPK; sc-
94; Santa Cruz) overnight at 4° C. A final incubation with HRP-conjugated secondary 
antibody (AP307P, AP308P; Chemicon, Temecula, CA) for 1 hat room temperature was 
followed by visualization using an ECL method. Each experiment was repeated three 
times, subjected to densitometry and normalized to mitogen-activated protein kinase 
(MAPK) to ensure equal protein for comparison. Statistical analysis was performed using 
GraphPad Prism 4 (GraphPad Software Inc., San Diego CA) with significance being 
determined using one-way ANOV A testing. 
3.2.6 Real-time RT -PCR 
For real time RT-PCR analysis, cells were subcultured on PL-coated 12-well plates under 
serum-starved conditions for 24 h in the presence or absence ofNGF (50 ng/ml) or Brain 
Derived Neurotrophic Factor (BDNF; 25 ng/ml; PeproTech, Inc., Rocky Hill, NJ). For 
inhibition studies, PLC-y inhibitor U73122 (5 1-1M; Calbiochem), or its inactive control 
analog U73343 (5 1-1M; Calbiochem) was added to cells 30 min post plating, and 2 h prior 
to stimulation with NGF (50 ng/ml). RNA was isolated using Trizol reagent (Invitrogen) 
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as per the manufacturer's instructions and was subsequently treated with DNase 
(Ambion; Austin TX) to remove traces of contaminating DNA. RNA (2 Jlg) was reverse 
transcribed to eDNA using MMLV reverse transcriptase (200 U for 30 min at 37 °C; 
Invitrogen) prior to use as template for real-time PCR amplification using the following 
PCR primer pairs: p75NTR forward 5'-TGCATCTGAGCTGGTGTCTGTCTT, p75NTR 
reverse 5'-TGCGTACAATGCTCCTGGTCTCTT, GAPDH forward 5' -
CCATCACCATCTTCCAGGAG, GAPDH reverse 
5'-CCTGCTTCACCACCTTCTTG, 28S forward 5'-GACCAAGGAGTCTAACGC, 28S 
reverse 5'-GTACGCTCGTGCTCCA. PCR amplification was performed using the 
Roche LightCycler (Roche) and quantified using SYBR green I. p75NTR mRNA 
expression was subsequently normalized using the housekeeping gene, GAPDH or 28S as 
indicated. 
3.2. 7 Cellular viability assay 
Cell survival in the presence ofthe various pharmacological inhibitors was determined 
based on the metabolic conversion of 3-( 4,5-dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium bromide (MTT, Sigma) to a formazan product, as described 
previously (Dodge et al., 2002; Mearow et al., 2002). Briefly, cells were subcultured in a 
PL-coated 96-well plate, and exposed to the pharmacological inhibitors in the medium for 
24 hat the following concentrations: K252a (200 nM), U0126 (10 J.!M), L Y294002 (10 
J.!M), U73343 (5 J.!M), U73122 (5 J.!M), or rottlerin (5 11M). After 24 h media was 
aspirated, replaced with MTT (1 mg/ml in PBS) and allowed to incubate for 4 hat 37°C. 
The reaction was stopped by aspirating the MTT solution and adding DMSO (Sigma) to 
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lyse the cells and solubilize the blue formazan product, which results from the 
mitochondrial metabolism of MTT in viable cells. After 10 min, relative quantities of 
formazan product were determined spectrophotometrically using a wavelength 570 nm 
and reference wavelength of 630 run. Percent survival was calculated as a comparison 
with untreated control cells grown in the absence of inhibitors. CoCh (150 ).!M; Sigma) 
added to the cells 30 min prior to the addition of MTT served as a positive control to 
validate the assay. Statistical analysis was performed using GraphPad Prism 4 with 
significance being determined using one-way ANOV A testing. 
3.3 Results 
Our previous work indicated that the individual phosphorylation sites on the 
cytoplasmic tail ofTrkA could alter the cellular response to NGF, including the 
upregulation of p75NTR expression (Rankin et al., 2005). To first ensure that 
exogenously supplied NGF induced this p75NTR upregulation, we incubated the cells in 
either anti-NGF (5 ).!M) or control IgG (5 ).!M) concomitant to stimulation with NGF (50 
ng/ml) for 24 h. The addition of anti-NGF or control IgG did not alter the constitutive 
levels ofp75NTR observed under these culture conditions in any of the cell lines. Only 
those cell lines expressing TrkA with a functional Y785 autophosphorylation site (PC12 
and Y490F cell lines) responded to NGF by upregulating p75NTR (Fig 3.1A-PC12 cells; 
3.1B-Y490F cells, p<0.01). In the PC12 and Y490F cell lines, the addition ofanti-NGF 
completely abolished the upregulation ofp75NTR in response to NGF, while the control 
IgG had no effect (Fig 3.1 A-PC12 cells, 3.1B-Y490F cells). None ofthe other cell lines 
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Figure 3.1 
(PC12nnr5, Y785F, Y490/785F) showed any alteration in p75NTR expression in 
response to NGF nor showed any significant alterations in response to anti-NGF or 
control IgG. 
PC12 cells and mutated derivatives co-express TrkA and p75NTR, both of which 
could potentially transduce signals following NGF binding. In order to confirm TrkA-
mediated NGF signalling was responsible for altered p75NTR expression, we utilized a 
selective inhibitor ofTrkA, K252a, to inhibit the activity ofTrk.A in response to NGF 
(Nakanishi et al., 1995). Cells were pre-incubated with K252a (200 nM) for 2 h prior to 
the addition ofNGF (50 ng/ml). The addition ofK252a reduced constitutive p75NTR 
levels in PC12 cells (Fig 3.1 C, p<O.Ol ), as well as in mutated derivatives expressing the 
TrkA Y490F (Fig 3.1D, p<0.01), to levels comparable to those seen in PC12nnr5 cells. 
K252a also completely prevented the NGF induced upregulation of p75NTR in PC12 (Fig 
3.1 C, p<O.O 1) and Y 490F cell lines (Fig 3.1 D, p<O.O 1 ). No significant effects of K252a 
were detected in the PC 12nnr5 cell line, or the mutated derivative expressing the TrkA 
Y785F mutation (data not shown). The role of TrkA activation in the NGF -induced 
upregulation was confirmed using antisense oligos against TrkA, which similarly 
decreased the expression ofp75NTR and prevented the upregulation of p75NTR in 
response to NGF (data not shown). 
In order to determine ifp75NTR activation contributes to an autocrine regulatory 
loop in response to ligand binding, p75NTR was stimulated in the absence ofTrkA 
activation via the addition ofBDNF (25 ng/ml) to the culture medium. Since PC12 cells 
are TrkB deficient, BDNF stimulation selectively activates p75NTR receptor signalling in 
the absence ofTrkA activation. BDNF stimulation resulted in no significant alterations 
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ofp75NTR expression in any of the PC12 cell lines (Fig 3.2A). In fact, BDNF 
stimulation of up to 200ng/ml was insufficient to upregulate p75NTR expression, 
although BDNF stimulation did result in the phosphorylation of Jun N-terminal kinase 
(JNK) at all tested concentrations (Fig 3.3). 
The p75NTR receptor is known to undergo ectodomain shedding and y-secretase 
mediated cleavage (Lee et al. , 2001; Struhl and Adachi, 2000). To ensure that the 
differing quantities ofp75NTR being detected by Western blotting were in fact due to 
upregulation of receptor expression, and not simply decreased detection in control 
samples due to ectodomain shedding, a real-time RT-PCR technique was utilized to 
quantitate relative amounts ofp75NTR mRNA in each cell line in response to NGF 
stimulation (50 ng/ml), or BDNF stimulation (25 ng/ml). In response to NGF, p75NTR 
mRNA upregulation is noted only in the PC12 and Y490F cell lines (Fig 3.2B), 
confirming results obtained by Western blotting. Furthermore, BDNF stimulation had no 
significant effect on p75NTR mRNA expression levels in any of the cell lines (Fig 3.2C). 
TrkA activation following ligand binding results in tyrosine autophosphorylation 
that is associated with the initiation of at least three distinct signalling cascades: the PI3K-
Akt cascade, the Ras-MAPK cascade, and the PLC-y-PKC cascade (Loeb et al. , 1994; 
Obermeier et al. , 1993a; Obermeier et al., 1993b; Stephens et al., 1994). Since TrkA 
appears to be responsible for the NGF-induced upregulation ofp75NTR, one of these 
three TrkA-associated signalling cascades may be directly responsible for mediating 
p75NTR upregulation. We used pharmacological inhibitors to analyze signalling 
intermediates to determine the relative influence of each pathway in mediating p75NTR 
upregulation in response to NGF. 
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Figure 3.2: Selective activation of p75NTR does not contribute to ligand-induced 
upregulation of p75NTR. A: PC 12 cells, PC 12nnr5 cells and PC 12nnr5 cells expressing TrkA 
with mutations Y 490F, Y785F or Y 490/785F were cultured in the presence or absence of BDNF 
(25 ng/ml) for 24 h. Since PC 12 cells are TrkB deficient, BDNF activates p75NTR in the absence 
ofTrkA activation. This selective p75NTR activation does not result in upregulation of p75NTR 
in any ofthe cell lines tested. B,C: Analysis ofp75NTR mRNA in response to NGF or BDNF 
stimulation reveals differential gene transcription. PC 12 cells, PC 12nnr5 cells and PC 12nnr5 
cells expressing TrkA with mutations Y490F, Y785F or Y490/785F were cultured in the presence 
or absence of(B) NGF (50 ng/ml) or (C) BDNF (25 ng/ml) for 24 h . p75NTR mRNA transcripts 
were quantitatively determined by real-time RT-PCR analysis revealing a significant increase in 
p75NTR mRNA expression only in response to NGF, and only in those cell lines expressing a 
functional Y785 autophosphorylation site (PC12 andY 490F cell lines). Values expressed 
represent the mean p75NTR expression, relative to MAPK (A) or GAPDH (B,C), of3 
experiments+/- SEM. *p<O.OS, **p<O.OOl as determined by one-way ANOVA. 
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Figure 3.3: p75NTR activation phosphorylates JNK. PC12 cells cultured in the presence of 
varying concentrations of BDNF (25ng/ml, 1 OOng/ml, 200ng/ml) did not upregulate p75NTR in 
response to p75NTR activation (A), though the stimulation was sufficient to phosphorylate JNK 
(B). The upregulation ofp75NTR in response to NGF stimulation (C) is also associated with a 
significant increase in phosphorylated JNK (D). *p<0.05, **p<O.OOI as determined by one-way 
ANOV A (A,B), *p<0.05, **p<0.005 as determined by ttest (C,D). 
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Firstly, an inhibitor ofPBK activity, L Y294002 (10 1-1M) was utilized to block 
downstream activation of intermediates in the PBK-Akt signalling cascade. The 
functionality of the inhibitor was validated by a notable decrease in the phosphorylation 
of Akt in response to NGF at the concentration used (Fig 3.4A). The addition of 
L Y294002 to the culture medium resulted in a small but significant decrease in 
constitutive p75NTR expression in PC12, Y490F and Y490/785F cell lines, consistent 
with previous reports (Musatov et al., 2004). However, the presence of L Y294002 failed 
to prevent the NGF-induced upregulation ofp75NTR seen in PC12 (Fig 3.4B, p<O.Ol) 
and Y490F cell lines (Fig 3.4C, p<O.Ol), thus indicating that PBK pathway does not 
seem to play a direct role in regulating p75NTR expression. 
Secondly, an inhibitor against the Y490 activated signalling cascade was utilized. 
U0126 inhibits MEK, as evidenced by decreased phosphorylation of downstream 
effector, MAPK (Fig 3.4D), thus interrupting the NGF-induced Ras-MAPK signalling 
cascade initiated by the binding of She adapter proteins to the Y 490 autophosphorylation 
site. The addition ofU0126 (10!-lM) to the culture medium resulted in a decrease in 
constitutive p75NTR expression in PC12 and Y490F cell lines, consistent with previous 
reports (Musatov et al. , 2004) but again did not prevent the NGF-induced upregulation of 
p75NTR in PC12 (Fig 3.4E, p<O.Ol) and Y490F cell lines (Fig 3.4F, p<O.Ol). These data 
indicate that MAPK signalling is not required for the NGF-dependent regulation of 
p75NTR expression. In order to analyze the involvement of the third and final TrkA 
activation induced signalling cascade in the NGF-induced upregulation of p75NTR, 
U73122 was utilized to inhibit agonist-induced PLC- y activation, thus preventing 
activation of downstream effectors. The inhibition caused by U73122 was contrasted 
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Figure 3.4: Inhibition ofPI3K or MEK activity reduces constitutive p75NTR expression, 
but does not prevent the NGF -induced up regulation of p75NTR. PC 12 cells (B,E) and PC 12 
cells expressing TrkA with a Y490F mutation (C,F) were cultured for 24 h in the presence or 
absence ofNGF (50 ng/ml) and/or LY294002 (I 0 ~M), an inhibitor of PI3K activity, or UO 126 
(I 0 ~M), an inhibitor of MEK activity. L Y294002 suppresses the phosphorylation of Akt (A). 
UO 126 suppresses the phosphorylation of MAPK (D). The addition of L Y294002 (B, C) or 
U0126 (E,F) each significantly decreased the constitutive expression ofp75NTR in both cell 
lines, but failed to abrogate the NGF-induced upregulation of p75NTR in either. Values 
expressed represent the mean p75NTR protein expression, relative to MAPK, of 3 experiments 
+/- SEM. *p<O.Ol as determined by one-way ANOVA. 
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Figure 3.4 
with effects caused by its inactive analog U73343. The addition ofU73343 (5~M) had no 
effect on constitutive expression ofp75NTR, nor did it prevent the upregulation of 
p75NTR in response to NGF (p<0.01). In contrast, the addition ofU73122 completely 
eliminated the NGF-induced upregulation ofp75NTR in both PC12 cells (Fig 3.5A) and 
Y490F cells (Fig 3.5B), without affecting constitutive expression. 
Since PKC isoforms can be activated downstream ofPLC- y, we assessed whether 
PLC-y inhibition had any influence on PKC activation using a pan-specific 
phosphorylated PKC antibody. Western determination of phosphorylated pan-PKC 
showed an increase in response to NGF stimulation, which was significantly blocked by 
the presence ofU73122 (Fig 3.5C). 
Further evidence for the involvement of PLC-y activity in the upregulation of 
p75NTR was obtained from real-time RT-PCR studies, which confirmed that inhibition of 
PLC-y using U73122 prevented p75NTR upregulation in response to NGF stimulation in 
PC12 cells, while the less active analog U73343 did not (Fig. 3.5D, p<0.01 ). 
PLC-y activation results in the downstream activation of various PKC isoforms. 
A previous study of osmotic insult (Peterson and Bogenmann, 2003) noted that 
fluctuations of p75NTR expression were partially eliminated by the addition of rottlerin, a 
PKC-o inhibitor. This indicated that PKC-o might play a regulatory role for p75NTR in 
the injury paradigm. Thus, to ascertain if PLC-y is signalling through PKC-o to regulate 
p75NTR upregulation in response to neurotrophin stimulation, we investigated the effect 
of rottlerin treatment. The addition of rottlerin (5 ~M) to culture medium for 24 h 
completely prevented the upregulation of p75NTR in response to NGF stimulation in both 
PC12 cells (Fig. 3.6A), and Y490F cells (Fig. 3.6B). 
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Figure 3.5: Inhibition ofPLC-y blocks the NGF-induced upregulation of p75NTR protein 
and mRNA transcription. PC 12 cells (A) and PC 12 cells expressing TrkA with a Y 490F 
mutation (B) were cultured in the presence or absence ofNGF (50 ng/ml) and/or PLC-y inhibitor, 
U73122 (5 11M), or its inactive analogue U73343 (5 11M) for 24 h. The addition ofU73343 had 
no significant effect on the constitutive expression of p75NTR, nor its upregulation in response to 
NGF stimulation. In contrast, the addition of U73122 completely prevented the NGF-induced 
upregulation ofp75NTR, thus demonstrating that p75NTR upregulation occurs via a PLC-y 
dependent mechanism. Similar results were noted for mRNA transcripts quantified using real-
time RT-PCR (D). The parallel result of mRNA to protein under these culture conditions 
eliminates the possibility that ectodomain shedding is responsible for reducing detectibility of 
p75NTR. Values expressed represent the mean p75NTR protein expression, relative to MAPK 
(A,B) or 28S (D), of3 experiments +/- SEM. *p<O.OI as determined by one-way ANOV A. PLC-
y activation results in the phosphorylation of several PKC isoforms detectible using an antibody 
directed against pan-phospho-PKC (bands shown range from 78 kDa to 116 kDa). This 
phosphorylation is notably decreased in the presence of U73122, but not in the presence of 
U73343 (C). 
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Figure 3.6: Inhibition ofPKC-o prevents the NGF-induced upregulation of p75NTR. PC12 
cells (A) and PC12 cells expressing TrkA with a Y490F mutation (B) were cultured in the 
presence or absence ofNGF (50 ng/ml) and/or PKC-8 inhibitor, rottlerin (5 !J.M) for 24 h. The 
addition ofrottlerin completely prevented the NGF induced upregulation ofp75NTR without 
influencing the constitutive expression, thus implicating PKC-8 isoforms in the upregulation of 
p75NTR. A more specific means of interfering with the action of PKC- 8, transfection with 
siRNA constructs specific to PKC- 8, successfully decreased the expression ofPKC-8 48 h 
following transfection (C). This decrease in PKC- 8 effectively prevented the NGF-induced 
upregulation ofp75NTR while a scramble control siRNA sequence had no effect (D). Values 
expressed represent the mean p75NTR protein expression, relative to MAPK (A,B), or actin 
(C,D), of3 experiments+/- SEM. *p<0.05 as determined by one-way ANOVA. 
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We then examined the involvement ofPKC-o in the upregulation of p75NTR 
expression, by employing a more specific means of inhibition in the form of small-
interfering RNA (siRNA). siRNA oligos specific to rat PKC-o were designed based on 
previously published sequences (lrie et al. , 2002), and PC 12 cells were transfected using 
nucleoporation. 48 h following transfection, cells were stimulated with NGF (50 ng/ml) 
for a further 24 h prior to protein collection. The introduction of siRNA constructs to 
PC12 cells efficiently decreased expression ofPKC-o over the experimental timeframe, 
while negative control siRNA constructs (scrambled) had no effect on PKC-o expression 
(Fig. 3.6C). NGF induced a significant upregulation of p75NTR in the presence of the 
scrambled construct (p<0.05), which is abolished in the presence ofPKC-o siRNA 
constructs (Fig. 3.6D). Although the magnitude ofNGF-induced upregulation of 
p75NTR was lower following electroporation (Fig. 3.6D) than is noted in other figures, 
we have consistently observed that electroporation of PC 12 cells reduces their capacity to 
upregulate p75NTR expression. Nonetheless, these data establish a role for PKC-o in the 
regulation ofp75NTR expression. 
Further evidence for the involvement of the PLCy-PKCo signalling intermediates 
in the regulation of p75NTR expression comes from the activation of this signalling 
cascade by a means alternative to Trk.A activation. The addition of epidermal growth 
factor (EGF; 50ng/mL) to PC12 cell cultures for 24h activates the PLCy-PKCo signalling 
cascade by binding to the EGF receptor (Chen et al. , 1996b; Welsh et al., 1991 ). This 
ligand is also able to induce the upregulation ofp75NTR, despite a lack ofTrkA receptor 
activation (Fig 3.7, p<0.05). However, p75NTR upregulation is not ubiquitous to all 
receptor tyrosine kinase activation, as exposure to IGFI (50ng/ml) for 24h, which does 
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Figure 3.7: Stimulation of the PLOy-PKC-o pathway via EGF-R or TrkA activation 
upregulates p75NTR expression, while selective activation ofiGF-R is insufficient to alter 
p75NTR expression level. PC12 cells were incubated with NGF (50 ng/ml), EGF (50 ng/ml) or 
IGF (50 ng/ml) for 24 h prior to collection and lys is for Western blot analysis. P75NTR was 
detected using an antibody directed against the intracellular domain of p75NTR (Upstate). Values 
expressed represent the mean p75NTR protein expression, relative to actin of 3 experiments+/-
SEM. *p<0.05 as determined by one-way ANOV A. 
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not activate PLC-y (Kimpinski and Mearow, 2001; Zapf-Colby et al., 1999), was 
insufficient to induce p75NTR upregulation (Fig 3.7). 
The study of p75NTR function has revealed a prominent role for this receptor in 
apoptosis (reviewed in Dechant and Barde, 2002). In order to distinguish the effects of 
the inhibitors on p75NTR expression from their effects on cell survival, an MTT survival 
assay was performed to ensure that decreased cellular viability under the culture 
conditions was not resulting in altered p75NTR expression. Only the use of L Y294002, 
an inhibitor of the PBK-Akt pathway for cell survival, resulted in a slight but significant 
decrease in cell viability (p<0.05). None ofthe other inhibitors influenced cell viability at 
the concentrations used (Fig. 3.8). CoCh (150~-tM) was used as a positive control since 
previous studies (Fleury et al. , 2006; Yang et al. , 2004) have demonstrated that this 
concentration induces cell death. Furthermore, a vehicle control (DMSO) for each 
inhibitor did not influence p75NTR expression or upregulation in response to NGF (data 
not shown). 
To determine the potential functional relevance of the proposed PKC8-dependent 
mechanism in primary neurons, we employed a culture model of primary cerebellar 
granule neurons (CGN). CGN express only TrkB, TrkC and p75NTR neurotrophin 
receptors (Zirrgiebel and Lindholm, 1996). Since TrkB ligation results in the activation 
of similar signalling pathways as TrkA, we hypothesized that BDNF exposure would 
result in the upregulation ofp75NTR. CGN were exposed to one ofNGF, BDNF or NT-
3 at the time of plating, and protein was sampled following 8 DIV. As illustrated in 
Figure 3.9A-C, the addition ofBDNF upregulated p75NTR protein expression in CGN 
(p<O.Ol), while NGF and NT-3 had no effect. Since CGN are TrkA-deficient, NGF 
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Figure 3.8: The decreased p75NTR expression in response to pharmacological inhibition is 
not associated with toxicity. Inhibitor concentrations were previously empirically determined to 
be the lowest effective concentration that resulted in biochemical inhibition with minimal or no 
cell death. PC 12 cells (A) and PC 12 cells expressing TrkA with a Y 490F mutation (B) were 
cultured in the presence or absence of K252a (200 nM), UO 126 (1 0 J.!M), L Y294002 (1 0 J.!M), 
U73343 (5 J.!M), U73122 (5 11M) or rottlerin (5 11M) for 24 h prior to the determination of cellular 
viability based on the conversion of MTT to a formazan product. Only the addition of L Y294002 
caused a slight but significant decrease in viability. The assay was validated by the addition of 
CoCI2 (150 mM), which perturbs mitochondrial activity, to control wells. Values expressed 
represent the mean percentage of survival, relative to untreated cells, of 3 experiments+/- SEM. 
*p<0.05, **p<O.OOO I as determined by one-way ANOV A. 
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Figure 3.9: Activation ofTrkB upregulates p75NTR via a PKC- o-dependent mechanism in 
cerebellar granule neurons. A: Cerebellar granule neurons were exposed to either NGF (50 
ng/ml), BDNF (25 ng/ml) or NT-3 (25 ng/ml) at the time of plating and harvested following 8 
DIV. The addition ofNGF or NT-3 had no significant effect on the expression ofp75NTR. In 
contrast, the addition of BDNF resulted in a dramatic upregulation of p75NTR. B,C: Cerebellar 
granule neurons were immunostained for p75NTR to show the upregulation of p75NTR in 
response to BDNF exposure. Note the punctate nature of the p75NTR immunostain. D: 
Cerebellar granule neurons were cultured in the presence or absence of LY294002, U0126, 
U73343 or U73122 andlor BDNF (25ng/ml). Only the PLC-y inhibitor U73122 prevented the 
BDNF-induced upregulation of p75NTR. E: Cerebellar granule neurons were plated on PL and 
cultured for 24h in the presence ofNGF (50 ng/ml), BDNF (25 ng/ml) or NT-3 (25 ng/ml) prior 
to protein collection and lysis for Western blot analysis using antibodies directed against 
phosphorylated PKC-8 and PKC-8. Stimulation of cerebellar granule neurons with BDNF, but 
not NGF or NT -3, results in the phosphorylation of PKC-8. F, G: The transfection with siRNA 
constructs specific to PKC- 8 successfully decreased the expression of PKC-8, and this decrease 
in PKC- 8 effectively prevented the BDNF-induced upregulation of p75NTR while a scramble 
control siRNA sequence had no effect. Values expressed represent the mean phosphorylated 
PKC-8 protein expression, relative to PKC of 3 experiments +/- SEM. *p<O.O l as determined by 
one-way ANOV A. 
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would bind only p75NTR in these cells, and as shown in Fig. 3.2, p75NTR stimulation is 
not sufficient for its upregulation. NT-3 binding TrkC was also insufficient to upregulate 
p75NTR, but past studies have highlighted the differences in activation of intracellular 
molecules by BDNF versus NT-3, including the inability ofNT-3 to activate the PLC-y 
signalling cascade in cerebellar granule neurons (Zirrgiebel and Lindholm, 1996). We 
confirmed the inability ofNT-3 stimulation to phosphorylate PKC-8 (Fig. 3.9D, p<0.01). 
To confirm that the BDNF-TrkB signalling for the upregulation ofp75NTR was 
occurring via the same mechanism as the NGF-Trk.A signalling, cerebellar granule 
neurons were exposed to a similar panel of pharmacological inhibitors. Inhibition of the 
PI3K cascade using L Y294002 was insufficient to prevent the BDNF-induced 
upregulation ofp75NTR, as was inhibition ofthe MEK-MAPK pathway using U0126. 
Conversely, treatment with the PLC-y inhibitor U73122 was able to prevent the BDNF-
induced upregulation ofp75NTR in cerebellar granule neurons (Fig. 3.9E). 
In order to determine ifthis BDNF-induced upregulation ofp75NTR was also 
occurring via a PKC-8 dependent mechanism, we once again employed the specific PKC-
8 siRNA oligos to suppress expression ofPKC-8. The siRNA was introduced to the 
cerebellar granule neurons using a calcium phosphate coprecipitation. 48h following 
transfection, cells were stimulated with BDNF (25 ng/ml) for a further 72 h prior to 
protein collection. The introduction of siRNA constructs to cerebellar granule neurons 
efficiently decreased expression of PKC-8 over the experimental timeframe (p<O.O 1 ), 
while negative control siRNA constructs (scrambled) had no effect on PKC-8 expression 
(Fig. 3.9F). BDNF induces a significant upregulation ofp75NTR in the presence of the 
scrambled construct (p<0.01), which is abolished in the presence ofPKC-8 siRNA (Fig. 
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3 .9G). These data confirm a role for PKC-8 in the regulation of p75NTR expression in 
cerebellar granule neurons. 
3.4 Discussion 
p75NTR expression levels play a central role in the regulation of neuronal 
survival and axonal growth in response to target-derived neurotrophins, and subsequently 
regulate innervation density in the developing nervous system. Elucidation of the 
mechanism regulating p75NTR upregulation provides insight into the regulation of these 
essential biological processes. 
We have utilized a well characterized model, consisting of PC 12 cells and 
derivatives expressing a TrkA receptor mutated to abrogate either one or both 
intracellular autophosphorylation sites (Loeb et al., 1994; Obermeier et al., 1993a; 
Obermeier et al. , 1993b; Stephens et al. , 1994), to investigate the molecular mechanism 
behind the neurotrophin-induced upregulation ofp75NTR. PC12nnr5 cells are TrkA 
deficient and are thus devoid of classical NGF responses, including the induction of 
neurite outgrowth and neuronal differentiation (Loeb et al. , 1991 ). These mutants were 
originally characterized as sharing most of the phenotypic properties expressed by the 
parental cell line in the absence ofNGF (Green et al., 1986). Transfection ofPC12nnr5 
cells with the mutated TrkA receptors partially restored NGF responses and allowed for 
the molecular dissection ofTrkA signalling pathways (Loeb and Greene, 1993). 
TrkA activation is known to initiate three distinct signalling cascades: Y490 
serves as a docking site for She to initiate the Ras-MAPK cascade, and also binds 
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adapters FRS2 and FRS3, and Y785 serves as an interaction site for PLC-y to initiate a 
PKC-MAPK cascade. Additionally, the PI3K/Akt cascade for neuronal survival is 
activated by TrkA:NGF binding (Dixon et al., 2006; Loeb et al. , 1994; Meakin et al., 
1999; Obermeier et al., 1993a; Obermeier et al. , 1993 b; Stephens et al., 1994 ). We have 
previously demonstrated that only those cells expressing TrkA with a functional Y785 
autophosphorylation site (eg. PC12, Y490F cells) respond to NGF stimulation with an 
upregulation ofp75NTR expression (Rankin et al., 2005), and that this is independent of 
TrkA expression changes. In the present study, we show that this upregulation is 
occurring via activation ofTrkA, not p75NTR, as p75NTR activation itself is insufficient 
to alter its expression in response to receptor stimulation. Furthermore, we now directly 
implicate downstream targets of the Y785 signalling pathway, specifically PKC-8. 
Finally we illustrate the relevance of this mechanism to primary cerebellar granule 
neurons and show that a similar mechanism exists for TrkB and BDNF regulation of 
p75NTR in granule neurons. 
An investigation of individual TrkA-mediated signalling intermediates in each of 
the three cascades was performed using pharmacological inhibition, and revealed no 
effects of the Y490-Ras-MAPK pathway, or the PI3K/Akt pathway on NGF-induced 
upregulation ofp75NTR. In contrast, inhibition ofPLC-y or PKC-8, both intermediates 
of the Y785-initiated cascade, prevented the upregulation ofp75NTR in response to NGF 
stimulation. These results indicate a PLC-y-PKC-8 -dependent mechanism in the control 
ofp75NTR upregulation. 
p75NTR is normally expressed during developmental stages of the vertebrate 
nervous system, but dramatic upregulation has been reported in the period just preceding 
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target innervation, marking the transition to NGF-dependence. This upregulation 
correlates with a period of naturally occurring cell death, during which those neurons that 
were unsuccessful in obtaining target territory with sufficient trophic support are 
eliminated apoptotically (Bamji et al. , 1998; Davies, 2003; Kohn et al., 1999; Nykjaer et 
al., 2005; Wyatt and Davies, 1993). p75NTR is also upregulated in the nervous system 
under certain pathological conditions of nerve injury or stress (reviewed in Dechant and 
Barde, 2002; Nykjaer et al., 2005), and is associated with neuronal degeneration. 
Interestingly, a PLC-y-dependent mechanism has been implicated in the upregulation of 
p75NTR in response to a cellular swelling insult (Peterson and Bogenrnann, 2003), 
highlighting a potentially universal mechanism of p75NTR control. 
A link between p75NTR upregulation and neuronal death has been established 
(Dechant and Barde, 2002), but that does not preclude the hypothesis that the regenerative 
response following injury or insult requires recapitulation of specific events that occur 
during development (Wood et al. , 1990). The expression ofp75NTR is not always 
associated with neuronal apoptosis; modulation of developmental innervation density and 
axonal pathfinding in the peripheral nervous system are also thought to be regulated by a 
p75NTR contribution. p75NTR may in fact enhance or prolong the signalling of the Trk 
receptor (Epa et al. , 2004). 
Various populations of sympathetic and sensory neurons constitutively express 
p75NTR throughout life in combination with expression of one or more of the Trk 
receptors, and exposure to NGF can upregulate p75NTR expression in adult dorsal root 
ganglion neurons (Lindsay et al. , 1990), PC12 cells (Doherty et al. , 1988), sympathetic 
neurons (Miller et al. , 1991), and adult basal forebrain cholinergic neurons (Cavicchioli et 
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al. , 1989). We now report that BDNF can upregulate p75NTR in CGN, using a similar 
PLC-y - PKC-8-dependent mechanism. BDNF is expressed in the developing cerebellum, 
with increased levels detectable in the postnatal period (Rocamora et al., 1993), and 
studies using mice deficient in BDNF have revealed an essential role for this neurotrophin 
in the survival, maturation, and motility of CGNs postnatally (Borghesani et al. , 2002; 
Schwartz et al., 1997). Similarly, p75NTR activity plays a notable role in the 
development of cerebellar foliation patterning, with pronounced defects when 
endogenous BDNF is also reduced (Carteret al. , 2003). 
Most neurons possess a complex dual growth control mechanism where 2 
different transmembrane receptors share the same ligand with potentially different 
biological outcomes. p75NTR can signal independently ofTrkA, activating 
sphingomyelinase (Dobrowsky et al. , 1994), NFkB (Carteret al., 1996) and JNK (Twiss 
et al. , 1998) signaling pathways, and activation can frequently result in apoptosis 
(Coulson et al., 1999). When coexpressed, p75NTR is known to cooperate with TrkA, 
regulating the activity of the Trk receptor (Epa et al., 2004; Roux and Barker, 2002; 
Zaccaro et al., 2001), enhancing the internalization ofNGF (Twiss et al. , 1998), and 
increasing the ligand specificity ofTrkA (Brennan et al. , 1999; Zaccaro et al., 2001). 
Thus, cellular responsiveness to NGF is at least partially determined, not only by the 
presence ofp75NTR, but by the ratio ofp75NTR:TrkA (Gatzinsky et al. , 2001 ; Miller et 
al., 1994; Twiss et al., 1998; Y an et al. , 2002). Regulation of this ratio seems to depend 
more upon alterations in p75NTR than TrkA (Miller et al. , 1994), and in fact, the balance 
between p75NTR and Trk activities is essential for normal physiological function (Miller 
and Kaplan, 1998). 
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In PC12 cells, the ratio ofp75NTR:TrkA is approximately 10-20:1 (Meakin and 
Shooter, 1992), which may be important in determining the relative activation of the 2 
alternative signaling pathways triggered by NGF, and thus the biological outcome of 
neurotrophin exposure (Gatzinsky et al. , 2001 ; Yan et al. , 2002). An appropriate 
p75NTR:TrkA ratio might play a protective role (Althaus and Kloppner, 2006) and allow 
a silencing ofp75NTR-induced cell death (Majdan et al., 2001), but could also regulate 
the number of high affinity binding sites (Wehrman et al. , 2007). 
Several studies have elucidated a role for p75NTR modulation in the homeostatic 
control ofNGF signaling within a fluctuating neurotrophin environment (Twiss et al. , 
1998). The ability of a neuron to respond to neurotrophins can be intricately refined 
through regulation of receptor expression on the cell surface, and the binding affinity can 
be altered simply by fine-tuning the ratio of expression ofp75NTR:TrkA (Esposito et al. , 
2001) to adjust cellular response to context (Bloch! and Bloch!, 2007). The upregulation 
of p75NTR in response to neurotrophins may be necessary for p75NTR to participate in a 
broad range of physiological functions, including axonal elongation or migration, in 
cellular context specific situations. 
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Chapter 4: Neurite Outgrowth is Enhanced by Laminin-Mediated Downregulation 
of the Low Affinity Neurotrophin Receptor, p75NTR. 
A portion of this study has been accepted for publication in Journal of Neurochemistry, 
August 2008, in press. 
4.0 Summary 
Laminin, an extracellular matrix (ECM) component, is a key factor in promoting axonal 
regeneration, coordinately regulating growth in conjunction with trophic signals provided 
by the neurotrophins, including nerve growth factor (NGF). This study investigated 
potential interactions between the LN and NGF-mediated signaling pathways in PC12 
cells and primary neurons. Neurite outgrowth stimulated by NGF was enhanced on a LN 
substrate. Western blot analysis of pertinent signal transduction components revealed 
both enhanced phosphorylation of early signaling intermediates upon co-stimulation, and 
a LN-induced downregulation of p75NTR which could be prevented by the addition of 
integrin inhibitory RGD peptides. This p75NTR downregulation was associated with a 
LN-mediated upregulation ofPTEN and resulted in a decrease in Rho activity. Studies 
using overexpression or siRNA-mediated knock-down ofPTEN demonstrate a consistent 
inverse relationship with p75NTR, and the overexpression of p75NTR impaired neurite 
outgrowth on a LN substrate, as well as resulting in sustained activation of Rho which is 
inhibitory to neurite outgrowth. p75NTR is documented for its role in the transduction of 
inhibitory myelin-derived signals, and our results point to ECM regulation ofp75NTR as 
a potential mechanism to ameliorate inhibitory signaling leading to optimized neurite 
outgrowth. 
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4.1 Introduction 
The extracellular matrix (ECM) is a key factor in the promotion of axonal 
regeneration following nerve injury. The interaction of the extending axon with a 
permissive microenvironment can increase the probability of axonal initiation, rate of 
elongation and degree of branching (reviewed in Lemons and Condie, 2008) It is 
generally accepted that central nervous system (CNS) regeneration does not occur readily 
due in part to the non-permissive growth environment and the lack of appropriate growth 
factors. In contrast, regeneration occurs quite readily in the peripheral nervous system 
(PNS). An elegant study by David and Aguayo (David and Aguayo, 1981) highlighted the 
importance of ECM cues by showing that a CNS neuron could regenerate when placed in 
a PNS-like environment. Laminin (LN) is the most abundant component of the peripheral 
ECM, is upregulated following peripheral nerve injury (Wallquist et al., 2002), and likely 
plays a physiological role in regeneration potentially by engaging a combination of 
enhanced growth programs and overriding inhibitory cues. The interaction between the 
ECM and the cell surface is mediated by a group of receptors known as integrins. When 
activated by specific ligands, integrins cluster within the cell membrane forming focal 
aggregations that initiate various signaling cascades (Wozniak et al., 2004). The 
overexpression of al or a5 integrin subunits can rescue the regenerative abilities of adult 
CNS neurons to embryonic levels in the presence of appropriate growth promoting factors 
(Condie, 2001 ). In addition, integrins can regulate the cellular response to growth factors, 
including platelet-derived growth factor (Miranti and Brugge, 2002; Schwartz and 
Ginsberg, 2002; Yamada and Even-Ram, 2002) and epidermal growth factor (Cabodi et 
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al. , 2004). Conversely, growth factors have been reported to modulate integrin signaling 
as well (Staniszewska et al., 2008). 
Another key factor involved in optimal axonal regeneration following damage is 
the trophic support provided by neurotrophins, including nerve growth factor (NGF), 
which stimulates the initiation and extension of neurites by binding to receptor Trk.A, and 
thus activating various signaling cascades (Reichardt, 2006). Trk.A is a receptor tyrosine 
kinase that has only 2 phosphorylatable tyrosine residues on the cytoplasmic tail outside 
of the activation loop. These tyrosine residues have been linked to individual signaling 
cascades: Y 490 phosphorylation activates the Shc-Ras-MAPK pathway, while Y785 
phosphorylation activates the PLCy-PKC pathway. These signaling pathways converge 
to phosphorylate the mitogen-activated protein kinases (MAPK), ERK 1 and ERK2 
(Stephens et al. , 1994). 
NGF can also bind to the low affinity receptor, p75NTR, which has multiple 
functions ranging from apoptosis to survival depending on the availability of co-receptors 
and intracellular signaling partners (Bloch! and Bloch!, 2007). Unliganded p75NTR is 
known to constitutively activate RhoA, a small GTPase whose signaling is inhibitory to 
growth; the binding ofNGF is thought to negate this activation and thus permit the 
extension of neurites (Yamashita et al., 1999). Furthermore, p75NTR is known to act as 
part of a signaling complex that includes Nogo-R and LINGO, which functions in the 
transduction of myelin-derived inhibitory signals (Domeniconi et al. , 2005). 
Alternatively, p75NTR has been shown to play a role in the enhancement ofTrkA 
activation and signaling (Epa et al. , 2004; Roux and Barker, 2002). 
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NGF and LN signaling has been studied extensively in various models (Liu et al., 
2002; Rankin et al. , 2006; Tucker et al., 2005), but LN-mediated mechanisms leading to 
enhanced growth are not well defined. We hypothesize that these mechanisms likely 
represent a complex interplay between enhancement of permissive cues and 
downregulation of those that are inhibitory. This study investigated potential interactions 
between the LN and NGF-mediated signaling pathways in PC12 cells and primary 
neurons. Elucidating neuronal growth or regeneration programs in a neuronal model, both 
in terms of neurotrophin responsiveness and effects of permissive growth environments is 
likely to provide insights into ways of enhancing CNS repair. 
4.2 Materials and Methods 
4.2.1 Cell Culture and Differentiation 
The experimental model consisted of wild-type rat pheochromocytoma (PC 12) 
cells, and a mutated PC 12 derivative cell line (gifts from Dr. David Kaplan, Hospital for 
Sick Children, Toronto, ON). PC12nnr5 cells were derived by mutating parental PC12 
cells using ethylmethanesulfonate, as described by Green et al. (1986). 
Cell lines were maintained on rat-tail collagen-coated tissue-culture flasks in 
RPMI 1640 medium (Invitrogen, Burlington ON) supplemented with 10% horse serum 
(Invitrogen), 5% fetal calf serum (Invitrogen) and 1% penicillin/streptomycin/glutamine 
solution (PSG; Invitrogen). Cells were incubated at 37 °C in 5% C02, and cultured to 
80% confluence prior to trypsinization for subculturing and differentiation. Cells were 
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differentiated by exposure to NGF (1 00 ng/ml) for 2 days in low serum conditions to 
prime, followed by exposure to NGF (1 00 ng/ml) for 5 days in the absence of serum. 
4.2.2 Primary Cell Culture 
Hippocampal cultures were prepared from postnatal day 0-2 (P0-2) Sprague-
Dawley rat pups as previously described (Jiang et al. , 2005). Briefly, the hippocampi 
were dissected and placed into ice-cold dissection buffer (Hank' s Balances Salt Solution 
(HBSS; Invitrogen) supplemented with 1 mM HEPES buffer (Invitrogen) and I% 
penicillin/streptomycin solution). The meninges were removed and tissue was minced. 
After washing in HBSS, tissue was trypsinized with 0.25% trypsin-EDT A for 15 minutes 
at 3 7 °C. Trypsinization was inhibited by the addition of fetal calf serum. Tissue was 
then washed with plating medium (EMEM supplemented with 10 mM sodium 
bicarbonate, 20 mM potassium chloride, 1 mM HEPES, 10% FCS and 1% PSG) and 
manually triturated with a flame-polished pipette 35 times to dissociate the cells. After 
washing and pelleting, cells were resuspended to a seeding density of 0.25x1 06 cells/ml 
and plated onto PL-coated ( 40 J.Lg/ml) 12- well tissue culture plates or 16 well chamber 
slides and incubated at 37 OC in 5% C02. Between 2 and 4 hours following plating, 
media was removed and replaced with neurobasal media containing 2% B27 supplement, 
2 mM HEPES and 1% PSG. On day in vitro 3 (3D IV), and every third day thereafter, 
half of the media was replaced and altered to include 20 J.LM cytosine arabinoside to 
discourage proliferation of the non-neuronal constituents. 
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4.2.3 Immunocytochemistry 
For immunocytochemical studies, cells were trypsinized and subcultured serum-
free on Poly-D-Lysine (PL)- or Laminin (LN)-coated 16-well chamber slides for 24 hours 
in the presence or absence ofNGF (50 ng/mL), prior to fixation in 4% paraformaldehyde 
for 15 minutes. Cells were then permeabil ized with 0.1% Triton-X-I 00 and blocked with 
1 0% normal goat serum in PBS for 1 hour at room temperature. Cells were incubated 
with either a monoclonal antibody directed against total tubulin (Sigma), TuJ 1 
(Chemicon, Temecula, CA) or the combination of a mouse monoclonal antibody directed 
against p75NTR (MC192, Oncogene) and a rabbit monoclonal antibody directed against 
PTEN (Cell Signaling) for 16 hours at 4° C. This was followed by incubation with Cy2-
and Cy5-tagged secondary antibodies (Jackson ImmunoResearch Laboratories Inc.) for 1 
hour at room temperature. Finally slides were coverslipped with glycerol, and the 
receptor expression patterns were visualized using confocal laser scanning microscopy. 
4.2.4 Growth Quantification 
All measurements of growth were obtained using images of PC 12 cells 
immunostained for total tubulin (Sigma), or hippocampal neurons immunostained for 
neuronal marker, TuJl (Millipore). Individual cell tracings were performed using NIH 
Image J software. Only neurons for which we were able to unambiguously identify the 
associated neurites were chosen for tracing analysis. Neurite length is a measure of the 
longest neurite extending from each neuron (n>250 cells per condition). Data were 
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imported into a graphing and statistical analysis program (Prism 4, Graphpad Corp.) for 
further analysis. 
4.2.5 Western Blot Analysis 
For Western analyses, cells were harvested in the presence of sodium 
orthovanadate and subsequently subjected to lysis (10% glycerol, 1% NP-40, sodium 
vanadate, sodium fluoride, magnesium chloride, octyl-~-thioglucopyranoside (Sigma), 
and 1 protease inhibitor cocktail tablet (Roche Scientific, Laval, QC) overnight at 4° C 
prior to centrifugation (I 0,000 rpm, 5 minutes). A BCA protein assay (Pierce, Rockford 
IL) was used to determine protein concentration and equivalent amounts of protein (50 
11g) were electrophoresed on 8% SDS-polyacrylamide gels. Protein was subsequently 
transferred to nitrocellulose membranes that were then exposed to Ponceau red to ensure 
equal protein loading. After washing in TBS, blots were blocked in 3% non-fat dry milk 
for 1 hour at room temperature, and then incubated with a primary antibody overnight at 
4° C. Antibodies used include: Anti-Actin (Sigma), Anti-phospho-Akt (S473, Cell 
Signaling), Anti-Akt (Cell Signaling), Anti-ERK-44/42 (Santa Cruz), Anti-phospho-
ERK-44/42 (Upstate), Anti-phospho-GSK3~ (Ser9, Cell Signaling), Anti-GSK3~ (Cell 
Signaling), Anti-Integrin ~-1 (Chemicon), Anti-p75NTR ECD (MC192; Oncogene), Anti-
p75NTR ICD (Upstate), Anti-PTEN (Cell Signaling), Anti-Rho (Upstate), and Anti-TrkA 
(Upstate). A final incubation with HRP-conjugated secondary antibody (AP307P, 
AP308P; Chemicon,) for 1 hour at room temperature was followed by visualization using 
an ECL method. Each experiment was repeated three times, subjected to densitometry 
and normalized to actin to ensure equal protein for comparison. Statistical analysis was 
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performed using GraphPad Prism 4 (GraphPad Software Inc., San Diego CA) with 
significance being determined using one-way ANOV A testing. 
4.2.6 Real-time RT -PCR 
For real time RT-PCR analysis, cells were subcultured on PL or LN-coated 12-
well plates under serum-starved conditions for 24 hours in the presence or absence of 
NGF (50 ng/ml). RNA was isolated using Trizol reagent (Invitrogen) as per the 
manufacturer's instructions and was subsequently treated with DNase (Ambion; Austin 
TX) to remove traces of contaminating DNA. RNA (2 J..Lg) was reverse transcribed to 
eDNA using MMLV reverse transcriptase (200 U for 30 minutes at 37°C; Invitrogen) 
prior to use as template for real-time PCR amplification using the following PCR primer 
pairs: p75NTR forward 5'-TGCATCTGAGCTGGTGTCTGTCTT, p75NTR reverse 5' -
TGCGTACAATGCTCCTGGTCTCTT, PTEN forward 5'-
ATTCGACTTAGACTTGACCT, PTEN reverse 5' -ACCAGTCCGTCCTTTC, 28S 
forward 5 '-GACCAAGGAGTCT AACGC, 28S reverse 5 '-GT ACGCTCGTGCTCCA. 
PCR amplification was performed using the Roche LightCycler (Roche) and quantified 
using SYBR green I. p75NTR and PTEN mRNA expression levels were subsequently 
normalized using the housekeeping gene, 28S. 
4.2. 7 Rho Activity Assay 
The activation ofRhoA was assessed using a pull-down assay kit (Upstate, 
Charlottesville, VA), in accordance with the manufacturer' s instructions. Briefly, cells 
were harvested and lysed. Rhotekin-bound beads were added to cleared lysate and 
rotated for 1 hour at 4 °C prior to pelleting, washing, and boiling in Laemmli buffer with 
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DTI. Rhotekin-bound Rho proteins were detected by Western blot analysis using a 
polyclonal anti-Rho antibody (Upstate, 06-770). The total amount of RhoA in cell lysate 
was used as a control for the cross-comparison of Rho activity. 
4.2.8 Plasmids and Transfection 
pcDNA3.1-p75NTR-orange: Plasmid sequence encoding orange fluorescent 
protein was excised from the pRSET vector (a kind gift from Dr. Lois Mulligan, Queen's 
University, Kingston ON) using BamHI and Hindlll restriction enzymes, and was 
inserted into the eukaryotic expression vector pcDNA3.1 (Invitrogen). Amplification of 
the full length rat p75NTR coding region was performed using forward primer 5'-
CTCGAGATGAGGAGGGCAGGTGCTGC-3' and reverse primer 5'-
GA T A TCTGCACTGGGGA TGTGGCAGTGG-3' encoding Xhol and EcoRV restriction 
sites, respectively, which facilitated directional, in-frame insertion into the engineered 
pcDNA3.1-orange vector yielding p75NTR with a C-terminus orange fluorescent tag. 
The pcDNA3.1-p75NTR (wild-type) plasmid and empty vector control were kind 
gifts from Dr. Donna Senger (University of Calgary). 
piRES-PTEN: Full length rat PTEN coding sequence was amplified from eDNA 
using PCR forward primer 5' -GAA TTCCCATGACAGCCA TCA TC and reverse primer 
5 ' -GGA TCCTCAGACTTTIGT AA TITGTG incorporating EcoRI and BamHI 
restriction enzyme sequences, respectively. The resulting PCR product was cloned into 
the TOPO TA cloning vector 2.1 (Invitrogen), subsequently excised using EcoRI and 
BamHI, and directionally inserted into the bi-cistronic GFP reporter vector, piRES 
(Promega). 
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Ras constructs: wild-type, V12 (constitutively active) and N17 (dominant 
negative), were purchased from Clontech. 
All plasmids were transfected into differentiated PC12 cells using Lipofectamine 
2000 (Invitrogen) as per the manufacturer's instructions. 
4.2.9 Small interfering RNA constructs and transfection 
PTEN siRNA constructs were purchased from Cell Signaling (PTEN Signal 
Silence siRNA). PC12 cells were transfected with 100 nM ofPTEN siRNA according to 
manufacturer's protocols. The siRNA transfection efficiency was assessed to be >70% 
based on transfection of Alexa fluor-labelled negative control siRNA (scrambled; target 
sequence AA TTCTCCGAACGTGTCACGT; Qiagen, Mississauga ON). 48 hours post-
transfection, cells were transferred onto PL or LN coated tissue culture plates for protein 
analysis, or 16-well chamber slides for growth analysis, after an additional 24 hours. 
4.3 Results 
4.3.1 Laminin enhances neurite regeneration via activation of early signaling 
intermediates essential to growth. 
Our initial investigations into the potential mechanisms underlying the synergistic 
effects ofNGF and LN on neurite outgrowth response were conducted using NGF-
differentiated PC12 cells. As PC12 cells differentiate, they extend an extensive network 
of neurites (Greene and Tischler, 1976). After scraping the cells from the tissue culture 
surface and mechanically triturating with a flame-polished Pasteur pipette to remove 
neurite outgrowth, we then investigated regeneration of these neuritic processes under 
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various conditions. Cells plated on PL in the absence of additional growth factors 
showed very little regenerative response (Fig. 4.1A). While NGF (50 ng/ml; Fig 4.1 B) or 
a LN substrate (Fig 4.1 C) each independently elicited a growth response, it was the 
combination ofNGF and LN (Fig 4.1D) that elicited the most robust growth response, in 
terms of length. Fig 4.1 E presents the quantitation of neurite growth as described in 
Materials and Methods. 
While effects ofLN + NGF-initiated growth can be assessed at 24 hours post-
plating, the initiating signals often occur much earlier. In fact, phosphorylation events 
leading to neurite outgrowth often occur within minutes of stimulation, and can be 
transient in nature (Tucker et al. , 2006; Tucker et al., 2008). The phosphorylation of 
extracellular signal related kinase (ERKI/2) is essential for neurite outgrowth in PC12 
cells (Fukuda et al., 1995; Pang eta!., 1995; Xiao and Liu, 2003). Phosphorylation of 
ERK is a component of both Trk and integrin signaling cascades (Yee et al., 2008). To 
assess the activation ofthis early signaling intermediate, cells were plated on PLunder 
serum-starved conditions for 24 hours prior to stimulation with either soluble NGF (50 
ng/ml), soluble LN (25 ~g/ml) or both for time periods of 10 minutes, 30 minutes or 1 
hour. Samples were then collected and protein prepared as described. Western blot 
assessment of phospho-ERK at each timepoint following stimulation showed significantly 
enhanced phosphorylation follows co-stimulation relative to phospho-ERK activation by 
either stimulus alone (Fig. 4.2 A). Interestingly, the phosphorylation ofERK by integrin 
activation was both delayed and shorter-lived relative to NGF signaling. To demonstrate 
the effects ofERK signaling on neurite outgrowth in PC12 cells, we manipulated the 
phosphorylation of ERK using mutated Ras constructs and examined the resultant effects 
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Figure 4.1: Neurite regeneration is enhanced on a LN substrate. A-D: Confocal 
images of differentiated PC 12 cells immunostained for total tubulin demonstrate the 
enhancement of neurite outgrowth on a permissive LN substrate relative to the neutral PL 
substrate, both in the presence and absence ofNGF. E: Graphical representation of 
neurite length measurements obtained using Image J, and presented as percent ofLN 
control. Scale bar -20 !lm, *p<O.OOl ANOV A. 
PL 
LN 
~ 
c 
0 
u 
-
0 
.. 
01 
... 
c 
.. 
u 
... 
.. 
0.. 
-NGF +NGF 
E 
Figure 4.1 
Figure 4.2: Phosphorylation of ERK is enhanced in the presence of NGF and LN co-
stimulation. (A) Differentiated PC12 cells were plated on PL overnight in serum-starved 
conditions in the absence ofNGF prior to stimulation with soluble NGF, soluble LN or 
both for 10 minutes, 30 minutes or 1 hour. Western blotting shows an increase in the 
phosphorylation of early signaling intermediate ERK in the presence ofNGF, which is 
significantly enhanced with LN co-stimulation at each timepoint tested. (B) Manipulation 
ofERK phosphorylation was accomplished using Ras V12 to enhance phosphorylation of 
ERK and Ras N17 to prevent it. (C-F). Enhanced phosphorylation ofERK was 
associated with enhanced neurite outgrowth. Values expressed represent the mean 
protein expression, relative to ERK, of 3 experiments +/- SEM. 
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on neurite outgrowth. Wild-type Ras, constitutively active Ras (V12) or dominant 
negative Ras (N 17) were transfected into PC 12 cells plated on PL. The introduction of 
wild-type Rasor Ras V12 increased the phosphorylation ofERK and elicited neurite 
outgrowth. Conversely, Ras N17 decreased the phosphorylation of ERK relative to 
empty vector control, and was not associated with a neurite outgrowth response (Fig. 4.2 
B-F). 
4.3.2 Laminin decreases p75NTR expression by a mechanism involving both 
transcriptional downregulation and cleavage. 
We next investigated the effects ofNGF and LN exposure on the expression of the 
relevant surface receptors. Cells subcultured on PL versus LN in the presence or absence 
ofNGF for 24 hours were sampled and protein assessed for TrkA, integrin PI and 
p75NTR expression levels. Results showed that NGF downregulated TrkA expression 
(Fig. 4.3A) and LN downregulated its receptor integrin Pl (Fig. 4.3B). Suppression of 
these cell surface receptors was ligand-specific, as NGF stimulation alone did not 
modulate integrin P 1 while LN exposure did not affect expression of TrkA. NGF 
upregulated p75NTR (Fig. 4.3C) as previously reported (Rankin et al. , 2005), but perhaps 
most interestingly, the LN substrate resulted in decreased detection of p75NTR (Fig. 
4.3C). 
Since the antibody used to detect p75NTR (clone MC192) was specific for the 
extracellular domain ofp75NTR, and p75NTR is known to undergo ectodomain shedding 
and secretase-mediated cleavage (Kanning et al. , 2003), we further investigated this 
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Figure 4.3: LN decreases the detection of p75NTR extracellular domain. 
Differentiated PC12 cells were subcultured on PL versus LN substrate in the presence or 
absence ofNGF for 24 hours. Western blotting assessment ofTrkA expression reveals a 
decrease following NGF exposure, but LN had no significant effect (A). Integrin ~1 was 
significantly reduced following exposure to the LN substrate, but NGF alone had no 
effect on protein expression (B). In contrast, NGF upregulates p75NTR expression, while 
LN significantly reduced the detectability of p75NTR protein, as assessed using an 
antibody directed against the ECD of the receptor (C). Values expressed represent the 
mean protein expression relative to actin, of 3 experiments +/- s.e.m. *p<0.05, 
**p<O.OOl (ANOVA). 
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apparent downregulation. Differentiated PC 12 cells were subcultured on PL versus LN 
substrates in the presence or absence ofNGF for 24 hours. Western blot detection using 
an antibody specific for the intracellular domain ofp75NTR also showed a 
downregulation in response to the LN substrate (Fig. 4.4A). Assessment of mRNA 
encoding p75NTR was performed using quantitative real-time RT-PCR, and confirmed 
that the downregulation of p75NTR also occurred on the transcriptional level (Fig. 4.4B). 
However, cleavage of the receptor cannot be excluded since a minor amount of a 25 kDa 
low molecular weight cleavage fragment was identifiable by Western blot analysis using 
the intracellular domain-specific p75NTR antibody, and is enhanced on the LN substrate 
(Fig. 4.4C). This low level of cleaved p75NTR could only be detected upon 
overexposure of the Western blot, and is in low abundance relative to the full-length 
receptor (Fig 4.5). 
4.3.3 Overexpression of p75NTR prevents neurite extension in differentiated PC12 
cells. 
To establish a direct link between p75NTR expression and the inhibition of 
neurite growth in these cells, we generated a full length p75NTR expression construct 
which incorporated a carboxy-terminal orange fluorescent tag (Fig. 4.6 A), and used it to 
compare the regenerative capacity of differentiated PC12 cells transfected with the 
p75NTR fusion construct versus cells expressing the control vector. Differentiated PC12 
cells were transfected with pcDNA3.1-p75NTR-orange or pcDNA3.1-orange control 
vectors for 24 hours, scraped and triturated to remove all neurite outgrowth, and then 
replated on LN. After 36 hours exposure to the LN substrate, the cells were fixed and 
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Figure 4.4: LN-mediated downregulation of p75NTR is dependent on reduced 
transcription and enhanced cleavage. Differentiated PC 12 cells were subcultured on 
PL versus LN substrates in the presence or absence ofNGF for 24 hours. LN induces a 
significant downregulation ofp75NTR intracellular domain protein (A), and mRNA (B) 
as assessed by real time RT-PCR. Concomitantly, LN is reported to induce matrix 
metalloproteinases, which can mediate p75NTR ectodomain shedding. In support of this 
paradigm, Western blotting reveals a LN-mediated increase in a smaller molecular weight 
p75NTR cleavage product (C), which is in low abundance relative to the full length 
receptor (see Suppl. Fig. 1 ). Values expressed represent the mean protein expression 
relative to actin or 28S, of 3 experiments +/-s.e.m. *p<0.05, **p<O.OOl (ANOVA). 
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Figure 4.5: Low molecular weight p75NTR fragments are in low abundance relative 
to the full-length receptor. As illustrated in Fig. 4C, Western blotting reveals a LN-
mediated increase in a smaller molecular weight p75NTR cleavage product. Here we 
show an image of the full blot to demonstrate that the cleaved band was only detectable 
after overexposure of the Western blot, and is thus in low abundance. This illustrates that 
cleavage may only be playing a very small role in the cellular decrease in p75NTR, and 
that transcriptional downregulation shown in Fig. 4B may be playing a larger role. 
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Figure 4.6: p75NTR overexpression impairs neurite extension. 
A eDNA construct consisting ofp75NTR with a C-terminus orange fluorescent tag was 
cloned into expression vector pcDNA3.1 as described, and can be detected as a fusion 
protein by Western blotting using a p75NTR lCD antibody (A). Differentiated PC12 
cells were transfected with either empty control vector or pcDNA3.1-p75NTR-orange 
fusion vector or pcDNA3.1-p75NTR wild type prior to transfer onto a LN-coated 
substrate. After 36 hours, cells expressing the empty vector had normal neurite extension 
in response to LN exposure (B, D-F), but this growth was effectively stunted in cells 
expressing the p75NTR-orange fusion protein (C), or the wild-type p75NTR (G-1). Anti-
p75NTR lCD was used to detect wild type p75NTR, and visualization was achieved using 
Cy3-tagged secondary (red). These cells were co-stained with total tubulin (green) to 
visualize neurite outgrowth. Arrow indicates cell overexpressing p75NTR wild-type 
construct. 
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imaged to assess growth of the transfected cells. While those cells expressing the empty 
vector responded to the LN substrate by extending long neuritic processes, the 
overexpression of p75NTR largely stunted neurite extension, or prevented initiation of 
neurite growth (Fig. 4.6 B,C). Because of the possibility that by placing the tag on the C-
terminus, we have potentially interfered with the function of p75NTR, these experiments 
were repeated using a wild-type p75NTR construct (Esposito et al., 2001). The results 
show that there were no obvious differences between the two constructs in the parameters 
being assessed. Relative to both the untransfected cells present in the same frame and the 
empty vector transfected cells (Fig 4.6D-F), increased levels of p75NTR were associated 
with short stunted neurites (Fig 4.6G-I). 
4.3.4 Laminin induces long-term depression of Rho activity. 
Since p75NTR constitutively activates Rho GTPase, a known inhibitor of neurite 
outgrowth (Yamashita et al. , 1999), and p75NTR siRNA has been shown to decrease Rho 
activity, thus promoting neurite outgrowth (Ahmed et al., 2005), we assessed Rho activity 
as a physiological consequence of downregulating p75NTR expression. Differentiated 
PC 12 cells were subcultured on PL versus LN substrates in the presence or absence of 
NGF for 24 hours. Active Rho was analyzed in protein samples using a Rho activity 
assay kit as described in Materials and Methods. In support of our initial experiments 
which demonstrated significant reductions ofp75NTR upon exposure to a LN substrate, 
we detected decreased Rho activity on a LN substrate in both the presence and absence of 
NGF (Fig. 4.7 A) suggesting that LN-mediated downregulation ofp75NTR may be of 
physiological relevance. The lack of effect on Rho activity observed in the presence of 
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Figure 4.7: LN induces long-term depression of Rho activity. Differentiated PC12 
cells were subcultured on PL versus LN substrates in the presence or absence ofNGF for 
24 hours. Active Rho was assessed in protein samples using a Rho activation assay kit 
(Upstate), utilizing Rho-Binding domain conjugated beads to capture and precipitate 
active Rho (A). Overexpression ofp75NTR-wild type or p75NTR-orange constructs 
resulted in increased activation of Rho (B). GTPyS loaded samples served as the positive 
control, while GDP loaded samples served as the negative control. Values expressed 
represent the mean of3 experiments+/- SEM **p<O.OOl (ANOVA). Inhibition of Rho 
effector, Rock, using Y27632 (1 O!J,M) resulted in enhanced neurite outgrowth (C-D). 
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NGF can be explained by the 24 hour timepoint. NGF inactivation of Rho occurs rapidly 
and returns to baseline by 24 hours (Moissoglu and Schwartz, 2006) (Fig. 4.8). To 
confirm a role for p75NTR in the modulation of Rho activity, we overexpressed empty 
control vectors versus both the wild-type p75NTR and the p75NTR-orange constructs and 
performed the assay to quantify activated Rho. Both the tagged and untagged p75NTR 
constructs resulted in enhanced Rho activity (Fig. 4.7 B). To demonstrate the impact of 
Rho signaling on neurite outgrowth in differentiated PC12 cells, we used the 
pharmacological inhibitor Y27632 (1 O~M) to inhibit the activity of the downstream Rho 
effector, Rho associated kinase (Rock). The introduction of the Rock inhibitor promoted 
the extension of neurite outgrowth in differentiated PC12 cells plated on PL (Fig. 4.7 C-
D). These results support the contention that sustained p75NTR-mediated activation of 
Rho (as observed with the enhanced expression ofp75NTR) is key in the inhibition of 
neurite growth. 
4.3.5 LN-mediated downregulation of p75NTR is associated with an upregulation of 
PTEN. 
We attempted to investigate the mechanism between integrin activation and 
modulation of p75NTR expression. A previously reported cell line stably overexpressing 
PTEN was characterized to express very low levels of p75NTR (Musatov et al., 2004). 
Thus, we investigated a potential role for PTEN in the regulation ofp75NTR in the 
present system. Differentiated PC12 cells were plated on PL versus LN substrates in the 
presence or absence ofNGF for 24 hours prior to protein collection for subsequent 
Western blot analysis. As demonstrated in Figure 4.9A, LN significantly upregulated 
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Figure 4.8: NGF induces a transient suppression of Rho activity which returns to 
baseline by 24 hours. Differentiated PC 12 cells were plated on PL for 24 hours prior to 
stimulation with NGF (50 J.!g/ml), collected at the indicated timepoints and used in a 
pulldown assay for the detection of active Rho. GDP-loaded samples served as negative 
control, while GTPyS-loaded samples served as a positive control. The total amount of 
RhoA in celllysates was used as a control for the cross-comparison of Rho activity. 
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Figure 4.9: LN upregulates PTEN expression, which causes p75NTR 
downregulation. Differentiated PC 12 cells were subcultured on PL versus LN substrates 
in the presence or absence ofNGF for 24 hours. Western blotting reveals an upregulation 
ofPTEN in cells plated on the LN substrate, while NGF has no effect on PTEN 
expression (A). Transient transfection of piRES-PTEN resulted in successful PTEN 
overexpression (B) which correlated with a downregulation of p75NTR expression (C). 
Values expressed represent the mean protein expression, relative to actin (A) or MAPK 
(B) of3 experiments +/-s.e.m. **p<O.OOOl. Cells were immunostained and imaged using 
confocal microscopy to illustrate the relative intensity and localizations of p75NTR 
(green) and PTEN (red) (D-0). Scale bar -20 J..Lm. 
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PTEN expression in differentiated PC12 cells in comparison with PL control cultures. A 
direct link between PTEN and p75NTR expression was established using a bicistronic 
piRES-PTEN construct as described in Materials and Methods. The piRES-PTEN or 
piRES control constructs were introduced into differentiated PC 12 cells using 
Lipofectamine 2000 reagent. Western blot analysis of protein lysates collected 24 hours 
post transfection showed that PTEN overexpression was associated with decreased levels 
ofp75NTR (Fig 4.9 B-C). The reciprocal expression ofp75NTR and PTEN upon 
exposure to a LN substrate was also confirmed by immunocytochemistry (Fig 4.9 D-0). 
To confirm that LN was inducing the upregulation ofPTEN and downregulation of 
p75NTR via the integrin receptors, we utilized an inhibitor of integrin ~1 , RGD peptide 
(Ruoslahti, 1996; Wildering et al. , 1998). PC 12 cells were pre-incubated in RGD (20)lM) 
for 2 h prior to plating on PL or LN substrates. Cells that were exposed to the RGD prior 
to LN exposure did not upregulate PTEN or downregulate p75NTR to the same degree as 
those not inhibited by RGD peptide (Fig 4.1 0), thereby confirming that these LN signals 
are mediated by integrin receptors. 
4.3.6 Silencing of PTEN increases p75NTR expression and impairs neurite 
regeneration on LN. 
To further establish that PTEN may regulate the expression of p75NTR, we used 
siRNA constructs to suppress PTEN protein expression. 48 hours following transfection 
with the siRNA constructs, differentiated PC12 cells were transferred to PL or LN coated 
substrates for a further 24 hours prior to protein collection for Western blotting, or 
analysis of growth. Suppression of PTEN protein expression (Fig 4.11 A) was associated 
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Figure 4.10: Inhibition of integrin IH signaling prevents LN-induced upregulation of 
PTEN and p75NTR. PC12 cells were pre-incubated with 20 J.!M RGD peptide for 2 h 
prior to plating on PL or LN substrates. Western blot analyses show that inhibition of 
integrin ~1 blocks the upregulation ofPTEN (A) and the downregulation ofp75NTR (B) 
upon exposure to LN. Values expressed represent the mean protein expression, relative to 
actin, of3 experiments +/- SEM. *p<O.Ol , (ANOVA). 
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Figure 4.11: Suppression ofPTEN increases p75NTR expression and impairs 
neurite regeneration. Differentiated PC 12 cells were transfected with either control 
siRNA or PTEN siRNA constructs 48 hours prior to subculturing on PL or LN-coated 
substrates for an additional 24 hours. Western blot analyses reveal that specific 
knockdown ofPTEN protein (A) is associated with an increase in p75NTR expression 
(B). Analysis of growth response demonstrates no noticeable impact ofPTEN 
suppression associated with the PL substrate (C,D), but significant growth impairment of 
cells lacking PTEN was evident in response to LN substrate relative to control (E,F). 
This observation was confirmed by measuring neurite length (G). Value expressed 
represent the mean protein expression, relative to actin, of 3 experiments +/- s.e.m. 
*p<0.05, **p<O.OOI (ANOVA). Scale bar -50 ~m. 
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with an increase in p75NTR expression on both PL and LN substrates relative to a control 
siRNA (Fig 4.11 B). Analysis of growth revealed that cells plated on PL showed very 
little regenerative response regardless of PTEN protein expression (Fig 4.11 C-D). In 
contrast, the LN substrate elicited a growth response that was significantly impaired 
following PTEN knockdown (Fig 4.11E-F). Fig 4.11G presents quantitation of the 
neurite growth response. 
4.3. 7 LN regulation of p75NTR expression does not require Trk.A activity. 
Because the cell line previously reported to overexpress PTEN displayed low 
levels ofTrkA, as well as low levels ofp75NTR (Musatov et al. , 2004), and TrkA has 
been shown to modulate p75NTR expression (Rankin et al., 2005; Rankin et al., 2008), 
the possibility existed that TrkA contributed to the observed levels of p75NTR. To 
explore this possibility we utilized a mutated ce111ine that does not express TrkA, 
PC12nnr5. The PC12nnr5 cells were plated on PL versus LN in the presence or absence 
ofNGF for 24 hours. Western blotting showed that LN upregulated PTEN expression 
(Fig. 4.12A) and downregulated p75NTR (Fig. 4.12B) in PC12nnr5. Furthermore, PTEN 
overexpression in PC12nnr5 cells via transient transfection also decreased p75NTR 
expression relative to untreated and empty vector controls (Fig. 4.12C,D). Thus the 
presence ofTrkA was not required for LN-mediated downregulation of p75NTR. 
4.3.8 LN-induced upregulation of PTEN impacts the PI3K signaling cascade 
The primary role ofPTEN is to negatively regulate the phosphatidyinositol-3-
kinase (PBK) signaling cascade, by dephosphorylating phosphatidylinositol-3,4,5-
triphosphate (PI(3,4,5)P3) into phosphatidylinositol-4,5-biphosphate (PI( 4,5)P2) , and 
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Figure 4.12: Regulation of p75NTR expression by LN is independent ofTrkA 
activity. PC12nnr5 cells, which lack endogenous TrkA, were plated on PL versus LN in 
the presence or absence ofNGF for 24 hours. Western blotting reveals that LN 
upregulates PTEN expression (A), and downregulates p75NTR (B) in these cells. 
Furthermore, PTEN overexpression via transient transfection (C) also decreases p75NTR 
expression in these cells relative to untreated and empty vector controls (D). Values 
expressed represent the mean protein expression, relative to actin or MAPK, of 3 
experiments +/- s.e.m. *p<O.Ol ,**p<O.OOl (ANOVA). 
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thereby inhibiting the phosphorylation of Akt, and GSK resulting in downstream effects 
that could impact both survival and growth (Downes et al., 2001 ). In this regard, PTEN 
overexpression has previously been reported to decrease the phosphorylation of GSK 
(Beckner et al., 2005). In order to assess the impact of the LN-induced upregulation of 
PTEN on the PI3-K signaling cascade, differentiated PC 12 cells were subcultured on PL 
versus LN for 24 hours, prior to stimulation with soluble NGF (50 ng/ml) for 10 minutes 
prior to protein collection. Subsequent Western blotting revealed that, while exposure to 
a LN substrate did not change the total amount of Akt that is phosphorylated in response 
to a short-term NGF stimulation, it did decrease the proportion of phosphorylated Akt as 
LN exposure appeared to upregulate Akt (Fig 4.13A). Similarly, there is a significant 
decrease in the proportion of available GSK3 that was phosphorylated in cells plated on 
the LN substrate prior to stimulation (Fig. 4.13B). Thus, the LN-induced upregulation of 
PTEN has an impact on the PI3K signaling cascade, but the influence on growth and 
survival does not appear to be detrimental suggesting either compensatory mechanisms 
employed by the cell or the existence of parallel signaling pathways initiated by the ECM 
and neurotrophin stimulation. 
4.3.9 A LN-mediated PTEN-p75NTR signaling cascade may promote neurite 
outgrowth in neonatal hippocampal neurons. 
While the LN-mediated upregulation ofPTEN and subsequent downregulation of 
p75NTR results in enhanced regenerative neurite outgrowth in NGF-differentiated PC12 
cells, a sympathetic neuron model, we sought to determine its physiological relevance in 
the central nervous system, specifically hippocampal neurons. Hippocampi were 
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Figure 4.13: LN-mediated upregulation ofPTEN affects the PI3K signaling 
pathway. 
In order to determine whether the LN -mediated increase in PTEN expression was 
affecting the PBK signaling cascade, differentiated PC12 cells were plated on PL versus 
LN for 24 hours prior to stimulation with NGF (50 ng/ml) for 10 minutes. Subsequent 
Western blotting of protein lysates reveals that NGF stimulation phosphorylates Akt 
regardless of substrate, but LN appears to upregulate Akt, resulting in a decrease in the 
proportion of available Akt being activated (A). The LN substrate also decreases the 
proportion of GSK phosphorylated (B). Values expressed represent the mean ratio of 
optical density (OD) of the phosphorylated protein relative to the total protein of 3 
experiments +/ -SEM. *p<O. 0 1. 
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dissected from postnatal day 0-2 rat pups and cultured on PL versus LN substrate as 
described in Materials and Methods. Western blotting showed that LN upregulated 
PTEN and downregulated p75NTR protein expression (Fig. 4.14A,B). Using real time 
RT-PCR to quantify the mRNA, we confirmed a transcriptional upregulation ofPTEN 
(Fig. 4.14C) and a transcriptional downregulation ofp75NTR (Fig. 4.14D) in response to 
the LN substrate. Finally, we confirm that LN upregulates PTEN and downregulates 
p75NTR using immunocytochemistry (Fig. 4.14 E-J). 
To assess the initial growth responses of these neurons to the different substrates, 
neurons were cultured on PL or LN coated chamber slides, fixed 24 hours post-plating, 
and stained for neuronal marker, TuJl , to visualize the initial extension of processes from 
neurons, which were subsequently traced for length measurements as described in 
Materials and Methods. The LN substrate appears to be associated with an enhanced 
extension of process outgrowth relative to the PL substrate (Fig. 4.14 K,L), which is 
confirmed by the growth quantification (Fig. 4.14M). Thus, these results confirm that the 
LN-induced upregulation ofPTEN and downregulation ofp75NTR is consistent with a 
role in the growth of hippocampal neurons, as it is in PC12 cells. 
4.4 Discussion 
This study used NGF-differentiated PC12 cells to explore a novel signaling 
pathway by which the ECM molecule, LN, enhances neurite outgrowth, by not only 
amplifying the phosphorylation of early signaling intermediates essential for growth, but 
also by diminishing surface expression of a potentially inhibitory receptor, p75NTR (Fig. 
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Figure 4.14: Hippocampal neurons show evidence of a LN-mediated PTEN-
p75NTR signaling cascade that enhances growth. 
To determine if the LN-mediated PTEN-p75NTR signaling cascade promotes growth in 
neonatal hippocampal neurons, hippocampi were dissected from P0-2 rat pups and 
cultured on PL versus LN substrates prior to harvesting for protein and RNA. Western 
blotting reveals that the LN substrate is associated with increased PTEN (A) and 
decreased p75NTR protein expression (B), and real-time RT-PCR confirms a 
transcriptional upregulation ofPTEN mRNA (C) and downregulation ofp75NTR (D). 
Neurons were immunostained and imaged using confocal microscopy to illustrate the 
relative intensity and localizations of p75NTR (green) and PTEN (red) (E-J). Growth 
was visualized following 24 hours in vitro by immunostaining with neuronal maker TuJl . 
Neurite extension is enhanced on the LN substrate (L) relative to the PL substrate (K). 
This observation was confirmed by measuring neurite length (M). Values represent mean 
protein expression relative to actin, or mean mRNA expression normalized to 28S of 3 
experiments +/- s.e.m. *p<O.OOl (ANOVA). Scale bar -25 J..Lm. 
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4.15). We show that LN acts in an integrin-dependent manner to increase the expression 
ofPTEN and decrease the expression ofp75NTR. Using both exogenous expression and 
siRNA-mediated downregulation, our results demonstrate that PTEN is important in the 
LN-dependent enhancement of neurite growth. We also show that p75NTR plays a key 
role in inhibition of neurite growth in the absence of neurotrophins, likely via its effects 
on activation of Rho; overexpression of p75NTR results in decreased growth and 
sustained activation of Rho. We suggest that LN, via its actions on PTEN, results in the 
downregulation ofp75NTR, and thus removal of its inhibitory influence. 
NGF-differentiated PC12 cells share many properties with cultured sympathetic 
ganglion neurons, including the initiation of neurite outgrowth in response to NGF on 
certain substrates (Greene and Tischler, 1976). ECM components can also work in 
cooperation with NGF-induced signaling pathways to mediate significant neurite 
outgrowth in PC 12 cells (Ishii et al. , 2001 ; Vogelezang et al., 2001 ), and differentiated 
PC12 cells plated on a LN substrate can undergo NGF-independent neurite formation 
(Begovac and Shur, 1990; Glowacka et al., 1992), which we have confirmed in the 
present study (Fig. 4.1 ). The ligation of integrins by ECM components provides a 
multitude of contextual and signaling information to orchestrate a wide variety of 
biological processes, including proliferation, differentiation, migration, growth, and gene 
transcription. Integrin signals not only connect the ECM to the cytoskeleton, but through 
a variety of adapter proteins and kinase actions, also initiate various intracellular 
signaling cascades, including the Ras/MAPK pathway, which results in the 
phosphorylation ofthe p42/44 MAPK, known as ERK (reviewed in Yee et al. , 2008). 
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Figure 4.15: LN both potentiates phosphorylation of early signaling intermediates 
essential to neurite outgrowth (ERK), and downregulates inhibitory signal 
transduction by decreasing the surface expression of p75NTR. This decreases a key 
element of the receptor complex (NogoR/LINGO/p75NTR), which transduces myelin-
derived inhibitory signals, and concomitantly depresses Rho activity. Furthermore the 
enhanced pool of PIP2 resulting from increased PTEN activity binds profilin preventing it 
from sequestering G-actin monomers, that can instead be used in the construction of actin 
filaments for neurite outgrowth. This collection of LN induced effects converges to 
promote neurite regeneration in response to a permissive environment. 
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The phosphorylation of ERK is an early and essential signaling event for the 
initiation and extension ofneurites in PC12 cells (Fukuda et al., 1995; Pang et al. , 1995; 
Xiao and Liu, 2003). Inhibition of the phosphorylation ofERK in sympathetic neurons 
causes growth cone collapse (Atwal et al. , 2003), and thus reduces neurite density 
(Creedon et al. , 1996; Virdee and Tolkovsky, 1996). In this study, we demonstrate 
signaling crosstalk resulting in enhanced phosphorylation of ERK in response to co-
stimulation with NGF and LN, greater than either stimulus alone. However, we also 
show that LN stimulation alone is sufficient for eliciting neurite outgrowth, suggesting 
that factors other than ERK activation contribute to the growth response. 
NGF has been extensively studied in its capacity to modulate substrate adhesion 
and increase the capacity for PC12 neuritogenesis (reviewed in Fujii et al. , 1982), by 
increasing the protein expression of integrin subunits (Danker et al., 2001 ; Rossino et al., 
1990), and stimulating the accumulation of integrin ~ 1 at the tips of filopodia in growth 
cones of sympathetic neurons (Grabham and Goldberg, 1997). While we failed to detect 
any upregulation effect ofNGF on integrin ~ 1 protein expression at 24 hours, we cannot 
rule out relocalization of the existing integrin ~ 1 protein. 
More interestingly, few studies have investigated the effect of the ECM molecules 
on the expression of growth factor receptors. While the LN substrate did not influence 
the expression ofTrkA, it was associated with a significant decrease in p75NTR (Fig. 
4.3), which appears to be due to a combination of metalloprotease-mediated cleavage and 
a transcriptional downregulation (Fig. 4.4). p75NTR undergoes ectodomain shedding by 
a membrane metalloprotease, which releases a C-terminal fragment (CTF) that is rapidly 
further cleaved to yield a 25 kDa intracellular domain (lCD) fragment (Kanning et al. , 
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2003). Metalloprotease expression can be altered by ECM molecules, including LN 
(reviewed in Yong, 2005), but triple and not single neurotrophin exposure is necessary to 
potentiate regulated intramembrane proteolysis of p75NTR (Logan et al. , 2006). 
The role of p75NTR in the growth response is less clear, and may be cell type and 
context specific, although p75NTR is often associated with growth inhibition. Not only 
does BDNF act via p75NTR to inhibit axonal outgrowth in sympathetic neurons (Kohn et 
al., 1999), and antagonize NGF -mediated axonal outgrowth in both adult dorsal root 
ganglion (DRG) neurons (Kimpinski et al., 1999) and sympathetic neurons (Kohn et al., 
1999), but a function blocking p75NTR antibody, REX, also directly enhances growth of 
sympathetic neurons elicited by NGF (Kohn et al., 1999). Finally, neurons deficient in 
p75NTR display more robust growth in response to Trk activation than wild-type 
neurons, and this growth cannot be inhibited by BDNF (Kohn et al. 1999). An 
examination of p75NTR knockout mice (Dhanoa et al. , 2006; Hannila and Kawaja, 1999) 
revealed enhanced sympathetic innervation of the cerebellum in response to elevated 
levels ofNGF, and enhanced sympathetic axonal arborization compared to wild-type. 
Mice deficient in p75NTR also display a higher spine density and greater complexity in 
hippocampal neurons than wild-type controls (Zagrebelsky et al. , 2005). ECM down-
regulation of p75NTR expression levels could be mimicking the enhanced growth effect 
caused by genetic silencing. 
Several studies have identified a role for p75NTR as the transducing element of a 
receptor complex that includes Nogo-R and LINGO I . This complex binds three known 
myelin associated inhibitors (MAl) of axonal regeneration: myelin associated 
glycoprotein (MAG), Nogo and oligodendrocyte myelin glycoprotein (reviewed in 
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Domeniconi et al., 2005). Since p75NTR siRNA has been shown to inhibit MAG-
induced neurite retraction (Higuchi et al., 2003a), a reduction in p75NTR signaling is 
hypothesized to reduce the transduction of MAl signals that prevent axonal regeneration. 
In support of this hypothesis, neurons deficient in p75NTR are no longer responsive to 
myelin or individual MAis (Wang et al. , 2002a), and cleavage ofp75NTR in DRG 
neurons disinhibits outgrowth and promotes branching of neurites in the presence of 
myelin (Ahmed et al., 2006). Furthermore, LN is able to prevent MAG inhibition of 
NGF-induced Rae activation, and thus override the inhibitory cues (Laforest et al. , 2005). 
The removal of p75NTR from the cell surface provides a potential mechanism for this 
phenomenon. 
The inhibitory effects of MAl on axonal growth, transduced by p75NTR, are 
mediated by the intracellular activation ofRho GTPase (Yamashita et al. , 2002; 
Yamashita et al., 1999), and subsequent activation of the Rho-ROCK signaling cascade 
(Alabed et al., 2006). In its active GTP-bound state, Rho inhibits axonal elongation and 
mediates growth cone collapse (Gehler et al., 2004; Nikolic, 2002) by interacting with 
proteins that regulate the assembly and stability of the actin cytoskeleton (Kaplan and 
Miller, 2003). Inactivation of Rho or ROCK is sufficient to allow neurite formation on 
myelin substrates (Kaplan and Miller, 2003; Yamashita et al., 1999), and facilitates 
regeneration after axonal injury (Ahmed et al. , 2005; Gehler et al., 2004). Rho is 
constitutively activated by unliganded p75NTR (Yamashita et al. , 1999), a relationship 
that is negated by neurotrophin binding. Unoccupied p75NTR negatively regulates 
filopodia! dynamics (Gehler et al., 2004), and thus negatively impacts neurite outgrowth. 
Our study demonstrates that LN decreases p75NTR expression, which mediates a 
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decrease in the activation ofRho (Fig 4.7), and could thus promote growth. A similar 
effect has been demonstrated using siRNA against p75NTR, which decreases active Rho 
and results in a subsequent growth response (Ahmed et al., 2005). Furthermore, we also 
show that the overexpression ofp75NTR results in inhibition of neurite growth, and 
sustained activation of Rho; the inhibitory effects can be blocked by the presence ofthe 
Rho kinase inhibitor (Fig. 4.7B,C). 
The LN-mediated downregulation of p75NTR is associated with an upregulation 
ofPTEN (Fig. 4.9). In addition to its well-known role as a tumor suppressor, recent 
studies reveal a role for PTEN in the regulation of multiple cellular functions, including 
cell size, migratory behaviour, modulation of the actin cytoskeleton (von Stein et al., 
2005) and growth (reviewed in Sulis and Parsons, 2003). In this regard, PTEN also has a 
role in neural development, particularly neurite extension, and the suppression of PTEN 
expression impairs neuritogenesis. (Fig 4.11 , (Lachyankar et al., 2000). 
As a dual specificity phosphatase, PTEN is capable of dephosphorylating both 
proteins and lipids. The lipid phosphatase activity of PTEN functions primarily in the 
negative regulation ofPI3K activity. Selective activation ofPI3K results in defective 
neurite outgrowth in PC12 cells (Ashcroft et al., 1999). Furthermore, recent studies 
utilizing a lipid phosphatase null mutant of PTEN demonstrated that loss of this domain, 
and its subsequent functions, impaired neurite outgrowth from primary cortical neurons; 
an effect hypothesized to be associated with the effect ofPTEN on tau phosphorylation 
and subsequent alteration of microtubule interactions (Kerr et al. , 2006; Zhang et al., 
2006a). 
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The upregulation ofPTEN in response to LN may result in multiple other 
signaling events in the cell that have direct effects on neurite outgrowth. PTEN 
hydrolyzes phosphoinositide PI(3,4,5)P3 to produce second messenger PI(4,5)P2, thus 
increasing the available pool ofPI(4,5)P2 and decreasing the downstream activation of 
PI(3,4,5)P3 targets, including Akt and GSK (Beckner et al. , 2005). Additionally, 
PI(4,5)P2, which is increased in response to PI3K inhibition, can bind profilin, a protein 
that functions to sequester G-actin monomers. The binding of profilin by PI( 4,5)P2 
releases G-actin, increasing the available monomers for actin filament building and 
associated neurite extension (reviewed in Witke, 2004). 
In summary, we propose a signaling model (Fig 1 0) wherein LN upregulates 
PTEN, which can impact neurite outgrowth through numerous effectors, but perhaps 
importantly, through the downregulation ofp75NTR, a receptor that is implicated in 
neurite growth inhibition in a variety of neuronal cell types. Thus, by decreasing surface 
expression of p75NTR, LN results in the decreased transduction of multiple inhibitory 
growth pathways, both myelin-derived and Rho associated. (Figure 4.15). LN is 
upregulated following peripheral nerve injury (Wallquist et al. , 2002), and likely plays a 
physiological role in regeneration, potentially by engaging in a combination of enhanced 
growth programs and over-riding inhibitory cues. 
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Chapter 5: A method to assess multiple aspects of the motile behaviour of adherent 
PC12 cells on applied biological substrates 
This study has been published in the Journal of Neuroscience Methods, 2006, volume 
156(1-2), pp. 55-63. 
5.0 Summary 
Cellular migration is central to a wide range of biological and pathological processes in 
vivo. In vitro cell migration assays can be used to obtain invaluable information relating 
to the mechanism of cell movement, but current available methods can be limiting. Here 
we describe a novel motility assay that allows the simultaneous investigation of both 
quantitative and qualitative aspects of a population of motile cells as they move across a 
variety of substrates. By plating cells in a confluent monolayer on a coverslip, the 
monolayer can then be inverted to migrate over a larger substrate-coated coverslip, which 
can subsequently be reliably quantified, and subjected to immunocytochemistry and 
confocal imaging. This assay can be used to assess multiple aspects of motility, including 
distance, quantity, morphology, polarization and component colocalization. To 
demonstrate the utility of this assay, it was applied to the study of a stimulator of PC 12 
cell migration, nerve growth factor (NGF), and how this migration is influenced by the 
extracellular substrate, laminin. Furthermore, since mutations to the NGF receptor, TrkA, 
have been noted to alter the behaviour ofPC12 cells in response to NGF, a PC12 subline 
that expresses a mutated TrkA receptor was utilized to illustrate that a Y785F mutation in 
the cytoplasmic tail ofTrkA results in increased migration in response to the stimulus 
compared to the control PC12s. 
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5.1. Introduction 
Cell migration plays an essential role in embryonic development and is of crucial 
importance to multiple physiological processes, including wound healing, angiogenesis, 
the immune response and inflammation (for review, see(Lauffenburger and Horwitz, 
1996). Furthermore, cellular motility is central to certain pathological conditions such as 
tumour invasion and metastasis (for review, see (Engers and Gabbert, 2000; Ervin and 
Cox, 2005). 
Cell movement follows a characteristic pattern of events, beginning with the 
protrusion of a leading edge lamellipodium, followed by translocation of the cell body 
and finally retraction ofthe trailing edge (for review, see(Howe, 2004). These steps are 
physically and spatially distinct, and are regulated by a complex myriad of intracellular 
biochemical events which ultimately influence the multiple components of the 
cytoskeleton. These processes are dynamically regulated to allow the cell to efficiently 
alter the direction or speed of movement, as each motile cell is continually changing 
position with respect to other cells and the surrounding extracellular environment (for 
review, see Vasiliev, 2004). 
Key modulators of cell motility include the extracellular matrix (ECM), and 
cytokines/growth factors (Strachan and Condie, 2004). A family of receptors known as 
integrins mediates signals from the ECM. When activated by ECM ligands, integrins 
aggregate to form focal adhesions which directly influence the actin cytoskeleton, often 
resulting in cell movement (Kanda et al., 2004). Growth factor signals are also mediated 
by various surface receptors; for example, nerve growth factor (NGF) signals are 
mediated by both the high affinity receptor TrkA, and the low affinity p75NTR. The 
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TrkA receptor is activated upon ligand binding, and activation is associated with the 
phosphorylation of individual tyrosine residues on the cytoplasmic tail of the receptor (for 
review, see (Kaplan and Miller, 2000). Phosphorylation of the tyrosine residue at 
position 490 (Y490) activates a Ras-ERK cascade, while the tyrosine residue at position 
785 (Y785) interacts with phospholipase C (PLC-y) to activate the PLC-y-PKC-ERK 
signalling pathway. Both of these pathways result in the activation ofERK (Loeb et al., 
1994; Obermeier et al. , 1993a; Stephens et al. , 1994), which is known to play a vital role 
in the motility ofPC12 cells (Ho et al., 2001 ; Ho et al., 2005). A previous study revealed 
that cells expressing mutations of TrkA at Y 490 and Y785 responded differently than 
wild-type PC12 cells to various combinations ofNGF and laminin (Rankin et al., 2005). 
In order to pursue our investigation of the ECM and NGF in regulating cell behaviours, it 
was necessary to establish a migration assay that could provide both quantitative and 
qualitative information regarding the motile behaviour of these cells. 
Investigation of cellular motility fundamentals in vitro is thought to provide 
insights into diverse in vivo biological processes, including tissue formation and tumour 
metastasis, and is essential to the development of pharmacological approaches that 
attempt to control these phenomena. Currently available motility assays do not afford the 
option of using surface applied biological substrates, studying motility over long time 
periods, or allowing both quantitation and qualitative examination of cellular movement 
at once, thus limiting their applicability to the study of substrate-receptor interactions in 
motility. This study presents a novel motility assay that quickly and easily provides 
information regarding distance, morphology, quantity, polarization and component 
colocalization in an easily quantifiable system. 
201 
To illustrate the utility of this assay, we examined the importance of the TrkA 
mutation to cellular motility on two different substrates. For illustrative purposes, we 
have focused solely on a highly motile mutation, the Y785F cell line. The approach 
outlined here would also be useful to the following types of studies: 
(I) Quantitative assay of adherent cell motility. 
(II) Qualitative assay of adherent cell motility, including morphological changes 
and component polarization. 
(Ill) Assessment of various inhibitors/mutations on cellular motility. 
5.2 Materials and Methods 
5.2.1 Cell Culture Model 
The experimental model consisted of wild-type rat pheochromocytoma (PC12) 
cells, and a mutated PC12 derivative cell line, Y785F (gifts from Dr. David Kaplan, 
Hospital for Sick Children, Toronto, ON). The Y785F cell line was created by Stephens 
et al. (1994). Briefly, a PC12 cell line that lacks a functional TrkA receptor (PC12nnr5) 
was transfected to express a TrkA receptor that had been altered via site-directed 
mutagenesis to abrogate the Y785 autophosphorylation site of the cytoplasmic tail. 
Cell lines were maintained on rat-tail collagen coated tissue-culture flasks in 
RPMI 1640 medium (Invitrogen, Burlington ON) supplemented with 10% horse serum 
(Invitrogen), 5% fetal calf serum (Invitrogen) and 1% penicillin/streptomycin/glutamine 
solution (Invitrogen). Cells were incubated at 37°C in 5% C02, and cultured to 80% 
confluence prior to trypsinization for subculturing purposes. 
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5.2.2 Detailed Procedure 
See Figure 5.1 for schematic diagram of procedure. 
5.2.2.1 Coverslip Preparation 
In order to prepare the coverslips so that PC 12 cells would adhere to the glass, 
they were first pre-coated on one side with poly-D-lysine (PL, BD Biosciences, 
Mississauga, ON). To accomplish this, 12 mm diameter glass coverslips (3 per 
experimental condition; Carolina Biologicals, Ottawa ON) were carefully spread over a 
piece of sterile filter paper that had been cut to fit inside of a 150 mm tissue culture dish. 
All coverslip manipulations were performed using sterile fine point tweezers within a 
biosafety cabinet to avoid introducing contamination into the cultures. 
Once coverslips were adequately separated, PL ( 40 Jlg/ml) was applied dropwise 
to the upward face of the coverslip, relying on surface tension to keep the liquid as close 
to the edges as possible. The tissue culture dish lid was gently placed on top to reduce 
evaporation. After 30 min, PL was aspirated and the coverslips were allowed to dry 
before a second coat was applied. After 30 min, the PL was again aspirated and 
coverslips were allowed to dry prior to rinsing with sterile distilled water, and air-drying 
once more. This coating method ensured that cells remained adherent to only one side of 
the coverslip. 
The PL-coated 12 mm coverslips were then placed, one per well, into a 24-well 
plate with the PL-coated side facing up. 
203 
Figure 5.1: Procedure Schematic. A. 12-mm coverslip (clear circle) is coated on one 
side with PL. B. PC12 cells (black circles) are plated onto the PL-coated coverslip and 
allowed to settle and synchronize overnight. C. 12-mm coverslip is inverted and placed 
cell-side down onto a PL- or LN-coated 18-mm coverslip (cross-hatched), which serves 
as the migratory field. D. Over a period of24-48 h, cells are allowed to migrate out from 
underneath the overlaid coverslip. E. After photographing, the 12-mm coverslip is 
removed and the remaining migratory cells are subjected to immunocytochemistry. 
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Figure 5.1 
5.2.2.2 Preparation of the Cells 
Cells were trypsinized using trypsin-EDT A (Invitrogen) in order to release them 
gently from the surface of the tissue culture flask. The trypsin reaction was stopped by 
the addition of serum-enriched RPMI 1640 medium, and cells were subsequently pelleted 
from the suspension by centrifugation (1000 rpm, 5 min). At this stage, the supernatant 
was aspirated to leave the cell pellet, which was then resuspended in serum-free RPMI. 
Cells were loaded onto the coverslips by pipetting between 1.5 x 105 and 2.5 x 105 cells 
into each well of the 24-well plate, ideally diluted to a final volume of 0.5 ml. This 
ensured 90-95% confluence. Cells were allowed to settle overnight (16 h) at 37°C, 5% 
C02. The serum free environment was designed to synchronize the population and 
reduce proliferation rates. 
5.2.2.3 Preparation of the Migration Substrate 
The following day, 18-mm diameter round glass coverslips (1 per 12-mm 
coverslip; Fisher Scientific, Fairlawn NJ) were undercoated with PL (1 coat x 30 min; see 
step 2.2.1), and allowed to dry. 18-mm coverslips were then separated into two groups: 
half of the coverslips were treated to a second coat of PL (30 min) and allowed to dry as 
before prior to washing with sterile distilled water. The other half of the coverslips was 
treated to 2 coats of laminin (LN, 25 J.!g/ml, Invitrogen) for 30 min each, allowing the 
coverslips to dry in between coats. 
The coated 18-mm coverslips were placed, 1 per well, within a 12-well plate, 
coating side facing upwards. 
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5.2.2.4 12-mm Coverslip Inversion 
1 ml of serum-enriched RPMI 1640 medium was added to each well ofthe 12-
well plate, and sterile tweezers were used to push out any air bubbles that may have 
become trapped underneath the 18-mm coverslip. This plate was set aside, and the 24-
well plate (containing cells on 12-mm coverslips) was removed from the incubator for 
preparation. Following aspiration of the media from the 24-well plate wells, the cell-
covered coverslips were washed twice with fresh medium in order to remove excess and 
non-adherent cells, ultimately replacing 0.5 ml of fresh medium to the 24-well plate. The 
12-mm coverslips were next gently removed from the 24-well plate by using a sterile 
needle bent to a 90° angle to raise the edge of the coverslip so that it could be gripped 
with the sterile tweezers. The 12-mm coverslip was then inverted and gently lowered, 
cell side down, onto the top of the 18-mm coverslip in the 12-well plate, moving slowly 
to ensure no air bubbles become entrapped between the glass coverslips that may damage 
the monolayer or interfere with microscopic visualization. 
Once the 12-mm coverslip was in position on top ofthe 18-mm coverslip, the 
medium was changed in the well to remove any floating debris that may have settled in 
the migratory field. This medium change also provided the option of adding a stimulus or 
inhibitor of motility to the culture medium. For the experimental conditions investigating 
the effects ofNGF, NGF (Harlan, Indianapolis IN) was added to the culture medium at a 
concentration of 50 ng/ml. Once fresh medium was replaced in the well, the coverslips 
were examined using a light microscope to ensure the edges of the coverslip were clear of 
cellular debris. This condition was photographed as a "time zero" control, and plates 
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were incubated at 37°C, 5% C02 for the migratory time period of choice, generally 24-48 
h. 
5.2.2.5 Collection and Analysis of Quantitative Data 
At the scheduled time point (24 or 48 h), plates were removed from the incubator 
and an inverted microscope fitted with a digital camera was used to photograph individual 
fields of view of the overlapping edges of the two coverslips in the well. These images 
were used to assess the various parameters of cellular motility: individual cells were 
either manually counted within each imaged field of view, or alternatively quantitated 
automatically using particle recognition software, such as Kodak™ Image Analysis 
Software (Molecular Imaging Systems, New Haven CT). Values were averaged per 
experimental condition to provide a relative quantity of cell motility for comparison. 
Statistical analysis was performed using Graph Pad Prism 4 (Graph Pad Software Inc., 
San Diego CA), with significance being determined using one-way ANOVA testing. 
The distance of migration can be assessed using an ocular micrometer to measure 
distance travelled. Alternatively, distance measurements can be derived retrospectively 
from the images. These images could also be used to assess the morphological stages as 
the cells migrated. 
5.2.2.6 Immunocytochemistry 
In order to subject the migratory cells on the 18-mm coverslip to 
immunocytochemistry, it was first necessary to carefully remove the 12-mm coverslip 
from the surface. This was accomplished using an aspirator fitted with a 3-mm hose as a 
208 
r-:"""'~----------------------------------~----- --
vacuum device. The aspirator was also used at this point to remove all remaining media 
from the well. 
18-mm coverslips were washed with phosphate buffered saline (PBS; Invitrogen) 
for 5 min. PBS was subsequently aspirated from the wells and replaced with 4% 
formaldehyde (Fisher Scientific) for 20 min for fixation purposes, and once again washed 
with PBS for 5 min. Cells were next permeabilized by incubation with 0.1 % Triton-X 
(Sigma, St. Louis MO) for 10 min, washed in PBS for 5 min, and blocked in 10% goat 
serum in PBS for 1 h. At this point, coverslips were placed cell-side-up on glass slides 
within a humidifying chamber. Primary antibodies directed against integrin ~ 1 (1 :250, 
polyclonal, Chemicon, Temecula CA), and total tubulin (1:1000, Sigma, monoclonal) 
were applied dropwise to the coverslips, just covering the cells. The humidifying 
chamber was subsequently placed at 4°C, and cells were allowed to incubate overnight 
(16 h). 
The following morning, 18-mm coverslips were placed in 35-mm tissue culture 
dishes of PBS and allowed to wash for 10 min prior to incubation of the cells in Cy2 and 
Cy5 tagged secondary antibodies (1: 100, Jackson ImmunoResearch Laboratories Inc., 
West Grove PA) for 1 h. Following a final10 min wash in PBS, 60 Jll of glycerol was 
placed onto the surface of a clean glass microscope slide (Fisher Scientific) and the 18-
mm coverslip was inverted and placed cell-side-down onto the glycerol. Excess glycerol 
was wicked away using filter paper, and edges of the coverslip were sealed using clear 
nailpolish. 
Slides were visualized using confocal scanning laser microscopy, and staining 
patterns were assessed based on the direction of locomotion. 
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5.3 Results 
PC12 cells and derivative mutants (Y785F) plated onto PL-coated coverslips and 
inverted onto an adhesive substrate (PL or LN), were induced to migrate across the 
substrate, thus moving out from underneath the overlaid coverslip, exposing a population 
of motile cells to study. This protocol was optimized using uncoated 18-mm glass 
coverslips as the migratory surface in lieu of an adhesive substrate (Fig. 5.2). This served 
as a negative control because the PC12 cells do not attach well to glass (Greene et al., 
1998); they are thus unlikely to locomote away from the PL coating of the overlaid 
coverslip, as noted by the lack of migration visible after 24 h in Figures 5.2B and 5.2D. 
The addition ofNGF to the culture medium has been shown to increase the rate of cell 
movement in PC12 cells (Ho et al. , 2001; Ho et al. , 2005), and thus this experimental 
condition also served as a positive control for cellular motility (Figs. 5.3C and F for 
PC12, Fig 5.4C and F for Y785F). 
In order to compare the effects of different biological substrates on cell motility, 
the cell-covered coverslip was inverted onto one of two substrates (PL or LN), and a 
digital photo was taken at the starting point, time zero. Fig 5.3A and Dare representative 
images taken at time zero, illustrating the clean, confluent edges of the overlaid coverslip 
and the initial lack ofPC12 cells in the migratory field. Fig 5.3B and E are representative 
of field of view (FOV) images used for the comparison of relative motility on the two 
different substrates, PL (Fig 5.3B) and LN (Fig 5.3E). As illustrated by the relative 
quantity of cells emerging from the confluent edges of the coverslips, the type of 
substrate available in the migratory field appears to influence the relative quantity of 
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Figure 5.2: Negative Controls. Photomicrographs illustrate negative controls for 
optimization of procedure. Panels A and B show PC 12 cells, and panels C and D show 
Y785F cells that have been plated on PL-coated 12-mm coverslips, and inverted onto 
uncoated 18-mm glass coverslips. Images are taken at time zero (A,C) and 24 h (B,D) to 
illustrate that there is no movement in the absence of an adhesive substrate. Scale bar = 
200 ~m. 
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Figure 5.3: Effect of Substrate on PC12 Cells in the Presence or Absence of NGF. 
Photomicrographs illustrate PC12 cells plated on PL-coated 12-mm coverslips, and 
subsequently inverted onto substrates ofPL (A-C) or LN (D-F), in the absence ofNGF 
(B,E) or in the presence ofNGF (C,F). Note the relative increase of motile cells on LN 
relative to PL, and the various cellular morphologies. Scale bar = 100 1-lm. 
PL 
LN 
Figure 5.3 
Figure 5.4: Effect of Substrate on Y785F Cells in the Presence or Absence of NGF. 
Photomicrographs illustrate Y785F cells plated on PL-coated 12-mm coverslips and 
subsequently inverted onto substrates of PL (A-C) or LN (D-F), in the absence ofNGF 
(B,E) or in the presence ofNGF (C,F). Similar to Figure 2, note the relative increase of 
motility on LN relative to PL, and the various cellular morphologies. Scale bar = 100 
IJ.m. 
time zero substrate +NGF 
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migration across the migratory field. It is also possible to note cellular morphology of the 
motile cells in these images (Figs 5.3 and 5.4). The addition ofNGF (50 ng/ml) to the 
culture media also influenced the motile behaviour of the PC12 cells. Fig 5.3C and Fare 
representative images for the comparison of relative motility on the different substrates, 
PL (Fig 5.3C) and LN (Fig 5.3F) in the presence ofNGF. Again it appears that the 
addition ofNGF increased chemokinesis. The experimental condition that exhibited the 
most motility in wild-type PC12 cells involved cells migrating across the laminin 
substrate in the presence ofNGF. An examination of the morphology reveals that the 
cells are spreading on LN, extending processes and leading edge protrusions. 
To examine the effects of the Y785F mutation ofthe TrkA receptor on motile 
behaviour, similar experiments were performed using the mutated cell line. The 
representative time zero images showed clean, confluent edges of the overlaid coverslip 
on both substrates (Fig 5.4A and C). The cells showed increased migration on LN 
compared to PL (Fig 5.4B and E), while NGF increased the chemokinesis of these cells 
on both PL and LN (Fig 5.4C and F). 
Quantitative analysis ofthe migratory behaviour consisted of counting the number 
of cells that moved out from underneath the overlaid coverslip and into the migratory 
field of view. This analysis revealed that PC12 cell motility is significantly increased on 
a LN substrate relative to the synthetic PL substrate (Fig 5.5A). The addition ofNGF 
also resulted in a significant increase in motile behaviour. The PC12 cells expressing the 
Y785F TrkA mutation are also significantly more motile than wild-type PC 12 cells, 
particularly when exposed to a LN substrate or NGF (Fig 5.5A). Fig 5.5B represents 
graphical comparison of the maximum migratory distance determined by ocular 
217 
Figure 5.5: Quantitation of Relative Motility. A. PC12 cells (black bars) treated with 
NGF (50 ng/ml) exhibit increased cellular motility. Cells exposed to a LN substrate also 
exhibit increased cell motility relative to the PL substrate. The combination of LN and 
NGF resulted in significantly more motility than either condition alone. In relation to 
wild-type PC12 cells, Y785F cells (white bars) demonstrated an increased rate of motility 
in response to NGF or LN, which increased significantly upon exposure to both stimuli 
(*p<O.Ol , **p<O.OOI). B. Graphical comparison of maximum migratory distance 
determined by ocular micrometer measurement. Distance traveled is enhanced by the 
addition ofNGF (50 ng/ml) or exposure to a LN substrate. The combination ofNGF and 
LN resulted in a trend of increased distance traveled than either condition alone (*p<O.Ol , 
**p<O.OOI). 
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Figure 5.5 
micrometer measurement. The addition ofNGF to culture medium enhanced the 
maximum distance travelled, as did exposure to the LN substrate. Interestingly, the 
combination ofNGF and LN resulted in enhanced distance travelled than either condition 
alone. 
By subjecting the 18-mrn coverslips to immunocytochemistry, it was possible to 
examine cellular components of the motile cells moving across the migratory field. For 
this experiment, cells were co-stained with antibodies directed against total tubulin and 
integrin ~ 1, and detected with fluorescently tagged secondary antibodies. The total 
tubulin and integrin ~ 1 stains were visualized using confocal laser scanning microscopy 
to examine the cellular morphology of the motile cells (Fig 5.6). The cells appear to be 
developing lamellipodia and leading edge protrusions. A closer examination of the 
confocal images revealed a polarization of integrin ~ 1 to the leading edge of the cellular 
processes, relative to the total tubulin localization (Fig 5.6). This pattern of component 
localization was consistent between both the wild type PC 12 cells and the derivative 
PC12 cells expressing the Y785F mutation of the TrkA receptor. 
5.4 Discussion 
5.4.1 Overall Assessment of the Protocol 
This study presents a relatively simple motility assay that allows the simultaneous 
study of multiple aspects of cellular movement, including distance, direction, quantity, 
morphology of the intermediate stages of movement and component polarization, with 
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Figure 5.6: Integrin ~1 Polarization. Confocal images representing PC12 cells (A, B) 
and Y785F (C, D) plated on PL-coated 12-mm coverslips and allowed to migrate onto a 
LN substrate. Cells were stained with integrin ~1 (red) and total tubulin (green) and 
visualized with Cy2 and Cy5 tagged secondary antibodies. Note the dense aggregation of 
integrin ~1 in the protruding leading edges (white arrows). A, C: scale bar = 100 J..Lm. B, 
D: scale bar = 20 J..Lm. 
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relatively low expenditure of time, space and materials. This assay allows the 
investigation of multiple parameters, such as cellular mutation and pharmacological 
inhibition of intracellular signalling intermediates, and allows the assessment of their 
effects on motility. Furthermore, the assay can be permutated to allow the use of any 
combination of coatings and substrates. Though numerous motility assays exist, to our 
knowledge, this is the only method that allows accurate quantitation and qualitative 
assessment of a population of motile cells across an artificially applied substrate (for 
example, LN coating) without inflicting scratches or damaging the migratory substrate or 
the cells in any way. In addition, the option of automated quantitation using particle 
recognition software reduces the time typically associated with analysis of motility 
assays, most of which require counting manually for accuracy. In this study, we have 
identified clear differences in the motility of wild-type PC12 cells and a derivative 
expressing the Y785F TrkA mutation. Because the phosphorylation of the Y785 residue 
is associated with an intracellular signalling pathway involving PLC-y and PKC, this 
information can provide clues as to the regulation of chemokinetic behaviour. Further 
investigation of these pathways is the subject of ongoing investigation. 
5.4.2 Troubleshooting 
With meticulous care and gentle coverslip handling, this protocol can be carried 
out with minimal damage to the cellular monolayer. However, due to the necessary 
manipulations/inversions of the covers lips, this protocol is suited only to the study of 
strongly adherent cells. Cells may become dissociated from the coverslip if the coverslip 
is initially overloaded. Should this be the case, the option exists to plate the cells less 
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confluently, and allow them to grow confluent over the coverslip prior to inversion. 
Furthermore, it is essential to gently rinse the monolayer and change the media in the 
final well to remove any cells that do become dislodged and may settle in the migratory 
field thus confounding counts. 
The initial step of plating the cells on a PL-coated coverslip and flipping it onto a 
LN-coated migratory field is key to this assay. It serves to confine the cells to a specific 
circular area without damaging the LN substrate, thus forcing the cells to migrate radially 
out from under the coverslip. The edge of the coverslip then serves as a definitive 
starting line, lending accuracy to the quantitation. Additionally, by confining the cells as 
such, it allows us to monitor population movement, rather than individual cell movement. 
Plating the cells directly onto the LN-coated coverslip would allow the study of 
individual cell movement, but the non-directional nature of migration in the absence of a 
chemotactic source would prevent the study of population movement, and eliminate the 
quantitation available with the dual coverslip system. 
It is also imperative to avoid the entrapment of air bubbles beneath the coverslips 
that may damage the cellular monolayer and interfere with microscopic visualization. To 
this end, coverslips that are coated with cells should not be placed into a dry well, but 
instead be lowered gently into a medium-containing well. 
If the weight of individual coverslips varies widely, it is possible that the weight 
of the coverslips could differentially influence the number of cells migrating. In our 
experiments, it is unlikely that the weight of the coverslip is influencing the number of 
cells emerging from beneath the glass, as the weight of the individual coverslips ranged 
no more than 3% of total weight. Notwithstanding, it is prudent to replicate experimental 
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results to eliminate the potential influence of differential coverslip weights. The present 
experiments were replicated three times without significant differences in results. 
This motility assay is likely affected by similar factors that limit the reliability of 
the traditional wound healing assays: proliferation is possibly playing a role in the 
increased number of cells noted in the migratory field. We addressed this issue by 
synchronizing the cell population in a serum deprivation state prior to beginning the 
migration. This issue could also be addressed by low-level irradiation or the addition of 
anti-mitotic agents to the culture medium. 
5.4.3 Alternative and/or Support Protocols 
This assay can be permutated in a number of different ways allowing for the use 
of different coverslip coatings and substrates to investigate their effects on motility. 
Additionally, alternate cytokines/ growth factors or pharmacological inhibitors can be 
added to the culture media of migrating cells to assess their effects on motility. 
Furthermore, it is possible to derive even more information from this assay by altering the 
endpoint; for example, rather than proceeding to immunocytochemistry, the cells can be 
scraped from the coverslip and the protein harvested for Western blot analysis of cellular 
components. Furthermore, a population of cells could easily be marked and followed 
over a finite period of time to determine the rate or speed of motility. 
As it stands, this assay measures chemokinesis (random movement), but can 
easily be converted to a chemotactic (directed migration) assay by the addition of a 
neurotrophin-soaked plug (for review, see Entschladen et al. , 2005) to one end of the well 
to create a concentration gradient for cells to migrate towards. 
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In general, cellular motility can alternately be assessed using colloidal gold 
particles to track movement of individual cells, which clear a path by phagocytosing 
synthetic bead substrate (for review, see Linger, 2003; Staton et al. , 2004; Windier-Hart 
et al., 2005). This method provides an accurate assessment of the distance and route a 
cell takes, but the importance of the substrate to this assay doesn' t allow for permutations 
to test alternate biological substrates. Also, population movement is harder to assess, 
which is potentially important because cellular relation may influence motility. 
Motility can also be assessed using a wound-healing assay in which a confluent 
cell monolayer is wounded by using a micropipette tip to denude an area of cells. This 
wound is then monitored microscopically to visualize the migration of cells into the 
scratch (for review, see Entschladen et al. , 2005). This assay is rapid and simple, but 
reliable quantification using a traditional scratch assay can be difficult due to differences 
in the precision of the initial scratch and the lack of a definitive starting point for 
movement. The wound-healing assay tends to damage the cells lining the edges of the 
wound, and results in floating debris that must be removed. This assay has been updated 
recently to include several variations designed to avoid the aforementioned pitfalls of the 
traditional method. Current scratch methods employ electrical current (Keese et al. , 
2004), polyelectrolyte patterns (Kumar et al. , 2005) or mechanical equipment (Yarrow et 
al., 2004) to standardize scratch size and avoid damage to edges of the monolayer. 
Unfortunately the scratch assay continues to eliminate the possibility of studying 
migration on alternate substrates, which can also be damaged or scratched off when the 
surface is scratched. Moreover, it is difficult to study motility over longer time points, as 
the scratch can entirely fill in and be disguised in the well. 
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Migration and invasiveness can also be quickly quantified using a transwell 
migration assay, including the Boyden Chamber, in which cells are plated on one side of 
a porous membrane and allowed or induced to migrate to the other side of the membrane 
over a 4-6 h time period (Ervin and Cox, 2005; Ho et al., 2001; Ho et al., 2005; Staton et 
al., 2004; Tezel et al., 2001; Windier-Hart et al., 2005). While this assay can accurately 
determine chemotactic versus chemokinetic stimulation, and allows screening of multiple 
substances for motile influence, it does not allow any analysis of cells in motion. This 
assay can be technically difficult and time-consuming, both in terms of set up and 
analysis, and accuracy of the counts can be problematic, particularly when only a small 
number of cells pass through the filter (for review, see Staton et al. , 2004). Furthermore, 
automated analysis is often confounded by the inability of software to differentiate 
between a migrated cell and a pore in the membrane, although manual analysis can 
provide accurate quantitative information for particular populations of cells. Updated 
versions of this assay employ membranes coated with applied biological substrates 
allowing quantitative assessment of motility in response to substrate. 
Another common method for the investigation of invasiveness is the 3-D matrix 
assay (for reviews, see Entschladen et al. , 2005; Fischer et al., 1990), in which cells are 
embedded within a matrix composed of agarose or extracellular matrix components, and 
allowed to migrate through it. Included in this category is the under/over agarose assay in 
which a chemoattractant is placed into a hole cut into the agarose gel, and cells are placed 
either on top of the gel or in a separate hole and induced to migrate. These assays are 
more relevant to the in vivo condition, but are unsuitable for screening pharmacological 
inhibitors/stimulators due to the complexity of the experimental setup and the reliance on 
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diffusion properties of inhibitors and stimuli within the gel. Conversely, it is possible to 
take advantage of the slower diffusion to set up gradients for chemotactic investigation. 
The Dunn chemotaxis chamber (Zicha et al. , 1991) is another 3D migration assay which 
is composed of concentric compartments allowed to communicate via a 1 mrn bridge. 
When cells are placed in one compartment and a chemoattractant is placed in the other, 
this assay can provide real-time data on qualitative cellular responses toward stable linear 
concentration gradients. This assay is useful to study the motility of a wide variety of cell 
types, and the influence of a wide variety of chemoattractant substances, but does not 
allow for the investigation of the effects of alternate substrates on motility. Additionally, 
3-D assays are often more difficult to analyze, and generally require time-lapse 
videography equipment for data collection and analysis. 
The ability of the assay presented here to allow the study of motility over various 
applied substrates, while at the same time allowing the simultaneous study of quantitative 
and qualitative aspects of motility which can be influenced by a variety of stimulators, 
inhibitors and mutations, makes this assay a practical and viable alternative to existing 
assays, and may be useful to a wide variety of fields of study. 
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Chapter 6: A Laminin-lnduced Upregulation ofPTEN Promotes Migratory 
Behaviour in Cerebellar Granule Neurons 
This study has been submitted for publication, 2008. 
6.0 Summary 
The development of proper cerebellar architecture is dependent upon the migration of 
cerebellar granule neurons (CGN) to the internal granule layer. The process of migration 
is, in tum, dependent on integrin receptors, which relay signals from the extracellular 
matrix (ECM) to the actin cytoskeleton. We have recently presented a novel signaling 
cascade whereby ECM component, laminin (LN), signals through integrin receptors to 
increase PTEN expression, which decreases p75NTR expression and subsequently 
depresses Rho A activity leading to enhanced axonal regeneration in PC 12 cells. Since 
PTEN is required for cerebellar granule neuron migration, and a role for p75NTR in 
cerebellar foliation has recently been determined, the present study sought to determine if 
this ECM-induced signalling cascade is associated with the developmental migration of 
CGN. Western blotting shows that exposure to a LN substrate results in increased PTEN 
and decreased p75NTR expression in these cells over the first 8 days in vitro (DIV), a 
response that disappears after 14 DIV. This timeline ofLN responsiveness correlates to 
the period of developmental migration in vivo and migratory behaviour in vitro. 
Furthermore, interference with the individual signalling components in this cascade 
impairs LN-induced motility in vitro. These results demonstrate a key role for ECM-
induced upregulation ofPTEN, and subsequent downregulation ofp75NTR in CGN 
migration. 
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6.1 Introduction 
The establishment of normal brain architecture in the developing nervous system 
depends upon the appropriate migration of neurons from their site of origin to their final 
destination in a specific lamina of the brain. The development of the cerebellum differs 
from cortex in that the migration of neurons occurs largely postnatally. Cerebellar 
granule neuron (CGN) precursors arise embryonically in the rhombic lip and migrate to 
form the external granule layer (EGL). After birth these precursors cease division, 
differentiate and migrate inwards through the molecular and the Purkinje layers, coming 
to reside in the internal granule layer (IGL). This migratory behaviour is guided by radial 
glial scaffolds (reviewed in Hatten, 1999; Komuro and Yacubova, 2003; Yacubova and 
Komuro, 2003). 
The process of migration is often dependent on integrin signalling. The integrins 
are a group of integral membrane receptors that relay signals from the extracellular matix 
(ECM) to the actin cytoskeleton to modulate cellular form and function. The formation 
of integrin-associated focal adhesions serves to anchor the leading process to the substrate 
and the subsequent turnover of focal adhesions is necessary to retract the trailing process. 
Furthermore, integrins are capable of initiating signalling cascades to change cellular 
behaviour. Binding of ECM components to their cognate receptor induces integrin 
clustering within the cell membrane forming focal aggregations which subsequently 
recruit a variety of kinases and adapter proteins to initiate signalling cascades that alter 
gene expression and thus manipulate cellular actions (reviewed in Moissoglu and 
Schwartz, 2006; Ridley et al. , 2003). 
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We have recently presented evidence for a signalling casade whereby a 
component of the ECM, laminin (LN), acts via integrin ligation to reduce the expression 
ofp75NTR, the low affinity pan-neurotrophin receptor through the signalling 
intermediate PTEN, a phosphatase (Rankin et al. 2008b). p75NTR constitutively 
activates Rho, a small GTPase with known inhibition of actin cytoskeleton remodelling 
(Yamashita et al. , 1999). The decrease in p75NTR expression results in sustained 
decrease of active Rho, thus eliminating the inhibition on lamellaepodial and filopodia! 
extension thereby promoting growth in both NGF-differentiated PC12 cells (a 
sympathetic neuronal model) and in postnatal hippocampal neurons (Rankin et al. 2008b ). 
Each of these signalling components has been individually implicated in directing 
migratory behaviour of the developing cerebellum. LN deposits are associated with 
Bergmann radial glia (Liesi, 1992), and are known to promote growth and developmental 
migration of CGN (Powell et al., 1998). Additionally, PTEN has been implicated in 
proper migratory behaviour ofCGN, as studies ofPTEN-deficient mice demonstrate 
severely impaired lamina formation due to improper CGN migration (Backman et al. , 
2001 ; Groszer et al. , 2001 ; Kwon et al. , 2001 ; Marino et al. , 2002; Nayeem et al. , 2007). 
More recently p75NTR has been noted to play a role in the proper foliation of the 
cerebellum (Carteret al., 2003); a phenomenon often related to appropriate migration. 
Finally, Rho has a known role in cytoskeleton remodelling (Raftopoulou and Hall, 2004), 
and thus modulates the migratory behaviour of several cell types from Dictyostelium to 
fibroblasts (reviewed in Raftopoulou and Hall, 2004). Since cellular motility shares 
several of the same underlying processes as the extension of axonal outgrowth, we 
investigated whether this LN-initiated signalling cascade occurs in CGNs. Furthermore, 
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we sought to determine the outcome of cascade activation in this cell type. We report 
here that the LN-mediated PTEN-p75NTR signalling cascade does occur in CGN during 
a period of time corresponding to in vivo migration and that interference with the 
individual pathway components results in defective migratory behaviour in vitro. 
6.2 Materials and Methods 
6.2.1 Primary Cell Culture 
Cultures enriched in granule neurons were obtained from cerebella of 8 day-old 
Sprague-Dawley rat pups as described previously (Jiang et al., 2003 ; Rankin et al., 2008). 
Cerebella were stripped of meninges, finely chopped and dissociated by enzymatic 
digestion using 0.25% trypsin-EDT A followed by mechanical trituration. The culture 
medium was Dulbecco's modified eagle medium (DMEM) supplemented with 10% FCS, 
25 mM KCl and 1% penicillin/streptomycin solution (Invitrogen). Cells were seeded 
onto polylysine (PL; 40 ~g/ml) or laminin (LN; 25 ~g/rnl)-coated tissue culture plates at a 
density of 1.8 x 106 cells per ml. Cells were incubated at 37°C in 5% C02 and cytosine 
arabinoside was added to longterm cultures to inhibit the proliferation of non-neuronal 
constituents. On the seventh day in vitro (DIY) of longterm cultures, glucose (50 ~1 of a 
100 mM solution) was added to each culture well to maintain survival, as culture medium 
was not replaced. This method yields cultures consisting of approximately 95% CGN 
(Jiang et al., 2003). For lentiviral transduction, cells were prepared with the following 
changes to the dissociation procedure, as dissociation using trypsin yielded no infection at 
the required timepoints. Briefly, in place of Trypsin-EDT A, neurons were enzymatically 
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digested with 5 ml papain (1 OU/ml) supplemented with EDT A, NaHC03 and DNase for 
30 min at 36°C. 
6.2.2 Western Blot Analysis 
For Western analyses, cells were harvested in the presence of sodium 
orthovanadate (100 mM in TBS) and subsequently subjected to lysis overnight at 4°C 
prior to centrifugation (1 0,000 x g, 5 min). A BCA protein assay (Pierce, Rockford IL) 
was used to determine protein concentration and equivalent amounts of protein (50 j.tg) 
were electrophoresed on 8% SDS-polyacrylamide gels. Protein was subsequently 
transferred to nitrocellulose membranes, which were then exposed to ponceau red to 
ensure equal protein loading. After washing in TBS, blots were blocked in 3% non-fat 
dry milk for lh at RT, then incubated with primary antibody directed against PTEN (Cell 
Signalling), p75NTR (Upstate) or actin (Sigma) overnight at 4° C. A final incubation 
with HRP-conjugated secondary antibody (Chemicon) for 1h at RT was followed by 
visualization using an ECL method. Each experiment was repeated three times, subjected 
to densitometry and normalized to actin to ensure equal protein for comparison. 
Statistical analyses were performed using GraphPad Prism 4 (GraphPad Software Inc, 
San Diego CA) with significance being determined using one way ANOV A testing. 
6.2.3 Real-time RT -PCR 
For real-time RT-PCR analyses, cells were subcultured on PL or LN-coated 12-
well plates for varying timepoints as indicated. RNA was isolated using Trizol reagent 
(Invitrogen) as per the manufacturer' s instructions, and was subsequently treated with 
DNase (Ambion, Austin TX) to remove traces of contaminating DNA. RNA (2 j.tg) was 
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reverse transcribed to eDNA using MMLV reverse transcriptase (200 U for 30 min at 37 
°C; Invitrogen) prior to use as template for real-time PCR amplification using the 
following PCR primer pairs: p75NTR forward primer 5' -
TGCATCTGAGCTGGTGTCTGTCTT and p75NTR reverse primer 5'-
TGCGTACAATGCTCCTGGTCTCTT, PTEN forward 5'-
ATTCGACTTAGACTTGACCT, PTEN reverse 5'-ACCAGTCCGTCCTTTC, 28s 
forward primer 5'-GACCAAGGAGTCTAACGC and 28s reverse primer 5'-
GT ACGCTCGTGCTCCA. PCR amplifications were performed using the Roche 
lightcycler and quantified using SYBR green I. p75NTR expression was subsequently 
normalized against 28s expression. 
6.2.4 Rho Activity Assay 
The activation ofRhoA was assessed using a pulldown assay kit (Upstate) in 
accordance with the manufacturer's instructions. Briefly, cells were harvested and lysed. 
Rhotekin-bound beads were added to cleared lysates and rotated for 1 hat 4° C prior to 
pelleting, washing and boiling in Laemmli buffer with DTT. Rhotekin-bound Rho 
proteins were detected by Western blot analysis using a polyclonal anti-Rho antibody 
(Upstate). The total amount ofRhoA in celllysates was used as a control for the cross-
comparison of Rho activity. 
6.2.5 Motility Assay 
Motility was assessed using a previously described assay (Rankin et al. , 2006). In 
brief, cells were plated in a monolayer on a PL-coated glass coverslip. Cells were 
allowed to attach and mature for the indicated time period before coverslips were inverted 
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onto 12-well tissue culture plates coated with PL or LN substrates. Cells were allowed to 
migrate from underneath the inverted coverslip into the migratory field for 36 h prior to 
image acquisition. Cell migration was quantified using a semi-automated cell counter 
plugin for Image 1 (NIH). 
6.2.6 Small Interfering RNA Constructs and Transfection 
PTEN siRNA was purchased from Cell Signalling (PTEN signal-silence siRNA). 
PTEN siRNA was introduced to the CGN using a calcium-phosphate co-precipitation 
method as previously described (Bingham et al. , 2006; Rankin et a!., 2008). Briefly, 
conditioned medium was removed and retained for replacement following transfection. 
Cells were washed twice with transfection medium (DMEM supplemented with 25 mM 
KCl). A calcium phosphate co-precipitate of siRNA oligos (100 nmol) was prepared and 
applied to the cells dropwise. Following an incubation of2 h cells were washed twice 
with transfection media and returned to incubate in the retained conditioned medium. 
Cell analyses were performed 48 hours post transfection. 
6.2. 7 Inhibitor Studies 
For pharmacological inhibition studies, cells were cultured on PL-coated 
coverslips. 2 h prior to establishment of motility assays, cells were primed with media 
supplemented with ROCK inhibitor Y27632, to a final concentration of 10 llM. 
Coverslips were subsequently inverted into wells in the presence of the inhibitor and 
motility was assessed 36 hours later. Inhibitor concentration was determined empirically 
to provide the required inhibition without detriment to cell viability. 
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6.2.8 Lentiviral Constructs and Transduction 
pcDNA3.1-p75NTR-Orange: Plasmid sequence encoding orange fluorescent 
protein was excised from the pRSET vector (a kind gift from Dr.Lois Mulligan) using 
BamHI and Hindiii restriction enzymes and was inserted into the eukaryotic expression 
vector pcDNA3.1. Amplification of the full length p75NTR coding region was 
performed using forward primer 5'-CTCGAGATGAGGAGGGCAGGTGCTGC and 
reverse primer 5 '-GAT A TCTGCACTGGGGA TGTGGCAGTGG encoding Xhol and 
EcoRV restriction enzyme sequences which facilited directional insertion into the 
engineered pcDNA3.1-orange vector yielding p75NTR with a C-terminus orange 
fluorescent tag. pGJ3-p75NTR-orange lentivial construct: The third generation 
replication deficient lentiviral vector denoted pGJ3 was kindly provided by Dr.Michael 
Sendtner (University of Wurzburg, Germany). The p75NTR-orange fusion construct, 
including upstream CMV promoter and enhancer regions were excised from pcDNA3.1 
and inserted into linearized pGJ3 lentiviral backbone. Lentiviral particles were produced 
by transfection of the 293T packaging cell line with the pGJ3-p75NTR-Orange construct, 
and an additional plasmid encoding VSV -glycoprotein to facilitate pseudotyping. 8 h 
post-transfection, viral transcription and packaging were induced by treatment with 
sodium butyrate (1 0 mM) for 8 h. Cell culture medium was collected at 24 hand 48 h 
post-induction, 0.45 J..Lm filtered to remove cellular debris, and ultracentrifuged for 90 min 
at 125,000 x g to concentrate lentiviral particles. Virus stocks were titred using 293HEK 
cells, and were frozen at -80° C until used for transduction of CGN at a multiplicity of 
infection (MOl) between 3 and 6. 
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6.3 Results 
6.3.1 LN-mediated regulation of PTEN and p75NTR occurs in cerebellar granule 
neurons 
Our previous study indicated that exposure to a LN substrate could induce an 
integrin-dependent upregulation ofPTEN, a downregulation ofp75NTR and a depression 
of active Rho which resulted in an enhanced regenerative growth response in NGF-
differentiated PC12 cells and primary hippocampal neurons (Rankin et al. 2008b). In 
order to determine whether LN-induced changes in PTEN, P75NTR and Rho activity 
occur in CGN, dissociated CGN were obtained from 8 day old rat pups and plated on PL 
(40 !lg/ml) or LN (25 !lg/ml) and harvested at 24 h intervals for 8 DIY. Western blot 
analysis demonstrates that exposure to the LN substrate results in an upregulation of 
PTEN protein expression (Figure 6.1A), and a concomitant downregulation ofp75NTR 
protein expression (Figure 6.1 B) at each timepoint assessed. 
LN-induced modulation ofPTEN and p75NTR protein expression levels was confirmed 
by real-time RT-PCR analyses ofPTEN and p75NTR mRNA expression (Figure 6.1C). 
Additionally, LN-induced changes in PTEN and p75NTR expression levels appear to be 
independent ofneurotrophin stimulation with nerve growth factor (NGF; 50 ng/ml) or 
brain-derived neurotrophin factor (BDNF; 25 ng/ml) assessed after 8DIV (Figure 
6.1D,E), although BDNF itself induces a well characterized upregulation of p75NTR in 
this cell type (Rankin et al., 2008). p75NTR is known to constitutively activate Rho 
(Yamashita et al. , 1999). Since a LN-induced decrease in p75NTR was previously found 
to be associated with a decrease in active Rho (Rankin et al. 2008b ), 
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Figure 6.1: LN regulates PTEN- p75NTR signalling cascade in CGNs. CGNs plated on PL or 
LN for 8 DN were analyzed by Western blotting for PTEN (A) and p75NTR (B) expression. 
LN-induced upregulation ofPTEN and downregulation ofp75NTR was confirmed by real-time 
RT-PCR analyses (C). The influence of LN after 8DIV persisted regardless ofneurotrophin 
stimulation with NGF or BDNF (D, E), and resulted in a depression in Rho activity as determined 
by a pull-down assay (F). Values expressed represent the mean expression relative to actin (A, B, 
D and E) or 28s (C) or total Rho (F) of three experiments +/- SEM where *p<O.Ol as determined 
by one-way ANOVA (A-E) or T-Test (F). Values are expressed as a percentage ofthe control 
condition, PL. 
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we assessed the effect of a LN substrate on Rho activity in CGN. Figure 6.1F shows 
decreased Rho activity in CON plated on a LN substrate for 8DIV in comparison with 
those plated on PL. Thus, these data are consistent with the existence of a LN-induced 
PTEN-P75NTR-Rho signalling cascade in CON. 
6.3.2 Laminin induces early morphological changes 
This LN-induced signalling cascade was previously associated with a neurite 
growth response in PC12 cells and hippocampal neurons (Rankin et al. 2008b). LN is 
also well characterized to promote growth of early postnatal CON (Powell et al., 1998). 
Thus, we analyzed CON cultures plated on PL versus LN substrates for changes in cell 
growth over a period of 8 DIY. Comparison of phase contrast images present in Figure 
6.2A and 6.2D suggests a modest enhancement of CGN growth when plated on a LN 
substrate (Figure 6.2D) in comparison with the PL control (Figure 6.2A). 
Slight differences in CGN growth observed at 24 h in culture are however indiscernable 
following 5 days in culture (Figure 6.2B and 6.2E), and CON growth morphology is 
indistinguishable following 8 days in culture on either PL (Figure 6.2C) or LN (Figure 
6.2F) substrates. Thus, while LN appears to enhance growth of CGN at an early 
timepoint post-plating, growth progresses normally on a PL substrate in the absence of 
integrin stimulation; differences in cell growth do not persist and thus appear incongruent 
with the observed differences in LN-induced PTEN and p75NTR expression observed in 
Figure 6.1. These results raised the possibility that this signalling paradigm may 
modulate other aspects of CON behaviour in addition to neurite growth. 
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Figure 6.2: Laminin induces early morphological changes which do not persist to 8 
DIV. Phase contrast micrographs of CGNs plated on PL (A-C) or LN (D-F) for 1 DIV 
(A,D), 5 DIV (B,E) or 8 DIV (C, F) show that early morphological differences are 
induced by the LN substrate at 1 DIV, but are indistinguishable following culture for 5 or 
8 DIV. Arrows indicate CGN that have taken on a typical elongated cell body and appear 
to have extended polarized processes. Scale bar = 25 J..lm. 
1 DIV 5DIV 8DIV 
Figure 6.2 
6.3.3 Cellular response to LN is temporally regulated and promotes migration 
In addition to neurite growth, LN has also been reported to stimulate CGN 
migration. Since the bulk of CGN migratory activity occurs between postnatal days 7 -
12 (P7 - P12), the CGN isolated at P8 correspond to a highly motile population in vivo. 
Since migratory activity in vivo ceases by P21 , we assessed the PTEN-p75NTR 
expression level changes in response to LN in CGN following 14 days cultured in vitro, 
corresponding to a timepoint by which all migratory behaviour has ended in vivo (P22). 
Western blot analysis demonstrates that CGN aged in culture for 14 days do not respond 
to a LN substrate by increasing PTEN (Figure 6.3A) or decreasing p75NTR (Figure 
6.3B). The responsiveness of these cells to LN appears to correlate with the temporal 
pattern of migration observed in vivo. To test the migration of CGN in vitro, we 
employed a recently developed coverslip migration assay (Rankin et al. , 2006) which 
facilitates exposure of the cells to a LN substrate at varying timepoints post isolation and 
allows the quantitative comparison of cell motility induced by various conditions. 
Analysis of CGN migration on PL or LN substrates commencing on DIV 1, 2, 3, 5, 7 or 
10 reveals significantly greater cell motility upon LN exposure compared with PL (Figure 
6.4A). However, migratory behaviour is absent, irrespective of substrate, by 14 and 22 
DIV (Figure 6.4A). Following 1 DIV, CGN readily migrate in response to a LN 
substrate, while only a minor amount of non-neuronal migration is evident across the PL 
substrate (Figure 6.4B-D). CGN aged for up to 5 DIV prior to the initiation of the 
motility assay show a similar enhancement of motility on a LN substrate in comparison 
with the control PL condition (Figure 6.4E-G), while CGN cultured for 10 DIV prior to 
the initiation of the motility assay demonstrate minimal movement when plated on a LN 
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Figure 6.3: CGNs response to LN is temporally regulated. CGNs plated on PL or LN for 14 
DTV were analyzed for PTEN (A) and p75NTR (B) protein expression, which did not 
significantly differ. PTEN and p75NTR expression values were normalized against actin and 
represent the mean of3 experiments+/- SEM. Optical density values are expressed as a 
percentage of the control condition, PL. 
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Figure 6.4: The motile response of CGNs plated on a LN substrate is temporally regulated. 
The motile behaviour ofCGNs was assessed using a coverslip assay wherein CGNs were plated 
on PL-coated coverslips and inverted over a PL or LN-coated migratory field following 
maturation in vitro for the time periods: 1, 2, 3, 5, 7, 10, 14, and 22 DIV, as indicated (A). Cell 
migration was assessed and quantitated following exposure to the migratory field for 36 h. Panels 
B - J are representative images of the cover slip assay initiated following 1, 5, or I 0 DN, across 
PL versus LN migratory substrates, as indicated. Long black arrows indicate the direction of 
movement, white arrows are indicating non-neuronal cells in the migratory field, and black 
arrowheads are indicating examples ofCGN cell bodies. Motility was graphically represented in 
(A) following enumeration of motile cells in 40 fields of view (FOV) per coverslip, with 3 
coverslips imaged per condition in a total of 3 independent experiments. 
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substrate and a complete absence of motility in response to PL (Figure 6.4H-J). These 
results strongly suggest that LN responsiveness in terms of both altered PTEN-p75NTR 
expression and subsequent motile behaviour corresponds to the developmental migration 
of CGN in vivo. 
6.3.4 Perturbation of individual signalling components of the cascade inhibits 
migration 
To confirm that LN-induced changes in PTEN and p75NTR are responsible for 
modulation of CGN motility in vitro, we assessed the ability of the individual signalling 
components to modify the cellular response to LN. Since LN induces an upregulation of 
PTEN, we evaluated whether RNAi-mediated knockdown ofPTEN expression would 
prevent cell motility in response to a LN substrate. As shown in Figure 6.5A-B, a LN 
substrate readily induces migration of CGN transfected with a fluorescently tagged 
scrambled siRNA sequence. In contrast, CGN treated with PTEN-specific siRNA 
demonstrate significantly impaired motility on a LN substrate (Figure 6.5C-D). 
Graphical representation of CGN motility following control scrambled or PTEN siRNA is 
depicted in Figure 6.5E, and Figure 6.5F illustrates the effective PTEN protein 
downregulation at 48 h by the siRNA delivery to the CGN. 
PTEN upregulation results in a decrease ofp75NTR (Rankin et al. 2008b). To 
determine if this association is necessary for appropriate migratory behaviour, we 
overexpressed p75NTR in CGN using lentiviral constructs and subsequently exposed 
them to a LN substrate for 36 h prior to quantitation of the motility of fluorescent cells. 
Relative to the empty vector control (Figure 6.6A-B), p75NTR 
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Figure 6.5: PTEN siRNA impairs motility of CGNs on a LN substrate. CGNs were plated on 
PL coated coverslips and transfected with fluorescently-labeled scrambled (A,B) or unlabeled 
PTEN siRNA (C,D) prior to inversion on a LN substrate. Motility was imaged at time 0 (A,C) or 
36 h post-inversion (B,D). Arrows indicate the direction of movement. (E) represents graphical 
quantitation of motile behaviour, determined by enumeration of cells migrating from underneath 
the coverslip. Motility is impaired by transfection with PTEN siRNA relative to the scrambled 
control. PTEN siRNA significantly reduces PTEN protein expression, as determined by optical 
density and expressed as a percent of the control siRNA condition (F). Values represent 
quantitation of 40 brightfield images per coverlip, with 3 covers! ips imaged per condition in a 
total of3 independent experiments. *p<O.OOOl. 
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Figure 6.6: p7SNTR overexpression impairs motility of CGNs on a LN substrate. CGNs 
were plated on PL coated coverslips and transduced with lentiviruses encoding orange 
fluorescence (A,B) or fluorescently-tagged p75NTR (C,D) prior to inversion onto a LN substrate. 
Motility was imaged at time 0 (A,C) or 36 h post-inversion (B,D). Arrows indicate the direction 
of cell movement. CGNs transduced with lentiviruses encoding the p75NTR fusion construct (F) 
show reduced motile behaviour to the LN substrate (E) as determined by enumeration of cells 
migrating from underneath the coverslip. Quantitation involved 40 FOV per coverslip, with 3 
covers lips imaged per condition in a total of 3 independent experiments. *p<O.OOO l. 
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overexpression impairs the LN-induced motility of CGN (Figure 6.6C-D). This 
impairment is significant, as depicted by graphical representation in Figure 6.6E. 
Finally, to assess whether the decrease in Rho activity observed on a LN substrate 
promotes motile behaviour, we utilized a pharmacological inhibitor of a downstream Rho 
effector molecule, Rho kinase (ROCKi; Y27632, I 011M). There is a clear absence of 
motile behaviour on the PL substrate in the absence ofthe ROCKi (Figure 6.7A,B). 
Inclusion ofthis inhibitor in the cell culture medium facilitates the motility of CGN 
across a PL substrate (Figure 6.7C-D), as quantitatively determined and presented in 
Figure 6.7E. Since manipulation of each component of this PTEN-p75NTR-Rho 
signalling cascade can alter the CGN motile response, these results suggest that this 
pathway is important for regulation of CGN motile behaviour in response to LN. 
In order to confirm the hierarchy of this signalling cascade in the regulation of cell 
motility, we assessed whether or not inhibition of downstream Rho activity using ROCKi 
could rescue the motility impairments induced by PTEN siRNA and p75NTR 
overexpression. P8 CGN were isolated, plated on PL-coated coverslips, and transfected 
with either control siRNA or PTEN siRNA. 48 h post-transfection, coverslips were 
inverted onto LN-coated wells containing medium supplemented with Rocki Y27632. 
Following an additional 36 h, migration was assessed. As shown in Figure 6.8A-E, the 
decrease in motility caused by PTEN siRNA can be restored to levels not significantly 
different from control by the downstream inhibition of Rho kinase. Additionally, P8 
CGN were isolated, plated onto PL-coated coverslips and infected with lentiviruses 
carrying sequences for either orange fluorescent protein (empty control) or p75NTR-
orange, and inverted into LN-coated wells containing medium supplemented with Rocki 
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Figure 6.7: Inhibition of Rho kinase promotes CGN motility on a PL substrate. CGNs were 
plated on PL coated coverslips and inverted into cell culture media in the absence (A, B) or 
presence (C, D) of the ROCK inhibitor, Y27632. Motility was imaged at time 0 (A, C) or 36 h 
post-inversion (B, D). Black arrows indicate the direction of cell movement. Treatment with 
ROCKi induces motile behaviour in CGN (E) as determined following quantitation of 40 images 
per coverlip, with 3 covers lips imaged per condition in a total of 3 independent experiments. 
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Figure 6.8: Inhibition of Rho kinase can restore motility impairments induced by PTEN 
siRNA or p75NTR overexpression. CGNs were plated on PL-coated coverslips and transfected 
with PTEN siRNA (A-E) or transduced with lentiviruses encoding fluorescently tagged p75NTR 
(F-J). Motility was assessed following inversion onto a LN substrate for 36 h in the presence or 
ab ence of ROCK inhibitor Y27632, and is graphically represented in (A) and (F) following 
quantitation of 40 fields of view per coverslip, with 3 covers lips imaged per condition in a total of 
3 independent experiments. Representative images of PTEN siRNA-transfected (B-E) or 
p75NTR-transduced (G-J) CGN are depicted. Arrows indicate the direction of cell movement. 
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Y27632 after 48 h. Following an additional 36 h, migration was assessed. As shown in 
Figure 6.8F-J, the decrease in motility caused by p75NTR overexpression can be partially 
restored by the downstream inhibition of Rho kinase. These results confirm the 
involvement ofthese signalling components in the regulation ofCGN motility, and 
confirm that Rho and Rho kinase are downstream components in this signalling cascade. 
6.4 Discussion 
The development of appropriate cerebellar architectonics is in large part reliant upon the 
process of directed cell migration, which in turn, relies upon the integration of a multitude 
of extracellular cues (short range, long range, soluble and substrate-bound) derived from 
the physiological environment in which cells reside (Hatten, 1999). These migration cues 
are tightly regulated in terms of temporal and spatial expression throughout development, 
thus accurately guiding granule cell precursors from their origin in the rhombic lip to the 
subpial proliferative zone, EGL, and following differentiation, to their ultimate residence 
in the IGL (Komuro and Yacubova, 2003 ; Yacubova and Komuro, 2003). External cues 
are essential for the selection of an appropriate migratory pathway as well as the 
termination of cell movement (Hatten, 1999), but the molecular mechanisms influencing 
the post-mitotic migratory behaviour of CGN are not well understood. 
In this study, we have used an in vitro CGN culture paradigm to determine if an 
ECM-induced signalling cascade previously shown to promote growth in CNS neurons 
could play a role in the developmental migration of post-mitotic CGNs. CGN isolated 
from 8 day old rat pups were cultured on PL versus LN-coated substrates to investigate 
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LN-mediated changes in PTEN, p75NTR and Rho, and neurons of varying ages were 
exposed to LN to discern the temporal regulation of this signal transduction and the 
subsequent migratory behaviour. We demonstrate that LN induces an upregulation of 
PTEN and a downregulation ofp75NTR protein expression in CGN, resulting in a 
decrease in active Rho and promotes cellular motility in an in vitro assay. In vitro studies 
of CGN migration have previously been reported to correlate well with their in vivo 
counterparts, in terms of time scale, speed, dynamics and basic patterning (Tarnok et al., 
2005) demonstrating that the intrinsic characteristics of migration can be preserved in 
vitro, though the stereotypical unidirectional migration (i.e. away from EGL only) is lost 
(Komuro and Rakic, 1995). 
In rats, the migration of post-mitotic granule cell neurons is most active during the 
first 2 postnatal weeks with maximum migration occurring between postnatal days 7 and 
12. The EGL is no longer histologically evident by P 15 and all migration is thought to be 
complete by P21 (Liesi, 1985; Yue eta!., 2005). By enzymatically dissecting CGN from 
P8 animals, we are effectively isolating EGL CGN, some of which have begun to migrate 
(Raetzman and Siegel, 1999), a behaviour we can encourage by exposure to the LN 
substrate, but not a PL substrate. 
LN has long been known to promote both in vitro growth (Powell et al., 1998) and 
the rapid and frequent migration of CGN (Fishell and Hatten, 1991; Fishell et al. , 1993; 
Liesi, 1990) in a manner that is dependent on integrin ligation but which is independent of 
the presence of glial cell processes (Liesi, 1992). This migration can be blocked by 
antibodies to the growth promoting domain of LN (Liesi et a!. , 1992; Selak et al., 1985) 
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or by genetic deletion of integrin ~1 in neurons and glia (Graus-Porta et al. , 2001), both of 
which result in ectopic localizations of CGN and poor cerebellar foliation. 
The spatial and temporal regulation and molecular distribution of LN corresponds 
to a role in both growth and migration, as these processes are intertwined in the 
cerebellum; axon extension must precede cell body migration (Liesi, 1985; Sobeih and 
Corfas, 2002). LN is a component of the basement membrane, and is well characterized 
to direct migration of granule cell precursors from the rhombic lip (Luckenbill-Edds, 
1997). LN is also localized to sites distinct from the basement membrane early in 
development and has been reported to associate with the EGL granule cell precursors and 
form punctate deposits along the Bergman radial glia whose processes form scaffolds for 
pioneering neurites (Liesi, 1992). In the CNS, LN expression does not persist to 
adulthood (Powell et al. , 1998). In fact, by P24 all LN immunoreactivity is lost from 
Bergman radial glia, EGL and Purkinje cells. This corresponds to a timepoint when all 
migration is complete (Liesi, 1985). We detected no migration after 10 DIV (analogous 
to P18) in our in vitro assay, indicating that the cells intrinsically lose the ability to 
respond to LN, thus indicating changes in the signal transduction pathways of the cell. 
One of these intrinsic changes was the ability of LN to induce PTEN upregulation, 
which was lost with age in vitro. PTEN is a dual specificity phosphatase that has been 
previously noted to play a role in migration, in a variety of cell types (Leslie et al. , 2005). 
In general, PTEN expression is inhibitory to migration, and is noted to suppress the 
migratory behaviours of mouse embryonic fibroblasts, B-lymphocytes, tumour cells and 
Dictyostelium (Liliental et al. , 2000; Lim et al. , 2004; Suzuki et al. , 2003) using either or 
both of its lipid and protein phosphatase activities (Gao et al. , 2005; Leslie et al. , 2007; 
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Liliental et al., 2000; Yamada and Araki, 2001 ), or simply its C2 domain in a cell type-
specific fashion (Raftopoulou et al., 2004). Proposed mechanisms include its impact on 
PDK-1-Akt signalling (Lim et al. , 2004), dephosphorylating Fak and She to prevent focal 
contact formation and p130Cas signalling (Gu et al., 1998; Tamura et al. , 1998), or 
simply antagonizing the ability ofPI3K to promote migration. Nonetheless, a different 
role emerged from the genetic deletion of PTEN in the cerebellum. Global PTEN 
knockout extensively impairs embryogenesis resulting in embryonic death precluding the 
study of cerebellar formation. However, selective knockout ofPTEN in specific tissues 
and cell types has allowed the study ofPTEN in the development ofthe cerebellum. All 
PTEN knockout animals which selectively inactivate PTEN in neural precursors (e.g 
utilizing Nestin or Engrailed2 promoters) display severely impaired CGN migration and 
positioning leading to distorted foliation, ectopia and substantial architectural 
abnormalities indicating a role for PTEN in positively regulating migration in this cell 
type (Backman et al. , 2001 ; Groszer et al. , 2001; Kwon et al. , 2001; Marino et al., 2002; 
Nayeem et al. , 2007). One study selectively eliminated PTEN using the hGF AP 
promoter, and attributed lack of oriented migration to defects in the differentiation of 
Bergman radial glia and therefore loss of appropriate guidance (Yue et al., 2005), 
highlighting another potentially important role for PTEN in cerebellar formation. 
We have previously demonstrated that one downstream effect ofPTEN expression 
is downregulation ofp75NTR (Rankin et al. 2008b), which has a widespread role in 
development of the nervous system, both by modulating the growth response and 
controlling developmental apoptosis which regulates innervation density (Roux and 
Barker, 2002). The role of p75NTR in migration is understudied, but its temporal and 
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spatial regulation in the cerebellum is consistent with a role in development (Carter et al., 
2003), and a role in cerebellar patterning and foliation has been proposed. 
p75NTR knockout mice show no defects in foliation (Carteret al. , 2003), a result 
that is consistent with our hypothesis that downregulation of this receptor promotes 
appropriate migration. In fact, we demonstrate that p75NTR overexpression impairs the 
migratory response to LN. The impact of p75NTR on migration could be due to loss of 
its downstream signalling capabilities, as ceramide, a product ofp75NTR-mediated 
sphingomyelinase activation, has recently been shown to play a role in plasma membrane 
reorganization and thus migration (Falluel-Morel et al. , 2005). Alternatively, the impact 
of p75NTR on migration is also likely related to the ability of p75NTR to constitutively 
activate Rho, a small GTPase known to regulate dynamics of the actin cytoskeleton 
thereby potently inhibiting neurite outgrowth (Yamashita et al. , 1999). 
Rho activity in migrating cells is associated with focal adhesion assembly and the 
formation of stress fibres by activating downstream effectors which enhance net 
polymerization of actin and crosslink it, thus increasing contractility (Ridley et al., 2003). 
This is converse to Rae and cdc42 which regulate leading edge protrusion. In our studies, 
the LN substrate is associated with a decreased level of active Rho, a phenomenon 
previously reported for fibronectin, another ECM component (Ren et al., 1999; Ren et al. , 
2000). The ECM acts via integrins to activate F AK, which is reported to suppress Rho 
activity leading to focal adhesion turnover, a necessary element of migration. We further 
demonstrate that inhibition of downstream Rho signalling can restore the migratory 
defects imposed by loss ofPTEN or overexpression ofp75NTR, confmning that Rho 
signalling is downstream to the PTEN and p75NTR changes in this migratory paradigm. 
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The appropriate migration of cells is imperative to nervous system development, 
but is also essential throughout life during tissue regeneration, wound healing and in 
facilitating immunity. The extracellular cues that direct migration cascades and mediate 
transcriptional changes necessary for cytoskeletal organization for movement have been 
previously independently linked to migration of CGN. This signalling cascade cohesively 
links the ECM, PTEN, p75NTR and Rho in a single mechanism to elicit a biological 
reaction necessary for development. 
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Chapter 7: PTEN downregulates p75NTR expression by decreasing the DNA 
binding activity of Spl 
This study has been accepted for publication in Biochemical and Biophysical Research 
Reports, December 2008, In press. 
7.0 Summary 
p75NTR is broadly expressed throughout the nervous system and its regulation is 
essential for the growth, development and survival of neurons. The dysregulation of 
p75NTR is associated with a multitude of pathological conditions. It is thus of broad 
interest to elucidate mechanisms underlying the regulation ofp75NTR expression. We 
have recently demonstrated a signalling cascade initiated by ECM molecule larninin 
(LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the 
mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that 
its protein phosphatase activity directly modulates p75NTR. Nuclear relocalization of 
PTEN subsequent to LN stimulation suggests transcriptional control ofp75NTR 
expression, which was confirmed following EMSA and ChiP analysis ofSpl 
transcription factor binding activity to the p75NTR promoter. LN and PTEN each 
independently decrease the DNA binding ability ofSpl to its consensus sequence and the 
p75NTR promoter. PTEN regulation of p75NTR occurs via dephosphorylation of Sp 1, 
thus reducing p75NTR transcription and protein expression. This mechanism represents a 
novel regulatory pathway which controls the expression level of a receptor that has broad 
implications not only for the development of the nervous system but also for progression 
of pathological conditions. 
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7.1 Introduction 
p75NTR is a pleiotropic receptor best known for its role as a low-affinity pan-
neurotrophin receptor working co-ordinately with the Trk family of receptor tyrosine 
kinases, transducing the signals from NGF, BDNF, NT3 and NT4/5 to regulate a broad 
array of processes essential to the development and maintenance of the nervous system 
(Blochl and Blochl, 2007). There is no intrinsic enzymatic activity associated with the 
cytoplasmic domain ofp75NTR. Instead, the physiological outcome of activation is 
dependent upon the availability of different co-receptors and the selective recruitment of 
intracellular signalling partners (Roux and Barker, 2002). 
In addition to functionally collaborating with Trk to enhance growth, p75NTR 
also initiates a variety ofTrk-independent effects, which are largely detrimental to cell 
survival and growth. p75NTR constitutively activates Rho, a small GTPase known to 
potently inhibit actin remodelling for growth, a relationship which is negated upon ligand 
binding (Yamashita et al. , 1999). p75NTR also plays a central role in the transduction of 
myelin-derived signals which are inhibitory to growth (Wang et al. , 2002a). Furthermore, 
p75NTR ligation results in activation of several apoptotic cascades (Rabizadeh and 
Bredesen, 2003). The dysregulation of p75NTR expression is central to a variety of 
pathological processes, as well. For example, p75NTR is implicated as a receptor for 
rabies virus (Langevin et al., 2002) and soluble ~-amyloid (Sotthibundhu et al., 2008), is a 
marker for invasive metastatic glioma (Johnston et al., 2007), and has been implicated in 
the pathogenesis of multiple neurodegenerative disorders (Dechant and Barde, 2002; 
Schor, 2005). The mechanism of p75NTR regulation is therefore of broad importance. 
265 
We have recently demonstrated evidence for a signalling cascade by which 
laminin (LN), an extracellular matrix (ECM) component, can regulate p75NTR 
expression to promote growth and motility (Rankin et al. 2008b). This ECM-mediated 
signal transduction is associated with an upregulation ofPTEN, a dual specificity 
phosphatase best known as a tumor suppressor. In this study, we have investigated the 
mechanism by which PTEN results in the transcriptional downregulation of p75NTR. 
7.2 Materials and Methods 
7.2.1 Cell Culture and Differentiation 
The experimental model consisted of rat pheochromocytoma cells (PC 12) (gift 
from Dr. David Kaplan, Hospital for Sick Children, Toronto ON) which were maintained 
on rat-tail collagen-coated tissue-culture flasks in RPMI-1640 medium (Invitrogen) 
supplemented with 10% horse serum, 5% fetal calf serum and 1% 
penicillin/streptomycin/glutamine solution (Invitrogen). Cells were incubated at 37 C in 
5% C02 and cultured to 80% confluence prior to typsinization for subculturing and 
differentiation. Cells were differentiated by exposure to NGF (100 ng/ml) for 2 days in 
low serum conditions to prime, followed to NGF (1 00 ng/ml) for 5 days in the absence of 
serum. 
7.2.2 Primary Neuronal Culture 
Cultures enriched in granule neurons were obtained from cerebella taken from 8d 
old Sprague-Dawley rat pups as previously described. Cerebella were stripped of 
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meninges, finely chopped and dissociated using enzymatic digestion using 0.5% trypsin-
EDT A followed by mechanical tritration. The culture medium was Dulbecco' s modified 
eagle medium (DMEM) supplemented with 1 0% FCS, 25 mM KCl and 1% 
penicillin/streptomycin solution (Invitrogen). Cells were seeded onto polylysine (PL) (40 
J..Lg/ml) or laminin (LN)-coated (25 J..Lg/ml) 12-well tissue culture plates of 1.8 x 108 
cells/mi. Cells were incubated at 3 7 C in 5% C02 and cytosine arabinoside was added 24 
h later to inhibit proliferation of non-neuronal constituents. On the seventh day in vitro 
(DIV) glucose (50 J.!l of a 100 mM solution) was added to each culture well to maintain 
survival as culture medium was not replaced. Cultures were used on 8 DIV unless 
otherwise specified. This method yields cultures consisting of approximately 95% 
cerebellar granule neurons (Jiang et al, 2003). 
7.2.3 PTEN Plasmid Constructs and Transfection 
piRES-PTEN: full length rat coding sequence was amplified from eDNA using 
PCR forward primer 5 '-GAATTCCCATGACAGCCATCATC and reverse primer 5' -
GGA TCCTCAGACTTTTGTAA TTTGTG incorporating EcoRI and BamHI restriction 
enzyme sequences respectively. The resulting PCR product was cloned into the TOPO 
T A cloning vector 2.1 (Invitrogen), subsequently excised using EcoRI and BamHI and 
directionally inserted into the bicistronic reporter vector piRES (Promega). Empty piRES 
control or PTEN-piRES vectors were transfected into differentiated PC12 cells using 
Lipofectamine 2000 (Invitrogen) as per the manufacturer's instructions. GFP-tagged 
wild-type or C 124S and G 129E mutant PTEN constructs were a kind gift from 
Dr.N.R.Leslie (University of Dundee, UK) and were transfected as above. 
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7 .2.4 Western Blot Analysis 
For Western blot analyses cells were harvested in the presence of sodium 
orthovanadate (1 OOmM in TBS) and subsequently subjected to lysis overnight at 4 C prior 
to centrifugation (1 0,000 x g, 5 min). A BCA protein assay (Pierce Rockford IL) was 
used to determine protein concentration and equivalent amounts of protein (50 J..Lg) were 
electrophoresed on 8% SDS-polyacrylamide gels. Protein was subsequently transferred 
to nitrocellulose membranes that were then exposed to ponceau red to ensure equal 
protein loading. After washing in TBS, blocks were blocked in 3% non-fat dry milk for 1 
h at room temperature prior to incubation with primary antibody overnight at 4 C. A fmal 
incubation with HRP-conjugated secondary antibody (Chemicon, Temecula CA) for 1 h 
at R T was followed using visualization using an ECL method. Each experiment was 
repeated three times, subjected to densitometry and normalized to actin to ensure equal 
protein for comparison. Statistical analysis was perforn1ed using GraphPad Prism 4 
(GraphPad Software Inc, San Diego CA) with significance being determined using one 
way ANOVA testing or student's t test as appropriate. 
7.2.5 Immunocytochemistry 
For immunocytochemical studies cells were trypsinized and subcultured serum-
free on PL or LN-coated 16-well chamber slides for 24h in the presence or absence of 
NGF (50ng/ml) prior to fixation in 4% paraformaldehyde for 15 min. Cells were then 
permeabilized with 0.1% TritonX-100 and blocked with 10% normal goat serum in PBS 
for 1 hat RT. Cells were incubated with a monoclonal antibody directed against PTEN 
(Cell Signaling) for 16 h at 4 C followed by incubation with Cy5-tagged secondary 
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antibody (Jackson ImmunoResearch Laboratories Inc) for lh at RT. Slides were 
coverslipped with glycerol and expression patterns were visualized using confocal laser 
scanning microscopy. 
7.2.6 Protein Fractionation 
Cells were subcultured on PL or LN-coated tissue culture plates and protein was 
collected using the NE-PER nuclear and cytoplasmic extraction reagents kit (Pierce) as 
per manufacturer's directions. 
7.2.7 Electrophoretic Mobility Shift Assay 
After exposure to PL or LN substrate, cells were washed in cold TBS, collected 
and fractionated as described above. Oligonucleotides complementary to the SPl binding 
sequence, as well as oligonucleotides comprising a mutated SP 1 consensus sequence 
(Ramos et al, 2007) were synthesized by Integrated DNA Technologies. 
Oligonucleotides were annealed using 10 pmol of each probe in a 10 ~1 reaction 
containing 20 mM Tris-HCL (pH 8.4) and 50 mM KCl which was incubated at 80 C for 5 
min, followed by cooling toRT. The Spl binding region of the rat p75NTR promoter 
was amplified by PCR using forward primer 5' -ACAGAGAAGCCGCAGCGG and 
reverse primer 5'GGCGCTGCAGGCAGCACC, and were subsequently cloned using a 
TOPO TA cloning kit (Invitrogen). The p75NTR promoter region was excised using 
vector-derived flanking restriction enzymes, electrophoresed using 1% agarose, and 
purified using a gel extraction kit (Qiagen). Double-stranded DNA oligos were end-
labeled using T4 polynucleotide kinase and i 2-dATP, while the purified p75NTR 
promoter region was radiolabelled using large fragment of DNA polymerase (Klenow) 
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and r32-dA TP. Radiolabelled probes were precipitated with 0.1 vol 3M NaAc and 3 vol 
100% ethanol at -20 C for 1 hand pelleted by centrifugation at 12,000 x g for 20 min at 4 
C. DNA pellets were washed with 70% ethanol, centrifuged for 10 min and resuspended 
in 30 j.ll H20. 15,000 cpm were incubated for 25 min on ice with 10 j.lg nuclear extract in 
the presence of20 mM Tris-HCL (pH 7.5), 75 mM KCl, 3.5 mM DTT, 20 nM ZnC12, 1 
j.lg!ul BSA, 5% glycerol and 1j.lg poly(dl-dC) in a total volume of20 j.!l. To confirm 
specificity of DNA binding, unlabelled competitor DNA (wt or mutant sequence) was 
added to the binding in 100-fold excess of the hot probe and allowed to incubate for 20 
min on ice. Following incubation with cold probe, hot probe was added and samples 
incubated for a further 30 min on ice. Samples were electrophoresed on a 5% non-
denaturing polyacrylamide gel in TBE (89 mM Tris, 89mM boric acid, 2 mM EDT A) for 
1.5 hr at 120V for Sp1 binding assays, or 3.5 hr at 120V for p75NTR promoter binding 
assays. Gels were subsequently dried under vacuum at 80 C for 2 h and visualized by 
autoradiography. 
7.2.8 Chromatin Immunoprecipitation 
Chromatin immunopricipitations (ChiP) were performed using the chromatin 
immunoprecipitation assay kit (Millipore) according to manufacturer's instruction. In 
brief, 1 x 106 cells were crosslinked by addition of 0.8% formaldehyde directly to the cell 
culture media for 10 min at 37 C and subsequently quenched with 0.125 M glycine for 5 
min at RT. Cells were washed twice with cold PBS, collected and pelleted, and finally 
resuspended in 200 j..Ll SDS lysis buffer. Chromatin was then sonicated to an average 
length of0.5 kb by 3 x 20 sec pulses at 15% power. Lysate was centrifuged at 14,000 
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rpm for 10 min at 4 C, diluted 1 OX in dilution buffer and precleared for 30 min at 4 C 
with 80 )ll salmon sperm DNA/protein A agarose. 100 )ll of diluted supernatant was 
retained for isolation of input DNA and to quantitate the DNA in different samples. 
Immunoprecipitation was performed using 4 )lg anti-Sp 1 or control lgG at 4 C overnight 
with rotation. 60 )ll of salmon sperm DNA/protein A agarose was added for lh at 4 C 
with rotation to collect the antibody-antigen-DNA complex. Complexes were then 
washed with low salt washing buffer (20 mM Tris, 2 mM EDTA, 0.1% SDS, 1% 
TritonX-1 00, 150 mM NaCl), once with high salt buffer (20 rnM Tris, 2 mM EDTA, 
0.1% SDS, 1% TritonX-1 00, 500 rnM NaCl), once with LiCl buffer (0.25 M LiCl, 1% 
NP-40, 1% deoxycholic acid, 1 rnM EDTA, 10 mM Tris) and 3 times with TE buffer (10 
mM Tris, 1 rnM EDT A). Complexes were eluted in 500 )ll freshly prepared elution 
buffer (1% SDS, 0.1 M NaHC03) and crosslinking was reversed by addition of 5M NaCl 
and incubation at 65 C overnight. Samples were treated with proteinase K and phenol 
chloroform-extracted. DNA was ethanol precipitated in the presence of glycoblue 
(Ambion). Pellets were resuspended in 20 )ll H20 for PCR analyses. PCR amplification 
ofimmunoprecipiated DNA was performed using primers specific for the Spl-binding 
region ofthe p75NTR promoter as follows: forward primer 5' -
TGCTGCATTGCCTTCACCC and reverse primer 5' -ACCTGCCCTCCTCATTGCAC. 
Control primers, amplifying a portion of the p75NTR promoter 1.5 kb distal to the Sp 1-
binding region were as follows: forward primer 5' -CAGTGATGTCTACCCTACCTT and 
reverse primer 5' -CCTCTTCAAAACTACAGTCC. 
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7.3 Results 
7.3.1 PTEN regulation of p75NTR expression requires protein phosphatase activity 
Our examination into the mechanism by which PTEN may regulate p75NTR 
expression was conducted using PC12 cells. Using this model, we have previously 
established that modulation ofPTEN expression directly influenced p75NTR expression 
(Rankin et al, submitted). PTEN is a dual specificity phosphatase capable of 
dephosphorylating both lipid and protein substrates. In order to determine which of these 
phosphatase activities was responsible for the modulation of p75NTR expression, we 
overexpressed GFP-tagged PTEN constructs in PC 12 cells. Overexpression of wild-type 
PTEN downregulated p75NTR as previously noted (Fig 7.1). The PTEN C124S mutant 
is devoid of phosphatase activity and failed to modulate p75NTR expression, indicating 
that phosphatase activity is required for PTEN regulation ofp75NTR. In contrast, the 
G 129E mutant which is lipid phosphatase dead but which retains protein phosphatase 
activity, significantly reduced the expression ofp75NTR (Fig 7.1), suggesting that it is 
the protein phosphatase activity ofPTEN that is able to regulate p75NTR expression. 
7.3.2 LN-induced up regulation of PTEN decreases Spl binding activity 
PTEN has been found to dephosphorylate the transcription factor Sp 1, thereby 
decreasing its DNA-binding capacity (Kang-Park et al. , 2003). LN stimulation is also 
noted to decrease in Spl binding activity (Gaudreault et al. , 2007). Furthermore, 
increased Spl binding activity has previously been associated with an upregulation of 
p75NTR (Ramos et al., 2007). To investigate the potential interaction ofPTEN with Spl , 
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Figure 7.1: Protein phosphatase activity of PTEN is required for regulation of 
p75NTR. PC12 cells were transfected with empty GFP, wt PTEN, or PTEN 
phosphorylation mutants, Cl24S (phosphatase dead) or Gl29E (lipid-phosphatase dead). 
p75NTR protein expression was analysed by Western blot, and found to be 
downregulated by wt and G 129E constructs. Values expressed represent mean protein 
expression, relative to actin, of3 experiments +/- SEM. *p<0.05. 
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Figure 7.1 
immunocytochemical analyses were performed initially to determine the subcellular 
localization of PTEN in response to a LN substrate. Cells were plated on PL or LN 
substrates, in the presence or absence ofNGF for 24 h prior to immunocytochemical 
localization ofPTEN. The PL substrate was associated with a cytoplasmic distribution, 
which appears to relocalize to the membrane upon NGF stimulation (Fig 7.2A,B). 
Interestingly, we noted a number of cells on the LN substrate which exhibited a distinct 
nuclear localization ofPTEN in both the presence and absence ofNGF (Fig 7.2C,D) 
which was confirmed by Western blot analyses of fractionated celllysates (Fig 7.2E). 
The LN substrate appears to relocalize PTEN into the nucleus, thus indicating a potential 
site for its activity. 
Since the LN substrate resulted in a redistribution of PTEN into the nucleus, we 
examined the impact ofLN or PTEN overexpression on the DNA binding ability ofSpl 
using electrophoretic mobility shift assays (EMSA) which were performed using nuclear 
extracts derived from PC12 cells cultured on PL or LN substrates for 24 h. Cold 
competition with an unlabelled Spl consensus sequence oligo, but not with a mutated Spl 
binding motif, resulted in decreased signal intensity on both PL and LN substrates (Fig 
7.3) thereby confirming that the gel shift was due to the binding ofSpl to its consensus 
sequence. Densitometric analysis ofEMSA revealed that the LN substrate was 
consistently associated with decreased Spl binding to its radiolabelled consensus 
sequence (Fig 7.3A, lane 3) relative to PL (lane 2) despite the observation that the LN 
substrate increased the total levels of Sp 1 protein detected by Western blot analysis (Fig 
7.3B). To determine ifthe LN effect could be directly attributed to elevated levels of 
PTEN, PC12 cells were transiently transfected with PTEN or empty control vectors 
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Figure 7.2: LN induces nuclear localization ofPTEN. Relative to PC12 cells plated 
on PL (A,B), cells plated on LN substrate demonstrate nuclear localization ofPTEN in 
both presence and absence ofNGF (C,D). This localization was confirmed by Western 
blot analysis of subcellular fractionated protein lysates (E). Scale bar -20 J.lffi. 
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Figure 7.3: LN-induced PTEN upregulation decreases Spl binding to its consensus 
sequence. A. PC12 cells plated on a LN substrate show decreased Spl binding to its 
consensus sequence during EMSA analysis, relative to the control PL substrate, despite 
an increase in Spl protein expression as determined by Western blotting (B). 
Overexpression of PTEN also reduces Sp 1 binding to its consensus sequence, relative to 
cells transfected with empty control vector (C). Binding can be diminished by 
competition with unlabeled probe, but not by competition with unlabeled mutated probe. 
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followed by EMSA analysis of Spl binding to its consensus sequence. PTEN 
overexpression resulted in a marked reduction in Spl binding activity (Fig 7.3C) relative 
to control vector. 
Since the capacity of Sp 1 to bind to regulatory elements tends to be gene-specific, 
we performed an EMSA to determine the ability ofSpl to bind specifically to the 
p75NTR promoter. The LN substrate resulted in significantly less binding to the 
radiolabelled p75NTR promoter region (Fig 7.4A, lane 3), in comparison with the control 
PL substrate (lane 2). To confirm that the decreased binding ofSpl to the p75NTR 
promoter was due to increased levels ofPTEN, we assessed Spl binding to the p75NTR 
promoter following PTEN overexpression. The binding of Spl to the p75NTR promoter 
was significantly reduced following transfection with a PTEN construct relative to the 
empty vector control (Fig 7.4B). Therefore, both the LN substrate and the 
overexpression of PTEN can decrease the ability of Sp 1 to bind to its consensus sequence 
on the p75NTR promoter. 
To determine ifLN results in decreased binding ofSpl to the p75NTR promoter 
in an in vivo situation, we utilized chromatin immunoprecipitation (ChiP) to directly 
assess the physical interaction of Spl with the p75NTR promoter in response to a LN 
substrate, or PTEN overexpression. PC12 cells plated on a LN substrate for 24 h 
exhibited a significant reduction in the amount of Sp !-precipitated p75NTR promoter 
(Fig 7.5A, lane 4) in comparison to the control PL substrate (Fig 7.5A, lane 3). Similarly, 
PTEN overexpression resulted in significantly reduced detection of Sp !-precipitated 
p75NTR DNA (Fig 7.5B, lane 4) in comparison with empty vector control (Fig 7.5B, lane 
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Figure 7.4: LN-induced PTEN upregulation decreases Spl binding to the p75NTR 
promoter. A. PC12 cells plated on a LN substrate show decreased Sp 1 binding to the 
p75NTR promoter during EMSA analyses relative to the control PL substrate. This 
binding can be diminished by competition with unlabeled probe, but not by competition 
with an unlabeled mutated probe. B. Overexpression of PTEN also reduces Sp 1 binding 
to the p75NTR promoter, in comparison to transfection with empty control vector. 
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Figure 7.5: LN-induced PTEN upregulation decreases Spl binding to the p75NTR 
promoter in vivo. A. LN exposed PC12 cells subjected to Spl ChiP show decreased 
PCR amplification of the Spl binding region of the p75NTR promoter (1664-1855), but 
not a distal fragment (16-219) relative to the control PL substrate. B. Overexpression of 
PTEN (P) also reduces amplification of the Spl binding region of the p75NTR promoter 
(1664-1855), in comparison to transfection with empty vector (E). *p<O.Ol. 
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3) thus confirming a link between the level of PTEN expression and the capacity of Sp 1 
to bind to the p75NTR promoter. 
Finally, we ascertained whether this mechanism of p75NTR regulation was valid 
in primary neurons which also display an inverse PTEN-p75NTR relationship. We have 
previously determined that cerebellar granule neurons (CGN) also upregulate PTEN 
expression in response to LN stimulation, leading to a downregulation of p75NTR 
(Rankin et al. In preparation). Thus, to assess the effects ofLN on Spl binding activity, 
CGN were purified from post-natal day 8 rats and were plated on PL or LN substrates. 
EMSA analysis shows that LN decreases Spl binding to its consensus sequence (Fig 
7.6A, lane 3) and to the p75NTR promoter (Fig 7.6B, lane 3) in CGN. Furthermore, ChiP 
assays confirmed a decreased interaction between Spl and the p75NTR promoter in CGN 
plated on LN compared to the control PL substrate (Fig 7.6C). These results suggest that 
the regulatory mechanism responsible for PTEN-mediated regulation of p75NTR 
observed in neuronal cell lines may also be operative in primary neurons. 
7.4 Discussion 
This study presents a mechanism by which a phosphatase, PTEN can control the 
transcriptional regulation of a pleiotropic receptor p75NTR as directed by the ECM in an 
integrin-dependent manner. We have previously shown that PTEN expression inversely 
correlates with p75NTR expression (Rankin et al, submitted). Furthermore, PTEN 
overexpression is associated with a decrease of p75NTR, and PTEN siRNA can increase 
p75NTR. Here we investigated the potential mechanisms for this and report that LN 
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Figure 7.6: LN reduces the binding activity of Spl in CGN. CGN plated on a LN 
substrate show decreased Sp1 binding to its consensus sequence (A) and the p75NTR 
promoter (B) relative to the control PL substrate during EMSA analyses. ChiP analyses 
confirm decreased amplification ofthe Spl binding domain of the p75NTR promoter 
(1664-1855), but not a distal fragment (16-219) (C) induced by the LN substrate. 
*p<O.Ol. 
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induces PTEN to relocalize to the nucleus, where it could dephosphorylate Sp 1, leading 
to a decreased ability to bind to the p75NTR promoter resulting in reduced p75NTR 
expressiOn. 
PTEN is capable of dephosphorylating both lipid and protein substrates. The lipid 
phosphatase activities ofPTEN have been intensively studied. PTEN is a well known 
antagonist ofPB kinase, with its primary substrate believed to be PIP3, though notably, it 
also has a minor effect on PLCy (Alvarez-Breckenridge et al., 2007), a phospholipase 
which increases p75NTR expression upon ligand binding to the Trk receptor (Rankin et 
al., 2008). The protein phosphatase activities of PTEN are less understood. Proposed 
targets include Fak and She (Tamura et al. , 1998), however these may be cell type and 
context-specific. Using a mutated PTEN construct (G 129E) that is lipid phosphatase 
dead but retains its activity against protein substrates, we demonstrate that the protein 
phosphatase activities are necessary to decrease p75NTR expression while mutants with a 
total loss of phosphatase activity could not. Our immunocytochemical studies revealed 
nuclear localization for PTEN induced by the LN substrate. Nuclear localization of 
PTEN is a well-documented phenomenon (Baker, 2007) which suggests regulatory 
functions but an exact role is largely unknown. PTEN is also noted to dephosphorylate 
transcription factor Sp1 (Kang-Park et al. , 2003), the phosphoryation status of which 
directly impacts its ability to bind to some DNA promoter regions (Bouwman and 
Philipsen, 2002; Li et al. , 2004). Previous reports confirm that LN decreases Spl activity 
(Gaudreault et al., 2007; Gehler et al. , 2004; Gentry et al., 2004; Glowacka et al. , 1992; 
Goettl et al., 2004), and Sp1 is highlighted to play a role in the induction of p75NTR 
expression in response to changes in osmolarity (Ramos et al., 2007). It is likely that the 
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LN-induced decrease ofSpl binding is mediated by PTEN protein phosphatase activities 
resulting in a decrease of p75NTR expression. Finally, we confirm that this relationship 
occurs in CGN where LN-mediated changes in PTEN and p75NTR have been shown to 
influence the developmental migration of these neurons to their final anatomical and 
functional location. 
7.4.1 Speculation 
PTEN is often lost or mutated in human cancer. The associated loss of function 
may upset the balance of physiological processes including cell cycle, growth, 
differentiation and motility. As such, decreased PTEN expression is associated with 
enhanced invasive potential of metastatic glioma (Knobbe et al., 2002). Notably, PTEN 
normally prevents this invasion through its protein phosphatase actions (Downes et al., 
2007). An increase in p75NTR has independently been noted to enhance the invasion of 
metastatic glioma (Johnston et al. , 2007). We hypothesize that the mechanism presented 
here may contribute to the pathogenesis of glioma. Furthermore, since Sp 1 is a highly 
prevalent transcription factor controlling the expression of a multitude of cellular 
proteins, the current study may be of relevance for many research paradigms. 
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Chapter 8: TrkA modulates the expression of PTEN resulting in alterations in 
motility and growth potential 
8.0 Summary 
The regulation of p75NTR expression is important to multiple cellular processes 
including survival, development and maintenance of the nervous system. Constitutive 
expression of p75NTR has been previously shown to be influenced by the high affinity 
NGF receptor TrkA. More recently, a role for the extracellular matrix in regulation of 
p75NTR has been ascribed to a laminin-mediated upregulation of the phosphatase, PTEN. 
I now report that the individual phosphorylation sites of TrkA modulate both constitutive 
PTEN expression and the capacity of the cells to respond to laminin by downregulation of 
p75NTR and subsequent depression of Rho activity. Finally, I demonstrate that TrkA 
mutations associated with decreased levels of PTEN functionally impair the cell ' s ability 
to remodel the actin cytoskeleton thus negatively impact both growth and motility. 
8.1 Introduction 
Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a well-
known tumor suppressor expressed by a wide variety of cells; its functions are frequently 
non-redundant requiring that PTEN expression be under tight regulatory control (Salmena 
et al., 2008). PTEN is a dual specificity phosphatase, capable of dephosphorylating both 
lipid and protein substrates. The lipid phosphatase actions ofPTEN are well 
characterized for antagonism of the PI3K-Akt survival pathway, in which PTEN 
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dephosphorylates PIP3, thus preventing downstream phosphorylation of Akt and its 
associated cascades, often inducing apoptosis (Downes et al. , 2001; Knobbe et al. , 2002; 
Salmena et al., 2008). The protein phosphatase substrates ofPTEN are still largely 
unknown, though recently we have demonstrated that a protein phosphatase action of 
PTEN is necessary for the downregulation of p75NTR (Rankin et al. 2008b). 
p75NTR is the low affinity pan-neurotrophin receptor well known for its essential 
roles in the development and maintenance of the nervous system (Bloch! and Blochl, 
2007). In the presence of neurotrophins, p75NTR signals co-ordinately with the high 
affinity receptor, a specific member of the Trk family of receptor tyrosine kinases, to 
promote neurite outgrowth by enhancing the phosphorylation ofTrk itself and its 
downstream signalling intermediates (Roux and Barker, 2002). 
The growth-promoting behaviour of p75NTR is, however, cell type and context 
specific, and depends upon the ratio ofTrk to p75NTR (Althaus and Kloppner, 2006; 
Gatzinsky et al., 2001; Yan et al., 2002) and the presence ofneurotrophins. In the 
absence of neurotrophins, p75NTR can inhibit growth through a variety of mechanisms 
including constitutive activation of Rho (Yamashita et al., 1999), a small GTPase that 
regulates the dynamics of the actin cytoskeleton, and by transducing myelin-derived 
inhibitory signals (Wang et al., 2002a). This growth inhibiting behaviour is dependent 
upon co-receptor availability and p75NTR expression levels. 
Ligation of the nerve growth factor (NGF) receptor, TrkA, initiates receptor 
homodimerization which results in the transphosphorylation of specific tyrosine residues 
on the cytoplasmic tail, subsequently initiating signalling cascades for growth and 
survival (Kaplan and Miller, 2000; Reichardt, 2006). Phosphorylation ofTrk Y490 
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creates a docking site for She, an adapter protein which initiates the Ras-MEK-MAPK 
cascade (Obermeier et al., 1993b). Phosphorylation ofTrk Y785 creates a site of 
interaction for PLCy, which activates downstream PKC and MAPK signalling 
(Obermeier et al. , 1993a). Additionally, phosphorylation of the Trk cytoplasmic domain 
is associated with the activation ofPBK signalling for survival. We have previously 
shown that TrkA, regulates the constitutive expression of p75NTR (Rankin et al. , 2005), 
and that Trk ligation results in the upregulation of p75NTR via a PLCy-PKC&-dependent 
mechanism to promote growth (Rankin et al. , 2008). More recently, we have elucidated a 
second mechanism by which the expression level of p75NTR can be manipulated. This 
cascade is initiated by extracellular matrix molecule laminin (LN), which upregulates 
PTEN (Rankin et al. 2008b ). PTEN then translocates to the nucleus where it has been 
shown by others to dephosphorylate transcription factor Spl (Kang-Park et al. , 2003). 
PTEN overexpression has been demonstrated to decrease the binding ability ofSpl to the 
p75NTR promoter thus decreasing p75NTR expression to again promote growth and 
motility (Rankin et al. Manuscript submitted). 
The goal of this study was to determine if there exists any interaction between 
these two p75NTR regulatory mechanisms. As we have previously demonstrated that a 
LN substrate and the associated high PTEN levels had no effect on TrkA expression 
(Rankin et al. 2008b ), we specifically sought to determine if TrkA signalling plays a role 
in the regulation of PTEN expression. Our results show that TrkA activation decreases 
PTEN expression, and that PTEN manipulation by TrkA mutations can regulate the 
growth and motility potential ofPC12 cells in response to a LN substrate. p75NTR is a 
pleiotropic receptor likely to be tightly regulated in terms of spatial, temporal and 
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molecular distribution. This link adds another layer of complexity to the regulation of 
p75NTR and its contribution to the growth response. 
8.2 Materials and Methods 
8.2.1 Cell culture and differentiation: 
The experimental model consisted of wild-type rat pheochromocytoma (PC12) 
cells, and 4 mutated PC12 derivative cell lines (gifts from Dr. David Kaplan, Hospital for 
Sick Children, Toronto, ON). PC12nnr5 cells were derived by mutating parental PC12 
cells using ethyl methanesulfonate (EMS), as described by Green eta!. (1986). PC12 
derivatives expressing mutated TrkA receptors (Y490F, Y785F, and Y490/785F) were 
created by Stephens eta!. (1994). Briefly, PC 12nnr5 cells, which lack endogenous TrkA, 
were transfected to express a TrkA receptor that had been altered via site-directed 
mutagenesis to abrogate either one or both of the autophosphorylation sites of the 
cytoplasmic tail. 
Cell lines were maintained on rat-tail collagen-coated tissue-culture flasks in 
RPMI 1640 medium (Invitrogen, Burlington ON) supplemented with 10% horse serum 
(Invitrogen), 5% fetal calf serum (Invitrogen) and i% penicillin/streptomycin/glutamine 
solution (Invitrogen). In the case of mutated lines Y490F, Y785F and Y490/785F, media 
was additionally supplemented with Geneticin G418 ( 4 !J.llml) to ensure continued 
selection of the mutant population. Cells were incubated at 37°C in 5% C02, and cultured 
to 80% confluence prior to trypsinization for subculturing purposes. Cells were 
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differentiated by exposure to NGF (100 ng/ml) for 2 days in low serum conditions to 
prime, followed by exposure to NGF (1 00 ng/ml) for 5 days in the absence of serum. 
8.2.2 Plasmids and Transfection: 
Full length rat TrkA coding sequence was amplified from eDNA using PCR 
forward primer 5'-CTCGAGATGCTGCGAGGCCAGC and reverse primer 5'-
GA TATCGTGCCCAGAACGTCC incorporating Xhoi and EcoRV restriction enzyme 
sequences, respectively. PCR amplicons were cloned into the TOPO TA cloning vector 
PCR2.1 (Invitrogen), and nucleotide sequence determined by automated sequencing prior 
to directional insertion into the eukaryotic expression vector pcDNA3 .1 (Invitrogen) 
engineered to include a carboxy terminal orange fluorescent protein tag. 
Empty pcDNA3.1-orange control or pcDNA3.1-TrkA-orange vectors were 
transfected into PC12 cells and derivatives using Lipofectarnine 2000 (Invitrogen) as per 
the manufacturer's instructions. 
8.2.3 TrkA anti-sense oligos: 
TrkA sense and antisense oligos were synthesized by the central facility of 
Institute for Molecular Biology and Biotechnology, McMaster University as per the 
following sequences: Control1: 5' -ATGGCGCGGCTCTGGGGCTTA, Control2: 5' -
GAACGGATTACCCGTCAGGAT, Antisense 1: 5' -CCGCTGGCCTCGCAGCATCGC, 
Antisense 2: 5' -CACA TCATTCTCTGCCCAGCA. Oligos were stored in lyophylized 
format at -20 C until use, when they were reconstituted for use at a final concentration of 
2.5 J..I.M each. Oligos were delivered to the cells using lipofectamine 2000 as per the 
manufacturer' s instructions. 
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8.2.4 Western blot analysis: 
For Western analyses, cells were harvested in the presence of sodium 
orthovanadate (100 rnM in TBS) and subsequently subjected to lysis (10% glycerol, 1% 
NP-40, sodium vanadate, sodium fluoride, sodium dodecyl sulphate (SDS) and 1 protease 
inhibitor cocktail tablet (Roche Scientific, Laval, QC) overnight at 4° C prior to 
centrifugation (10,000 g, 5 min). A BCA protein assay (Pierce, Rockford IL) was used to 
determine protein concentration and equivalent amounts of protein (50 j.!g) were 
electrophoresed on 8% SDS-polyacrylamide gels. Protein was subsequently transferred 
to nitrocellulose membranes that were then exposed to Ponceau red to ensure equal 
protein loading. After washing in TBS, blots were blocked in 3% non-fat dry milk for 1 h 
at room temperature, and then incubated with a primary antibody directed toward either 
p75NTR (Upstate), PTEN (Cell Signalling), TrkA (Upstate) or actin (Sigma) overnight at 
4° C. A fmal incubation with HRP-conjugated secondary antibody (AP307P, AP308P; 
Chemicon, Temecula, CA) for 1 h at room temperature was followed by visualization 
using an ECL method. Each experiment was repeated three times, subjected to 
densitometry and normalized to actin to ensure equal protein for comparison. Statistical 
analysis was performed using GraphPad Prism 4 (GraphPad Software Inc., San Diego 
CA) with significance being determined using one-way ANOVA testing. 
8.2.5 Real-time RT-PCR: 
For real time RT-PCR analysis, cells were subcultured on Poly-D-Lysine (PL)- or 
Larninin (LN)-coated 12-well plates under serum-starved conditions for 24 hours. RNA 
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was isolated using Trizol reagent (Invitrogen) as per the manufacturer's instructions and 
was subsequently treated with DNase (Ambion; Austin TX) to remove traces of 
contaminating DNA. RNA (2 J.lg) was reverse transcribed to eDNA using MML V 
reverse transcriptase (200 U for 30 minutes at 37 C; Invitrogen) prior to use as template 
for real-time PCR amplification using the following PCR primer pairs: p75NTR forward 
5'-TGCATCTGAGCTGGTGTCTGTCTT, p75NTR reverse 5'-
TGCGTACAATGCTCCTGGTCTCTT, PTEN forward 5' -
ATTCGACTTAGACTTGACCT, PTEN reverse 5' -ACCAGTCCGTCCTTTC, 28S 
forward 5'-GACCAAGGAGTCTAACGC, 28S reverse 5' -GTACGCTCGTGCTCCA. 
PCR amplification was performed using the Roche LightCycler (Roche) and quantified 
using SYBR green I. p75NTR and PTEN mRNA expression levels were subsequently 
normalized using the housekeeping gene, 28S. 
8.2.6 Rho activity assay: 
The activation ofRhoA was assessed using a pull-down assay kit (Upstate, 
Charlottesville, VA), in accordance with the manufacturer's instructions. Briefly, cells 
were harvested and lysed. Rhotekin-bound beads were added to cleared lysate and 
rotated for 1 hour at 4°C prior to pelleting, washing, and boiling in Laemrnli buffer with 
DTT. Rhotekin-bound Rho proteins were detected by Western blot analysis using a 
polyclonal anti-Rho antibody (Upstate). The total an1ount ofRhoA in cell lysate was 
used as a control for the cross-comparison of Rho activity. 
296 
8.2. 7 Immunocytochemistry: 
For immunocytochemical studies, cells were trypsinized and subcultured serum-
free on PL or LN-coated I6-well chamber slides for 24 hours prior to fixation in 4% 
paraformaldehyde for 15 minutes. Cells were then permeabilized with 0.1% Triton-X-
I 00 and blocked with 10% normal goat serum in PBS for I hour at room temperature. 
Cells were incubated with either a monoclonal antibody directed against total tubulin 
(Sigma) or the combination of a mouse monoclonal antibody directed against p75NTR 
(MCI92, Oncogene) and a rabbit monoclonal antibody directed against PTEN (Cell 
Signaling) for I6 hours at 4° C. This was followed by incubation with Cy2- and Cy5-
tagged secondary antibodies (Jackson ImmunoResearch Laboratories Inc.) for I hour at 
room temperature. Finally, slides were coverslipped with glycerol, and the receptor 
expression patterns were visualized using confocal laser scanning microscopy. 
8.2.8 Growth quantification: 
All measurements of growth were obtained using images ofPCI2 cells 
immunostained for total tubulin (Sigma). Individual cell tracings were performed using 
NIH Image J software. Only cells for which we were able to unambiguously identify the 
associated neurites were chosen for tracing analysis. Neurite length is a measure of the 
longest neurite extending from each cell (n>250 cells per condition). Data were imported 
into a graphing and statistical analysis program (Prism 4, Graphpad Corp.) for further 
analysis. 
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8.2.9 Motility Assay: 
Motility was assessed using a previously described assay (Rankin et al., 2006). In 
brief, cells were plated in a monolayer on a PL-coated glass coverslip. Once cells became 
attached, coverslips were inverted onto 12-well tissue culture plates coated with PL or LN 
substrates. Cells were allowed to migrate from underneath the inverted coverslip into the 
migratory field for 36h prior to image acquisition. Cell migration was quantified using a 
semi-automated cell counter plugin for Image J (NIH). 
8.3 Results 
8.3.1 Manipulation of TrkA modulates PTEN expression 
TrkA has been previously shown to regulate the constitutive expression of 
p75NTR (Rankin et al. , 2005). Additionally, p75NTR expression can be regulated by the 
phosphatase, PTEN (Rankin et al. 2008b). Since TrkA and PTEN have been 
independently shown to regulate p75NTR, I assessed whether these regulatory pathways 
may intersect, specifically ifTrkA plays a role in the modulation ofPTEN expression. 
For this purpose, PC12nnr5 cells, which lack endogenous TrkA expression, were 
transiently transfected with a full-length TrkA-orange fluorescent construct or empty 
vector control. It has been previously demonstrated that expression of TrkA with a C-
terminus GFP tag in PC12nnr5 cells does not interfere with NGF-induced TrkA 
phosphorylation or the initiation of signalling cascades (Jullien et al., 2003). Western blot 
analyses of protein lysates collected 48 h post-transfection revealed that the 
overexpression ofTrkA significantly reduced PTEN expression levels relative to the 
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control empty vector (Figure 8.1A). Since PC12 nnr5 cells lack endogenous TrkA and 
subsequently express constitutively higher levels of PTEN relative to the parental PC 12 
cells, I determined whether abrogation of endogenous TrkA expression is sufficient to 
increase PTEN expression. Thus, PC 12 cells were transfected with antisense oligos 
directed against TrkA, and celllysates were analyzed by Western blot. Tranfection with 
TrkA antisense, but not control sense oligos, resulted in a significant increase in PTEN 
expression (Figure 8.1 B) in parental PC 12 cells. This fmding was replicated using a 
pharmacological inhibitor of TrkA, K252a (200 nM), which induced the upregulation of 
PTEN within an hour of inhibition (Figure 8.1 C). Since we have previously 
demonstrated that PTEN expression downregulates p75NTR (Rankin et al. 2008b), and 
that K252a downregulates p75NTR (Rankin et al. 2008), we examined the temporal 
relationship ofK252a induction ofPTEN with changes to p75NTR. The downregulation 
ofp75NTR was subsequently detectable 6 hours after the initiation ofTrkA inhibition 
(Figure 8.1 C). I have further determined that p75NTR overexpression does not impact 
expression ofPTEN (data not shown). Taken together, these results suggest a regulatory 
role for TrkA in the constitutive expression ofPTEN, which occurs upstream of changes 
to p75NTR expression. 
8.3.2 PTEN expression is influenced by mutation of Trk.A phosphorylation sites 
TrkA possesses two phosphorylatable tyrosines outside of the kinase domain 
which, upon phosphorylation, initiate well described signal transduction cascades (Kaplan 
and Miller, 2000; Lei and Parada, 2007). Since TrkA constitutively regulates PTEN 
expression in the parental PC 12 cells, it remained possible that PTEN regulation could 
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Figure 8.1: PTEN expression is modulated following manipulation ofTrk.A. 
PC12nnr5 cells which lack endogenous TrkA (A) were transiently transfected with empty 
vector or fluorescently tagged full length TrkA prior to Western blot analyses which 
showed decrease PTEN expression in response to TrkA overexpression. Conversely, 
transfection ofPC12 cells with TrkA antisense oligos (B) increased PTEN expression 
relative to transfection with Trk sense oligos. Values expressed represent the mean 
expression level, relative to actin,+/- SEM as determined in three experiments, where 
*p<0.05, **p<O.Ol as determined by one way ANOVA, and expressed as a percentage of 
the PL control condition .. Culturing PC12 cells in the presence ofTrk inhibitor, K252a, 
resulted in the early upregulation ofPTEN, detectable within an hour of exposure, and the 
subsequent downregulation of p75NTR, detectable 6 h following exposure (C). 
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occur through either of these TrkA-associated signalling cascades. Therefore, I assessed 
constitutive expression of PTEN in a series of PC 12 mutant cell lines that stably express 
TrkA which has been mutated by site-directed mutagenesis to abrogate either one, or both 
of these phosphorylatable tyrosine residues. Western blot analyses of the parental and 
PC12 derivatives reveals that in the absence ofTrkA (PC12nnr5 cells), there is an 
increase in PTEN relative to the parental PC12 cell line (Figure 8.2A). While there is no 
detectable PTEN expression in cells expressing a mutant TrkA with the inactive Y490 
phosphorylation site, analysis of cells carrying a mutated Y785 site showed similar PTEN 
expression levels as observed in the TrkA deficient PC12nnr5 cells (Figure 8.2A). 
Mutation of both tyrosine phosphorylation sites restores PTEN expression to levels 
comparable to those observed in the parental PC12 cell line (Figure 8.2A). This pattern 
of expression was confirmed by real-time RT-PCR analyses (Figure 8.2B). These results 
further indicated that while the Y 490 TrkA mutant cell lines did not express PTEN 
protein detectable by Western blot analysis, mRNA expression was minimally detected, 
although at levels approximately 10-fold less than those observed in the wild type PC12 
cells. In support of our recent report which suggested a regulatory role for PTEN in the 
expression ofp75NTR (Rankin et al. 2008b), the current data are in line with our initial 
report which demonstrated that Y490 mutant PC12 cells constitutively express 
significantly greater p75NTR in comparison with the parental PC12 line (Rankin et al., 
2005). Furthermore, the efficacy ofK252a in the induction ofPTEN (Figure 8.1C) 
suggests that there is constitutive activation ofTrkA in the absence ofligand, a 
phenomenon previously reported to be associated with high levels ofTrk expression or 
overexpression (Leoni and Valtorta, 2002). To determine ifthe overexpression of the 
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Figure 8.2: Mutation of individual phosphorylation sites of TrkA modulates PTEN 
expression. Parental PC12 cells, PC12nnr5 cells, or PC12 derivative cell lines 
expressing Trk.A Y490F, Y785F or both Y490F/Y785F mutations, were analyzed by 
Western blotting (A) or real-time RT-PCR (B) for PTEN expression levels. Relative to 
the parental line, PC12nnr5 and Y785F cells exhibit increased PTEN, while Y490F cells 
lack detectable PTEN protein expression and display significantly reduced PTEN mRNA 
transcription. Y490F/Y785F cells did not significantly differ from the parental PC12 line. 
To determine if the changes in PTEN expression were due to constitutive TrkA 
activation, celllysates were analyzed for phosphorylation ofTrk.A at Y674 (C), and show 
low level activation relative to a positive control (5 min NGF stimulation) in each cell 
line except PC12nnr5. Arrow indicates Trk.A band. Data represent mean values+/- SEM 
obtained from three independent experiments following protein normalization to actin, or 
mRNA expression normalized to 28s, and are expressed relative to the control PC12 
parental line where *p<O.Ol as determined by one way ANOVA. 
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mutated Trk receptors results in their constitutive activation, I subjected lysates to 
immunoblotting for TrkA phosphorylation ofY674 of the activation domain. Results 
indicate that there is in fact low level activation of TrkA detectable in all cell lines except 
PC12nnr5 (Figure 8.2 C). Thus, an inverse correlation of cellular expression levels of 
PTEN and p75NTR are consistently observed and may be ascribed to alterations in the 
TrkA signal transduction cascade. 
8.3.3 TrkA mutations modulate the capacity of LN to regulate PTEN, p75NTR and 
the activity of Rho 
We have recently demonstrated that LN-mediated downregulation ofp75NTR 
results in enhanced neurite outgrowth, and that LN-induced PTEN expression is a key 
component of this downregulation (Rankin et al. 2008b). To determine whether this LN-
induced cascade is impacted by TrkA-mediated alterations in PTEN expression as we 
have noted above, PC12 cells and TrkA mutated derivatives were plated on PL or LN 
substrates for 24 hand subsequently analyzed by Western blotting. Wild type and PC12 
derivatives demonstrated increased PTEN in response to LN, with the exception of the 
Y490F TrkA mutant cell line, in which LN failed to induce expression ofPTEN (Figure 
8.3A). In agreement with our previously established signalling cascade (Rankin et al. 
2008b), LN significantly reduced p75NTR expression in those cell lines which had the 
ability to upregulate PTEN (Figure 8.3B). In contrast, Y 490F TrkA mutants which failed 
to upregulate PTEN in response to the LN substrate, did not demonstrate reduced 
p75NTR expression following exposure to LN (Figure 8.3B). These results were 
confirmed by real-time RT-PCR analyses (Figure 8.3C-D) and by immunocytochemistry 
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Figure 8.3: TrkA modulates the capacity ofPTEN to upregulate in response to LN 
and subsequently regulate p75NTR. Parental PC12 cells, PC12nnr5 cells, or PC12 
derivative cell lines expressing either TrkA Y490F, Y785F or both Y490F/Y785F 
mutations were subcultured on PL or LN for 24 h prior to Western blot (A, B) or real-
time RT-PCR analyses (C, D) ofPTEN (A, C) or p75NTR (B, D) expression. LN 
induces an upregulation ofPTEN and converse downregulation ofp75NTR in all cell 
lines excluding those with the TrkA Y 490F mutation. This relationship was confirmed by 
irnmunocyochemical analyses of the 5 cell lines plated on PL or LN substrates, and 
representative images are depicted (E - T). Densitometric analyses of protein expression 
were normalized to actin, while real-time RT-PCR analyses were normalized using 28s. 
Values expressed in A - D represent the mean expression levels obtained from 3 
independent experiments +/- SEM where *p<O.Ol as determined by one way ANOV A. 
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for PTEN and p75NTR localizations in response to a LN substrate, relative to PL (Figures 
8.3E-3T). Cells expressing TrkA with the double mutation (Y490/785F) do not 
significantly differ from wild-type in PTEN or p75NTR expression or localization, and 
thus are not shown in Figure 8.3E-T photomicrographs. Together these results 
demonstrate that TrkA plays a role in the response of PC 12 cells to a LN substrate 
wherein PTEN modulation may represent a key signalling intermediate. 
8.3.4 Biological response to LN is altered in TrkA mutant PC12 cells 
Since p75NTR constitutively activates Rho (Yamashita et al., 1999), and we have 
previously demonstrated that LN-induced changes in p75NTR coincide with decreased 
Rho activity (Rankin et al. 2008b ), I assessed the activation of Rho in response to a LN 
substrate in wild type PC12 cells, or Y490F and Y785F mutant cell lines which 
demonstrate constitutively low or high levels ofPTEN, respectively. While wildtype 
PC12 cells and Y785F mutants responded to a LN substrate by decreasing Rho activity, 
the Y490F mutants did not (Figure 8.4). Wildtype PC12 cells, Y490F and Y785F TrkA 
mutants can be differentiated into a sympathetic neuronal phenotype and respond to NGF 
by extension of neuritic processes (Greene and Tischler, 1976). Since Rho is a potent 
inhibitor of neurite extension, and these three cell lines exhibit differential abilities to 
decrease Rho activity in response to a LN substrate, I compared the neurite growth 
response ofNGF-differentiated cells following plating on LN. Growth quantification 
analyses revealed significantly reduced neurite growth in Y 490F TrkA mutants plated on 
LN versus the parental PC12 cells (Figure 8.5A). In contrast, Y785F TrkA mutants 
demonstrated significantly enhanced growth in comparison with the parental line (Figure 
308 
Figure 8.4: LN fails to induce depressed Rho activity in PC12 cell lines expressing a 
mutated Y 490F TrkA receptor. Parental PC 12 cells, or PC 12 derivative cell lines 
expressing either TrkA Y 490F or Y785F mutations were subcultured on PL or LN 
substrates for 24 h prior to assessment of active Rho using a pulldown assay. GTPyS-
loaded samples served as a positive control while GDP-loaded samples were utilized as a 
negative control. Values expressed represent the mean of3 experiments +/- SEM where 
*p<O.OOl as determined by one way ANOV A. 
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Figure 8.5: Growth response to LN is altered in TrkA mutant PC12 cells. NGF-
differentiated PC12 cells, or PC12 derivative cell lines expressing either TrkA Y490F or 
Y785F mutations were subcultured on LN for 24 h prior to immunostaining with 
antibodies directed against total tubulin and growth assessment using image 1 software 
and a total analysis of250 cells per condition (A). Relative to parental PC12 cells, 
Y 490F cells exhibit an impaired growth response and Y785F cells show enhanced 
growth. Representative images of cell growth are depicted for PC12 cel ls (B), Y490F (C) 
and Y785F (D) TrkA mutants. Differences in neurite length (A) were considered 
significant at *p<0.05 as determined by one way ANOVA. Scale bar = 25flm. 
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8.5A). Representative images of the growth response of each cell line to a LN substrate 
are depicted in Figure 8.5B-5D. These results suggest that TrkA regulation ofPTEN and 
the subsequent impact on a LN-induced p75NTR-Rho signalling cascade alters the 
growth potential of differentiated PC 12 cells when exposed to LN in the absence ofNGF. 
Rho activity and its regulation of the cytoskeleton also play a key role in cell 
migration (Raftopoulou and Hall, 2004). Since naive PC12 cells are motile in nature, I 
tested whether TrkA mutation regulation of PTEN and subsequent modulation of 
p75NTR and Rho activity, plays a role in the motile response of these cells to LN. Using 
our recently reported cell motility assay (Rankin et al., 2006), we examined the LN-
induced motility ofwildtype PC12 cells, or the Y490F and Y785F TrkA mutants show 
low or high expression ofPTEN, respectively (see Figure 8.2). Y490F TrkA mutants 
were observed to exhibit significantly decreased migratory behaviour on a LN substrate, 
relative to wildtype PC12 cells (Figure 8.6A), while Y785F TrkA mutants are highly 
motile, in agreement with previous results (Rankin et al., 2006). Representative images 
of cell migration are depicted for wildtype PC12 cells (Figure 8.6B, 8.6C), Y490F (Figure 
8.6D, 8.6E) and Y785F TrkA mutants (Figure 8.6F, 8.6G). These results suggest that in 
addition to altering the neurite growth potential ofPC12 cells, TrkA may also influence 
the motile behaviour of these cells in response to a LN substrate. 
8.4 Discussion 
PTEN, a phosphatase best known as a tumour suppressor and for its well 
characterized antagonism of PI3K signal transduction, is emerging as a key player in the 
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Figure 8.6: Motile response to LN is altered in TrkA mutant PC12 cells. PC12 cells 
or PC12 derivative cell lines expressing either TrkA Y490F or Y785F mutations were 
cultured on PL-coated coverslips prior to inversion onto a LN substrate. Motility was 
assessed following 36 h culture wherein the number of motile cells was enumerated using 
40 images per coverslip with 3 covers! ips per cell line in a total of 3 independent 
experiments (A). Y490F mutant cells exhibit significantly reduced motility in 
comparison with wt PC12 cells, while Y785F cells are significantly more motile than 
control PC12 cells. Significant differences were determined using one way ANOVA 
where *p<0.05. Representative images of cell motility are depicted for PC12 cells (8, E), 
and TrkA mutants Y490F (C, F) and Y785F (0, G). Arrows indicate the direction of cell 
movement. 
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manipulation of the cytoskeleton for neuronal growth and motility. This study integrates 
PTEN's role in the growth response within the context of previously recognized 
components TrkA, p75NTR and Rho. Binding of individual Trk family members with 
their cognate ligand is well known to promote growth and migratory responses in the 
developing nervous system based on a well characterized series of signalling cascades 
(Reichardt, 2006). We have previously shown that neurotrophin stimulation via Trk 
and/or p75NTR does not affect PTEN expression by 24 h (Rankin et al. 2008b). I now 
report that constitutive expression of TrkA itself does impact the basal level of PTEN 
expression, likely over longer time periods. In fact, the presence of particular 
autophosphorylation sites within the cytoplasmic tail ofTrkA differentially regulates 
PTEN expression in a manner that is inverse to p75NTR expression alterations previously 
reported (Rankin et al., 2005). This regulation may in fact be due to the low level of 
constitutive activation of the overexpressed Trk receptors, raising the possibility that this 
low level stimulation produces maximal effects on PTEN expression, which cannot be 
further enhanced by ligand binding. This phenomenon is noted in cerebellar granule 
neurons where a low level constitiutive activation ofTrkC is thought to prevent further 
stimulation by NT -3(Zirrgiebel and Lindholm, 1996), thereby preventing the further 
activation of specific signalling responses. Alternatively, the receptor transactivation in 
the absence of ligand may be initiating different signalling than NGF-induced activation. 
As TrkA regulates constitutive p75NTR expression, and we have reported that 
PTEN can regulate p75NTR expression (Rankin et al, 2008b), this raises the possibility 
that the modulation of constitutive p75NTR by TrkA is actually occurring via 
intermediate PTEN. Ligand binding to TrkA causes receptor dimerization resulting in the 
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transphosphorylation of two tyrosine residues outside of the kinase domain. 
Phosphorylation of Y 490 facilitates interaction with She, an adapter protein which 
regulates the Ras/MAP kinase pathway for growth and differentiation. Phosphorylation 
of Y785 recruits PLCy to activate the PKC/MAP kinase pathway which similarly 
influences cell growth. Additionally, activation of the Trk receptor is associated with 
induction of the PI3K/Akt pathway for neuronal survival. The fact that abrogation of 
either one, or both of these phosphorylation sites can manipulate PTEN expression levels 
provides preliminary evidence regarding the cell signalling pathways which may regulate 
PTEN, an area currently under investigation, though it appears from this mutational 
analysis that the lack of PLCy signalling increases PTEN expression, while a lack of 
Ras/MAP kinase activation decreases PTEN expression. This is consistent with our 
previous results that loss ofPLCy signalling results in reduced p75NTR expression 
(Rankin et al., 2008). 
The role of TrkA in the promotion of both growth and motility (Ho et al., 2001 ; 
Ho et al., 2005) is a well-known phenomenon, and in PC12 cells, this NGF-induced 
response appears to be dependent upon the phosphorylation of ERK, which is 
accomplished by phosphorylation of either Y 490 or Y785, two pathways that seem to 
compensate for each other in this regard. However, despite similar NGF-stimulation-
induced phosphorylation of ERK in the cells expressing TrkA Y 490F and Y785F (data 
not shown), they demonstrate variable amplitude of response in terms ofboth growth and 
motility, indicating that the ECM is able to provide modulatory signals to amplify the 
response and adjust biological outcomes. 
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We have previously reported that in the absence ofneurotrophins, a LN substrate 
is sufficient to promote neurite outgrowth ofPC12 cells and hippocampal neurons 
(Rankin et al. 2008b ), and cell migration of cerebellar granule neurons (Rankin et al. 
Manuscript submitted), by downregulating p75NTR and subsequently suppressing Rho 
activity. This cascade requires PTEN as a signalling intermediate (Rankin et al. 2008b). 
Here I demonstrate that the absence of PTEN associated with the Y 490F TrkA mutation 
renders the cells incapable of modulating p75NTR in response to LN, and these cells 
subsequently fail to decrease Rho activity in response to LN substrate, leading to 
impaired growth and motility. The extension of neurites does occur in the absence of 
detectible PTEN protein expression, but to a lesser degree, while motility is severely 
limited. These findings highlight the importance ofPTEN expression in facilitating LN-
induced modulation of signal transduction cascades for remodelling of the actin 
cytoskeleton, likely via alterations in Rho activity. 
The results of the current study suggest that TrkA modulates PTEN expression. 
This significantly contributes to the cells ability to respond to a LN substrate, which could 
impact the development or regenerative capacity of the nervous system. PTEN and 
p75NTR dysregulation have also been independently associated with a wide variety of 
diseases (Dechant and Barde, 2002; Schor, 2005). Therefore determination oftheir 
regulatory cascades is of key importance to further our understanding of both how 
pathological conditions may arise and how they may be therapeutically targeted. 
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Chapter 9: The rapid upregulation of PTEN following integrin ligation is dependent 
upon focal adhesion signalling through Egr-1. 
9.0 Summary 
Extracellular matrix signals are mediated by integrins, receptors that link 
extracellular signals to the actin cytoskeleton and activate signalling cascades to regulate 
axonal outgrowth and motility. We have recently reported that integrin ligation by 
laminin (LN), an extracellular matrix component, can induce upregulation of PTEN, a 
phosphatase, thus initiating a signalling cascade for the promotion of growth and 
migration. I now investigate the mechanism by which LN upregulates PTEN through a 
series of experiments designed to address the temporal and dose-dependent response to 
LN, and to ascertain the contribution of integrin-associated intermediates to this cascade. 
I demonstrate that integrin activation induces the upregulation of PTEN very quickly and 
at low concentrations of the LN stimulus, and in a variety of cell lines including PC1 2 
cells and the human hepatoma-derived cell lines HepG2 and Huh7. This signalling 
paradigm occurs via a pathway involving focal adhesion components Src, ILK and F AK, 
as inhibition of these components decreases PTEN induction in response to LN exposure. 
Furthermore, I report a role for transcription factor Egr-1, which is upregulated by LN 
exposure; the selective decrease ofEgr-1 using siRNA impairs the upregulation ofPTEN 
in response to LN. These results provide details of a novel signalling mechanism which 
may influence neurite outgrowth and motility. 
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9.1 Introduction 
The three-dimensional extracellular environment of a cell is comprised of the 
extracellular matrix (ECM), which itself is composed of a variety of proteins (e.g. 
laminin, fibronectin) synthesized and secreted by resident cells. During development, the 
ECM serves as a substrate for axonal growth, and subtle differences in its composition 
can effectively guide axons long distances to appropriate targets (reviewed in Luckenbill-
Edds, 1997). The ECM persists into adulthood, and differs between the peripheral and 
central nervous system thereby contributing to differences in the regenerative growth 
response of PNS or CNS neurons (reviewed in Filbin, 2006). 
ECM molecules interact with a group of receptors known as integrins. Integrins 
are a/~ heterodimers, wherein specific combinations recognize and bind particular 
molecules of the ECM. Ligand binding results in integrin aggregation within the cell 
membrane and in subsequent recruitment of a variety of different adapter proteins and 
kinases forming focal adhesions. It is through these focal adhesions that integrin 
signalling can initiate a variety of downstream signal transduction cascades to alter gene 
transcription to regulate the actin cytoskeleton for a variety of physiological outcomes, 
including neurite outgrowth and motility (Reviewed in Lemons and Condie, 2008). 
We have recently presented evidence that laminin (LN), a common component of 
the peripheral ECM with known growth-promoting abilities, can act via integrin receptors 
to upregulate the expression ofPTEN, thus initiating a signalling cascade that promotes 
neurite outgrowth in the absence of neurotrophins (Rankin et al. 2008b ). PTEN is a 
phosphatase, best known for its role as a tumour suppressor and its antagonism of the 
PI3K survival pathway, and is thus under tight regulatory control. PTEN is, however, a 
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dual specificity phosphatase able to dephosphorylate both lipid and proteins substrates 
(Salmena et al., 2008). New functions in growth and motility are beginning to emerge for 
the protein phosphatase abilities of this enzyme (Leslie et al., 2007). We have previously 
demonstrated that the protein phosphatase activity of PTEN decreases the DNA binding 
ability of transcription factor Spl in cells exposed to LN, thereby decreasing p75NTR 
transcription and subsequent protein expression (Rankin et al. manuscript submitted). 
This cascade results in enhanced axonal regeneration in differentiated PC12 cells and 
developing hippocampal neurons (Rankin et al. 2008b ), as well as increased motility of 
cerebellar granule neurons (Rankin et a!. manuscript submitted) by Rho-induced 
modulation of the actin cytoskeleton. 
The present study investigates the mechanism by which LN results in the 
upregulation of PTEN via downstream activation of integrin-associated signalling 
intermediates. My results show that ECM molecules act via integrin focal adhesion 
components and the transcription factor Egr-1 to upregulate PTEN. This regulation may 
play a role in determining survival and axonal growth in response to the ECM in the 
developing nervous system and during the regenerative growth response promoted by 
exposure to LN. 
321 
9.2 Materials and Methods 
9.2.1 Cell Culture and Differentiation 
The experimental model consisted of wild-type rat pheochromocytoma (PC12) 
cells, and a series of mutated PC12 derivative cell lines (gifts from Dr. David Kaplan, 
Hospital for Sick Children, Toronto, ON). PC12nnr5 cells were derived by mutating 
parental PC 12 cells using ethylmethanesulfonate, as described by Green et al. (1986). 
PC12 derivatives expressing mutant TrkA receptors (Y490F or Y785F) were created by 
Stephens et al. (1994). Briefly, PC12nnr5 cells were transfected to express a TrkA 
receptor that had been altered via site-directed mutagenesis to abrogate either of the 
autophosphorylation sites of the cytoplasmic tail. 
Cell lines were maintained on rat-tail collagen-coated tissue-culture flasks in 
RPMI 1640 medium (Invitrogen, Burlington ON) supplemented with 1 0% horse serum 
(Invitrogen), 5% fetal calf serum (Invitrogen) and 1% penicillin/streptomycin/glutamine 
solution (PSG; Invitrogen) as previously described (Rankin et al., 2005; Rankin et al., 
2008; Rankin et al., 2006). In the case of mutated cell lines Y490F and Y785F, media 
was additionally supplemented with Geneticin G418 to ensure continued selection of the 
mutant population. Cells were incubated at 3 7 °C in 5% C02, and cultured to 80% 
confluence prior to trypsinization for subculturing and differentiation. 
HepG2 and Huh7 human hepatoma-derived cells were maintained in DMEM 
containing 10% fetal calf serum and 1% penicillin/streptomycin/glutamine solution. 
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9.2.2 Primary Cell Culture 
Cultures enriched in granule neurons were obtained from cerebella of 8 day-old 
Sprague-Dawley rat pups as described previously (Jiang et al., 2003; Rankin et al., 2008). 
Cerebella were stripped of meninges, finely chopped and dissociated by enzymatic 
digestion using 0:25% trypsin-EDT A followed by mechanical trituration. The culture 
medium was Dulbecco' s modified eagle medium (DMEM) supplemented with 10% FCS, 
25 mM KCl and 1% penicillin/streptomycin solution (Invitrogen). Cells were seeded 
onto polylysine (PL; 40 ~g/ml) or laminin (LN; 25 ~g/ml)-coated tissue culture plates at a 
density of 1.8 x 106 cells per ml. Cells were incubated at 37°C in 5% C02 and cytosine 
arabinoside was added to longterm cultures to inhibit the proliferation of non-neuronal 
constituents. On the seventh day in vitro (DIV) oflongterm cultures, glucose (50 ~1 of a 
100 mM solution) was added to each culture well to maintain survival, as culture medium 
was not replaced. This method yields cultures consisting of approximately 95% CGN 
(Jiang et al., 2003). 
9.2.3 Constructs and Transfection 
HA-FRNK plasmid DNA was a gift from Dr. K. Vuori, Burnham Institute, La 
Jolla, CA. Plasmids encoding ILK wildtype, kinase dead ILK (R211A) and dominant 
negative ILK (E359K) were a gift from Dr. Daniel MacPhee (Memorial University of 
Newfoundland). Vectors were introduced to the differentiated PC12 cells using 
Lipofectamine 2000 as per the manufacturer's instructions. 
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9.2.4 Inhibition Studies 
For pharmacological inhibition studies, cells were similarly subcultured on PL-
coated 12-well plates under serum-starved conditions. The pharmacological inhibitor, 
PP2 (various concentrations as indicated; Calbiochem) were separately added to 
individual wells at the time of plating. Inhibitor concentrations were empirically 
determined to provide the required inhibition (Fig 3A, 3D, 4C) with no detriment to 
viability (Dodge et al., 2002; Mearow et al., 2002). Cells were then allowed to incubate 
for 24 h at 3 7°C in 5% C02• 
9.2.5 Western Blot Analysis 
For Western analyses, cells were harvested in the presence of sodium 
orthovanadate and subsequently subjected to lysis (1 0% glycerol, 1% NP-40, sodium 
vanadate, sodium fluoride, magnesium chloride, octyl-~-thioglucopyranoside (Sigma), 
and 1 protease inhibitor cocktail tablet (Roche Scientific, Laval, QC) overnight at 4° C 
prior to centrifugation (10,000 rpm, 5 minutes). A BCA protein assay (Pierce, Rockford 
IL) was used to determine protein concentration and equivalent amounts of protein (50 
1-!g) were electrophoresed on 8% SDS-polyacrylamide gels. Protein was subsequently 
transferred to nitrocellulose membranes that were then exposed to Ponceau red to ensure 
equal protein loading. After washing in TBS, blots were blocked in 3% non-fat dry milk 
for 1 hat room temperature, and then incubated with a primary antibody overnight at 4° 
C. Antibodies used include: Anti-Actin (Sigma), Anti-PTEN (Cell Signaling). A final 
incubation with HRP-conjugated secondary antibody (AP307P, AP308P; Chemicon,) for 
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1 h at room temperature was followed by visualization using an ECL method. Each 
experiment was repeated three times, subjected to densitometry and normalized to actin to 
ensure equal protein for comparison. Statistical analysis was performed using GraphPad 
Prism 4 (GraphPad Software Inc., San Diego CA) with significance being determined 
using one-way ANOV A testing. 
9.2.6 Real-time RT-PCR 
For real time RT-PCR analysis, cells were subcultured on PL or LN-coated 12-
well plates under serum-starved conditions for 24 h in the presence or absence ofNGF 
(50 ng/ml). RNA was isolated using Trizol reagent (Invitrogen) as per the manufacturer' s 
instructions and was subsequently treated with DNase (Ambion; Austin TX) to remove 
traces of contaminating DNA. RNA (2 J..tg) was reverse transcribed to eDNA using 
MMLV reverse transcriptase (200 U for 30 minutes at 37 °C; Invitrogen) prior to use as 
template for real-time PCR amplification using the following PCR primer pairs: PTEN 
forward 5'-ATTCGACTTAGACTTGACCT, PTEN reverse 5' -
ACCAGTCCGTCCTTTC, 28S forward 5' -GACCAAGGAGTCTAACGC, 28S reverse 
5 ' -GT ACGCTCGTGCTCCA, Egr-1 forward 5 ' -CAGGAGTGA TGAACGCAAGA, Egr-
1 reverse 5' - AGCCCGGAGAGGAGTAAGAG. PCR amplification was performed 
using the Roche LightCycler (Roche) and quantified using SYBR green I. Egr-1 and 
PTEN mRNA expression levels were subsequently normalized to 28S. 
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9.2.7 Small interfering RNA constructs and transfection 
Egr-1 siRNA constructs were synthesized by Dharmacon as follows: target 
sequence 5'-GCGAACAACCCUACGAGCA. PC12 cells were transfected with 1 j.!M of 
Egr-1 siRNA using Dharmafect transfection reagent according to manufacturer' s 
protocols. The siRNA transfection efficiency was assessed to be >70% based on 
transfection of Alexa fluor-labelled negative control siRNA (scrambled; target sequence 
AA TTCTCCGAACGTGTCACGT; Qiagen, Mississauga ON). 24-48 hours post-
transfection, cells were transferred onto PL or LN coated tissue culture plates for protein 
analysis after an additional 24 hours. 
9.3 Results 
9.3.1 LN is a potent upregulator of PTEN expression 
We have previously determined that exposure ofPC12 cells to a laminin substrate 
upregulated PTEN mRNA and protein expression, and downregulated p75NTR 
expression (Rankin et al2008b). To ascertain whether there existed a dose-dependent 
relationship between integrin activation and modulation of PTEN, PC 12 cells and 
cerebellar granule neurons were plated on substrates coated with varying LN 
concentrations (Figure 9.1 ). The results show that the minimum concentration of LN 
utilized, (1j.tg/ml), was sufficient to induce an upregulation ofPTEN as assessed by 
Western blotting in both PC12 cells (Figure 9.1A) and CGN (Figure 9.1C). The 
expression of p75NTR changes inversely in each cell type, downregulating in response to 
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Figure 9.1: PTEN expression is induced by low concentrations of LN. PC12 cells 
(A,B) or CGN (C,D) were plated on varying concentrations of LN as indicated and 
stimulated for 24 h prior to analyses by Western blotting. The lowest concentration of 
LN tested (lf.!g/ml) elicited a significant increase in PTEN expression (A,C) which 
remained elevated throughout the range of concentrations evaluated. Exposure to all 
tested LN concentrations was also associated with a significant downregulation of 
p75NTR (B,D). Values represent the mean +/- SEM expression level following 
normalization against actin, obtained from 3 independent experiments, where *p<0.05 as 
determined by one way ANOV A. Values are expressed as a percentage of the control PL 
condition. 
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each LN concentration (Figure 9.1B, D). Interestingly, the increase in PTEN expression 
and decrease in p75NTR expression was maximal upon stimulation with 1 ~J.g/ml LN, and 
failed to demonstrate a dose-dependent response to LN when utilized at concentrations up 
to 1 00 !J.g/ml. 
9.3.2 Exposure to a LN substrate rapidly modulates PTEN expression 
Since integrin activation was observed to modulate PTEN expression (Figure 9.1), 
we assessed the kinetics of the LN-mediated upregulation ofPTEN in cultured PC12 cells 
or a mutated derivative, PC12nnr5. PC12nnr5 cells lack TrkA, but express a significantly 
greater constitutive level of PTEN expression. Cells were subcultured and plated on 
either PL or LN substrates for culture periods varying between 1 to 24 h as indicated in 
Figure 9.2, prior to protein collection and analysis by Western blotting. The results 
indicate that exposure to the LN substrate results in significant upregulation of PTEN 
protein in both PC12 (Figure 9.2A) and PC12nnr5 cells (Figure 9.2C) as early as 1 h post-
LN exposure, while significant differences in p75NTR expression between the PL and 
LN conditions were not apparent until6 h in both PC12 cells (Figure 9.2B) and PC12nnr5 
cells (Figure 9.2D). To confirm that this increased expression ofPTEN was actually 
transcriptional in nature, I performed real-time RT-PCR analysis for PTEN expression 
following timed intervals of LN exposure from 1-24 h as indicated (Figure 9 .2E). 
Elevated levels ofPTEN mRNA are evident as early as 1 h post-LN exposure, and 
persisted throughout the first 24 h in culture, in agreement with our previously reported 
results (Rankin et al. 2008b). p75NTR mRNA expression was suppressed by 6 h 
following exposure to the LN substrate (Figure 9.2F). Taken together, 
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Figure 9.2: LN stimulation modulates PTEN gene transcription and protein 
expression as early as 1 h post stimulation. PC12 (A, B, E, F) and PC12nnr5 (C, D) 
cells were plated on a LN substrate and analyzed for changes in PTEN protein (A, C) and 
mRNA (E) or p75NTR protein (B, D) and mRNA (F) expression using Western blot and 
real-time RT-PCR analyses, respectively. PT N protein expression was significantly 
elevated as early as 1 h post-stimulation (A, C), co-incident with increased PTEN mRNA 
transcription (E). Downregulation of p75NTR protein (B, D) and mRNA (F) could be 
detected by 6 h following exposure to the LN substrate. Protein levels were normalized 
against actin, while eDNA samples were normalized using 28s. Values represent mean 
expression levels +/- SEM obtained from three independent experiments, and are 
presented relative to the control PL condition where *p<0.05 as determined by one way 
ANOV A. Values are expressed as a percentage of control condition PL 1 h (A-D) or time 
0 (E-F). 
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my results suggest that LN may potently induce PTEN expression levels both in terms of 
the minimal threshold of integrin activation required (Figure 9.1 ), and in the expediency 
of this signalling paradigm (Figure 9.2). Furthermore, p75NTR expression is consistently 
inverse, but is subject to slower expression changes, suggesting that PTEN changes are 
upstream of changes to p75NTR. 
9.3.3 Regulation of PTEN expression following integrin stimulation is not restricted 
to a single cell type or to exposure to a LN substrate. 
PC 12 cells are maintained on a collagen substrate which itself imparts integrin 
activation. Thus, while the LN substrate was a potent inducer of PTEN expression in 
these cells relative to PL, I confirmed whether integrin activation may modulate PTEN 
expression in cell lines which are maintained in the absence of exogenous integrin 
stimulation. Thus, human hepatoma cell lines HepG2 and Huh7 which are normally 
maintained on tissue culture plastic in the absence of exogenous integrin activating 
substrates, were plated on PL or LN substrates for 24 h prior to analysis ofPTEN protein 
expression by Western blotting. The results confirm that these two cell lines also respond 
to the LN substrate with a significant upregulation ofPTEN (Figure 9.3). Thus, integrin 
activation is sufficient to activate this LN-induced signalling response in multiple cell 
types. 
Integrin activation is not strictly a function of LN stimulation, but rather specific 
ap heterodimers respond to particular components of the ECM. However, integrin 
clustering and initiation of downstream signalling pathways is largely conserved, with 
subtle differences and proceeds via formation of focal adhesions and recruitment of 
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Figure 9.3: LN mediates changes in PTEN expression in cells which are not of 
neuronal lineage. Human hepatoma-derived HepG2 and Huh7 cells were plated on PL 
or LN substrates for 24 h prior to Western blot analysis ofPTEN expression. LN induced 
significant upregulation of PTEN expression relative to the control PL condition. Values 
represent mean expression levels following normalization to actin, and are presented as a 
percentage of the control PL condition, +/- SEM, where *p<0.05 as determined by one 
way ANOVA. 
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common signalling adaptor proteins and kinases (Coppolino and Dedhar, 2000; Lemons 
and Condie, 2008). To examine whether integrin activation and signalling in general, was 
sufficient to initiate upregulation of PTEN expression, I utilized several integrin-
activating substrates and assessed their capacity to modulate PTEN (Figure 9.4). Thus, 
PC12 cells or CGN were plated on PL, LN, matrigel (a synthetic basement membrane 
composed largely ofLN), collagen (Col) and fibronectin (FN) for 24 h prior to Western 
blot analyses. Each of these substrates was associated with a significant upregulation of 
PTEN expression in PC12 cells (Figure 9.4A), and all but collagen resulted in significant 
upregulation ofPTEN in CGN (Figure 9.4B). Thus, integrin regulation ofPTEN extends 
beyond the LN substrate, and likely includes any integrin activating substrate for which 
the cell expresses the appropriate integrin pair. 
9.3.4 Inhibition of integrin-associated signalling components impairs PTEN 
expression 
Intramembrane clustering of integrin receptors in response to ligand binding 
results in recruitment of a variety of kinases, including Src family kinases, focal adhesion 
kinase (F AK) and integrin-linked kinase (ILK) and adapter molecules which subsequently 
initiate signalling cascades to shape cellular behaviour. To investigate whether integrin-
associated kinases, recruited to the focal adhesions, are necessary for PTEN regulation, 
we utilized pharmacological or genetic inhibition of these common protein kinases. When 
cultured on a PL substrate, the basal activation of integrin associated signalling 
components is quite low in general, but dramatically increases when the cells are exposed 
to LN. Treatment ofPC12 cells with the Src inhibitor PP2 for 24 h inhibits the 
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Figure 9.4: LN-independent integrin activation is sufficient to alter PTEN 
expression. PC12 cells (A) or CGN (B) were plated on control PL, or integrin-activating 
substrates LN, matrigel, collagen or fibronectin for 24 h prior to Western blot analyses for 
PTEN expression. Each of the substrates was associated with an upregulation of PTEN 
expression in PC 12 cells (A), and all substrates with the exception of collagen were 
associated with an upregulation of PTEN expression in CGN (B). Values represent mean 
expression levels following normalization to actin, and are presented as a percentage of 
the control condition, PL, +/- SEM, where *p<O.Ol as determined by one way ANOVA. 
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phosphorylation ofSrc and impaired the upregulation ofPTEN expression normally 
induced by LN exposure, and appeared to act in a dose-dependent fashion (Figure 9.5). I 
further investigated the importance of focal adhesion signalling in mediating the LN-
induced upregulation of PTEN by interfering with F AK, which is recruited to sites of 
focal adhesions following integrin ligation. For this purpose, we utilized plasmid DNA 
encoding FAK-related non-kinase (FRNK), a non-catalytic C-terminal region ofFAK 
which serves to inhibit endogenous F AK phosphorylation and downstream signalling. 36 
h following transient transfection in PC12 cells, PC12 cells were exposed to either a PL 
or LN substrate for 24 h. Western blot analyses showed that inhibition ofFAK activity 
significantly reduced the upregulation ofPTEN in response to LN (Figure 9.6) relative to 
an empty vector control. ILK is an additional kinase which interacts with the cytoplasmic 
tail ofintegrin ~1 subunit following integrin ligation. To examine whether this 
component of integrin signalling also impairs LN -mediated induction of PTEN I utilized 
constructs encoding wild-type ILK, or the mutations rendering ILK kinase dead (R211A), 
or dominant negative (E359K). As shown in Figure 9.7, overexpression of E359K in 
PC 12 cells significantly impairs the upregulation of PTEN in response to a 24 h LN 
exposure, while the wild-type and kinase dead constructs had no effect (Figure 9.7). 
Thus, interference with any of the key components of focal adhesions tested significantly 
impaired the capacity of LN to modulate PTEN levels. 
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Figure 9.5: Inhibition of integin-associated signalling molecule Src impairs PTEN 
upregulation in response to LN exposure. PC12 cells were plated on LN in the 
presence or absence of varying concentrations of the Src inhibitor PP2 for 24 h, as 
indicated. Western blot analyses confirm a dose-dependent reliance upon Src activation 
for the LN-induced expression ofPTEN. Values represent the mean expression values 
+/- SEM following normalization to actin, obtained in 3 independent experiments, and are 
presented as a percentage of the control condition in the absence of Src inhibition. 
Differences were considered significant where *p<0.05 as determined by one way 
ANOVA. 
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Figure 9.6: Inhibition of focal adhesion kinase impairs LN-induced alterations in 
PTEN. PC12 cells were transiently transfected with control empty vector, or vector 
encoding the FAK inhibitor FRNK, for 24 h prior to Western blot analyses. FRNK 
expression abrogated the LN-mediated upregulation ofPTEN. Data represent the mean 
expression values obtained in 3 independent experiments following protein normalization 
to actin, and are presented as the mean +/- SEM relative to the empty vector control 
condition, where *p<0.05 as determined by one way ANOVA. 
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Figure 9.7: Interference with integrin linked kinase impairs LN-induced alterations 
in PTEN. PC12 cells were transiently transfected with control vector, or vectors 
encoding ILK wt, kinase dead ILK (R211A) or dominant negative ILK (E359K), prior to 
plating on LN substrates for 24 h. Dominant negative ILK construct (E359K) prevented 
the LN-induced upregulation ofPTEN. Values are expressed relative to the control 
empty vector following protein normalization to actin, obtained in 3 independent 
experiments. Data represent the mean,+/- SEM, and changes in PTEN expression were 
considered significant when *p<0.05 as determined by one way ANOV A. 
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9.3.5 LN mediated regulation of PTEN expression requires the transcription factor, 
Egr-1. 
Previous reports have suggested that collagen stimulation results in an 
upregulation of the transcription factor Egr-1 (Barbolina et al., 2007), and Egr-1 is known 
to promote the transcriptional upregulation of PTEN in response to UV irradiation 
(Virolle et al., 2001 ). Furthermore, Egr-1 has been shown to be upregulated and 
translocated to the nucleus in vascular smooth muscle cells upon LN exposure 
(Morawietz et al., 1999), and LN induces the upregulation of Egr-1 in synovial fibroblasts 
(Warstat et al. , 2008). Thus, I investigated whether exposure to a LN substrate modified 
the expression of Egr-1, as a potential mechanism regulating the observed LN -induced 
upregulation ofPTEN. Semi-quantitative and real-time RT-PCR analyses confirmed that 
LN stimulation resulted in significant upregulation ofEgr-1 mRNA in PC12 cells (Figure 
9.8A). Interestingly, analyses of two PC12-derivative cell lines which express TrkA 
mutations, suggested that the Y 490F mutants which constitutively express very low levels 
ofPTEN and do not upregulate PTEN in response to LN (Rankin et al. Manuscript in 
preparation), express comparatively low levels of Egr-1 (Figure 9.8A). In contrast, 
Y785F mutants which constitutively express greater amounts ofPTEN, and do respond to 
LN stimulation with increased PTEN expression (Rankin et al. Manuscript in 
preparation), transcribe significantly greater Egr-1 mRNA (Figure 9.8A). To determine if 
Egr-1activity is associated with the LN-induced upregulation ofPTEN, I utilized Egr-1 
siRNA to reduce the expression ofEgr-1 prior to exposing cells to either a PL or LN 
substrate. The Egr-1 siRN A significantly decreased the protein expression of Egr-1 
(Figure 9.8B), and this selective abrogation ofEgr-1 significantly impaired the 
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Figure 9.8: Egr-1 transcription factor expression correlates with constitutive PTEN 
expression and its modulation in response to LN. PC12 cells or derivative cell lines 
expressing TrkA mutations Y490F or Y785F, were plated on PL or LN substrates for 24 h 
prior to PTEN mRNA analysis using real-time RT-PCR (A). LN stimulation upregulated 
Egr-1 transcription in parental PC12 cells and the Y785F mutant, while Y490F mutants 
exhibited decreased constitutive expression ofEgr-1 which was not influenced by LN 
stimulation (A). PC 12 cells were transiently transfected with scrambled or Egr-1-specific 
siRNA prior to exposure to a LN substrate for 24 h (B, C). Western blot analyses confirm 
the successful downregulation of Egr-1 protein (B) and a requirement for Egr-1 in the 
LN-induced upregulation of PTEN protein expression. Data represent mean values 
obtained in 3 independent experiments, following eDNA normalization to 28s (A) or 
protein equalization to actin (B), and are presented relative to control PL (A) or 
scrambled (B) conditions. Differences were considered to be significant at *p<0.05 as 
determined by one way ANOV A. 
A 
B 
c 
PL 
0 
... 
-c 0 
0 
-0 
-c Cll 
u 
... 
Cll 
0.. 
+ 
LN 
ControlsiRNA + 
Egr-1 siRNA 
PL 
LN 
Egr-1 
Actin 
0 
... 
-c 0 
0 
0 
-c ~ 
Cll 
0.. 
+ 
Control siRNA + 
Egr-1 siRNA 
PTEN 
Actin 
0 
... 
-
c 
0 
0 
0 
-
c 
Cll 
u 
... 
Ql 
0.. 
+ 
+ 
+ 
+ 
+ 
+ 
+ + 
+ 
+ 
+ + 
Figure 9.8 
,.--------- --------------------
upregulation ofPTEN in response to LN exposure (Figure 9.8C). Together, these results 
suggest an important role for Egr-1 both in the constitutive regulation of PTEN, and in 
regulating the induction of PTEN in response to integrin activation in PC 12 cells. 
9.4 Discussion: 
This study explores a signalling mechanism initiated by ECM-integrin interaction 
which results in the upregulation of phosphatase, PTEN. I demonstrate that PTEN 
upregulation is a remarkably sensitive response that occurs at low concentrations of LN 
stimulus (1 J..lg/ml), and occurs very quickly with increased mRNA and protein evident 
within an hour ofLN exposure. This rapid and sensitive induction ofPTEN is dependent 
upon signalling through various focal adhesion components, including F AK, Src and ILK, 
and involves transcription factor Egr-1 , an immediate early gene. Importantly, this early 
induction of PTEN occurs within an appropriate timeframe to induce other genetic 
changes, including the downregulation ofp75NTR; a sequence of signalling events which 
we have previously shown to enhance axonal regeneration (Rankin et al. 2008b ). 
The ECM provides structural support, but can also regulate the biological 
responses of cells that it contacts by activating signalling cascades through integrin 
receptors, thus influencing critical developmental processes, including neuronal 
differentiation, migration and neurite outgrowth (Porcionatto, 2006). The ECM is of 
dynamic composition, as its individual components are temporally and spatially regulated 
throughout development, thus contributing to the growth and guidance of developing 
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neurons (Lemons and Condie, 2008; Porcionatto, 2006). Additionally, ECM components 
can be induced in the adult PNS following injury (Lemons and Condie, 2008). 
The growth cone of an extending axon is able to readily adapt to and extend over 
the various different concentrations of LN it encounters as it extends through the 
developing embryo, from low levels in mesenchymal tissues to very high levels in 
basement membranes. This flexibility is necessary for accurate peripheral innervations 
(Lemons and Condie, 2006; Pietri et al. , 2004), and may be attributable to the rapid 
modulation of receptor expression levels. The expression of integrin receptors are tightly 
regulated to match cellular requirements and maintain an intermediate level of attachment 
for efficient growth and motility (Condie and Letourneau, 1997), though forced 
expression of particular integrin subunits, and presumably enhancement of integrin-
related signalling, can restore adult regenerative growth to embryonic levels (Condie, 
2001). Injury, and the regenerative response, can induce the expression ofa4, a5, a6, a7 
and ~1 integrins in the PNS (Ekstrom et al., 2003; Vogelezang et al., 2001; Wallquist et 
al., 2004; Yanagida et al., 1999). The ability of a particular ECM component to induce 
PTEN expression is dependent on the repertoire of integrin subunits expressed by the cell. 
Each a/~ heterodimer is selective for particular ECM components, though there is 
considerable overlap, as several a/~ pairs recognize the same components. 
In neurons, integrin activation occurs rapidly, within 2 minutes of ligand binding 
(Lemons and Condie, 2006), but these receptors lack intrinsic enzymatic activity 
(Schlaepfer and Hunter, 1998). In order for integrins to become activated, they must not 
only bind to the appropriate ligand, but must aggregate within the plane of the membrane 
(Miyamoto et al., 1995) and recruit various adapter proteins and kinases to transduce 
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signals (Giancotti and Ruoslahti, 1999). ECM-integrin interaction recruits non-receptor 
tyrosine kinase, F AK (Schaller et al. , 1992), whose N-terminal domain binds directly to 
the ~ subunit cytoplasmic domain (Dedhar and Hannigan, 1996). This interaction induces 
the autophosphorylation ofFAK on Y397, which creates docking sites for SH2-domain 
containing proteins, the Src Family Kinases (SFK). This interaction in turn results in 
further phosphorylation events that include cytoskeletal proteins (paxillin and tensin), 
adapter proteins (p130cas) and kinases (F AK itself is further activated creating binding 
sites for Grb2-SOS complex which activates the Ras-MAPK cascade). Additionally, 
phosphorylated F AK can interact with PBK, both directly and via Src, and some integrin 
subunits can recruit She, which also activates Ras-MAPK signalling (reviewed in 
Giancotti and Ruoslahti, 1999; Kumar, 1998; Miranti and Brugge, 2002). Furthermore, 
integrin-linked kinase (ILK) is a serine/threonine kinase with scaffolding functions that 
directly associates with the cytoplasmic tail of the ~ 1 subunit (Hannigan et al., 1996), and 
serves as a key regulator of adhesion-dependent signal transduction (Mills et al., 2006). 
The genetic deletion of ILK mimics the phenotypes observed with integrin ~ 1 deletion 
(Graus-Porta et al. , 2001), and ILK is critical to cerebellar development (Mills et al. , 
2006), as is PTEN (Marino et al., 2002). Focal adhesion associated proteins, including 
F AK and Src, often contain multiple domains which can each link together a number of 
other proteins creating a web-like effect that is difficult to trace the sequence of activation 
signals from integrin ligation to signal transduction cascade (Zaidel-Bar et al. , 2007). Our 
results show that interference with F AK, Src or ILK is sufficient to impair the LN-
mediated upregulation ofPTEN. 
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A Src-related signalling cascade induced by integrin ligation to a collagen 
substrate has been recently implicated in the induction of Egr-1 expression which results 
in the promotion of an invasive phenotype of ovarian carcinoma (Barbolina et al. , 2007). 
Our results demonstrate that integrin activation by a LN substrate also results in the 
induction of Egr-1 . Egr-1 is classified as an immediate early gene (Knapska and 
Kaczmarek, 2004), and the activation of Egr-1 synthesis by ultraviolet radiation has been 
shown to directly regulate expression of PTEN by binding a GC-rich site within the 
5 'UTR (Virolle et a!. , 2001 ), a response that was lost in Egr-1 deficient mice. My results 
are in agreement with those ofVirolle (2001), as Egr-1 suppression using siRNA was 
sufficient to impair the LN-induced upregulation ofPTEN. Multiple biological roles are 
attributable to Egr-1 , including neurite outgrowth, plasticity, growth control and apoptosis 
(Thiel and Cibelli, 2002), and these largely overlap with roles attributable to PTEN. 
Integrin receptors are by no means limited to neurons, but are in fact expressed by 
a wide variety of cell types. PTEN induction has previously been associated with a4p 1 
ligation in fibroblasts, where it is thought to prevent invasive phenotype associated with 
pulmonary fibrosis (White et al. , 2003). PTEN plays a major role in anoikis, apoptosis 
caused by loss of attachment to the ECM (Lu et al. , 1999) and the loss of PTEN is 
associated with a variety of human pathologies, including cancer (Salmena et al. , 2008) 
and rheumatoid arthritis (Pap et al., 2000). Integrin receptors and their downstream 
signalling cascades, including PTEN induction, play an important role in embryonic 
development, regenerative axon repair, migratory responses and a plethora of 
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pathological conditions. Elucidating regulatory mechanisms may provide clues to 
therapeutic targets in the future. 
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Chapter 10: General Discussion and Future Directions 
The goal of the present series of studies was to examine the molecular 
mechanisms underlying successful axonal regeneration, specifically signalling cascades 
initiated by neurotrophin and ECM ligands binding to their cognate receptors, and 
determine how these signalling cascades might interact or cooperate to result in the 
promotion of an optimized growth response. The success or failure of axonal 
regeneration following nerve injury is largely attributable to factors present in the 
extracellular environment. The promotion of regenerative growth requires the 
orchestration of a multitude of signalling cascades which can be activated to varying 
degrees by a variety of different surface receptors depending on the availability of trophic 
and tropic cues in the extracellular environment, and the presence of inhibitory 
components which can activate parallel or antagonistic signalling that is 
counterproductive to growth. As such, the failure of CNS regenerative growth is ascribed 
to a lack of growth promoting factors, as well as the presence of numerous inhibitory 
components derived from myelin and the glial scar. Conversely, the success of axonal 
regeneration following peripheral nerve injury is ascribed to the presence of neurotrophic 
factors, including NGF, and permissive ECM components, including LN. These growth 
promoting molecules are often upregulated following axonal injury. The receptors for 
these cues also display altered expression patterns in response to injury, and are inevitably 
important to the cellular regenerative response. 
353 
10.1 p75NTR upregulation in the presence of neurotrophins 
Ligation ofTrkA, the high affinity NGF receptor, is well known to initiate 
signalling cascades for growth and survival of the developing nervous system via well 
characterized Ras-MAPK, PLOy and PI3K signalling cascades (Obermeier et al. , 1993b; 
Stephens et al., 1994). Functions of p75NTR, the low affinity pan-neurotrophin receptor 
have been extensively investigated (Reviewed in Blochl and Blochl, 2007; Roux and 
Barker, 2002), and this receptor is recognized to participate in a multitude of functions 
which are often paradoxical in nature and can involve promotion of survival or apoptosis, 
and the promotion or inhibition of neurite growth depending upon cellular context. This 
pleiotropic receptor can signal in ligand-dependent and ligand-independent fashion, and 
the outcome is dependent upon activation status of a variety of co-receptors, including 
TrkA, thus the contribution ofp75NTR to regenerative growth is far less clearly 
delineated. 
It is well recognized that NGF upregulates p75NTR expression in multiple neuron 
types in vivo (Lindsay et al. , 1990) and in vitro (Kitzman et al., 1998; Wyatt and Davies, 
1993), and in PC12 cells (Doherty et al. , 1988). The upregulation ofp75NTR is 
associated with both nerve injury and NGF exposure, and induction in the developing 
nervous system is particularly robust in the period preceding target innervations, 
suggesting that the increase in p75NTR expression could be contributing to a neurite 
outgrowth response both during development and following injury (Goettl et al. , 2004; 
Wyatt and Davies, 1993). Thus the mechanism of p75NTR upregulation could be critical 
to the regenerative response. In my initial studies, I investigated whether the individual 
phosphorylation sites present on the cytoplasmic tail of TrkA, and their associated 
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signalling cascades, contributed to the regulation of p75NTR expression in both the 
presence and the absence ofNGF. Using a series ofPC12 derivative cell lines expressing 
either no TrkA (PC12nnr5 cells) or TrkA mutated to eliminate Y490, Y785 or both 
tyrosine phosphorylation sites of the TrkA cytoplasmic tail, I demonstrated that 
constitutive p75NTR expression was significantly reduced in the absence ofTrkA 
expression, and could be restored to different degrees by the introduction of TrkA 
mutated to abrogate Y490 or Y490/785, but not by introduction ofTrkA mutated to 
abrogate Y785 (Figure 2.1 ). I further demonstrated that exposure of these PC 12 
derivatives to NGF resulted in increased p75NTR expression only in those cells 
expressing TrkA with a functional Y785 phosphorylation site. Only the parental line and 
the derivative expressing TrkA Y490F responded to NGF by upregulating p75NTR 
expression above the unstimulated condition (Figure 2.4). These results suggest that 
p75NTR expression is regulated by TrkA-induced activation ofPLCy, since loss of the 
PLCy interaction site (Y785) resulted in low levels of p75NTR and failure to upregulate 
in response to NGF. This hypothesis was subsequently confirmed in my second study, 
using pharmacological inhibition ofPLCy. PLCy activity results in generation ofiP3 and 
DAG, which subsequently activates a variety of PKC isoforms. PKC8 is of particular 
importance to neurite outgrowth in PC12 cells (Corbit et al., 1999) and has previously 
been associated with the induction ofp75NTR in response to hypo-osmolarity (Peterson 
and Bogenmann, 2003). Its importance in p75NTR induction in response to neurotrophin 
stimulation was confimed using pharmacological inhibition and siRNAs (Figure 3.6). 
Thus, NGF stimulation acts via TrkA Y785 phosphorylation to initiate PLCy-PKC8 
signalling resulting in the upregulation ofp75NTR. 
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One of my goals for this project was to apply signalling for the promotion of 
successful PNS regeneration to CNS neurons, and determine if similar effects are elicited. 
Neurotrophins can also promote the extension of CNS axons, and are especially adept at 
encouraging growth into grafted tissue to help overcome graft-host barriers when tissue 
grafts are employed (Menei et al. , 1998; Xu et al. , 1995a). I sought to translate my 
findings related to NGF-induced upregulation ofp75NTR into CNS neurons, specifically 
CGN. CGN do not express the NGF receptor, TrkA, but do express the BDNF receptor, 
TrkB. All Trk isoforms activate a similar sequence of signalling events (Atwal et al. , 
2000; Middlemas et al. , 1994; Yuen and Mobley, 1999; Zirrgiebel et al., 1995) and in 
fact, I demonstrated that BDNF stimulation ofTrkB appears to act via PLCy-PKCo 
signalling cascade to upregulate p75NTR in CON (Figure 3.9). 
Trk and p75NTR are coexpressed throughout much of the nervous system; 
typically cells that express both receptors display 10 fold more p75NTR than Trk (Chao 
and Hempstead, 1995). While p75NTR can signal autonomously, coexpression with Trk 
allows these receptors to functionally interact resulting in reciprocal modulation of 
function. As such, p75NTR is appreciated to enhance the function ofTrk on multiple 
levels. p75NTR collaborates with Trk to alter cellular response to neurotrophins: its 
presence is found to increase the rate ofNGF binding and retrograde transport, enhance 
Trk responsiveness when ligand levels are low, and increase the specificity of ligand-
receptor interactions (Bibel et al. , 1999; Clary and Reichardt, 1994; Hantzopoulos et al., 
1994; Verdi et al., 1994). p75NTR has also been demonstrated to enhance the 
phosphorylation of Trk and its downstream intermediates, including She (Berg et al. , 
1991; Epa et al. , 2004 ), and can influence the kinetics of Trk ubiquitination and 
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internalization to prolong signalling (Arevalo et al. , 2006; Geetha et al. , 2005 ; Makkerh et 
al., 2005). Much of this collaboration has long been believed to be due to p75NTR 
assisting in the formation ofhigh affinity binding sites (Hempstead et al. , 1991), a 
concept recently challenged by structural models and biochemical data that preclude the 
formation ofp75NTR-Trk heterodimers (Wehrman et al. , 2007). p75NTR may instead 
bind neurotrophin, concentrate it at the cell surface and pass it to Trk in an appropriate 
conformation for binding (Barker, 2007). Furthermore, the binding ofNGF to p75NTR is 
sufficient to negate the constitutive activation of Rho, thereby removing a second form of 
growth inhibition (Yamashita et al., 1999). Hence the upregulation of p 7 5NTR in 
response to neurotrophin stimulation may be contributing to amplification of the growth 
response by creating a positive feedback loop to enhance Trk signalling for growth and 
survival in the presence of its cognate ligand (see schematic Figure 10.1). In support, 
studies examining p75NTR upregulation after PNS injury demonstrate that liganded 
p75NTR can promote survival and regeneration, whereas unliganded p75NTR induces 
apoptosis (Sorensen et al., 2003) and complexes with NgR to activate Rho and inhibit 
growth. My results are also consistent with the observed modulation ofp75NTR during 
development of the nervous system. In the period just preceding target innervation, final 
target derived neurotrophin (NGF) induces p75NTR expression in sympathetic neurons to 
decrease their sensitivity to NT3 (Kuruvilla et al., 2004). p75NTR expression levels are 
central to the regulation of neuronal survival and axonal growth in response to target 
derived neurotrophin and subsequently regulate innervation density in the developing 
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Figure 10.1 Schematic illustration of proposed positive feedback model. The addition 
ofNGF to PC12 cells in culture activates two structurally distinct receptors, p75NTR and 
TrkA. Neurotrophin binding to p75NTR disengages the constitutive activation of Rho, 
which promotes neurite outgrowth. Binding ofTrkA by NGF results in phosphorylation 
of the cytoplasmic tail which initiates specific signalling cascades. The present studies 
demonstrate that Trk ligation and subsequent PLCy-PKC& signalling upregulates p75NTR 
expression, and I speculate that this also promotes neurite growth by enhancing the 
function of TrkA. 
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nervous system, as increased p75NTR can induce apoptosis of those neurons unsuccessful 
at obtaining appropriate neurotrophin support (Kuruvilla et al., 2004). Recently a concept 
of axon pruning was described wherein competing sympathetic axons secrete BDNF in an 
activity dependent fashion which selectively binds p75NTR to eliminate less active 
neurons (Singh et al. , 2008). Elucidation ofthe mechanism ofp75NTR upregulation 
provides insight into the regulation of essential biological processes and may yield 
additional insight into the process of neuronal degeneration since injury, stress and 
pathology are also recognized to upregulate p75NTR (Dechant and Barde, 2002; Schor, 
2005). 
10.2 Role of ECM in enhanced regenerative growth 
While my initial studies indicated that the presence of neurotrophin up regulated 
p75NTR expression, which I speculate would result in enhanced Trk-induced signalling 
for growth, it is likely that multiple factors are required to realize optimal regenerative 
growth. A second factor well recognized to promote regenerative axonal growth is a 
permissive ECM, including LN, found in abundance in the PNS (Lentz et al. , 1997). 
ECM cues are mediated by integrin heterodimers which aggregate upon ligation exerting 
direct control over the actin cytoskeleton, as well as initiating biochemical signalling 
cascades. Integrin signalling has emerged as a key modulator of regenerative growth, and 
integrin ligation can promote a growth response in PNS neurons in the absence of 
additional neurotrophin support (Tucker et al. , 2005; Tucker et al. , 2006; Tucker et al. , 
2008). Furthermore, integrin signalling can potentiate growth promotion induced by 
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neurotrophin stimulation, synergistically or cooperatively activating pathways necessary 
for growth (Tucker et al. , 2005; Tucker et al., 2006; Tucker et al., 2008). 
My third study examined the contribution of the ECM component LN to 
regenerative growth of a sympathetic neuron model. I demonstrated that both LN and 
NGF are capable of independently eliciting growth from PC 12 cells, but the combination 
of both stimuli promotes more robust response than either alone (Figure 4.1 ). Because 
ECM proteins and neurotrophins utilize similar intracellular signalling pathways to 
promote axon elongation, my initial investigations focused on enhanced activation of 
intermediates of known importance to sympathetic neurite growth, including ERK. I 
determined that LN was able to phosphorylate ERK autonomously, but also contributed 
to the enhanced phosphorylation noted in response to co-stimulation with NGF. 
Manipulation of ERK phosphorylation using constitutively active or dominant negative 
Ras constructs promoted and inhibited growth ofPC12 cells, respectively (Figure 4.2). 
Since my initial studies indicated that NGF potentially enhances growth by 
increasing p75NTR expression, I speculated that LN might have similar effects on 
p75NTR expression, since LN associated signalling intermediates are reported to 
phosphorylate PKC8 (Parekh et al., 2000; Steinberg, 2004). The consequently enhanced 
Trk activation could provide an explanation for enhanced phosphorylation ofERK. 
Interestingly, I found the opposite: both Western blotting and quantitative PCR revealed 
that the LN substrate was associated with significantly decreased p75NTR expression 
(Figure 4.3, 4.4), and in fact, the overexpression ofp75NTR in the absence ofligand 
resulted in impaired growth on LN (Figure 4.6). This effect on neurite outgrowth may be 
due to the influence ofp75NTR on the activation of Rho, a known modulator of 
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cytoskeletal dynamics which is well recognized to inhibit neurite extension when 
activated. p75NTR constitutively activates Rho (Yamashita et al. , 1999), and p75NTR 
siRNA has been demonstrated to decrease active Rho resulting in the promotion of 
neurite outgrowth (Ahmed et al. , 2005). I therefore investigated LN and p75NTR effects 
on Rho activity to determine if this was in fact valid in this scenario. I determined that 
the LN substrate was associated with a decreased level of active Rho, and the 
overexpression ofp75NTR resulted in an increased level of active Rho (Figure 4.7), 
thereby elucidating a mechanism for the effects ofunliganded p75NTR on modulation of 
the cytoskeleton required for neurite outgrowth. Thus I concluded that LN is able to 
enhance growth, in part by diminishing the expression of a potentially inhjbitory receptor, 
p75NTR. This decrease in p75NTR may result in decreased Rho activity, but I also 
speculate it could result in decreased transduction of inhibitory signals from myelin 
associated proteins that bind co-receptor NgR. As p75NTR has both ligand-dependent 
and independent signalling, its role in the growth response is largely unclear and is often 
cell type and context dependent. Blocking p75NTR has been shown to promote growth 
in several scenarios, generally those in which myelin inhibition and activation of Rho 
directly inhibit growth (Ahmed et al. , 2005; Gehler et al., 2004; Higuchi et al. , 2003a). 
LN can override inhibitory actions of myelin and CSPGs on CNS neurons, likely by 
manipulating Rho activation, which may occur via decreased p75NTR expression. 
Within this study, I further determined a mechanism for integrin-mediated 
regulation of p75NTR (see schematic Figure 1 0.2). A previous report indicated that 
PTEN overexpression in PC12 cells resulted in decreased p75NTR expression (Musatov 
et al., 2004). This study, combined with my own observations and the emerging role for 
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Figure 10.2 Model of LN-induced signalling cascade. LN binding to integrin receptors 
promotes neurite growth and motility. Integrin signalling through F AK, Src and ILK, and 
the downstream induction of transcription factor Egr-1 results in the upregulation of 
PTEN. PTEN translocates to the nucleus where it decreases the DNA binding ability of 
Spl , resulting in decreased transcription ofp75NTR. As p75NTR constitutively activates 
Rho, decreased p75NTR expression results in decreased Rho activity which promotes 
neurite outgrowth. Furthermore, LN signals result in the phosphorylation of ERK, which 
promotes growth in PC12 cells and sympathetic neurons. LN is also associated with 
enhanced MMP activity, possibly contributing to the decrease in p75NTR expression, and 
the decrease in p75NTR could further enhance growth by reducing the transduction of 
myelin associated inhibition. 
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PTEN in the development of the nervous system (van Diepen and Eickholt, 2008) led me 
to investigate a possible role for PTEN in this signalling cascade. I determined that LN 
substrate upregulated PTEN expression in an integrin-dependent manner (Figure 4.9), and 
used PTEN siRNA and overexpression techniques to demonstrate a consistently inverse 
relationship between PTEN and p75NTR expression (Figure 4.11). Furthermore, PTEN 
siRNA impaired neurite extension in response to a LN substrate. 
A more detailed investigation of the relationship between PTEN and p75NTR was 
performed to establish if there was a direct relationship or simply a correlation between 
expression levels. As PTEN has the ability to dephosphorylate both lipid and protein 
substrates, I used a series of mutated PTEN constructs to establish which of these 
phosphatase activities was responsible for the downregulation ofp75NTR expression. I 
hypothesized that the lipid phosphatase activity could be negatively impacting the PLOy 
signalling previously established to upregulate p75NTR. However, I again demonstrated 
the opposite was true: while the overexpression of a phosphatase-dead PTEN (C124S) 
had no impact on p75NTR expression, the overexpression of either the wild-type PTEN 
or a mutant version that is devoid of lipid phosphatase activity but retains protein 
phosphatase activity (G129E) both resulted in decreased p75NTR expression levels 
(Figure 7.1 ). These results suggested the protein phosphatase activity of PTEN was 
responsible for modulation ofp75NTR expression. 
While the protein phosphatase activity ofPTEN is far less studied than the lipid 
phosphatase activities, a few protein substrates have been demonstrated to be 
dephosphorylated by PTEN. Of interest to my studies was the report that PTEN could 
dephosphorylate FAK and She (Tamura et al. , 1998), which was associated with impaired 
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migratory abilities of fibroblasts. My results, however, indicated that the LN substrate 
was associated with increased phosphorylation ofF AK (data not shown) despite 
enhanced PTEN expression, and we were further unable to detect any impact of PTEN 
overexpression on the phosphorylation ofF AK. Therefore, while the concept of 
dephosphorylating F AK is attractive, as focal adhesion turnover is necessary for the 
extension of axons and cell migration, it is not necessarily the case in this system, and 
may require further analysis to determine if it is occurring in a spatially localized manner 
and thus undetectable by Western blotting. 
In an attempt to determine where PTEN was localizing, I performed 
immunocytochemistry, which revealed a large number of cells that appeared to have 
PTEN localized to the nucleus on the LN substrate, but not on the PL substrate (Figure 
7.2). Nuclear PTEN has become a well-documented phenomenon (Barker, 2007), despite 
the absence of a canonical nuclear localization sequence. It is instead reported that PTEN 
enters the nucleus either via passive diffusion, or through calcium dependent association 
with a major vault protein that acts as a carrier (Chung et al., 2005; Liu et al. , 2005; 
Minaguchi et al., 2006). Nuclear PTEN is notably increased during neuronal 
differentiation (Lachyankar et al., 2000) and several functions for the nuclear pool of 
PTEN have been proposed: as nuclear PIP3 appears to be insensitive to PTEN (Lindsay et 
al., 2006), alternate demonstrated functions include maintenance of chromosomal 
integrity (Shen et al., 2007), protein-protein interactions to stabilize p53 (Li et al. , 2006; 
Lian and Di Cristofano, 2005) and a clear influence over transcriptional activities. In this 
regard, transcription factor, Sp 1, represents another protein substrate demonstrated to be 
dephosphorylated by PTEN (Kang-Park et al. , 2003). Since Spl is reported to upregulate 
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p75NTR expression under conditions of hypo-osmolarity (Ramos et al., 2007), and LN is 
reported to decrease Spl activity (Gaudreault et al. , 2007), the effect ofPTEN on Spl 
phosphorylation was potentially of key importance to this mechanism. As the 
phosphorylation status of Sp 1 is a critical regulator of its DNA binding ability (Bouwman 
and Philipsen, 2002; Li et al., 2004), I used EMSA and ChiP assays to demonstrate that 
both the LN substrate and PTEN overexpression decreased the ability ofSpl to bind to 
the p75NTR promoter (Figure 7.4), which results in decreased transcription (Figure 4.4) 
and the ultimate downregulation of p75NTR protein expression. Thus it appears that LN-
induced PTEN can decrease the ability of Spl to transcribe p75NTR, and I speculate that 
this is occurring by dephosphorylation of Sp 1, though I have not shown this. Of note to 
my earlier studies, PKC has been demonstrated to phosphorylate Spl (Kang-Park et al., 
2003), thereby increasing its DNA binding ability, and thus providing a potential 
mechanism for the upregulation ofp75NTR in response to neurotrophin stimulation. 
These studies established both a novel role for PTEN in the regulation ofp75NTR 
expression and neurite outgrowth, and a novel mechanism for the regulation ofPTEN, an 
important tumour suppressor with functions well beyond the nervous system. Questions 
remain as to the physiological signals which regulate PTEN localization, as well as 
stability and activity and these areas require additional investigation. Furthermore, Spl is 
a highly prevalent transcription factor which controls the expression of several genes. 
There is the distinct possibility that PTEN regulation ofSpl DNA binding ability has 
broader downstream implications that also warrant further investigation. 
Both in its role as a tumour suppressor and a PBK antagonist, PTEN is associated 
with impaired survival (Li et al. , 1998a; Toker and Newton, 2000). The lack of apoptosis 
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observed on a LN substrate can partially be explained by the compensatory upregulation 
oftotal Akt, but may also be reconciled by examination ofPTEN phosphorylation. In 
order for PTEN to act as a lipid phosphatase and antagonize PI3K to impair the 
phosphorylation of Akt and downstream survival signals, it must be present in an active 
form. Phosphorylation ofS380, T382 and T383 residues of the C-terminus renders PTEN 
catalytically inactive against lipid substrates (Odriozola et al., 2007), and thus unable to 
negatively impact the phosphorylation of Akt. In contrast to PTEN induction by noxious 
stimuli, PTEN induced by integrin activation is largely phosphorylated as detected by an 
antibody against phosphorylation of S3 80 on a Western blot (see preliminary data in 
Figure 1 0.3). While the ratio of phosphorylated PTEN to total PTEN is not significantly 
different between the PL and LN conditions, the fact that the induced PTEN is present in 
a phosphorylated state ensures that there are no negative survival-related consequences 
associated with the upregulation ofPTEN. The impact of phosphorylation on protein 
phosphatase activity of PTEN remains to be determined, but our data would suggest that 
it remains functional. In addition to inhibiting PTEN activity directly, the 
phosphorylation of the C-terminus is also required for stability of the protein and may 
impact its ability to associate with other proteins or localize (Tolkacheva et al. , 2001 ; 
Vazquez et al. , 2001 ; Vazquez et al. , 2000). The phosphorylation of particular sites of the 
C-terminus is due to the actions ofkinases CK2 and PICT-1 (Okahara et al., 2006; Torres 
and Pulido, 2001; Yim et al., 2007). Further investigation into the impact of integrin 
activation on these kinases may yield additional insight into the regulation ofPTEN 
activity, expression level and localization, and whether the outcome involves apoptosis or 
growth. As well, stimuli necessary for autodephosphorylation ofPTEN and the 
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Figure 10.3 PTEN induced by integrin activation is phosphorylated on Ser 380. A) 
Cells plated on PL vs LN for the indicated period of time were harvested for protein 
analysis. Results indicate that the LN-induced PTEN is highly phosphorylated on S380 
as early as lh post LN exposure. B) A comparison ofPC12 vs nnr cells subjected to 
short-term (10 min) stimulation with NGF, LN, or both, reveals no influence of these 
stimuli on the phosphorylation ofPTEN, but does reveal that the nnr cells, which express 
constitutively higher PTEN, also have constitutively higher level of phosphorylated 
PTEN. 
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identification of other phosphatases that could regulate PTEN phosphorylation status 
remain undetermined. 
Again, one of the main objectives of this project was to elucidate signalling 
mechanisms induced by the extracellular environment to promote successful axonal 
regeneration in PNS neurons and translate these findings into CNS neurons to determine 
if similar signalling mechanisms can be exploited to promote regenerative growth in the 
CNS. For this reason, I analyzed the presence of this LN-mediated cascade in primary 
neonatal hippocampal neurons and determined that LN was able to induce similar 
changes in PTEN and p75NTR, which were again associated with enhanced neurite 
outgrowth (Figure 4.14). This may indicate a role for LN-induced signals in hippocampal 
development. Whether or not this cascade could be utilized to promote regenerative 
growth after injury in the CNS warrants further investigation. I have also analyzed the 
presence of this LN-mediated cascade in primary CGN, where I determined that while a 
similar signalling cascade exists (Figure 6.1 ), it persisted beyond the establishment of 
axonal outgrowth, but notably ceased in correlation with the temporal period of 
developmental migration (Figure 6.3), suggesting perhaps another function for this LN-
induced signalling cascade. 
10.3 Regulation of PTEN-p75NTR signalling for migration 
There is vast overlap between the processes of cytoskeletal remodelling that apply 
to both growth and motility. In fact, integrin signalling is key to cell migration, and the 
manipulation of Rho activity is well recognized to influence both neurite growth and 
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motility (Moissoglu and Schwartz, 2006; Ridley et al., 2003). Furthermore, previous 
studies have determined that PTEN and p75NTR have roles in proper lamina formation 
and foliation of the cerebellum respectively (Backman et al. , 2001 ; Groszer et al. , 2001; 
Kwon et al. , 2001; Marino et al. , 2002; Nayeem et al. , 2007), which are both processes 
dependent upon appropriate migration. For these reasons, I developed a novel motility 
assay that would allow the quantitative study of population movement across an applied 
LN substrate (Figure 5.1), and subsequently utilized this assay to investigate the 
contributions ofPTEN, p75NTR and Rho to LN-induced migration ofCGN. I 
demonstrated that manipulation of any one of these pathway components can influence 
motility: PTEN siRNA and p75NTR overexpression each inhibit cell migration (Figures 
6.5, 6.6), whereas Rock inhibition can both promote migration and rescue the migratory 
defects imposed by the aforementioned treatments (Figures 6.7, 6.8). LN is well 
recognized for its role promoting growth and migration in the developing cerebellum. As 
such, this signaJiing cascade could be crucial to the development of appropriate cerebellar 
architecture. 
The influence of PTEN on cell migration appears to be cell type specific. PTEN 
has been shown to suppress migration of a variety of cell types, as genetic ablation of 
PTEN enhances the migration of mouse embryonic fibroblasts and PTEN reconstitution 
or overexpression can inhibit the migration of fibroblasts and various tumour cells 
(Liliental et al., 2000; Lim et al., 2004; Suzuki et al. , 2003). Interestingly, the ability of 
PTEN to impair migration is often linked to its protein phosphatase activity (Leslie et al. , 
2007) and proposed mechanisms include effects on small G proteins (Liliental et al. , 
2000) and the direct dephosphorylation ofFAK (Tamura et al., 1998). However, PTEN 
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deletion has no impact on levels of phosphorylated F AK and an independent study could 
not demonstrate PTEN-F AK interaction or F AK dephosphorylation upon PTEN 
overexpression (Maier et al., 1999; Sun et al., 1999). Nonetheless, selective genetic 
deletion ofPTEN in the cerebellum results in animals that display CGN ectopia, distorted 
foliation and architectural abnormalities typically attributed to poor migration (Backman 
et al., 2001; Groszer et al., 2001; Kwon et al., 2001; Marino et al. , 2002; Nayeem et al., 
2007). This suggests that PTEN is critical for the promotion of appropriate CGN 
migration during development. 
10.4 Regulation of PTEN expression 
Since PTEN appears critical for the regulation of cytoskeletal remodelling for 
growth and migration, my final studies examined the modulation of PTEN expression. 
Having established previously that Trk modulates p75NTR expression in both the 
presence and absence of ligand, and that PTEN is of key importance to ECM-mediated 
regulation ofp75NTR expression, I sought to determine if these two seemingly 
independent signalling cascades intersected upstream ofp75NTR transcription. I 
previously demonstrated that LN-induced PTEN upregulation had no effect on Trk.A 
expression, and thus speculated that Trk.A may modulate the expression level ofPTEN. I 
was able to show that Trk.A reconstitution in Trk-deficient cells (PC12nnr5) resulted in 
decreased PTEN expression (Figure 8.1), and that Trk.A inhibition using K252a or 
antisense oligonucleotides resulted in increased PTEN expression in a temporally 
appropriate timecourse for downstream regulation ofp75NTR. Furthermore, the Trk.A 
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mutations eliminating phosphorylation sites on the cytoplasmic tail also altered PTEN 
expression (Figure 8.2) in a manner inverse to that previously noted for p75NTR (Figure 
2.1). Specifically, loss ofTrkA or just the Y785 phosphorylation site resulted in 
significantly elevated PTEN levels. Conversely, loss of the Y490 phosphorylation site 
resulted in no detectable PTEN protein expression. Y 490F results in the inability to 
activate the Ras-MAPK signalling cascade. Previous studies have linked activity of the 
Ras-MAPK cascade with aberrant downregulation ofPTEN in epithelial and fibroblast 
cells types, as well as in particular cancers (Chow et al., 2007; Vasudevan et al. , 2007); 
all systems in which PTEN is able to prevent cell migration and invasiveness. It would 
appear the neuronal response is again opposite to that of cancer, as loss of the Ras-MAPK 
pathway is associated with significant downregulation ofPTEN and loss ofPTEN is 
associated with impaired ability to migrate across a LN substrate. 
I further demonstrated that this lack of detectable PTEN expression associated 
with the Y490F mutation was associated with an inability to modulate p75NTR (Figure 
8.3) or Rho activity (Figure 8.4) in response to a LN substrate, and a resultant poor 
growth response (Figure 8.5). In contrast, the Y785F mutation resulted in very high 
PTEN expression and a robust response to LN in terms of both growth and motility. 
TrkA modulation ofPTEN in the absence ofligand may be due to constitutive low 
level activation of the receptor and its associated pathways, a common phenomenon when 
TrkA is overexpressed (Leoni and Valtorta, 2002). I demonstrated previously that the 
addition ofNGF to cultures had no impact on PTEN expression at 24h. However, Trk 
activation is reported by others to have longer term effects on PTEN expression (6-8 
days) (Lachyankar et al., 2000) consistent with the idea that low level activation is 
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affecting a response which gradually amplifies over time. Either way, it is clear that Trk 
exerts a modulatory influence over PTEN expression which may ultimately dictate 
constitutive levels of p75NTR expression. Unravelling the signalling cascades 
responsible for the Trk-induced modulation ofPTEN requires further investigation (see 
schematic Figure 10.4). 
I have further shown that PTEN expression is also regulated by the ECM. As the 
ECM clearly regulates PTEN expression resulting in downstream influence over 
cytoskeletal remodelling for neurite outgrowth, the ultimate goal was to characterize all 
the signal transduction steps arising from receptor-ligand interaction that culminate in a 
direct effect on the cytoskeleton. Towards this end, I investigated the mechanism by 
which LN induced the upregulation of PTEN by downstream activation of integrin 
associated signalling intermediates. I began by establishing that low concentrations of 
LN (1 J..lg/mL) could induce maximal induction ofPTEN (Figure 9.1) and demonstrated 
that increased PTEN protein is evident by 1 h post-stimulation likely due to rapidly 
increased transcription (Figure 9.2). The ability of LN to upregulate PTEN is not specific 
to neurons or neuronal cell lines, nor is it specific to LN. I demonstrate that exposure to a 
variety of integrin-activating substrates upregulated PTEN expression and subsequently 
downregulated p75NTR expression. Cells appear able to respond to any substrate for 
which they express the appropriate integrin heterodimers to recognize, as each of these 
substrates, LN, MG, Col, FN, were able to induce PTEN upregulation (Figure 9.4). This 
did not however extend to all substrates. Exposure of PC 12 cells to inhibitory substrates 
including CSPG-A and CSPG-C did not induce PTEN upregulation and did not impact 
p75NTR expression (see preliminary data Figure 10.5). It would be interesting to see 
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Figure 10.4 Schematic illustration of role of TrkA in the regulation of PTEN and 
p75NTR expression. TrkA overexpression results in the downregulation ofPTEN, 
possibly due in part to the constitutive activation of the receptor frequently noted in cases 
of overexpression. As loss of the Y785 phosphorylation site is associated with an 
increase in PTEN, this suggests a role for PLCy signalling in the suppression ofPTEN. 
Earlier results demonstrate that PLCy-PKC8 is associated with an upregulation of 
p75NTR in response to neurotrophin stimulation. 
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Figure 10.5 A chondroitin sulfate substrate does not induce PTEN expression. PC12 
cells cultured on CSPG-A or CSPG-C for 24 h did not upregulate PTEN expression (A) 
or downregulate p75NTR expression (B) relative to a PL control substrate. Values 
represent the mean of 3 independent experiments+/- SEM, relative to actin. 
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how PC12 cells respond to myelin substrates in terms ofPTEN-p75NTR regulation, as 
well as the impact of myelin on the phosphorylation status ofPTEN C-terminus, as 
phosphorylation is crucial to regulating PTEN stablility and catalytic activity. 
Since integrin ligation results in the formation of focal adhesions and the 
activation of biochemical signalling cascades regardless of ligand:heterodimer 
interaction, this suggests that focal adhesion components may be involved in signalling 
for the induction ofPTEN. I show that this is indeed the case, as inhibition ofSrc using 
PP2 inhibited the induction ofPTEN on LN in a dose-dependent manner (Figure 9.5). 
Furthermore, inhibition ofF AK or ILK using dominant negative constructs yields a more 
modest impairment ofPTEN induction (Figures 9.6, 9.7), but this may be due to 
interactions within the focal adhesion that promote or inhibit the activity of other focal 
adhesion components, or it may be a direct impact on the PTEN induction cascade; this 
remains to be determined. 
LN is associated with the induction of transcription factor, Egr-1 in several model 
systems, including vascular smooth muscle cells and synoviotes (Morawietz et al. , 1999; 
Warstat et al. , 2008). This appears to be the case in PC12 cells as well, as LN induces 
increased Egr-1 expression in wild type and Y785F cell lines, but not in the Y 490F line 
(Figure 9.8). Egr-1 is reported to activate rapidly upon stimulation and induces PTEN 
expression in response to UV irradiation, a response lost in Egr-1 knockout mice (Virolle 
et al., 2001). The induction ofEgr-1 in our model system correlates with PTEN 
expression levels, and Egr-1 siRNA was sufficient to prevent the induction of PTEN in 
response to LN exposure (Figure 9.8). These results suggest that LN signalling through 
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integrin focal adhesion components, Src, F AK and ILK results in the rapid activation of 
Egr-1 which in turn induces PTEN upregulation (see schematic Figure 10.1). 
The regulation of PTEN expression is vastly understudied. PTEN is a non-
redundant protein whose loss is associated with a variety of human cancers, and its 
regulation is therefore very important and likely tightly controlled. The exact pattern of 
regulation throughout development remains unclear, but it is reported that PTEN is 
transcriptionally upregulated not only by Egr-1 but also by PPARy, p53 and Sprouty2, 
and is downregulated by TGF-P (Edwin et al. , 2006; Patel et al., 2001 ; Stambolic et al., 
2001 ). It would be interesting to determine if any of these other transcription factors have 
a role in LN-mediated induction of PTEN, or if it is solely attributable to the actions of 
Egr-1. Further regulation of PTEN activity is accomplished by phosphorylation, 
acetylation, oxidation and controlled localization (Tamguney and Stokoe, 2007). 
Stability of PTEN protein is also modulated by phosphorylation, but is further subject to 
protein-protein interactions. Notably an interaction between PTEN and MAGI-2 is 
facilitated by focal adhesion component, vinculin, and this is necessary for the prevention 
of PTEN degradation, as vinculin knockout mice display no PTEN protein despite normal 
RNA levels (Subauste et al., 2005). 
The roles ofPTEN in development, normal physiology as well as pathological 
states are just beginning to be unravelled, but an important novel role for PTEN outlined 
in these studies appears to be the regulation ofp75NTR expression, which in turn is key 
to the modulation of cytoskeletal remodelling to promote growth and migration. By 
downregulating p 7 5NTR in the absence of neurotrophins, LN-induced PTEN is acting to 
decrease the presence of a potentially inhibitory receptor, thereby tipping the balance in 
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favour of regenerative growth. Regeneration is more likely to succeed when local 
permissive signals balance and exceed inhibitory signals from the extracellular 
environment. 
Taken together in the context of current literature, my studies collectively suggest 
that p75NTR is emerging as a flexible receptor that can be manipulated, not just 
evolutionarily (Bloch! and Blochl, 2007), but acutely by contextually available external 
cues to achieve cellular goals of growth and motility in both PNS and CNS neurons. 
p75NTR expression is under the control of multiple signalling pathways, the balance of 
which decides the ultimate expression and consequent downstream effects. Both the 
addition ofNGF and the decrease in p75NTR expression exerted by LN ultimately lead to 
the disengagement of Rho activity which promotes cytoskeletal rearrangements necessary 
for growth and migration. The regulation of p75NTR expression levels impacts a variety 
of developmental processes, including innervations patterning and axonal pruning, 
growth and guidance of both developing and regenerating axons. The dysregulation of 
both PTEN and p75NTR expression are key to pathology of various disorders and 
determination of regulatory cascades could lead to the identification of therapeutic 
targets. 
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10.5 Future Directions 
The results of the current studies have further supported the potential importance 
of the extracellular environment on the regulation of axonal regeneration. These findings 
raise the following issues and, among others, impose several intriguing questions: 
1. I have demonstrated that LN-mediated regulation ofPTEN and p75NTR can 
modulate cytoskeletal dynamics to enhance axonal regeneration or motility in a 
sympathetic neuron model, as well as in populations of CNS neurons, including neonatal 
hippocampal neurons and postnatal CGN. However, the outcome of signalling cascades 
is often cell type specific, and it remains unclear if this response applies to all neurons. 
Adult sensory neurons of the DRG are also recognized to respond to LN and NGF 
co-stimulation with enhanced neurite outgrowth resulting from the cooperative signalling 
ofTrk and integrin receptors (Tucker et al., 2005; Tucker et al. , 2006; Tucker et al., 2008) 
and although the role ofp75NTR in mechanisms for this enhanced growth remain largely 
undefined, it is reported that direct and selective activation ofp75NTR impairs 
regenerative growth (Kimpinski et al., 1999). Furthermore, successfully regenerating 
DRG axons have been reported by one group to be devoid of p75NTR expression (Song 
et al. , 2008), and p75NTR siRNA in DRG is reported to decrease the activity of Rho and 
promote outgrowth in the presence of myelin (Ahmed et al., 2005). Conversely, p75NTR 
knockout mice displayed no growth advantage of sensory neurons, but sympathetic 
neurons were endowed with the ability to extend over myelin in response to 
neurotrophins (Hannila and Kawaja, 1999). 
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Preliminary evidence suggests that LN modulation ofPTEN and p75NTR inverse 
relationship and cascade is functional based on quantitative PCR analysis of mRNA 
transcription in the total DRG population (Figure 1 0.6). However, the DRG is comprised 
of multiple subpopulations of sensory neurons which display different growth outcomes 
in response to LN and NGF exposure (Tucker et al. , 2005; Tucker et al., 2006). 
Immunocytochemical analysis reveals different PTEN and p75NTR expression levels 
across populations (Figure 10. 7). While the inverse relationship holds true, the 
populations expressing high PTEN levels do not extend neurites on LN or in response to 
NGF (as they are likely to be GDNF responsive based on IB4+ staining). Cryosections 
and qPCR confirm that those neurons expressing the high levels ofPTEN are in fact the 
IB4+ population (Figure 10.8). Both subpopulations ofDRG are dependent upon PBK-
Akt signalling for growth (Tucker et al., 2005; Tucker et al. , 2006). PTEN, by virtue of 
its antagonism of PBK, negatively regulates the Akt cascades and thus impairs growth. 
I have identified different PTEN expression levels between the NGF-responsive 
and NGF-nonresponsive populations ofDRG, which suggests an area in which these 
populations differ dramatically. Exploration of this area may yield further insight into the 
signalling that impairs the growth potential of the IB4+ population in response to LN. In 
this regard, PI3K pathway focussed microarray should yield novel insights into the 
intrinsic differences between the populations. 
Importantly, these preliminary results suggest that LN-induced PTEN-p75NTR 
alterations do not promote growth in all neurons for reasons that remain unclear. The role 
of PTEN in the DRG remains unresolved, as does its activation status. If PTEN is 
phosphorylated, presumably it is catalytically inactive against lipid substrates of the 
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Figure 10.6 Evaluation of total DRG mRNA reveals an increase in PTEN and 
decrease in p75NTR in response to a LN substrate. DRG neurons isolated and 
cultured on PL versus LN coated substrates for 48 h were analyzed using real time RT-
PCR to quantitate rnRNA levels. Results demonstrate the LN substrate is associated with 
an increase in PTEN and a decrease in p75NTR, consistent with results obtained for PC12 
cells and CNS neurons. Values represent the mean expression of 3 independent 
experiments +/-SEM, relative to 28S. *p<O.OO 1 (ANOV A). 
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Figure 10.7 Immunocytochemistry analysis reveals differential PTEN and p7SNTR 
expression across DRG populations. DRG neurons were isolated and cultured on PL vs 
LN coated 16 well chamber slides in the presence or absence ofNGF for 24h, prior to 
irnrnunostaining for PTEN (red) and p75NTR (green). Results demonstrate a clear 
inverse relationship between PTEN and p75NTR, as cells that are highly expressing 
PTEN are low in p75NTR and vice versa. Cells expressing high PTEN do not respond to 
either NGF or LN with neurite growth, leading us to speculate that this represents the 
GDNF-responsive IB4+ population. 
-NGF +NGF 
PL 
LN 
Figure 10.7 
Figure 10.8 IB4+ DRG neurons express high levels ofPTEN. Whole DRG were 
cryosectioned and irnrnunostained in an attempt to determine the biochemical identity of 
those cells expressing high PTEN. A-C) PTEN (red) and p75NTR (green) clearly stain 
individual populations ofDRG neurons. D-F) p75NTR and CGRP costaining reveals 
significant overlap between expression of patterns, as does costaining with RT-97 and 
p75NTR (G-1). However, RT-97 and PTEN did not appear to costain (J-L). M) IB4+ 
DRG neurons were selected using antibody-coated Dyna beads and separated from the 
NGF-responsive population (Tucker et al. 2006) Real time RT-PCR analyses of these 
two individual populations demonstrates that the IB4+ DRG neurons are high in PTEN 
expression relative to the NGF responsive population. 
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PBK -Akt cascade. If it is not phosphorylated, this suggests differential regulation of 
PTEN phosphorylation between the DRG and PC12 cells, which could be due to 
differential kinase or phosphatase activity. Activation status ofPTEN perhaps represents 
an area that could be subject to intervention. 
2. I have thus far provided LN exposure to PC12 cells and assorted neurons in the 
form of a two-dimensional (2D) substrate. It has been suggested that the culture of 
neurons on a 2D tissue culture surface is somewhat artificial, and that the provision of a 
three-dimensional (3D) culture substrate would provide the neurons with a more 
physiologically relevant growth scenario, as the ability of cells to interact with the ECM 
depends on the physical and biochemical characteristics of the particular matrix, as well 
as cellular properties and a 3D substrate may alter contact-dependent signalling elicited 
by the ECM. 
We have started to use synthetic 3D matrices to study signalling. The ultra-web 
synthetic nanofibrillar surfaces used in these experiments were provided by Donaldson 
Company Inc (Minneapolis MN, USA). CGN were plated on either 2D PL-coated tissue 
culture plates, or on uncoated (NANS) or polyamine coated (SANS) 3D nanofibre tissue 
culture dishes and subsequently examined for signalling differences to yield insight into 
environmental conditions required for neurite outgrowth in vivo. Initial investigations 
revealed an upregulation ofPTEN and a downregulation ofp75NTR associated with both 
of the 3D substrates relative to the 2D substrate (Figure 10.9). Subsequent MTT survival 
assays demonstrated enhanced survival associated with the 3D matrices relative to the 2D 
substrate (Figure 10.1 0). The enhanced PTEN expression is therefore not associated with 
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Figure 10.9 A 3D substrate upregulates PTEN and downregulates p75NTR mRNA. 
CGN cultured on 2D tissue culture surface verses 3D NANS or SANS tissue culture 
surfaces for 8DIV were sampled and subjected to real-time RT-PCR to quantify the 
relative mRNA. Results demonstrate that the 3D NANS and SANS substrates were both 
associated with increased PTEN mRNA (A) and decreased p75NTR mRNA (B). Values 
expressed represent the mean of only 2 replicates +/-SEM relative to 28S. *p<0.05 
(ANOVA). 
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Figure 10.10 A 3D substrate is invariably associated with enhanced neuronal 
survival. CGN were cultured on 2D tissue culture surfaces or 3D nanofibre substrates, 
NANS (uncoated) or SANS (polyamine coated) 96 well plates for 8DIV. MTT survival 
assay demonstrates enhanced survival of CGN on 3D substrates relative to 2D substrates 
when substrates are untreated (A), PL-coated (B) or LN-coated (C). Values represent the 
mean survival of 3 independent experiments +/- SEM expressed relative to the control 
condition (2D). *p<0.05, **p<O.Ol (ANOVA). 
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an apoptotic response to the nanofibres, but may instead be associated with enhanced 
growth or motility, both of which warrant further investigation. I have also performed 
ECM pathway focussed microarrays to sample a wider variety ofECM associated 
signalling intermediates, and the preliminary results are displayed (Figure 10.11 ). 
Multiple genes are altered in response to the 2D and 3D substrates, including integrin a5, 
MMP9, and Lamb2 to name a few. 
3. In addition to extracellular factors investigated in these studies, axonal 
regeneration is dependent upon the intrinsic state of the neuron, which is largely 
dependent upon cAMP levels. LN is able to decrease cAMP levels depending upon 
concentration, but notably high intracellular cAMP and laminin-mediated integrin 
activation together result in Rho GTPase dependent growth cone collapse (Lemons and 
Condie, 2006). cAMP is nonetheless recognized to promote growth over inhibitory 
substrates (Bandtlow, 2003; Cai et al. , 2002) suggesting that cAMP acts to either alter the 
reception or interpretation of inhibitory cues. I therefore sought to investigate if cAMP 
could influence the expression ofPTEN and p75NTR. Activation of cAMP in PC12 cells 
using Forskolin (10 J.!M) decreased the expression ofPTEN (Figure 10.12 A) and 
increased the expression ofp75NTR on a LN substrate (Figure 10.12 B). This would 
seem to suggest that decreased PTEN and increased p75NTR elicited by forskolin could 
be involved in the growth cone collapse via downstream regulation of Rho, but obviously 
this requires further investigation. 
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Figure 10.11 ECM array gene expression and representative clustergram from 
CGN cultured on 2D versus 3D substrates. Representative microarray gene expression 
and analysis for CGN before (time 0) and after being plated on 2D PL, 3D NANS or 3D 
SANS substrates for 8DIV. A, A2: Clustergram and microarray ofCGN immediately 
following isolation. B, B2: Clustergram and microarray of CGN plated on 2D PL-coated 
surface for 8DIV. C, C2: Clustergram and microarray ofCGN plated on 3D NANS 
substrate for 8DIV. D, D2: Clustergram and microarray of CGN plated on 3D SANS for 
8DIV. E. Map of gene probes and array locations. 
~ .. .. 
.. , .. .. 
........... 
ot :;. - 3 
Soc-
Ad-• • •t ,. I 
.......... . 
C'"o l -* a _ , ,. ........ ,....., ... ..., 
·-''U"'J! n ua.,1 d -
C ol :3-l. 
~ .... :... 2 
tea•••• 
~ ........ q. 
... ._. I 
·· ~,. ...... .. 
.......,., ... .., 
' 'U<ft.'V- I JI I cc.lt c .. c:c.t 
f'1.11n-..,,. 1 5 1 ~ • C:C-Itctc:cl 
ro"' ••~-•~rec::l tctec:l 
ho .. c Nc-••• > 
......... 
L.- •••- :r_ ,,r_c::ltct-d 
Nc-••• • 
n o • 
MtH t--.> 
. . .... ~ 2_, ,_ , -e~ <""oect 
"" ........ .. 
r cc-••• 
...... ., .. ::z 
.-.. • .-..~ 7 
,.. •••.••• 2 
f'.11tt t t -. I G M••••• a -._ , -...-... .-J acw ... c t 
E 
Ppa 
C"'2 
• 
Col18al 
7 
Col Sal 
25 
Ct<S 
3 
.._, 
m 4 
l tg;J~ 
ltQbS_prt!diet«t 
,..,..,, 
7) 
Mmp16 
61 
~3 
69 
Se~ 
97 
Tgfti 
!OS 
""ml 
1J.J 
Rjj32 
121 
A2 time 0 
• ., 0 
• 
• 
• • 
0 
• a • 
II 
• 
••-n• 
C2 NANS 
a @ 
• 
•• 
• 
• 
• 
~ 
• 
• a 
• 
• 
•••••••• 
A -mts5 Adarrts8_j)11!(1cted 4 
~ Cd>4 Cd1S_J)'edcted 
10 11 12 
Collal Col27al Cc1Ja1 
18 19 20 
Co!Sa) Cot6aLprctlctad Ccl6e2 
26 27 28 
Qnob1 Qnrdi_peddd Ecml 
14 JS ]6 
Jcaml It-gal ltQillO__pn:!dta«< 
42 43 « 
'':. ltga7 , .... 51 52 
'""' '"'"' '""' 58 59 60 
Lama~ LMna2_sra:ilaed t.ama3 
.. 67 .. 
La<r<l M""W Mmpll 
74 75 76 
P'mp17 _p-edcted MJ'I1)19_ pndcte:l Mnl)la_predcted 
62 83 ...-...--.., 
Mmp7 ~ ~ 90 91 ... Selp 2 98 .. 100 
ThbSl ,_2 Th ... 
l06 107 W6 
1/tn I\JC18 61ank 
l14 liS U6 
""" 
Aldoo A-L22 123 124 
8 2 20 PL 
• .o 
• a 
a • • 
0 
.o 
a 
• • • 
•••••• • 
0 2 SANS 
0 
..  
• 
• • • 
liD Q 
• • 
• 
• 
C.tTe1 anno2.....- 8 CdH • 
O>tn1 CoiUII ?am'f CcHl~l 
J.J 14 15 16 
CdlBl ~·1 CoHII2___sndcted CcMal 
21 22 2l ,. 
Cd7a Lprwftaed Col8al_p-.t1Cted Cd9a1 c.pg2 
29 30 31 32 
Emilinl_Pf9(1C:ted Ettpcn Fblnl_pndiCt.cl Fnt 
]7 3!1 39 40 
ltQall_~t!!d ,..., Ttga3_p-edk'ed ltga" 
45 46 47 •• 
I toad 
,_ 
ltoaf 
'"'"" 53 54 55 56 
, ..... 
'"'"" '""" 
ltgb7 
61 62 63 ~ Utnit4_predlaed LamaS lAfl'OUndcted 
"" 
70 7 
Hf11)12 ,....,pll ~14 
-
77 78 79 80 
~2 M~_p-«<icteci ~23 M"">o 
85 66 7 ~ 8JL 
Ncaml Ncam2 P«am Paru\_precla:ed 
93 .. 95 .. 
Spuc Spod<1 
"""' 
5\<1 
101 
"" 
l03 104 
Tmpl r.,.,2 r.,.,J Tnc 
109 IW Ill 112 
... "' ASIR2 ASlRl AS! 
117 118 119 120 
Gaplh 
-
6AS2C BAS2C 
l25 ,,. 127 128 
Figure 10.11 
Figure 10.12 Elevated cAMP decreases PTEN and increases p7SNTR expression on 
LN. PC12 cells were cultured on LN in the presence or absence ofForskolin (lOJ.LM) , an 
activator of cAMP. Addition offorskolin resulted in decreased PTEN (A) and increased 
p75NTR (B) expression. Values represent the mean expression of 3 independent 
experiments +/- SEM relative to actin. *p<0.05 (ttest). 
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4. There is strength in combining in vitro and in vivo techniques, and validation of 
the in vitro mechanisms presented here could be achieved by investigation of a variety of 
animal models. For example, the study of selective PTEN deletion in the mouse 
cerebellum could determine whether artificial regulation ofp75NTR levels is sufficient to 
rescue architectural defects related to CGN migration, or if PTEN could have effects 
beyond the regulation of p75NTR that influence growth and migration of developing 
neurons. 
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Chapter 11: Summary and Conclusions 
Over the course of this series of studies, I have investigated signalling cascades 
initiated by neurotrophin and ECM stimuli independently and cooperatively in an attempt 
to characterize signalling associated with optimized axonal regeneration. My initial 
studies were all performed in PC12 cells, a sympathetic neuron model, and subsequent 
findings were confirmed in CNS neurons. The results obtained can be summarized as 
follows: 
1. Molecular analysis of a series of PC 12 derivative cell lines expressing either no 
TrkA (PC12nnr5) or TrkA mutated to abrogate Y490, Y785 or both Y490/785 
phosphorylation sites of the TrkA cytoplasmic tail demonstrated a role for TrkA-
associated phosphorylation sites in the regulation ofp75NTR expression in both the 
presence and absence ofNGF. This study demonstrated the critical role of the Y785 
phosphorylation site to the NGF-induced upregulation ofp75NTR, suggesting a role for 
Y785 interacting protein, PLOy. 
2. A more detailed follow up study confirmed that the upregulation ofp75NTR was 
due to the activation ofTrkA by exogenously applied NGF, as selective activation of 
p75NTR itself had no impact on p75NTR expression, despite clear activation of the 
receptor as assessed by phosphorylation of JNK. I subsequently ruled out any 
involvement of the Ras-MAPK or PI3K signalling cascades using pharmacological 
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inhibition. As my initial study revealed an essential role for PLCy interaction site, Y785, 
in the regulation ofp75NTR, I investigated the role ofPLCy and associated downstream 
signalling in the induction ofp75NTR expression in response to NGF stimulation. I used 
pharmacological inhibition of PLCy and both pharmacological inhibition and siRNAs 
against its downstream target PKC& to confirm their involvement in the regulation of 
p75NTR expression in response to NGF stimulation. Finally, I investigated the nature of 
this signalling mechanism in CGN, which express TrkB and TrkC, but not TrkA, and was 
able to confirm that BDNF stimulation acts via TrkB-mediated PLCy-PKC& signalling to 
induce p75NTR upregulation in CGN. These results provide a mechanism for the 
neurotrophin-induced upregulation of p75NTR, which may be of key importance to both 
developmental and regenerative axon growth. 
3. A second factor well recognized to augment the growth response initiated by 
NGF-stimulation is a permissive substrate provided by the ECM. I therefore examined 
signalling initiated by neurotrophin and ECM ligands, both independently and 
cooperatively. As the phosphorylation ofERK is of paramount importance to a neurite 
outgrowth response in PC12 cells and sympathetic neurons, I used Western blotting to 
analyze the impact of individual and co-stimulation on ERK activation, and demonstrated 
that while LN and NGF both phosphorylate ERK, co-stimulation with both ligands results 
in enhanced phosphorylation than either stimulus alone. I further show that manipulation 
of ERK phosphorylation using wild-type or constitutively activated Ras constructs can 
induce neurite outgrowth, while dominant negative Ras is not associated with a growth 
response. 
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Because my initial studies illustrated that alterations in p75NTR expression were 
of potential importance to NGF-mediated signalling, I investigated the influence of LN on 
p75NTR expression. I demonstrate that a LN substrate downregulates p75NTR via both 
transcriptional and cleavage dependent processes, and that this downregulation is 
associated with a decrease in active Rho and enhanced regenerative growth. Conversely, 
overexpression ofp75NTR, either wild-type or tagged, impaired neurite outgrowth on a 
LN substrate, and resulted in sustained Rho activation. The ability of LN to suppress 
p75NTR expression was demonstrated to be integrin dependent and furthermore was 
dependent upon LN-mediated upregulation ofPTEN. PTEN expression displayed a 
consistently inverse relationship with p75NTR expression, and PTEN overexpression or 
siRNA manipulated p75NTR expression inversely. LN-mediated alterations in PTEN 
and p75NTR were further demonstrated to occur independently ofthe presence ofTrkA 
and were correlated with the upregulation of Akt and GSK protein expression. Finally, I 
demonstrate the ability ofLN to alter PTEN and p75NTR expression and promote 
enhanced regenerative growth in neonatal hippocampal neurons. These results 
characterize a novel ECM-mediated regulatory mechanism for both PTEN and p75NTR 
expression and provide evidence that LN promotes neurite outgrowth not only by 
enhancing the activation of signalling intermediates important for growth promotion, but 
also by suppression of a potentially inhibitory receptor, unliganded p75NTR (Figure 
10.2). 
4. Since ECM-integrin ligation and the subsequent manipulation of Rho activity 
could be critical to the promotion of cell migration in addition to neurite outgrowth, I 
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developed a novel assay to allow the study of the movement of a population of cells 
across an applied biological substrate with both qualitative and quantitative outcomes. 
By plating cells in a monolayer on one side of a small coverslip and subsequently 
inverting that coverslip over a LN-coated substrate, I was able to monitor and quantify the 
migration of cells across the LN substrate in the presence or absence of various stimuli or 
inhibitors, or after genetic modifications. 
5. As my previous studies demonstrated that LN-induced alterations in PTEN and 
p75NTR expression could alter Rho activity for the promotion of neurite outgrowth in 
PC12 cells and neonatal hippocampal neurons, I investigated the presence of this cascade 
in CGN. While I discovered LN-induced changes in PTEN and p75NTR expression, and 
Rho activity levels were consistent with my previous findings, and indeed associated with 
early morphological changes, the signalling persisted beyond the period of neurite 
extension. A longer timecourse revealed that the differential expression of PTEN and 
p75NTR on LN versus PL was undetectable by 14 days in vitro, a timepoint correlating 
with the cessation of developmental migration. Motility analyses revealed enhanced 
migration on a LN substrate which correlated with increased PTEN and decreased 
p75NTR expression and again ceased by 14 days in vitro. PTEN siRNA and p75NTR 
overexpression inhibited CGN migration, while inhibition of Rho effector, Rock, both 
enhanced migration and rescued the migratory defects imposed by the aforementioned 
treatments. Based on the data collected, I concluded that LN-mediated PTEN 
upregulation and p75NTR downregulation promotes the migration of postnatal CGN and 
may thus be important to the development of proper cerebellar architecture. 
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6. I have demonstrated that PTEN played a role in the regulation of p75NTR 
expression. I subsequently investigated the mechanism by which this regulation may 
occur. Using a series ofPTEN constructs mutated to eliminate all phosphatase activity 
(Cl24S) or selectively eliminate lipid phosphatase activity while retaining protein 
phosphatase activity (Gl29E), I determined that the ability ofPTEN to downregulate 
p75NTR expression is dependent upon its protein phosphatase activity. 
Immunocytochemical analyses revealed a nuclear localization for PTEN on LN, and 
subsequent EMSA and ChiP analyses of transcription factor Sp 1 activity revealed 
decreased DNA binding to the p75NTR promoter associated with both the LN substrate 
and the overexpression ofPTEN. This mechanism provides an explanation for the 
decreased transcription ofp75NTR. These studies were replicated in CGN with identical 
outcome. These results represent a detailed mechanism for the direct PTEN-mediated 
regulation ofp75NTR expression. 
7. My previous studies demonstrated that both Trk and PTEN play a role in the 
regulation ofp75NTR expression. I therefore investigated if there was any interaction 
between Trk and PTEN. LN-induced PTEN upregulation had no impact on Trk 
expression. Conversely, TrkA reconstitution in Trk-deficient PC12nnr5 cells decreased 
PTEN expression in both the presence and absence ofNGF. Mutation of the individual 
phosphorylation sites on the cytoplasmic tail of TrkA also influenced PTEN expression: 
loss ofTrkA or Y785 site resulted in higher PTEN expression, while abrogation ofY490 
phosphorylation site resulted in undetectable PTEN protein expression, and 10 fold lower 
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mRNA as determined by quantitative PCR. Trk-induced alterations in PTEN impacted 
the ability of the cells to respond to the LN substrate. The Y 490F cell line did not 
downregulate p75NTR or decrease the level of active Rho in response to LN substrate, 
and subsequently displayed impaired growth and motility responses. Conversely Y785F 
cells displayed high PTEN expression and exhibited enhanced growth and motility in 
response to LN, relative to the parental cell line. These results appear to indicate a 
modulatory role for TrkA in the control of PTEN expression, with subsequent 
downstream influence over growth and migration responses, and lead us to conclude that 
the presence ofPTEN protein is critical to the mediation of LN-induced modulation of the 
cytoskeleton in PC 12 cells. 
8. Since I previously demonstrated a role for ECM-integrin ligation in the regulation 
ofPTEN expression, I investigated the kinetics and the mechanism underlying the LN-
mediated induction of PTEN expression. Timecourse and concentration curve 
assessments indicated that PTEN mRNA and protein are induced within an hour exposure 
to LN substrate and that 1 J..Lg/ml LN is sufficient to elicit robust PTEN expression in both 
PC12 cells and CGN. I demonstrate that LN-mediated regulation ofPTEN occurs in 
hepatoma-derived cell lines and is thus not a neuron specific response. We also expand 
our repertoire of substrates to demonstrate that integrin activation following exposure to 
LN, MG, FN or collagen results in PTEN induction, but exposure to CSPGs does not. 
Analysis of signalling intermediates necessary for PTEN induction in response to LN 
revealed roles for Src, FAK and ILK. Finally, LN-induced upregulation oftranscription 
factor Egr-1 appears to play a critical role in this mechanism, as Egr-1 siRNA is sufficient 
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to prevent LN-induced PTEN upregulation. I conclude that the induction ofPTEN is a 
robust response associated with integrin-mediated activation of Src, F AK, ILK and Egr-1 , 
and that by virtue of downstream regulation of p75NTR and Rho activity, these steps may 
be critical components of the LN-induced promotion of axonal regeneration. 
11.1 Conclusions 
To highlight my results, I will conclude by summarizing my findings: 
1. The presence or absence of the individual phosphorylation sites of the cytoplasmic tail 
of TrkA modulates the constitutive expression of p75NTR. 
2. Neurotrophin stimulation acts via TrkA to upregulate p75NTR expression. This 
occurs via the recruitment and phosphorylation of PLCy by phosphorylated Y785 on the 
Trk cytoplasmic tail, which results in the downstream activation of PKCo and the 
subsequent upregulation of p75NTR. 
3. ECM proteins signalling via integrin activation can autonomously activate signalling 
cascades essential for neurite outgrowth, and can cooperate with Trk signalling, resulting 
in enhanced activation of these cascades. 
4. The ECM can act via integrin receptors to downregulate p75NTR expression by 
upregulating PTEN expression. This decrease in p75NTR results in a sustained 
408 
-- ---- -- -- --------------------------------
depression of active Rho, and as such, promotes regenerative growth ofNGF-
differentiated PC12 cells and neonatal hippocampal neurons. 
5. The development of a novel motility assay allowed for the quantitation of migratory 
behaviour of cells plated on an applied biological substrate. 
6. The ECM-mediated regulation ofp75NTR via PTEN regulates the migratory abilities 
of postnatal CGN, and may direct their developmental migration. 
7. LN induces nuclear localization ofPTEN, where it acts to decrease the DNA binding 
ability ofSpl to the p75NTR promoter via a mechanism dependent upon the protein 
phosphatase activities ofPTEN. This decreased binding translates into decreased 
p75NTR transcription, and thereby downregulates p75NTR expression. 
8. Trk.A plays a role in the modulation ofPTEN expression. Trk.A expression inversely 
correlates with PTEN expression and the presence of particular phosphorylation sites on 
the cytoplasmic tail of Trk were able to modulate PTEN expression inversely to 
previously observed p75NTR expression levels. 
9. Trk mutations that decreased the expression ofPTEN impacted the ability ofthe cells 
to respond to LN by decreasing p75NTR and Rho activity, and ultimately determined the 
growth and migratory potential of the cells in response to a LN substrate. 
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10. LN-induced PTEN upregulation occurs rapidly following LN exposure and is 
dependent upon integrin signalling through Src, F AK and ILK, and ultimately depends 
upon the LN-induced alterations in transcription factor Egr-1. 
Overall conclusion: From the results of these studies, I conclude that neuronal cells can 
respond to cues available from the extracellular environment, including neurotrophins and 
ECM molecules and alter p75NTR accordingly to promote an optimized growth response. 
In this way, the regenerative growth response following nerve injury is adaptable to 
context via the modulation ofp75NTR expression, and the subsequent impact on the 
activity of Rho which has direct influence over the dynamics of the actin cytoskeleton. 
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